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ABSTRACT 
 
Background:  
Individuals infected with the human immunodeficiency virus (HIV) are living longer due to effective 
disease management with highly active antiretroviral therapy (HAART). International literature 
suggest that mortality in people living with HIV and AIDS (PLWHA) is shifting to non-AIDS defining 
diseases such as cardiovascular disease. It is suggested that PLWHA are at an increased risk for 
developing ischemic heart disease (IHD) due to HIV mediated processes, traditional risk factors of 
IHD and factors related to HAART exposure. In the South African context risk factors for IHD are 
reported to be on the increase in the general population but published information regarding the 
risk factors for IHD in PLWHA is limited. Human immunodeficiency virus infection is a significant 
Sub-Saharan Africa challenge with 5.26 million people living in South Africa (SA) reported to be 
infected with HIV. Only Swaziland, Lesotho and Botswana report higher prevalence rates of HIV 
infection. Due to the high prevalence rate of HIV in SA, the reported increase in risk factors for IHD 
in the general population and the suggested increased risk for IHD in PLWHA, screening these risk 
factors in PLWHA in the South African context may be necessary. Innovative prevention strategies 
for IHD are also required to manage the risk for IHD in PLWHA in SA due to the high prevalence 
rate. A home-based education and pedometer walking programme could be such a strategy. The 
aims of the research project were therefore firstly to screen selected risk factors for IHD in PLWHA 
attending a primary care clinic and secondly to evaluate said individuals’ self-perception regarding 
their risk of IHD. Lastly the project set out to determine the effects of an individualised education 
and home-based pedometer walking programme on the risk of IHD as a potential prevention 
management strategy for IHD in PLWHA.  
 
Methodology:  
The research project consisted of four studies divided into phase 1 (study 1, 2, 3) and phase 2 
(study 4). The study aims, methods and data analysis approaches were:  
 
Study 1: Aimed to screen a sample of PLWHA (on HAART) for physical activity and selected risk 
factors of IHD using the Yamax SW200 pedometer and other appropriate methods respectively. 
This study was an observational study and data analysis consisted of descriptive analysis and 
reviewing associations with univariate logistic regression analysis. A p–value less than 0.05 was 
considered statistically significant. 
 
Study 2: Aimed to evaluate participants’ self-perception and behaviour in relation to the risk of IHD 
using a semi-structured interview and card sort technique. This study was a qualitative study and 
data analysis consisted of descriptive and conventional content analysis.   
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Study 3: Aimed to develop the education physical activity diary that was used in phase 2. The 
methodological processes included a literature review, a review of the education material to be 
included in the physical activity diary by an academic peer–review panel, review by a clinician 
working with PLWHA and a sample of PLWHA. Following these activities the diary was constructed 
and translated into isiZulu. 
 
Study 4: Aimed to assess the effects of an education and home-based pedometer walking 
programme on the risk factors of IHD in a sample of PLWHA (on HAART) with an increased risk for 
IHD as determined in study 1. The study was a randomised controlled trial consisting of an 
intervention and control group. Assessments were done at baseline, six and 12 months. Control 
participants continued with standard clinic care and were phoned once a month for five months 
during the baseline and six month interval. The intervention participants received a Yamax SW200 
pedometer, an education physical activity diary, individualised walking programme and had once a 
month face-to-face education sessions in the baseline to six month interval. Intervention 
participants were instructed to continue with their physical activity modification programme during 
the six to 12 months period. No contact was made with control or intervention participants during 
this time. Intention-to-treat analysis was the primary approach for study 4. Data analysis consisted 
of descriptive analysis (mean [±SD] and frequencies [percentages]) and randomisation to group 
allocation was assessed using a two sample/ independent t-test or Wilcoxon rank–sum (Mann–
Whitney) for non-normally distributed continuous data. Categorical data were evaluated with the 
Pearson Chi Square test. A p–value less than 0.05 was considered statistically significant. To 
evaluate the effect of time on outcomes assessed, repeated measures ANOVA for within-group 
changes were performed. To evaluate the effect of the programme on outcomes assessed, 
repeated measures ANCOVA with baseline values as co-variates were performed to highlight the 
between-group effect. To assess the associations between dependent variables and the time and 
intervention/control interaction the pedometer data were log-transformed due to skewness. The 
generalised estimation equation (GEE) and mixed effects model (MEM) approaches were used to 
fit the univariate and multivariable models. The correlation structure selected was the 
exchangeable option with the identity link function suitable for Gaussian data.  The relationship 
between high sensitivity C-reactive protein (hs-CRP) at baseline and evaluated risk factors for IHD 
was assessed with the Pearson correlation coefficient and univariate logistic regression in MEM 
respectively on log-transformed hs-CRP.  
 
Results:  
Study 1: Two hundred and five PLWHA (on HAART) were screened for selected risk factors for 
IHD. The demographic characteristics of participants consisted of the following: mean age (38.2 
[±9.5] years), gender (men [n=47; 22.9%] and women [n=158; 77.1%]), most participants had a 
secondary educational level (n=95; 46.3%), were employed (n=115; 56.1%) and were supporting 
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dependents (n=158; 85.4%). The majority of participants perceived their general health as good 
(n=120; 58.5%), but felt their body shape had changed in the last six months (n=123; 60%). This 
was mostly due to a reported increase in weight (n=132; 64.4%). The mean time on HAART was 
8.7 (±2.3) months, with the majority of participants being diagnosed as HIV positive between 2009 
to 2011 (n=134; 66%). The majority of participants were on Lamivudine, Efavirenz and Tenofovir 
(n=139; 67.8%) therapy with a mean CD4 count of 285.1 (±157) cells/mm3 and viral load of 12 
513.2 (±59 710.6) copies/ml. The physical activity levels of participants were reduced with the 
mean pedometer step count per day found to be 7 673.2 (±4 017.7) with men being more active 
(10 076.3 [±4 885.6] steps per day) than women (6 993.3 [±3 462.6] steps per day). The majority of 
study participants (n=150; 77%) took less than 10 000 steps per day. Taking less than 10 000 
steps per day was related to waist circumference (WC) (odds ratio=1.04; 95% CI: 1.00–1.08; 
p=0.03) when adjusted for age and gender. Eight participants (3.9%) participated in formal sporting 
activities that were supervised and 123 participants (60%) tried to incorporate exercise into their 
daily lives. The preferred activity method for exercise was walking (n=56; 45.5%) and running 
(n=33; 26.8%). Perceived stress was moderately high with a mean Cohen’s Perceived Stress 
score at 19.2 (±7.8) with women reporting higher levels of stress (20 [±7.1]) than men (16.9 [±9.1]). 
A family history of IHD was low in participants (n=29; 14.2%) as well as a known diagnosis of 
diabetes mellitus (n=1; 0.005%), hypertension (n=19; 9%) and current smoking status (n=33; 
16.1%). The majority of participants reported not being able to consume fish weekly (n=114; 
55.6%) and reported weekly consumption of fruit and vegetables (n=110; 53.7%). Few participants 
were able to consume three to five vegetables and fruit combined per day (n=68; 33.2%). The 
mean resting heart rate (RHR) of the sample was slightly elevated (82.7 [±11.4] bpm) with having a 
RHR ≥ 80 bpm related to diastolic blood pressure (DBP) (odds ratio=1.07; 95% CI: 1.03–1.11; 
p<0.00) and physical activity (odds ratio=0.99; 95% CI: 0.99–0.99; p=0.02) as adjusted for age and 
gender. The sample as a whole was overweight with a mean body mass index (BMI) of 25.6 (±1.4) 
kg/m2. Having a BMI ≥ 25 kg/m2 was related to systolic blood pressure (SBP) (odds ratio=1.07; 
95% CI: 1.04–1.10; p<0.00), WC (odds ratio=1.34; 95% CI: 1.22–1.46; p<0.00), hip circumference 
(odds ratio=1.53; 95% CI: 1.38–1.75; p<0.00) and CD4 count (odds ratio=1.00; 95% CI: 1.00–1.01; 
p=0.01) as adjusted for age and gender.  
 
Study 2: Thirty PLWHA (on HAART) were purposefully sampled according to the following criteria: 
individuals had to be on HAART for six to 12 months, between the ages of 20 and 65 years and 
ambulatory without an assistive device with no pre-existing history of cardiovascular disease, 
mental illness, current acute infection, current pregnancy or breast-feeding women. The 
demographic details of participants were as follows: median age 36.5 (31.8–45.0) years; women 
(n=25; 83.3%) and men (n=5; 16.7%); the majority of participants (n=16; 53.3%) had a secondary 
school education, were employed (n=17; 56.7%) and were supporting dependents (n=26; 86.7%). 
Knowledge and understanding related to IHD, insight into own risk for IHD and health character in 
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the HIV context were identified as three prominent themes. An important finding that the study 
highlighted was that participants did not perceive themselves to be at risk for IHD due to being 
HIV+ or using HAART in any way. The majority of participants (n=15; 50%) did not perceive 
themselves to be at risk for IHD due to reporting having adequate coping behaviour and living a 
healthy lifestyle. Twelve (40%) participants did however perceive a risk for IHD due to physical 
symptoms experienced and their behaviour consisting of a poor diet, elevated stress levels and 
lack of exercise. Three (10%) participants were unsure concerning their risk for IHD in the future.  
 
Study 3: A selection of pages from the education physical activity diary can be found in Appendix 
31. 
 
Study 4: Eighty four PLWHA (on HAART) participated in study 4.  
The education and home-based walking programme implemented in study 4 was successful in 
improving physical activity levels in both the control and intervention groups, as participants’ 
pedometer-determined step-count increased from baseline. The within-group change at six months 
were statistically significant (p=0.03) for both groups but not so for the 12 month period (control 
group [p=0.33] and intervention group [p=0.21]). It was however of clinical value in the intervention 
group, due to the group exceeding the step count aim of the programme, that being 3 000 steps 
above baseline at each assessment point. Translating the step count into time, would amount to 
approximately 30 minutes of added walking per day. The group therefore reached the Public 
Health recommendations for physical activity. Social support in the form of encouragement, 
motivation and participation from friends and family was noted as important enablers that assisted 
intervention participants to adhere to their programme. 
 
No significant differences were observed in the sociodemographic profile, HIV related clinical 
markers and antiretroviral therapy and IHD risk factors evaluated at baseline. The study highlighted 
that inflammation (hs-CRP) was a significant risk factor for IHD in the study cohort due to mean 
baseline values of 8.6 (±8.4) mg/l in the intervention and 5.4 (±6.5) mg/l in the control group. 
Inflammation (hs-CRP) was related to perceived stress (Pearson correlation [r=0.23; p=0.03] and 
MEM univariate logistic regression [log B=0.04; 95% CI: 0.0004– 0.08; p=0.03]), weight (Pearson 
correlation [r=2.8; p=0.01] and MEM univariate logistic regression [log B=0.02; 95% CI: 0.01–0.04; 
p=0.01]), BMI (Pearson correlation [r=0.35; p<0.00] and MEM univariate logistic regression [log 
B=0.07; 95% CI: 0.03–0.12; p<0.00]), WC (Pearson correlation [r=0.28; p=0.01] and MEM 
univariate logistic regression [log B=0.03; 95% CI: 0.06–0.36; p=0.01]) and hip circumference 
(Pearson correlation [r=0.28; p=0.01] and MEM univariate logistic regression [log B=0.02; 95% CI: 
0.01–0.04; p=0.01]). The risk for IHD according to Framingham Risk Score (FRS) calculation was 
low as baseline FRS points were 3.3 (±6.5) points in the control group and 2.5 (±6.5) points in the 
intervention group.  
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The education and home-based walking programme was effective in increasing physical function 
capacity (six-minute walk test mean difference: 15.70 [±9.33] meters), reducing waist: hip ratio 
(mean difference of -0.003 [±0.01] cm), reducing glucose level (mean difference of -0.12 [±0.09] 
mmol/l) and increasing HDL (mean difference of 0.07 [±0.05] mmol/l) as evaluated during between-
group analysis.  
 
The within-group analysis indicated that a significant reduction in SBP occurred in both groups at 
the six months time period (control group: p=0.03 and intervention group: p<0.00). A slight 
increase in BMI occurred in both groups at the six and 12 month period that were statistically 
significant (p<0.00). A significant reduction in total cholesterol (p=0.04) and LDL (p<0.00) at the 12 
month period were also noted in the control group.   
 
The log-transformed univariate logistic regression model highlighted many associations between 
the interaction (time and treatment: control or intervention group effect) and secondary outcomes 
assessed. The inverse associations between  perceived stress levels (p<0.00) and BMI (p=0.02) 
with the six month time interval of the control and intervention groups compared to baseline control 
findings were confirmed during multivariable analysis in the log-transformed GEE model. 
Additionally an inverse association between perceived stress levels (p<0.00), BMI (p<0.00), LDL 
(p=0.01) and triglycerides (TG) (p=0.01) at the six month time interval of the intervention group 
compared to baseline control findings were confirmed in the multivariable analysis in the log-
transformed MEM model. 
 
Conclusion:  
This project showed that physical inactivity, elevated perceived stress levels, inadequate diet of 
fruit, vegetable and fish intake, elevated RHR, increased BMI and raised hs-CRP were risk factors 
for IHD in the study cohort. These risk factors screened indicated an elevated risk for IHD in the 
future even though the FRS demonstrated a low risk for IHD. An IHD predictive model that 
incorporate hs-CRP when evaluating risk for IHD and which has been validated for use in PLWHA 
is therefore necessary to adequately evaluate the risk for IHD in this population. This is especially 
of relevance in the South African context considering the prevalence of HIV infection in women and 
the association of female gender with hs-CRP as indicated in the literature.   
 
The project highlighted that an elevated stress level was a significant risk factor for IHD in the 
study cohort and was also given as one reason why participants perceived themselves to be at risk 
for IHD. The positive association between perceived stress and hs-CRP was also of value. The 
stress lowering effect of the education and home-based pedometer walking programme was 
therefore of significant importance as it could manage this risk factor. Additionally if stress declines 
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it could potentially also influence hs-CRP in the long term. The study therefore contributes to the 
body of knowledge related to the effects of exercise on psychological parameters in PLWHA.  
 
Additionally the project confirmed that an optimistic bias in individuals living with HIV is present 
regarding their future possibility for developing IHD. Their perception for the risk for IHD did not 
always align with the risk factors present as screened. This might be due to the fair application of 
knowledge related to IHD when evaluating their risk for IHD. It also confirmed that education 
strategies are needed to explain the risk factors for IHD and how HIV infection and HAART 
influence these risk factors of IHD.  
 
Lastly the project found that an education and individualised home-based pedometer walking 
programme was able to influence physical activity levels positively and was successful in reducing 
the risk of some factors for IHD in PLWHA at primary care level. Such a programme can be 
implemented as an innovative method to manage risk factors for IHD in PLWHA by 
physiotherapists especially in regions where physiotherapy numbers are low and HIV prevalence 
high.   
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“Above all else, guard your heart, for it is the wellspring of life.” 
 
(Proverbs 4: 23) 
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CHAPTER 1 
1.  BACKGROUND AND NEED 
 
1.1  INTRODUCTION 
Individuals infected with the human immunodeficiency virus (HIV) are living longer due to 
effective management with highly active antiretroviral therapy (HAART) (United Nations 
Programme on HIV/AIDS [UNAIDS], 2013; Bhaskaran et al., 2008; Palella et al., 1998). 
Sub-Saharan Africa remains the region most affected by the disease, accounting for 24.7 
million people living with HIV (UNAIDS, 2013). The estimated number of people receiving 
HAART in this region increased by 59% (an additional 2.3 million people) between 2010 
and 2012 alone (UNAIDS, 2012). South Africa increased roll-out of HAART by 75% over 
this period, providing 1.7 million people with access to antiretroviral therapy (UNAIDS, 
2012). It is claimed that antiretroviral therapy has saved nine million life-years in sub-
Saraharan Africa, allowing individuals to improve their health and contribute to their society 
(UNAIDS, 2012). With this increased longevity, chronic lifestyle diseases, such as ischemic 
heart disease (IHD), are becoming a greater cause for concern. This is due in part to known 
controllable risk factors for IHD, e.g. smoking, and also to the metabolic effects of HAART, 
e.g., metabolic syndrome (Grinspoon et al., 2008; Jerico et al., 2006; Grinspoon and 
Andrews; 2005; Saves et al., 2003) and viral effects, e.g., increased inflammatory markers 
(Triant et al., 2009).  
 
Ischemic heart disease is a health concern worldwide, and the leading cause of death in 
most First World countries (Lozano et al., 2012; Mackay and Menash, 2004). Globally, IHD 
and stroke combined killed 12.9 million people in 2010, and the ratio of deaths due to IHD 
increased to one in four people in 2010, compared to one in five in 1990 (Lozano et al., 
2012). Globally, the burden of this disease, as reflected by disability-adjusted life years 
(years of life lived with disability), is second only to HIV in men and third, following unipolar 
depressive disorders and HIV, in women aged 15 years and above (Mackay and Menash, 
2004). The greatest burden associated with this disease occurs in developing countries, 
due to epidemiological transition: increased longevity of individuals, urbanization and 
lifestyle changes (Mensah, 2008; Gaziano, 2005). In sub-Saharan Africa, epidemiological 
transition is resulting in an increase in risk factors for IHD, such as hypertension, diabetes, 
overweight/obesity, physical inactivity and dyslipidaemia (Onen, 2013; Danaei et al., 2011; 
Finucane et al., 2011). It is estimated that age-standardised mortality rates for IHD will rise 
by 27% in African men and 25% in women by 2015 in this region (Onen, 2013). It is also 
postulated that by 2030 IHD will be the leading cause of death in low and middle income 
countries (Abegunde et al., 2007).  
2 
 
In the South African context the anticipated burden of cardiovascular disorders is of 
particular concern due to the increased prevalence of lifestyle risk factors, and also to the 
high prevalence of individuals infected with HIV (Mayosi et al., 2009). International studies 
have suggested that individuals infected with HIV are at greater risk of developing IHD than 
those with a negative status (Triant, Meigs and Grinspoon, 2009; Triant et al., 2007; De 
Socio et al., 2007; Currier et al., 2003; Saves et al., 2003). The incidence of IHD among 
young men (before age 34) and women (up to age 44) living with HIV is significantly higher 
than non-infected individuals (Currrier et al., 2003). The prevalence and degree of 
subclinical coronary arteriosclerosis is also greater in young asymptomatic HIV-infected 
individuals than negative individuals (Abbara et al., 2010). Additionally, Triant, Meigs and 
Grinspoon (2009) indicated that the chance of an acute myocardial infarction is four times 
more likely in an individual who is HIV positive with an elevated C-reactive protein level 
compared to a non-infected individual. Lastly, atherosclerotic cholesterol plaque in HIV-
infected individuals has also been reported to be more vulnerable than non-infected 
individuals, which could lead to plaque rupture and an increased risk of myocardial 
infarction (Zanni et al., 2013). As the roll-out of HAART increases in South Africa (SA) the 
disability related to HIV and IHD could escalate and place a significant burden on the 
economy, health services and society. It is therefore important to screen for risk factors for 
IHD and implement interventions where needed to prevent, and possibly reduce, the future 
burden of this disease. 
 
Promoting a healthy lifestyle and prevention of IHD by screening, and thus identifying and 
treating controllable risk factors at primary care level, are recommended as cornerstone 
management strategies in the general population (Mensah, 2008). The American Heart 
Association State of Science conference proposed two broad screening strategies for IHD 
in individuals living with HIV due to their increased risk (Hsue et al., 2008). The first is to 
identify IHD-predisposing risk factors, e.g., physical inactivity, and the second is to detect 
IHD at the earliest possible stage. A literature search produced limited information on 
research on physical activity in individuals infected with HIV at conceptualization of the 
project. Similarly, no published information on the South African population was available. 
In all, only three international studies on physical activity evaluation were available. Fillipas 
et al. (2008) assessed physical activity with the International Physical Activity Questionnaire 
(IPAQ); Bopp et al. (2004) did likewise with an Actigraph accelerometer, and Ramirez-
Marrero et al. (2008) used the IPAQ, Yamax Pedometer and Actigraph accelerometer. 
These studies were performed in Australia, the United States of America (USA) and Puerto 
Rico respectively. Ramirez-Marrero et al. (2008) reported that the IPAQ overestimated 
physical activity when compared with objective tools, namely a pedometer and 
accelerometer. It is therefore suggested that an objective tool should be used to assess 
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physical activity when conducting research. A pedometer is less expensive than an 
accelerometer, and hence it would be sensible to use it in evaluating physical activity in 
individuals infected with HIV at primary care level in the SA context. 
 
Promoting wellness and a healthy lifestyle is also encouraged in individuals living with HIV 
(American Heart Association, 2013; Mascolini, 2010).  Physical activity levels of individuals 
can be modified by making healthy activity choices, e.g., climbing stairs instead of taking a 
lift, and by participating in a specific structured exercise programme (Haskell et al., 2007). A 
substantial body of knowledge is available concerning the effects of exercise in individuals 
infected with HIV. Randomized controlled trials are evaluated regularly and two reviews are 
particularly worth discussing: O’Brien et al. (2010); and Nixon et al. (2005). It has been 
established that performing aerobic exercise or a combination of aerobic and resistance 
exercise for 20 minutes, three times per week for at least five weeks appears to be safe, 
and may improve physical fitness, body composition and well-being in individuals infected 
with HIV (O’Brien et al., 2010). In these two reviews most of the studies were conducted at 
a centre, laboratory or gymnasium. It is uncertain if such an intervention would be possible 
for modifying physical activity levels of individuals in a real-world situation, or, specifically, 
in the SA context. Publicly-funded health services in SA provide services to the majority of 
the population and face enormous challenges, including inadequate staffing, inadequate 
financing of health care and poor access to health facilities (Bradshaw et al., 2007). 
Structured supervised exercise programmes at a health centre are therefore not always 
possible due to limited facilities, lack of equipment and limited availability of health care 
staff. Adherence to such an intervention may also be inadequate due to the participants’ 
lack of access to facilities close to their homes and financial constraints e.g. costs related to 
travelling to a facility. Study participants in the two systematic reviews were also mostly 
men. Considering SA HIV infection rates, higher in women than men (Statistics South 
Africa, 2013 [Stats SA]; Rehle et al., 2010), these reviews do not give a true reflection of 
difficulties that might be common in the SA and African context. The effect of exercise on 
the inflammatory risk factor for IHD, namely high sensitivity C-reactive protein (hs-CRP), 
has also not yet been investigated in the HIV population.   
 
Adherence to the exercise programmes in the above two reviews was also often poor 
(O’Brien et al., 2010; Nixon et al., 2005). In the first instance, it has been suggested that 
adherence to exercise in the wider population is better with a home-based rehabilitation 
programme (Ashworth et al., 2005). One such study is available in the HIV population. 
Dolan et al. (2006) conducted a supervised home-based aerobic and progressive resistant 
training programme in women infected with HIV in the USA. Home visits were made to 
participants with mobile equipment. The researchers found a significant improvement in 
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oxygen uptake and muscle endurance, but no significant improvements in IHD risk factors, 
such as body mass index (BMI), blood pressure and lipid profile at the end of the 16-week 
intervention period. In this study no mention was made of progression, such as instructing 
participants to try to increase physical activity on days when they were not supervised. The 
focus was thus on supervised activity, rather than on improving self-monitored physical 
activity as a means of reducing IHD risk over the longer term.  
 
Secondly, self-management has also been reported to play an important part in adhering to 
IHD preventive therapies (Ockene et al., 2011). Walking is often given as an example of 
how to accumulate physical activity throughout the day and achieve the general public 
health physical activity guidelines (Tudor-Locke, 2012; Haskell et al., 2007). It could also be 
a way to enhance self-management of risk factors for IHD, as walking is often the preferred 
physical activity (Burton, Khan and Brown, 2013; Forbes et al., 2010). Walking is well-
suited to enhancing physical activity in any individual, as it does not require any specific 
skill or access to a sport facility. It also bypasses barriers such as “lack of time” or not being 
a “sporty type”, as often mentioned (Murtagh et al., 2010).  A self-monitoring tool to 
increase walking activity is a pedometer (step counter) (Tudor-Locke, 2009). Activity 
programmes including the use of pedometers have been shown to reduce some of the risk 
factors associated with IHD, e.g., physical inactivity, blood pressure and BMI (Richardson 
et al., 2008; Bravata et al., 2007). No published information focusing on home-based 
education and walking programmes (incorporating a pedometer) and their effect on IHD risk 
factors in the HIV population could be found at the commencement of this study.  
 
Perceptions of one’s own risk for IHD can greatly influence decision-making with regard to 
making healthcare choices. Limited information is available concerning perceptions, 
knowledge and attitudes related to IHD in individuals, especially prior to a diagnosis of IHD. 
Two recent studies were found for review in the general population. Ansa, Oyo-Ita and 
Essien (2007) conducted a study in senior and junior staff at a Nigerian university. They 
found that knowledge of risk factors was poor and mostly influenced by educational level. 
Smoking was identified by 70.6% as a risk factor, excessive alcohol abuse by 52.8% and 
obesity by 41.6%. Sedentary lifestyle (16.6%) and oral contraceptive (6.4%) were least 
identified as risk factors for IHD. The study also revealed that lifestyle modification 
strategies were not yet greatly accepted. The second study by Hart (2005) evaluated 
women’s perceptions of IHD risk. The researcher found that their participants’ perception of 
IHD risk was often underestimated, their health-promoting behaviours were not influenced 
by their risk perceptions and that society often imposed barriers to their participation in 
health-promotion behaviour. In general, then, there is a dearth of published data concerning 
IHD in individuals living with HIV. Considering the increased risk of IHD in individuals 
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infected with HIV and the findings of the studies detailed above (Ansa, Oyo-Ita and Essien, 
2007; Hart, 2005) it seems important to establish correct perceptions of the risk of 
developing IHD in the general population, and particularly individuals living with HIV. 
 
The present study aims to add to the body of knowledge in the field of HIV rehabilitation by 
filling several gaps. It could provide information regarding: the physical activity levels 
(specifically, walking) of individuals living with HIV in SA; challenges surrounding physical 
activity evaluation in SA; the effects of a home-based education and walking programme 
(with pedometer as self-monitoring tool) on the risk factors for IHD; adherence to the 
programme implemented; and information regarding the affected individuals’ self-
perception concerning their risk for IHD. Lastly, the study should result in evidence-based 
education material in the form of a physical activity diary that could be used at primary care 
clinics to assist with promoting a physically active lifestyle. Finally, this study may also add 
to the existing knowledge of controllable risk factors for IHD in the SA context.  
 
1.2  PROBLEM STATEMENT 
Little is known about the risk factors for IHD or perceptions of the risk of developing IHD in 
the South African HIV population (on HAART). The effect of an individualised home-based 
education and walking programme on the controllable risk factors in individuals infected 
with HIV (on HAART) in the South African context is also unclear. 
 
1.3 RESEARCH QUESTIONS 
The appropriate research questions are: 
1. What are the risk factors for IHD in individuals that are HIV+ (on HAART), and resident 
in Johannesburg, SA? 
 
2. What is the affected individual’s perception of the risk of developing IHD, and what is 
his/her behaviour regarding this risk? 
 
3. Does an individualised home-based education and walking programme reduce the 
associated risk factors for IHD in HIV+ individuals resident in Johannesburg, SA?  
 
1.4  AIMS AND OBJECTIVES OF THE STUDY 
Aim 1: To determine the associated risk factors for IHD in individuals who are HIV+ (on 
HAART) in Johannesburg, SA. 
 
Objectives of aim 1: 
1) To determine, in individuals infected by HIV and on HAART:  
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 current physical activity levels  
 perceived levels of stress 
 the presence of selected known associated risk factors for IHD (smoking history, 
diet, resting heart rate [RHR], blood pressure, waist circumference [WC], waist:hip 
ratio [WHR], BMI) 
 
Aim 2: To determine the nature of the individual’s self-perception and behaviour in relation 
to the risk of IHD. 
 
Aim 3: To determine the effects of a six-month individualised education and home-based 
walking programme on the associated risk factors of IHD in individuals infected by 
HIV, on HAART.   
 
Objectives of aim 3: 
1) To determine, in individuals infected by HIV: 
 
 physical activity level 
 perceived level of stress 
 RHR and blood pressure 
 waist and hip circumference, WHR and BMI 
 hs-CRP 
 lipid profiles (total cholesterol, high density lipoprotein [HDL], low density lipoprotein 
[LDL] and triglycerides [TG] level) 
 glucose levels 
 
2) To create an education physical activity diary.  
 
3) To implement an individualised education and home-based walking programme for 
affected individuals at risk of IHD, and monitor adherence to the programme. 
 
4) To determine whether an education and home-based walking programme has an effect 
on physical activity level, perceived stress level, RHR, blood pressure, WC, WHR, BMI, 
hs-CRP, lipid profile and glucose levels of affected individuals. 
 
5) To determine if a correlation exists between Hs-CRP and evaluated related IHD risk 
markers. 
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6) To calculate the 10-year relative risk for IHD events in individuals living with HIV using 
the Framingham Risk equation, and to determine what effect, if any, the education and 
home-based walking programme had on the relative risk. 
 
1.5  SETTING OF THE STUDY 
The project was conducted at Themba Lethu clinic at Helen Joseph hospital, Gauteng.  
Themba Lethu is an Nguni phrase that means “our hope”. This clinic was selected as a 
research site as it is the largest national antiretroviral roll-out site in SA, and has been 
active since 2004 (Right to Care, 2010). The clinic forms part of Right to Care and the 
Medicine department of Helen Joseph hospital, which forms part of the academic complex 
of the University of the Witwatersrand. Right to Care is a non-profit organisation that 
provides prevention, care and treatment for individuals living with HIV and associated 
diseases (Right to Care, 2010). The client base at the clinic is more than 24 000 patients 
since the start of the clinic, of whom 14 000 patients have been initiated on HAART (Right 
to Care, 2010). The clinic serves patients across Gauteng, and many patients travel from 
outside Gauteng province, due to the clinic’s high quality of care (Right to Care, 2010). 
Individuals infected with HIV and on HAART were invited to participate in the project. In the 
first part of the project IHD risk factors were screened in affected individuals. Participants 
then continued with the fourth study. To determine which Yamax pedometer should be 
used in the project, the first pilot study was conducted, using full-time Wits University staff 
members.  
 
1.6  SIGNIFICANCE OF THE STUDY 
This study aims to contribute to understanding IHD among people infected with HIV, and 
also to the body of knowledge regarding associated risk factors for IHD in South African 
individuals with HIV. Furthermore, understanding the individual’s self-perception for the risk 
of developing IHD may provide information regarding subjective internal risk factors for IHD. 
In addition, the study will test the effect of an individualised home-based education and 
walking programme, and its effect on cardiovascular risk factors at primary care level. In 
conclusion, this study may result in evidence-based education material, and provide an 
example of a low-cost exercise programme. Such a programme could be implemented as 
part of the primary care management of individuals living with HIV in Johannesburg in an 
attempt to decrease the future morbidity and mortality caused when HIV and IHD occur 
together. 
 
1.7  ETHICAL CONSIDERATIONS DURING THE STUDY 
The PhD research project was submitted to the University of the Witwatersrand’s Human 
Research Ethics Committee, and ethical clearance was granted (clearance certificate 
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10238; 23 March 2010 [Appendix 1]). The project was approved by the Faculty of Health 
Sciences of the University of the Witwatersrand (Appendix 2, 3 June 2010). Permission to 
conduct the project at Helen Joseph hospital and Themba Lethu clinic was received from 
the hospital management following consultation with the medical manager of the clinic 
(Appendix 3). The physiotherapy department at Helen Joseph hospital was informed about 
the project, and verbal permission was received to use the physiotherapy room in Themba 
Lethu clinic for data collection. Project particulars were explained to participants by two 
research assistants during recruitment, and participants provided informed consent. The 
information document (Appendix 4) and consent forms (1) (Appendix 5) and (2) (Appendix 
6) are attached. Participants’ names and contact details were collected on a coding form 
(Appendix 7) and kept separate from data-capturing evaluation forms to ensure anonymity. 
During data collection and analysis study participants’ codes were used for identification 
purposes. Consultations with participants were held in a private physiotherapy room in the 
clinic to ensure privacy. Participants were paid R50 to cover their transport expenses for 
each session scheduled with the researcher. Study 4 was registered with the Department of 
Health (DOH) of South Africa as clinical trial (DOH trial number: DOH-27-0512-3982; 
Appendix 8; 4 May 2012). During study 4 blood sampling from study participants was 
necessary to achieve the aims stated above. The glucose and serum sampling tubes and 
laboratory requisition forms used during the laboratory analysis contained the study 
participants’ code, and not his/her name or surname, to ensure confidentiality.  
 
1.8  OUTLINE OF THE STUDY 
The study was designed as depicted in the flow diagram below to address the research 
questions. 
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Pilot study 1 
Selection of pedometer 
and inter-rater reliability of 
pedometers (n = 12). 
♦ Accuracy of Yamax 
SW200 pedometer  
(r = 0.96; p < 0.00) 
♦ Accuracy of Yamax 
CW600 pedometer  
(r = 0.82; p < 0.00) 
♦ Yamax SW200 and 
CW600 association 
 (r = 0.96; p < 0.00) 
Pilot study 2 
Testing accuracy of tools and intra-rater reliability 
of researcher (assessor) in PLWHA (n = 24). 
♦ Accuracy of Yamax SW200 pedometer (r = 
0.59; p = 0.03) 
♦ Cohen’s Perceived Stress scale (Cronbach α = 
0.82)  
♦ Microlife BP A100 electronic 
sphygmomanometer (r = 0.82 – r = 0.93) 
♦ Simple Choice portable electronic scale (r = 
1.00; p < 0.00) 
♦ Waist and hip circumference measurement (r = 
0.99; p < 0.00) 
♦ Height measurement (r = 0.99; p < 0.00) 
Study 1 
Risk factors of IHD screening in PLWHA (n = 205) 
Pilot study 3 
Evaluate card sort method  
(n = 4) 
Study 2 
Self-perception and behaviour towards IHD in PLWHA (n = 30) 
PHASE 1 
Outcome of Phase 1 
Risk factors for IHD determined and associated contextual factors highlighted in 
PLWHA 
Study 3 
Development and content validation of 
education material for implementation 
during intervention: 
♦ Physical activity diary 
- Content for knowledge, application 
and practice of prevention for IHD 
in PLWHA.  
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Figure 1.1: Flow Diagram of Phases 1 and 2 of the Research Project 
 
 
PHASE 2 
Pilot study 4 
Testing accuracy of tools and intra-rater reliability of research assistant 4 (assessor) in PLWHA (n = 8). 
♦ Accuracy of Yamax SW200 pedometer (r = 0.66; p = 0.07) 
♦ Microlife BP A100 electronic sphygmomanometer (r = 0.61 – r = 1.00) 
♦ Micro Health Stadiometer (r = 0.93; p < 0.00) 
♦ Simple Choice portable electronic scale (r = 1.00; p < 0.00) 
♦ Waist and hip circumference measurement (r = 0.97; p < 0.00) 
♦ 6MWT trial association (r = 0.95; p < 0.00) 
Study 4 
Intervention conducted by randomised control trial to test the effects of an education and home-based 
individualised walking programme on physical activity levels and secondary risk factors of IHD in 
PLWHA.  
♦ Control group (n = 42) 
♦ Intervention group (n = 42) 
See Consort diagram in Chapter 6b for flow of participants through study 4. 
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1.9  GENERAL OUTLINE OF THE THESIS 
The general outline of the thesis is summarised below: 
 
Chapter 2 : Literature Review 
Chapter 3 : Instrumentation for testing and measuring outcomes 
Chapter 4 : Study 1 – Screening non-invasive risk factors for IHD 
Chapter 5 : Study 2 – Self-perception and behaviour towards IHD 
Chapter 6a : Study 3 - Development of the education physical activity diary 
Chapter 6b : Study 4 – Physical activity modification as prevention strategy for IHD 
Chapter 7 : Conclusion, limitations and recommendations 
 
Chapter 2 consists of a review of the literature supporting the rationale for the research 
questions.  
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CHAPTER 2 
 
2.  LITERATURE REVIEW 
 
2.1  INTRODUCTION 
The literature review is divided into three sections. Section 1 consists of a presentation of 
the literature related to the burden of diseases in SA as a means of contextualising the 
burden related to HIV and IHD. Section 2 provides information related to the definition of 
IHD, and its pathophysiology, risk factors, risk calculation and self-perception. This is done 
to provide the background for phase 1 of the research, in which the risk factors for IHD 
were screened and individuals’ self-perception of the risk of IHD was assessed in people 
living with HIV and acquired immune deficiency syndrome (AIDS) (PLWHA). Lastly, section 
3 is a discussion related to physical activity modification as a therapeutic management 
strategy for IHD risk factors. Section 3 provides the literature related to phase 2 of the 
research project, in which the effects of an education and home-based pedometer walking 
programme in PLWHA was assessed.  
 
Methodology of Literature Review 
The literature review was carried out according to the following research pathways as a 
means of generating the literature in this chapter. Various research portals were accessed 
to search for articles related to the topic of interest e.g. PubMed, Science Direct, Mary 
Liebert, Springer, Wiley Interscience, Pedro database, Scopus, Cochrane reviews and 
Google Scholar. Specific websites were accessed for gathering explanatory information 
e.g. Google, Centre for Disease Control, World Health Organisation (WHO), American 
Heart Association, Medical Research Council, UNAIDS and South African National AIDS 
Council. In addition, the following research methods were conducted to gather information 
relevant to the project: individual review of journals and textbooks; individual review of 
specific researcher publications, congress presentations and abstracts.  
 
2.2  SECTION 1 - BURDEN OF DISEASES IN SOUTH AFRICA 
South Africa is facing a health transition characterised by an escalation of non-
communicable diseases, while the need for managing infectious diseases persists. A 
quadruple burden of disease split exists between HIV, chronic lifestyle diseases, perinatal 
and maternal disease and violence-related injuries in SA (Mayosi et al., 2009). The ten 
leading underlying natural causes of death in SA in 2010 for both sexes and all ages as per 
death notifications were, in descending order, as follows: tuberculosis (TB), influenza and 
pneumonia, intestinal infectious diseases, other forms of heart disease, cerebrovascular 
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disease, diabetes mellitus, HIV, hypertension (HTN), chronic lower respiratory tract 
diseases and, lastly, other viral diseases (Stats SA, 2013). It is important to note that 65% 
of individuals infected with TB in SA are said to have HIV co-infection (Mayosi et al., 2012). 
Secondly, communicable diseases such as influenza and pneumonia are opportunistic 
infections that often present in individuals living with HIV (Van Dyk, 2008). Thus mortality 
due to HIV and HIV-related opportunistic illnesses presented in the Stats SA data might 
camouflage the true burden of HIV in SA.  
 
The order and rank of certain causes of mortality change when age groups are introduced 
into the analysis as demonstrated by Stats SA (2013). HIV is ranked higher in the 15 to 49 
age group, and risk factors for IHD, e.g. diabetes mellitus and HTN are ranked higher in the 
50 to 64 age group. IHD is also included as the eighth leading cause of death in individuals 
50 to 64 years of age. A number of strategies have been implemented recently in SA 
specifically to address the influence of HIV on the causes of death in an attempt to attain 
the sixth United Nation’s Health Millennium Development Goal. 
 
The sixth United Nation’s Health Millennium Development Goal aims to reduce the impact 
of HIV/AIDS, malaria and other diseases in populations by 2015 (WHO, 2013). The 2012 to 
2016 National Strategic Plan for HIV, sexually-transmitted infections and tuberculosis of 
SA, aims to halve the number of new HIV infections, and to ensure that at least 80% of 
individuals eligible for treatment are receiving it (South African National AIDS Council, 
2011). Highly active antiretroviral therapy initiation guidelines in SA are now aligned with 
international guidelines allowing for HAART initiation when the CD4 count is less than 350 
cells per μL in adults (Department of Health, 2013; Mayosi et al., 2012). The country is also 
said to have the largest HAART programme in the world (Mayosi et al., 2012; Rehle et al., 
2010), with 1.7 million people receiving it (UNAIDS, 2012). The estimated number of adults 
and children receiving HAART increases yearly, and this scenario has resulted in mortality 
rates of HIV or AIDS reducing progressively from 52.3% in 2006 to 43.6% in 2011 (Mayosi 
et al., 2012). The increased accessibility of HAART in conjunction with good adherence to 
treatment could result in individuals living longer lives, though with conceivable disability 
related to HIV and its related opportunistic infections, as well as side effects of HAART. The 
HAART roll-out modification could also alter future causes of mortality in SA, shifting the 
focus from communicable diseases to a more pronounced non-communicable diseases 
pattern such as IHD and/or stroke, in both the HIV and general population.   
  
2.2.1  Prevalence and Incidence Rates of HIV  
Prevalence of HIV infection is a significant sub-Saharan Africa problem, as 23.5 million 
people are living with HIV in this region (UNAIDS, 2012). Only Swaziland, Botswana and 
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Lesotho report higher rates of HIV infection than SA (WHO, 2010). Moreover, SA is 
reported to have the highest number of HIV infections (UNAIDS, 2012). Table 2.1 shows 
the prevalence estimates according to age groups and the total number of PLWHA from 
2002 to 2013 in SA.  
 
Table 2.1:  HIV Prevalence Estimates and Number of PLWHA in SA (2002 – 2013) 
Year 
Prevalence (%) Incidence 
Adults 
15–49 
(years) 
HIV population 
(Millions) 
Women 
15–49 
(years)
Adults 
15–49 
(years) 
Youth 
15–24 
(years)
Total 
Population
2002 15.9 15.1 13.6 8.7 1.26 4.00 
2003 16.0 15.1 12.8 8.9 1.25 4.10 
2004 16.1 15.1 12.0 8.9 1.28 4.18 
2005 16.2 15.1 11.4 9.0 1.32 4.25 
2006 16.4 15.2 10.9 9.1 1.29 4.34 
2007 16.5 15.3 10.5 9.2 1.21 4.46 
2008 16.7 15.4 10.1 9.3 1.12 4.59 
2009 16.9 15.5 9.7 9.5 1.03 4.74 
2010 17.1 15.6 9.3 9.6 0.98 4.88 
2011 17.2 15.7 9.0 9.8 0.95 5.01 
2012 17.3 15.8 8.7 9.9 0.87 5.13 
2013 17.4 15.9 8.5 10.0 0.85 5.26 
(Source: Stats SA, 2013) 
 
Adult HIV incidence in SA is higher amongst women than men, and a ratio of 1.5 female to 
male exists in those aged 15-49 (Stats SA, 2013). Approximately 17% of South African 
women in their reproductive years are HIV positive (Stats SA, 2013). A positive finding from 
Stats SA (2013) is that new incidences of HIV infection in the 15–49 age group is slowly on 
the decline when reviewing information of incidence rates from 2002–2013. In addition, the 
South African National HIV Prevalence, Incidence and Behaviour Survey conducted in 
2012 indicated an encouraging finding among young females aged 15-24 years. The 
survey indicated that HIV incidence declined from 5.3% in 2002-2005 to 2.1% in 2008-2012 
in this age group indicating a significant reduction of 60% HIV incidence (Shisana et al., 
2014).  
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2.2.2 Disability-Adjusted Life Years of HIV  
The mere prevalence and mortality rates of HIV do not adequately describe the burden of 
disease related to this condition on the Health Care system of SA, as it does not reflect the 
added social implications on the community. Disability-adjusted life years (DALYs) of a 
condition need to be considered for an estimate of total disease burden, as this measure 
calculates the years lived with disability (Bradshaw et al., 2003). HIV accounts for the 
largest portion of DALYs in SA, namely, 40.7% as a percentage of total DALYs in 2004 
(WHO, 2009). Neuropsychiatric conditions rated second at 6.3% and cardiovascular 
disease third at 5.8% of DALYs in 2004 (WHO, 2009). In light of the high DALYs attributed 
to HIV, the need for rehabilitative professionals is great, to assist in screening, preventing, 
treating and managing disability in individuals living with HIV.  
 
2.2.3  Changing Causes of Death in Individuals Living with HIV on HAART 
HIV is no longer a terminal disease, but is considered chronic in the HAART era where 
therapy is accessible. Since the roll-out of HAART individuals infected with HIV are living 
longer (Johnson et al., 2013; UNAIDS, 2013; Bhaskaran et al., 2008; Palella et al., 1998). 
Various researchers have recommended that a CD4 count threshold of 350 cells/μl should 
be considered as a guide for when to initiate HAART, as mortality rates are reduced if 
therapy is initiated prior to dropping to that level (When to Start Consortium, 2009; 
Hammer, Eron and Reiss, 2008). Studies conducted in SA report that pre-treatment and 
early HAART-treated deaths are associated with advanced immunodeficiency at enrolment 
(Peltzer et al., 2011; Lawn et al., 2006). Causes of mortality in individuals living with HIV in 
the sub-Saharan region appear to be related to conditions such as TB, acute sepsis, 
cryptococcal meningitis, malignancy and wasting syndrome (Lawn et al., 2008). 
Additionally, in SA, TB remains the leading cause of death in PLWHA with 87 000 TB 
deaths occurring in 2011 alone (UNAIDS, 2013). At present the median time from HIV 
infection to death is reported to be 10.5 years for men and 11.5 years for women in SA 
(Stat SSA, 2013). Johnson et al. (2013) did however estimate that the life-expectancy of 
men when initiated on HAART at age 20 was 27.6 years (95% CI: 25.2-30.2) compared to 
10.1 years (95% CI: 9.3-10.8) at age 60. The estimated life-expectancy of women were 
significantly higher than men following HAART initiation: 20 year old women (36.8 years 
[95% CI: 34.0-39.7] and at 20 [14.4 years [13.3-15.3]). With current South African HAART 
guidelines, mortality rates could decline and causes of death begin to match findings found 
from international studies.  
  
Researchers in the USA and Brazil have noted that AIDS-related illnesses are decreasing, 
while non-AIDS-defining illnesses are increasing to varying degrees (Grinsztejn et al., 2013; 
French et al., 2009; Palella et al., 2006). Palella et al. (2006) reported the highest increase, 
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13.1%, in 1996 to 42.5% in 2004 in individuals participating in the HIV Outpatient study in 
the USA. Both Palella et al. (2006) and French et al. (2009) noted that non-AIDS-defining 
illnesses in their respective studies included cardiovascular disease, non-AIDS malignancy 
and liver disease. However, the latter authors also noted that trauma was a frequent cause 
of death, and that depressive symptoms were an independent predictor of mortality in their 
Women’s Interagency HIV study in the USA. It is therefore important for health care 
professionals to be aware of the increasing incidence of non-AIDS-defining illnesses, such 
as cardiovascular disease, in individuals living with HIV on HAART. Health care 
professionals should vigorously screen, monitor, treat and manage such conditions (Hsue 
et al., 2008).   
 
2.2.4  Prevalence, Incidence and Mortality Rates of Ischemic Heart Disease  
Current incidence rates for IHD are not available for either the general or the HIV 
population in SA. It is therefore not possible to determine how morbidity related to IHD in 
SA compares to the rest of the world. The definition of IHD includes a number of conditions, 
e.g. myocardial infarction or angina pectoris, and so the statistics are often misleading, and 
fail to reveal the composite extent of incidence due to these different conditions. Composite 
evaluation of IHD can therefore only be made by reviewing mortality rates of IHD. Kim and 
Johnson (2011) reviewed the relative burden of stroke and IHD between various countries. 
Ishemic heart disease mortality rates per 100 000 individuals (as percentage of total 
mortality rate) from selected countries in the WHO Global Burden of Disease Programme 
mortality rate estimates in 2004 were as follows: SA 114 per 100 000 (5.7% of total 
mortality rate); USA 98 per 100 000 (18.2% of total mortality rate) and the United Kingdom 
(UK) 90 per 100 000 (17.9% of total mortality rate). Mortality from IHD was higher in the 
USA and UK than SA due to infectious diseases being the leading cause of death in SA at 
that time – as it continues at present (Statistics South Africa, 2013; Bradshaw et al., 2010). 
The DALYs attributed to IHD in SA is also much less than those attributed to HIV. Kim and 
Johanson (2011) reported that the DALYs attributed to IHD in SA, as expressed per 100 
000 (and as a percentage of total DALYs loss rate) was 990 (2.1).  
 
When reviewing the statistics related to IHD it is important to bear in mind that risk factors 
of IHD such as diabetes mellitus and HTN already rank within the ten leading causes of 
death in SA (Stat SA, 2013). The prevalence of risk factors for IHD among South Africans is 
also reported to be increasing as revealed by findings on selected risk factors of IHD from 
specific studies (Ibrahim and Damasceno, 2012; Finucane et al., 2011; Shaw, Sicree and 
Zimmet; 2010).  The prevalence of HTN in SA increased from 54% to 78% from 1998-2003, 
with urban prevalence said to be higher (25%) than rural (10.5%) (Ibrahim and Damasceno, 
2012). The prevalence of diabetes mellitus in SA is anticipated to increase from 4.5% of the 
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national population in 2010 to 4.9% by 2030 (Shaw, Sicree and Zimmet, 2010). Obesity in 
Southern African individuals also increased from 1998-2008. Mean BMI in Southern African 
men is reported to be lower than women, with mean BMI values in women in 1998 being 
25.8–26.6 kg/m2 (Finucane et al., 2011). Mean BMI values in women were noted to have 
increased to more than 28 kg/m2 in Southern Africa by 2008 (Finucane et al., 2011). If 
management of these respective risk factors improve to such an extent as not to result in 
death, the longitudinal effect of the presence of these risk factors could influence the 
burden of cardiovascular disease in SA in the future.  
 
Section 2 of the literature review consists of pertinent literature pertaining to IHD, and is 
presented in section 2.3 below. 
 
2.3  SECTION 2 - ISCHEMIC HEART DISEASE  
This section will be discussed as follows: definition of IHD, its pathophysiology, risk factors, 
risk calculation and self-perception of risk. 
 
2.3.1  Definition of IHD 
The definition of IHD includes a number of medical conditions. The International 
Classification of Diseases divides IHD into the following conditions: acute myocardial 
infarction (AMI), other acute and sub-acute forms of IHD, other forms of chronic IHD, 
angina pectoris and old MI (International Classification of Diseases, 2013). IHD develops 
over time due to narrowing of the coronary arteries that perfuse the myocardium (Collins 
and Dias, 2009). The narrowing is most often caused by arteriosclerosis. 
 
2.3.2  Pathophysiology of IHD  
Arteriosclerosis occurs due to a process involving local blood flow, wall shear stress and an 
inflammatory cascade. Wall shear stress is the force applied to the blood vessel walls, and 
is the product of the wall shear rate (speed of blood flow) and viscosity of the blood (Caro, 
2009). Arteriosclerosis is said to occur in a patchy distribution pattern in areas where the 
wall shear stress due to blood flow is low, allowing for fatty streaking of the endothelium 
(Caro, 2009). The fatty streak is thought to be the result of the transformation of monocytes 
to macrophages with the subsequent uptake of cholesterol lipoproteins at the endothelium 
(Pearson et al., 2003). Inflammation plays a key role in this process. 
 
Certain risk factors of IHD promote systemic inflammation that gives rise to a number of 
noxious stimuli. Under normal physiological conditions the endothelium produces 
vasodilator nitric oxide that protects the arterial wall against atherothrombosis (Van Leuven 
et al., 2008). Systemic inflammation results in a decreased expression of endothelial nitric 
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oxide synthase in conjunction with an increased expression of inducible nitric oxide 
synthase, resulting in an imbalance, causing endothelium dysfunction (Van Leuven et al., 
2008). The noxious stimuli that are the result of systemic inflammation further promote 
secretion of leukocyte soluble adhesion molecules which result in the attachment of 
monocytes to endothelium cells (Pearson et al., 2003). Proinflammatory cytokines, namely 
interleukin one alpha (IL-1α), interleukin one beta (IL-1ß), tumour necrotic factor alpha 
(TNF-α) and interleukin 18 (IL-18), enhance chemotactic factors release (Mehra et al., 
2005). These chemotactic factors encourage monocyte migration into the sub-intimal space 
of blood vessels that subsequently lead to cholesterol lipoprotein uptake over time and the 
development of plaque.  
 
Plaque growth and the formation of a fibrous cap are the result of the localisation of smooth 
muscle cells (SMC), monocyte-macrophage and monocyte-generated foam cells (Mehra et 
al., 2005). Pro-inflammatory cytokines, namely, IL-1 and TNF-α, enhance the production of 
SMC and monocytes to facilitate this process (Mehra et al., 2005). Plaque macrophages 
also secrete inflammatory cytokines such as TNF-α and matrix metalloproteinase, which 
can degrade the fibrous plaque cap (Zanni and Grinspoon, 2012). Over time death of the 
cellular components by apoptosis results in a lipid-rich plaque with minimal SMC that can 
lead to plaque rupture (Mehra et al., 2005). A coagulation cascade is stimulated when a 
plaque ruptures, and that again activates inflammatory mediated processes to manage the 
rupture site. It is, however, important to note that systematic inflammation in itself can also 
result in a coagulation cascade long before the rupture of a plaque (Van Leuven et al., 
2008). This consequence of systematic inflammation further assists with the development 
of atherothrombosis by activating platelets and promoting platelet adherence to the 
endothelium (Van Leuven et al., 2008). Thus, virtually every step in the formation of 
atherosclerosis involves processes related to inflammation and can therefore be monitored 
by evaluating risk factors that promote systemic inflammation as well as specific 
biochemical inflammatory markers. Section 2.3.2.1 explains how HIV infection influences 
the pathophysiology of arteriosclerosis, thereby increasing risk of IHD in PLWHA. 
 
2.3.2.1 HIV infection-mediated effect on the pathophysiology of arteriosclerosis 
Literature suggests HIV infection in itself contributes significantly to arteriosclerosis 
development, independent of known risk factors of IHD and HAART exposure. Figure 2.1 is 
a representation of how HIV infection is suggested to advance arteriosclerosis as explained 
by Zanni and Grinspoon (2012). 
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Figure 2.1:  HIV Infection-Mediated Effect on Pathophysiology of Arteriosclerosis 
 
2.3.3  Risk Factors for IHD  
The development of IHD occurs over time due to the presence of risk factors for IHD 
leading to arteriosclerosis. Traditional risk factors for IHD also contribute to increased risk 
of IHD in PLWHA (Triant et al., 2007). They found AMI rates per 1 000 person-years in HIV 
patients to be 11.13 (95% CI: 9.58–12.68) compared with 6.98 per 1 000 person-years 
(95% CI: 6.89–7.06) for non-infected individuals. The authors reported that, in addition to 
HIV infection, risk factors for AMI included male gender (relative risk (RR)=1.72; 95% CI: 
1.68–1.77; p<0.0001), age (RR=17.24 for ages 75–84 versus 18-34; 95% CI: 15.87–18.52; 
p<0.0001), African-American race (RR=1.44; 95% CI: 1.38–1.50; p<0.0001), diabetes 
(RR=1.98; 95% CI: 1.93-2.04; p<0.0001), HTN (RR=1.62; 95% CI: 1.57–1.66; p<0.0001) 
and dyslipidaemia (RR=3.03; 95% CI: 2.93–3.13; p<0.0001), as assessed in a combined 
model. Of notable interest, however, is that the difference in AMI rates was more 
pronounced in women infected with HIV than non-infected individuals. In gender-stratified 
models adjusting for age, race, HTN, diabetes and dyslipidaemia the RR of AMI was 2.98 
(95% CI: 2.33–3.75; p<0.0001) in women and 1.40 (95% CI: 1.16–1.67; p=0.0003) for men 
(Triant et al., 2007). This finding is important when considering that the prevalence of HIV 
infection is higher in women than men in SA, leading to the potential for increased number 
of individuals being at risk for IHD (Stats SA, 2013).   
 
  
HIV infection 
Activates endothelial cells  
Encourage recruitment and adhesion of atherogenic monocytes to vascular endothelial 
Activates monocyte-derived macrophages 
Endothelial cells express higher density of leukocyte adhesion molecules 
HIV monocytes secrete increased levels of pro-inflammatory cytokines e.g. TNF-α, IL-6 and matrix 
metalloproteinase 
Promotes plaque rupture 
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Traditional risk factors for IHD can be divided into non-controllable and controllable 
(National Cholesterol Education Program Expert Panel Adult Treatment Panel-III [NCEP 
ATP-III], 2002). A focus on traditional risk factors for IHD is presented first, followed by how 
it differs in PLWHA, where applicable.  
 
2.3.3.1 Non-controllable risk factors for IHD 
Non-controllable risk factors for IHD include age, gender and family history of premature 
IHD (NCEP ATP-III, 2002). Risk for IHD increases in individuals with advancing age due to 
the progressive accumulation of arteriosclerosis in the blood vessels (NCEP ATP-III, 2002). 
Risk of IHD is increased in men older than 45 years and in women older than 55 years in 
the general population (NCEP ATP-III, 2002). Similarly, in PLWHA the incidence of IHD is 
reported to increase from 0.77 cases per 100 person-years in the 18–24-year age group to 
5.5 in the 75 years and older age group in HIV-infected men (Currier et al., 2003). In HIV-
infected women the incidence of IHD increases from 0.40 cases per 100 person-years in 
the 18–24-year age group to 5.43 in the 56–74-year age group (Currier et al., 2003). Of 
notable interest however is that the RR for IHD was higher in younger HIV-infected men 
and women than the general population (Currier et al., 2003). The authors reported the RR 
for IHD in HIV infected men aged 18–24 years was 6.76 (95% CI: 3.36–13.58), and 
between 25–34 years was 2.16 (95% CI: 1.81–2.58). The RR in women aged 18–24 years 
was 2.47 (95% CI: 1.23–4.95), 25–34 years was 1.53 (95% CI: 1.10–2.13) and 35–44 years 
1.67 (95% CI: 1.41–1.97). Screening and monitoring controllable risk factors of IHD are 
therefore important from an earlier age in PLWHA than the general population.  
 
2.3.3.2 Controllable risk factors for IHD 
Lifestyle-controllable risk factors related to behaviour are physical inactivity, smoking, 
unhealthy diet and excessive stress (NCEP ATP-III, 2002). These behaviours have 
physiological, anthropometric, metabolic and inflammatory consequences resulting in the 
following risk factors: elevated RHR; HTN; obesity; abdominal obesity; diabetes mellitus; 
altered cholesterol profiles and increased hs-CRP (Hsia et al., 2009; Steyn et al., 2005; 
Yusuf et al., 2004; Pearson et al., 2003; Greenland et al., 1999). The controllable risk 
factors of IHD specific to individuals’ behaviour is discussed in section 2.3.3.2.1 to section 
2.3.3.2.4. 
 
2.3.3.2.1 Behavioural risk factor: Physical inactivity  
Physical activity protects against IHD by influencing known modifiable risk factors 
for IHD, and also having protective cardiovascular effects despite the presence of 
risk factors. It is known that an inverse relationship exists between physical activity 
levels and risk for mortality (Reddigan et al., 2011; Mora et al., 2007; Lee and 
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Skerrett, 2001; Lakka et al., 1994). Lee and Skerrett (2001) maintain that minimal 
adherence to the public health recommendations for physical activity (an energy 
expenditure of approximately 1 000 kcal/wk) is associated with a 20–30% reduction 
of risk of all-cause mortality in men and women. Lakka et al. (1994), while 
evaluating the relationship between leisure-time physical activity and first AMI in 
men, found the relative hazard for AMI to be 0.31 (95% CI: 0.12–0.85; p=0.02) in 
those who undertook more than two hours of physical activity per week. In 
individuals who engaged in 0.7 to 2.2 hours per week the relative hazard was 1.11 
(95% CI: 0.58–2.12; p=0.75) (Lakka et al., 1994). Mora et al. (2007) quantified the 
contribution of traditional - e.g. BMI - and novel risk factors, e.g. hs-CRP, to the 
activity-related reduction in cardiovascular events in the large Women’s Health 
Study. The authors noted that the RR for cardiovascular events decreased by 27% 
to 32% to 41% as physical activity level energy expenditure increased from 200 to 
599 kcl/wk, 600 to 1499 kcl/wk and more than 1500 kcal/wk respectively. The 
authors noted that 59% reduction in cardiovascular events associated with physical 
activity was explained by risk factor modification, and a reduction in hs-CRP 
contributed most to reduced risk of a cardiovascular event. Furthermore, Reddigan 
et al. (2011) proposed that engaging in light to moderate or vigorous physical 
activity is associated with a 30% reduction in cardiovascular disease mortality, 
which is independent of adjustment for metabolic risk factors such as dyslipidaemia, 
diabetes mellitus and obesity. This decrease in risk that is independent of alteration 
in known risk factors for IHD is suggested to be due to the positive effect of physical 
activity on endothelial blood vessel function (Reddigan et al., 2011; Joyner and 
Green, 2009). Engaging in regular physical activity is therefore important in 
attempting to reduce one’s risk factors for IHD, but, in the absence of risk factor 
reduction, cardiovascular mortality could also be reduced by additional benefits of 
physical activity on blood vessel function. 
 
A relationship between amount, type and intensity of physical activity has also been 
shown to be relevant to risk for IHD. Tanasescu et al. (2002) conducted the Health 
Professional’s Follow-up study from 1986-1998 in men from the USA to assess the 
influence of amount, type and intensity of leisure-time physical activity on the risk of 
IHD. The sample consisted of 44 452 participants, who attended follow-ups every 
two years during the study period. Tanasescu et al. (2002) indicated that the RR for 
IHD reduced significantly (p<0.001) as volume of physical activity (hours per week 
[hrs/wk]) increased: 6.33–14.49 hrs/wk (RR=0.93; 95% CI: 0.80–1.06), 14.50–25.08 
hrs/wk (RR=0.90; 95% CI: 0.78–1.05), 25.09–41.98 hrs/wk (RR=0.87; 95% CI: 
0.71–1.01) and more than 41.99 hrs/wk (RR=0.74; 95% CI: 0.63–0.87) - adjusted 
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for alcohol consumption, smoking, family history of AMI, nutrient intake, diabetes, 
high cholesterol, HTN and BMI. Furthermore, the RR reduced significantly (p=0.01) 
as exercise intensity increased from moderate to vigorous: RR=0.93; 95% CI: 0.83–
1.04 and RR=0.82; 95% CI: 0.71–0.97 respectively, adjusting for the variables 
mentioned above (Tanasescu et al., 2002). In multivariate analysis running 
(p<0.001), walking (p=0.04) and weight training (p=0.03) were significantly 
associated with a reduction in RR for IHD. Walking pace was also shown to 
significantly reduce (p<0.001) RR for IHD, with a faster pace lowering risk more: two 
to three mph (RR=0.72; 95% CI: 0.54–0.94), three to four mph (RR=0.61; 95% CI: 
0.45–0.81) and more than four mph (RR=0.51; 95% CI: 0.31–0.84). Walking pace 
was independently associated with reduced risk, irrespective of the number of hours 
walked. In addition, the authors found that 30 minutes or more of walking at a brisk 
pace was associated with an 18% RR reduction (RR=0.82; 95% CI: 0.67–1.00) in 
IHD.  
 
Lee, Sesso and Paffenbarger (2000) set out to determine whether a difference 
could be noted between duration of physical activity bouts and RR of IHD in the 
Harvard Alumni Health Study. The study was conducted between 1988-1993, with 
7307 men participants. The authors reported the RR for IHD to reduce significantly 
(p=0.04) as bouts of physical activity differed when adjusting for age: less than 15 
minutes (RR=0.85; 95% CI: 0.55–1.31), 16–30 minutes (RR=0.76; 95% CI: 0.57–
1.03), 31–45 minutes (RR=0.85; 95% CI: 0.58–1.24), more than 60 minutes 
(RR=0.78; 95% CI: 0.62–0.98). Interestingly, the largest reduction was noted when 
16–30 minutes of activity was performed. During multivariate analysis when findings 
were adjusted for age and total energy expenditure or age, total energy expenditure, 
cigarette smoking, HTN, diabetes, early parental death, alcohol, red meat, 
vegetable consumption and participation in vigorous exercise, no significant 
differences (p=0.68, p=0.25) were noted in RR for IHD and time bouts of physical 
activity respectively (Lee, Sesso, Paffenbarger, 2000). The dose response literature 
related to physical activity and RR for IHD has contributed to providing the evidence 
for the Public Health physical activity recommendations and guidelines. Information 
related to the Public Health physical activity recommendations and guidelines for 
adults are discussed in section 2.4.2 in section 3 of this literature review.  
 
Physical inactivity is a health concern worldwide, due to the increased burden 
related to this risk factor for many non-communicable diseases, including IHD. The 
prevalence of physical inactivity in the sub-Saraharan African region is reported to 
be 19.6% in men and 22.9% in women (Onen, 2013), with urbanisation reported to 
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be one reason for this statistic (Belue et al., 2009). The prevalence of physically 
inactive individuals in SA is much higher than the general sub-Saraharan African 
region data. The World Health Survey reported the crude prevalence rates for 
physical inactivity in SA to be 43% for men and 47% for women in 2002–2003 
(Guthold et al., 2008). When the burden of physical inactivity is reviewed in relation 
to IHD, 30% of IHD cases in SA are attributed to physical inactivity (Joubert et al., 
2007), compared to international statistics of 6% (Lee et al., 2012). Physical activity 
modification by encouraging individuals to increase their activity level is therefore of 
significant importance in the South African context specifically.  
 
Literature regarding PLWHA’s physical activity levels is available internationally. 
Fillipas et al. (2008) evaluated the physical activity levels of PLWHA (n=191) 
attending a public hospital infectious disease clinic in Melbourne Australia compared 
to an HIV- negative group of patients (n=70) attending the same clinic due to 
complaints related to general infectious diseases. Physical activity levels were 
assessed with the short version of the IPAQ. The authors reported that 73.8% of 
PLWHA and 65.8% of non-infected study participants achieved the recommended 
physical activity guidelines of ≥ 150 min/wk (Fillipas et al., 2008). There was no 
significant difference (p>0.05) between the proportion of study participants who met 
the physical activity recommended guidelines according to age, gender or HIV 
status. A possible explanation for the higher percentage of PLWHA that achieved 
the recommendations could be due to the fact that they were healthier at the time of 
assessment. Three-quarters of them were on HAART, the mean CD4 count was 368 
cells/mm3 and viral load 50 log10 copies. Secondly, they might have exaggerated 
their activity level as a means of indicating that they comply with their HIV 
management, as exercise forms part of HIV management. On the other hand, those 
not infected with HIV were of impaired health, as the reason for them attending the 
clinic was due to them having general infectious diseases.  
 
In contrast, Ramirez-Marrero et al. (2008) evaluated the physical activity levels of 58 
Hispanic adults (35 men and 23 women) living with HIV in San Juan, Puerto Rico. 
Physical activity levels were assessed with the short version of the IPAQ, Yamax 
SW200 pedometer and Actigraph GT7164 accelerometer. The authors classified 
individuals as active if they took ≥ 10 000 steps per day as measured with the 
pedometer or if they achieved ≥ 150 min/wk of moderate to vigorous physical 
activity as measured with the IPAQ and accelerometer. The proportion of 
participants that were considered active in the study was 81% as measured with the 
IPAQ, 54% with the accelerometer and 17% with the pedometer respectively. The 
24 
 
walking behaviour of the study cohort as measured in mean steps per day was 7 
418 (±2 714) as assessed with the pedometer and 6 862 (±2 246) with the 
accelerometer. Both Ramirez-Marrero et al. (2008) and Fillipas et al. (2010) 
subsequently reported that the IPAQ overreads physical activity levels, and an 
objective physical assessment tool such as a pedometer or accelerometer is 
preferred for precise levels. Even though Ramirez-Marrero et al. (2008) found a 
difference in steps recorded between the pedometer and accelerometer, agreement 
was still significant (61%, Kappa=0.25, p=0.01) and the sensitivity of the pedometer 
high (96%).  
 
Information regarding physical activity levels of PLWHA longitudinally is also 
available internationally as assessed over a one year period. Fillipas et al. (2012) 
monitored physical activity levels and cardiovascular fitness in PLWHA in 
Melbourne Australia over a period of a year. They found that 19-37% of participants 
reported suboptimal physical activity levels at each study visit at six and twelve 
months. Higher cardiovascular fitness was associated with better body composition 
(p=0.05) and greater energy expenditure with improved body image (r=0.325, 
p=0.027). Being in a permanent relationship was also associated with higher activity 
levels (p=0.032) providing evidence that less support might increase the risk for 
physical inactivity.   
 
Information pertaining to the physical activity levels of PLWHA in SA is limited. 
When reviewing literature regarding disability amongst PLWHA in SA, two studies 
were found that provided information regarding the physical mobility of PLWHA. 
Myezwa et al. (2009) and Van As et al. (2009) used the International Classification 
of Function Disability and Health to evaluate PLWHA in a hospital and out-patient 
setting respectively. The authors found that the physical mobility of their study 
participants was affected. Explanatory factors reported to influence physical mobility 
significantly in their respective study cohorts included sensory function and pain, 
neuromusculoskeletal and movement-related function, muscle power, energy and 
drive function (Myezwa et al., 2009; Van As et al., 2009). The authors’ findings 
could suggest that physical activity levels might be less than health 
recommendation levels and thus predispose PLWHA in SA to risk of IHD. 
 
In a further article pertaining to how HAART exposure influenced physical activity 
levels in PLWHA in SA, Kinsey, McVeigh and Chantler (2008) evaluated habitual 
physical activity levels by questionnaire, and assessed the relationship to CD4 count 
in PLWHA. The questionnaire was developed combining components of the 
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Modifiable Activity Questionnaire, the Minnesota Leisure-Time Physical Activity 
Questionnaire and the Baecke Questionnaire of Habitual Physical Activity. The 
authors found a positive and significant correlation between length of HAART 
exposure and CD4 count (r=0.45; p<0.0001) and CD4 count and physical activity 
levels (r=0.20; p<0.0067). Exposure to HAART was therefore associated with higher 
immune parameters and improved habitual physical activity levels. These findings 
are of particular importance in the South African context when one aligns it with the 
country’s HAART initiation practice. In SA until recently HAART was initiated when 
individuals were already severely immunocompromised (Peltzer et al., 2011; Lawn 
et al., 2006). According to the WHO PLWHA with severe immune deficiencies can 
be placed in Performance Scale 4 when reviewing their activity level (Van Dyk, 
2008). Individuals in this Performance Scale are reported to have been bedridden 
for more than 50% of the day during the preceding month (Van Dyk, 2008). Habitual 
physical activity levels would therefore be significantly reduced in these individuals, 
and inadequate to promote health. It can therefore be concluded that during the 
early stage of HAART initiation such individuals could benefit from therapy to 
improve their activity level sufficiently to such promote health. During this literature 
review, no published information pertaining to the walking behaviour of PLWHA in 
SA and how it relates to IHD risk could be found. This project will provide this 
additional physical activity level information.     
    
2.3.3.2.2 Behavioural risk factor: Smoking 
Cigarette smoking is an important modifiable risk factor for IHD in the general 
population, as well as in PLWHA, especially men. Smoking is believed to influence 
the pathophysiology of IHD by impairing the vasodilatory function of blood vessels, 
promoting systemic inflammation and modifying cholesterol profiles, thereby 
initiating and aggravating arteriosclerosis (Ambrose and Barua, 2004). Smoking 
contributes to the inflammatory cascade by increasing circulating pro-inflammatory 
markers such as IL-6, TNF-α and CRP (Ambrose and Barua, 2004). Furthermore, 
smokers are reported to have significantly higher total cholesterol (3%), LDL (1.7%), 
TG (9.1%), very low LDL (10.4%) and a lower concentration of HDL (5.7%) than 
non-smokers (Graig, Palomaki and Haddow, 1989). This altered lipid profile 
increases smokers’ risk of IHD.  
 
The extent of the relationship between smoking and IHD was determined in the 
INTERHEART study, a large international case-controlled study including 52 
countries. It was specifically designed to assess the risk factors for IHD worldwide. 
The study reported the odds ratio (OR) to be 2.87 (2.58–3.19) between smoking 
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and the risk of having an AMI when adjusting for all other risk factors for IHD (Yusuf 
et al., 2004). Similarly, in the African context, Steyn et al. (2005) found the OR to be 
2.17 (1.70–2.77) in the INTERHEART Africa study. In addition, the study also 
reported that on cessation of smoking the OR declined to 1.87 (1.55-2.24) within 
three years of stopping, but that a residual risk remained for up to 20 years (OR 
1.22 [1.09-1.37]) (Teo et al., 2006). Smoking cessation is said to have the biggest 
effect on reducing the risk of IHD when compared to other risk factor modifications, 
as it diminishes this risk by 50% (Lundgren et al., 2008). Smoking cessation should 
therefore be a core management strategy for primary and secondary management 
of IHD. 
  
International data from studies conducted in PLWHA report that smoking prevalence 
among PLWHA is higher than non-infected individuals. Saves et al. (2003) found 
that 55% of a sample of 223 HIV-infected men and 58% of a sample of 51 HIV-
infected women were smokers.  By comparison, only 32.7% of a sample of 527 non-
infected men and 28.1% of a sample of 511 non-infected women were smokers 
(Saves et al., 2003). The authors reported that the estimated attributable risk of IHD 
due to smoking was 65% in HIV-infected men and 29% in HIV-infected women 
(Saves et al., 2003). In SA a relative comparison regarding smoking status between 
HIV-infected and non-infected individuals can be made when reviewing the following 
two articles. In the general SA population smoking prevalence is reported to be 10 
to 11% in women, 35% in men, with lower prevalence associated with higher 
income and education, and higher prevalence with living in an urban area (Peer et 
al., 2009). A further article was available for review regarding smoking status in 
PLWHA admitted to a hospital for management of cardiac symptoms. Sliwa et al. 
(2012) reported that the smoking prevalence was 45% in a sample of 196 PLWHA 
when the influence of HIV infection was evaluated in the Heart of Soweto Study 
cohort. Individuals included in this study consisted of individuals admitted to Chris 
Hani Baragwanath hospital for secondary management due to the presence of 
cardiac symptoms. The authors also reported that men (77%) included in the study 
were more likely to be smokers than women (23%). It therefore appears that 
smoking in South African PLWHA could also be a more significant problem. 
Published information pertaining to smoking prevalence of PLWHA at primary care 
level in SA could not be sourced. Considering that more women are reported to 
access HAART in Sub-Saharan Africa (Braitstein et al., 2008), as well as in the 
South African context (Cornell et al., 2012), it would be prudent to assess the 
smoking status of PLWHA at a primary care level. It would generate the information 
27 
 
necessary to evaluate the need for smoking cessation programmes as a means of 
managing IHD at primary care level.  
 
2.3.3.2.3  Behavioural risk factor: Diet 
Diet can reduce or increase the risk of IHD. The INTERHEART study assessed the 
relationship between following an oriental diet (high intake of tofu, soy with sauces), 
western diet (high intake of fried foods, salty snacks, eggs and meats) and prudent 
diet (high intake of fruit and vegetables) with the risk of AMI (Iqbal et al., 2008). The 
authors found that the prudent diet was associated with a reduced risk for AMI, the 
western diet was weakly associated with an increased risk for AMI and the oriental 
diet had no relationship with AMI (Iqbal et al., 2008). The investigators further 
analysed the influence of selected food items on the risk for AMI. A significant 
inverse association between the intake of the following items and AMI existed 
respectively for: raw vegetables, green leafy vegetables, cooked vegetables and 
fruits. Conversely, a positive association between AMI and the intake of fried foods 
and salty snacks (p<0.001) and a weak association with meat intake and AMI 
(p<0.08) existed (Iqbal et al., 2008). In addition, Artalejo et al. (1996) indicated how 
a Mediterranean diet, that contains fish and wine, influenced the mortality ratio of 
IHD. The authors reported that a diet containing fish reduced the risk of dying from 
IHD (r=-0.32; p=0.037) and that a moderate consumption of wine had an inverse 
relationship with IHD mortality (r=-0.31; p=0.038). They, however, highlighted that 
heavy consumption of wine revealed a positive association with IHD mortality 
(r=0.35; p=0.037). From all this, the WHO suggests an intake of at least five 
vegetables and fruit combined (400 grams) per day in an attempt to prevent non-
communicable diseases such as IHD (WHO, 2013). A high intake of fruit and 
vegetables and fish as preferred protein source is also suggested in both the 
general and the HIV population as a means of prevention and secondary 
management of IHD (Alpert, 2011; Lundgren et al., 2008). 
 
International data suggest that the dietary quality of PLWHA on HAART requires 
improvement. Duran et al. (2008) conducted a cross-sectional study in 56 HIV-
infected adults between the ages of 20–59 years of age in Sao Paulo, Brazil. 
Dietary intake was assessed as the average of two 24-hours dietary recall of 
participants spaced a week apart. Foods were grouped according to their 
composition and classification following the dietary guidelines of Brazil. The majority 
of participants in the study were men (82%), and the authors found that most 
individuals had an inadequate diet (64.3%) that required improvement, but only 
8.7% had a poor diet. The diet quality was better in those individuals that were not 
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overweight (p=0.033) as they also had higher dairy and grains scores (p=0.039 and 
0.005 respectively). Participants in the study had a low intake of fruit and vegetables 
irrespective of their weight status, as well as a high intake of meats, eggs, total fat 
and cholesterol (Duran et al., 2008).  
 
A study conducted in SA among PLWHA, not on HAART, and non-infected 
individuals had slightly different findings. Voster et al. (2004) investigated the 
nutritional status of “apparently healthy” asymptomatic HIV-infected Africans 
compared to non-infected Africans older than 15 years in the Thusa study, 
conducted in the North West Province of SA.  Thusa is an acronym for Transition 
and Health during Urbanisation of South Africans. The main aim of the larger Thusa 
study was to monitor the impact of urbanisation on health to provide information on 
specific interventions needed to improve health. The authors reported that all 
groups seemed to follow a prudent diet containing vegetables with total fat providing 
26% of total energy intake, in line with the guideline of less than 30%. An interesting 
finding was that a moderate to high intake of maize meal porridge and/or samp 
resulted in higher liver enzymes than individuals who consumed a diet of meat and 
vegetables (Vorster et al. 2004). The relationship between the dietary content and 
liver function parameters is worth bearing in mind, considering that PLWHA often 
present with, or develop, liver dysfunction (Crum-Cianflone et al., 2009). In such 
cases advice regarding reducing the consumption of maize meal porridge and/or 
samp as their main source of dietary intake could influence their liver function 
favourably.  
 
By contrast, more recent literature on the general South African population has 
shown that vegetable and fruit intake is less than the WHO recommended daily 
amount. Faber, Laubscher and Laurie (2013), when assessing the consumption of 
fruit and vegetables in individuals living in a peri-urban area in KwaZulu Natal, found 
that intake in two- to five year old children was 99 grams daily, and 124 grams per 
day for their adult caregivers. Similarly, Peltzer and Phaswana-Mafuya (2012), in a 
national cross-sectional study found that the overall prevalence rate for insufficient 
fruit and vegetable intake in adults older than 50 years of age was 68.5%, with a 
mean intake of four servings reported per day. In multivariate analysis, coming from 
a Black African or coloured population group, lower educational level and being a 
smoker were associated with inadequate fruit and vegetable intake (Peltzer and 
Phaswana-Mafuya, 2012). Putting the burden of disease attributable to low fruit and 
vegetable intake in SA into perspective is possible due to findings from Schneider et 
al. (2007). They reported that, for both men and women, the largest portion of total 
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years of healthy life lost due to low fruit and vegetable intake was for IHD (60.6% 
and 52.2% gender respectively). Considering the contrasting findings related to fruit 
and vegetable intake reported above, the need for assessing the intake of fruit and 
vegetable in PLWHA on HAART at primary care level as a means of screening for 
risk for IHD is indicated.  
 
2.3.3.2.4 Behavioural risk factor: Perceived stress levels 
Psychosocial stress is a modifiable risk factor for IHD, as it is independently 
associated with IHD, but facilitates changes in health behaviour, thereby influencing 
the pathophysiology of IHD. The INTERHEART study highlighted the association of 
psychosocial stress with the risk of AMI after adjustment for age, sex and 
geographical region with an OR of 3.49 (95% CI: 2.41–5.04) in women and 2.58 
(95% CI: 2.11–3.14) in men (Yusuf et al., 2004). Psychosocial stress was assessed 
by evaluating responses to four questions regarding stressful factors, namely, stress 
at work and home, financial stress and major life events in the past year (Rosengren 
et al., 2004). People presenting for their first AMI had higher prevalence of all four 
stress factors (p<0.0001) than their matched control subjects (Rosengren et al., 
2004).  
 
The close relationship between IHD and stress can firstly be explained by the 
internal body response to stress. Psychosocial stress adversely affects autonomic 
and hormonal homeostasis, resulting in metabolic abnormalities, systemic 
inflammation and insulin resistance (Das and O’Keefe, 2008). Secondly, due to 
different ways of processing psychosocial stress, it has the ability to influence 
individuals’ health behaviour. Rod et al. (2009) indicate that individuals with higher 
levels of stress were less likely to quit smoking (OR=0.58; 95% CI: 0.41–0.83) and 
more likely to become physically inactive (OR=1.90; 95% CI: 1.41–2.55) than those 
with low levels of stress. The authors also found that stressed women were more 
likely to become overweight (OR=1.55; 95% CI: 1.12–2.15) and stressed men were 
twice as likely to develop diabetes mellitus (OR=2.36; 95% CI: 1.22–4.59). 
Consequently, stress management strategies could decrease the risk of IHD by 
influencing how individuals perceive and interpret stressful stimuli and also by 
preventing or minimising poor health style habits.  
 
Literature of perceived psychosocial stress levels for SA is available. Hamad et al. 
(2008) assessed the perceived stress levels of low-income individuals in Cape 
Town, Port Elizabeth and Durban who applied for loans at a local microcredit 
lending organisation. Stress in individuals was evaluated with the 10-item version of 
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the Cohen’s Perceived Stress Scale (PSS) and the authors found that men had a 
mean PSS score of 17.5 and women 19.6 (standard deviations were not included). 
The HIV status of those in the study was not collected, though the authors reported 
that an HIV-positive status might significantly influence participants’ stress levels. 
This suggestion is supported by findings from Garcia et al. (2013). They evaluated 
Ghanaian women’s perceived stress levels with the 4-item PSS 12 months after 
childbirth. The authors found that being HIV-positive had an independent 
relationship (OR=2.31; 95% CI: 1.29–4.12) with the PSS score compared to non-
infected mothers. Literature pertaining to perceived stress levels in PLWHA in SA 
could not be sourced. Comparing the South African findings of Hamad et al. (2008) 
with an international study is, however, beneficial in highlighting the differences in 
levels of perceived stress between countries.  
 
The South African mean PSS scores were higher than PSS scores collected in a 
survey conducted on the general USA public in 2009. Cohen and Janicki-Deverts 
(2012) reported that the mean PSS score in the survey for men was 15.52 (±7.44) 
and women 16.14 (±7.56) when the 10-item version of the PSS was used. It 
therefore seems that the South African public experiences higher levels of stress 
than that of the USA. Review of the findings of perceived stress in the 
INTERHEART study and the studies reported above shows a trend towards women 
experiencing higher levels of stress than men. This particular risk factor for IHD 
could be more significant for PLWHA in SA as the prevalence rate of HIV infection is 
higher in women than men (Stats SA, 2013). In view of the absence of literature 
regarding perceived stress levels of PLWHA in SA, collecting this data would 
determine whether high stress levels among PLWHA is a problem. This, in turn, 
would provide support for implementing strategies to manage stress as a means of 
improving individuals’ health. The physiological parameters of stress, namely, 
elevated RHR and blood pressure that are considered controllable risk factors for 
IHD, will be discussed in section 2.3.3.2.5 and the effects of HIV infection on these 
parameters will be highlighted. 
 
2.3.3.2.5 Physiological risk factors: RHR and blood pressure  
An elevated RHR has been shown to be a risk factor for IHD as it is an independent 
predictor of IHD events in men and women. A RHR more than 79 beats per minute 
(bpm) is suggested as a risk factor for IHD (Hsia et al., 2009; Palatini, 2007).  They 
evaluated the relationship between RHR and IHD events in postmenopausal women 
included in the Women’s Health Initiative study over a 7.8 (±1.6) year follow-up 
period. The authors found the hazard ratio to be 1.29 (95% CI: 1.11–1.42) for the 
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highest RHR (>76 bpm) versus the lowest RHR (≤62 bpm; p=0.001). The 
relationship between RHR and IHD events did not differ between ethnic groups or 
between women with or without diabetes. It was, however, stronger in women aged 
50-64 years at baseline than those aged 65-79 years. Similarly, Greenland et al. 
(1999) evaluated the relationship between RHR and risk of IHD, cardiovascular 
disease, cancer and all-cause mortality in age-specific cohorts in black and white 
men and women over a 22 year period. The authors’ findings specific to IHD were 
as follows: for men aged 18-39 years, RR=1.27 (95% CI: 1.08–1.48); for men aged 
40-59 years, RR=1.13 (95% CI: 1.05–1.21); for men aged 60-74 years, RR=1.00 
(95% CI: 0.89–1.12); for women aged 40-59 years, RR=1.21 (95% CI: 1.07–1.36); 
and for women aged 60-74 years, RR=1.16 (95% CI: 0.99–1.37). Heart rate was not 
associated with mortality in women in the age group of 18-39 years. The 
relationship between an elevated RHR and the risk for IHD can be explained by the 
relationship of this parameter with other known modifiable risk factors for IHD, as 
well as the physiological changes that occur as a result (Palatini, 2007; Greenland 
et al., 1999). 
 
An elevated RHR could be the result of known modifiable risk factors for IHD. 
Greenland et al. (1999) indicated that RHR correlated significantly and positively 
with SBP and DBP and smoking status in all age groups (p<0.01). In contrast, 
correlations with cholesterol levels and BMI were small or inconsistent between age 
groups (Greenland et al., 1999). The suggested physiological mechanisms for the 
relationship between elevated RHR and the risk of IHD can be explained thus: the 
relationship is considered to be due to heightened sympathetic nervous system 
activity resulting in the rapid RHR (Palatini, 2007). The rapid RHR increases the 
pulsatile nature of the arterial blood flow and causes greater mechanical stress and 
shear forces on the endothelium, resulting in increased arteriosclerosis (Palatini, 
2007). In addition, the elevated RHR causes an increase in cardiac work load, and 
that, over time, greatly stresses the heart (Palatini, 2007). Evaluating RHR is often 
the first vital sign assessed in a health care environment, and is therefore a 
convenient parameter for assessing risk for IHD. 
 
An international study suggests that elevated RHR occurs in PLWHA on HAART 
when compared to age-matched healthy control group volunteers. Lebech et al. 
(2007) conducted a study with PLWHA (n=16) and non-infected individuals (n=12) 
that were non-smokers, did not have diabetes and had not previously received any 
medication for HTN or dyslipidaemia. The PLWHA included in the study had to have 
been on HAART for three years. The authors found that the RHR of PLWHA was 
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significantly higher than control participants (69 bpm [62–74] compared with 57 bpm 
[52–60]; p<0.001). In addition, the authors found that heart rate variability and 
parasympathetic activity in PLWHA was also lower than their age-matched controls. 
They concluded that the elevated RHR might be due to parasympathetic nervous 
system dysfunction. Considering the findings of Lebech et al. (2007), evaluating 
RHR in PLWHA in SA at primary care level would be beneficial in determining 
whether this physiological risk factor for IHD is present.  
 
Hypertension is an important modifiable risk factor for IHD internationally, and also 
in the African context, due in part to the increased prevalence of this risk factor. 
Hypertension is defined as a blood pressure reading of more than 140/90 
millimetres mercury (mmHg) (Seedat et al., 2006). The INTERHEART study 
indicated that the association, as reflected by OR between HTN and AMI adjusted 
for age, sex and geographical area, was 2.95 (95% CI: 2.57–3.39) in women and 
2.32 (2.12–2.53) in men (Yusuf et al., 2004). The INTERHEART Africa study 
highlighted that this risk factor was more closely related to AMI in Black Africans 
(OR=6.99; 95% CI: 4.23–11.55) than Coloured Africans (OR=2.31; 95% CI: 1.61–
3.32) or European or Other Africans (OR=3.90; 95% CI: 1.92–7.94) (Steyn et al., 
2005). Additional literature suggests that prevalence of HTN in women is twice that 
of men for Black Africans, Coloured and Indian or Asian individuals in SA as 
assessed during a nationwide survey (Hasumi and Jacobsen, 2012). No significant 
difference in prevalence rates for HTN was observed by gender for White South 
Africans (Hasumi and Jacobsen, 2012). Literature regarding the effect of HIV 
infection on blood pressure differs when reviewing data concerning HAART 
exposure. 
   
Bärnighausen et al. (2008) conducted a study in 25-49-year-old men and women 
living in Umkhanyakude in rural KwaZulu-Natal in SA as a means of evaluating the 
influence of HIV infection on BMI and HTN in individuals not on HAART compared 
to non-infected controls. The study took place in 2003–2004, before HAART was 
widely available in SA, and this area was reported to have high prevalence rates of 
HIV (Bärnighausen et al., 2008). The authors found that SBP was on average 3 
mmHg lower and BMI 1.9 kg/mm2 lower in PLWHA than their controls. Further 
analysis highlighted that HIV infection reduced SBP independently of its lowering 
effect on BMI (Bärnighausen et al., 2008). Possible reasons for this finding included 
HIV-related hypoadrenalism or side effects of traditional medicines against HIV 
(Bärnighausen et al., 2008).  
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International data provide information regarding the prevalence of HTN in PLWHA. 
Medina-Torne et al. (2012) reported that the prevalence of HTN was not significantly 
different (p=0.47) between HIV-positive individuals on HAART (32%) compared to 
those not receiving HAART (29%) (Medina-Torne et al., 2012). Factors associated 
with HTN included increasing age, longer duration of HIV infection, higher BMI and 
diabetes, and a trend also existed for African American ethinicity.  Considering the 
reported increase of HTN in the general SA population, it would be beneficial to 
investigate whether HTN is a significant health concern in PLWHA on HAART at 
primary care level that requires therapeutic strategies to improve. Section 2.3.3.2.6 
consists of a discussion related to the anthropometric risk factors for IHD and how 
this differs in PLWHA.  
 
2.3.3.2.6  Anthropometric risk factors: BMI, WC and WHR 
Obesity, measured by BMI, and abdominal obesity measured by WC and WHR are 
considered risk factors for IHD. The INTERHEART study indicated that an elevated 
BMI had a modest association with AMI (OR=1.44; 95% CI: 1.32–1.57) that 
decreased when adjusting for WHR (OR=1.12; 95% CI: 1.03–1.22), and was absent 
when adjusting for all other risk factors for IHD (OR=0.98; 95% CI: 0.88–1.09) 
(Yusuf et al., 2005). On the other hand, WC and WHR were significantly associated 
with AMI when adjusting for all other risk factors for IHD (OR for top quartile versus 
lower quartile were 1.33 and 1.75 respectively [p<0.0001]) (Yusuf et al., 2005). 
When evaluating obesity it is therefore suggested that BMI, WC and WHR 
measures be included in risk factor screening for IHD to provide a more reliable 
evaluation.  
 
The European AIDS Clinical Society guidelines on the prevention and management 
of metabolic diseases in HIV suggest that screening of body composition, e.g., BMI, 
WC and WHR, should be done on every patient at diagnosis, before initiation of 
HAART and annually thereafter (Lundgren et al., 2008). Specific BMI, WC and WHR 
ranges are available to facilitate effective screening. The following ranges are 
suggested as normal abdominal obesity measurements for men and women 
respectively: men, WC<102 cm and WHR<0.95; women, WC<88 cm and 
WHR<0.86 (American College of Sports Medicine [ACSM], 2010; NCEP ATP-III, 
2002). The International Classification of adult underweight, overweight and obesity 
as per BMI measurements are presented in Table 2.2 (WHO, 2004).  
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Table 2.2:  The International Classification of Adult Underweight, Overweight and 
Obesity According to BMI 
Classification BMI (kg/m2) 
Underweight 
 Severe thinness 
 Moderate thinness 
 Mild thinness 
< 18.50 
< 16.00 
16.00 – 16.99 
17.00 – 18.49 
Normal range 18.50 – 24.99 
Overweight ≥ 25.00 
Pre-obese 25.00 – 29.99 
Obese 
 Obese class 1 
 Obese class 2 
 Obese class 3 
≥ 30.00 
30.00 – 34.99 
35.00 – 39.99 
≥ 40.00 
 
Obesity in PLWHA is an increasing health concern as individuals are living longer. 
Crum-Cianflone et al. (2010) found that 62% of individuals included in the US 
Military HIV Natural History Study (1985–2004) gained weight during HIV infection 
(Crum-Cianflone et al., 2010). Weight-gain in itself should not be considered 
problematic, considering that an HIV-positive status is reported to reduce 
individuals’ BMI by 1.9 kg/m2 prior to initiation of HAART (Bärnighausen et al., 
2008). The concern is about weight-gain in individuals already overweight or obese 
at diagnosis or initiated on HAART. Of notable interest, as reported by Crum-
Cianflone et al. (2010), is that 37% of individuals were already overweight and 9% 
obese at diagnosis of HIV infection. Factors that influenced a higher BMI value at 
diagnosis were African-American ethnicity, age, being HIV-positive and earlier HIV 
stage (Crum-Cianflone et al., 2010). Weight gain in the study was related to lower 
BMI at diagnosis, a higher CD4 count, lower viral load values, a lack of AIDS 
diagnosis and longer HIV duration (all parameters p<0.05). Similarly, Hurley et al. 
(2011), when evaluating weight gain in a group of South African individuals initiated 
on a Stavudine-containing HAART regimen, found a mean BMI change of 2.4 kg/m2 
(95% CI: 1.7–3.1; p<0.001) in men and 2.2 kg/m2 (95% CI: 1.5–2.9; p<0.001) in 
women during the first year of HAART. At commencement of HAART 12% of the 
study cohort were obese and 21% were overweight. That changed to 22% obese 
and 36% overweight at 12 months (Hurley et al., 2011). Increase in BMI was 
positively associated with age (p=0.001) in both genders, and inversely associated 
with TB diagnosis in female participants (p=0.018) (Hurley et al., 2011). The 
presence of obesity with the subsequent increase in weight following initiation of 
HAART could therefore increase individuals’ risk of IHD. Abdominal obesity is also a 
body composition change that can occur in PLWHA. 
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Body composition changes are known to occur in PLWHA, and consist of 
subcutaneous lipoatrophy in the face, limbs and buttocks, with increased 
accumulation of central body fat representing visceral adipose tissue (Grinspoon 
and Carr, 2005). Saves et al. (2003), in evaluating risk factors for IHD in PLWHA 
compared to non-infected individuals, found that body composition changes as 
measured with WHR were higher in PLWHA. They noted the mean WHR of HIV-
positive men to be 0.94 (±0.06) compared to HIV-negative men 0.92 (±0.06), and 
HIV-positive women 0.85 (±0.07) compared to HIV-negative women 0.80 (±0.07) 
(Saves et al., 2003). The higher WHR in PLWHA could be due to the influence of 
HAART. Lipodystrophy (body composition changes in fat distribution) is associated 
with HAART (Friis-Møller et al., 2003). In multivariate analysis the authors indicated 
that the association between HAART and lipodystrophy was as follows: nucleoside 
reverse transcriptase inhibitor (NRTI) OR=8.93 (95% CI: 6.45–12.3; p=0.0001); non-
NRTI (NNRTI) OR=12.99 (95% CI: 9.46–17.8; p=0.0001); protease inhibitor (PI) 
OR=12.40 (95% CI: 9.10–16.9; p=0.0001); NNRTI and PI combined OR=15.62 
(95% CI: 1.23–21.7; p=0.0001). Thus HAART could increase the likelihood of 
PLWHA developing lipodystrophy to varying degrees, but an advanced regimen 
containing PI seems to contribute more to its development.  
 
Body composition changes were investigated by George et al. (2009) in a cohort of 
PLWHA in SA initiated on a HAART regimen containing Stavudine over a two-year 
period. This HAART regimen was the first line HAART regimen in use in SA. The 
authors reported that participants that developed lipodystrophy tended to have a 
greater BMI prior to initiation of HAART (p<0.05). In addition, all participants had a 
significant increase in WC from baseline to the end of the study, with changes 
occurring more in participants that developed lipodystrophy (p<0.005) than those 
who did not (p<0.001) (George et al., 2009). Additionally Hurley et al. (2011) also 
noted a significant (p<0.001) increase in WC from baseline of 7.2 cm in men and 
7.8 cm in women during the first year when initiated on a Stavudine containing 
regimen. Waist circumference was positively associated with age in women 
(p=0.003) and men (p=0.006) in the study conducted by Hurley et al. (2011). 
Increasing WC in individuals is an indication of visceral adipose tissue accumulation 
(Katzmarzyk, Heymsfield and Bouchard, 2013). The presence of visceral adipose 
tissue has been linked to an increased risk of IHD in the general population (Smith 
et al., 2012). These authors indicated that markers for insulin resistance (e.g. fasting 
glucose and insulin levels), lipid profile (e.g. total cholesterol, LDL) and inflammation 
(e.g. CRP levels) increased with visceral adipose tissue accumulation in men and 
women with and without diabetes mellitus. They also found that visceral adipose 
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tissue was positively associated with type two diabetes for men (OR=1.25; 95% CI: 
1.09–1.44) and more so in women (OR=1.78; 95% CI: 1.50–2.12). They further 
reported that cardiovascular disease increased with visceral adipose tissue 
categories irrespective of whether individuals had diabetes mellitus. Thus the body 
composition changes associated with an increased WC and WHR as found by the 
various authors could increase the risk for IHD in PLWHA and require management. 
Section 2.3.3.2.7 consists of a discussion of the metabolic risk factors for IHD and 
how management of HIV infection increases them in PLWHA. 
 
2.3.3.2.7  Metabolic risk factors: Diabetes Mellitus and altered lipid profile 
Diabetes mellitus and an altered lipid profile are known risk factors for IHD. The 
INTERHEART study demonstrated that the association between diabetes mellitus 
and AMI when adjusting for age, sex and geographical region was OR=4.26 (95% 
CI: 3.51–5.18) for women and OR=2.67 (95% CI: 2.36–3.02) for men (Yusuf et al., 
2004). Jeppesen et al. (1997) indicated that the age-adjusted incidence of an IHD 
event during an eight-year follow-up period differed according to lipid profile 
component changes in men. The prevalence of an IHD event was 11.4% in 
individuals with high TG and low HDL, 8.2% in high LDL and 17.5% in individuals 
with combined high TG, low HDL and high LDL levels.  
 
Diabetes and altered lipid profiles are a concern in PLWHA due to the relationship 
between HAART and diabetes and altered lipid profiles. De Wit et al. (2008) have 
shown the incidence of diabetes per person-years of follow-up to be 5.72 per 1 000 
person-years of follow-up (95% CI: 5.31–6.13) in PLWHA. The incidence also 
increased significantly with cumulative exposure of HAART (p=0.0001) (De Wit et 
al., 2008). The following antiretroviral drugs were associated with diabetes: 
Stavudine (RR=1.13; 95% CI: 1.08–1.15; p=0.0001), Zidovudine (RR=1.05; 95% CI: 
1.01–1.10; p = 0.01) and Didanosine (RR=1.06; 95% CI: 1.01–1.11; p=0.02) 
Additional factors associated with new-onset diabetes were a reduction in HDL 
(RR=0.75; 95% CI: 0.58–0.96; p=0.02), an increase in TG (RR=1.64; 95% CI: 1.50–
1.80; p=0.0001) and fat gain (RR=1.36; 95% CI: 1.09–1.68; p=0.006) (De Wit et al., 
2008).  
 
Changes in lipid profiles occur in PLWHA, but there are differences when individuals 
are on HAART compared to HAART-naïve. Borato et al. (2012) found that a 
significant reduction in HDL occurs in PLWHA treated with HAART compared to 
those who were not. In contrast, individuals receiving therapy also had significant 
increases in total cholesterol, LDL and TG (Borato et al., 2012). Literature from 
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Friis-Møller et al. (2003) sheds light on how the various antiretroviral drug classes 
influence the lipid profile in PLWHA. They demonstrated an altered cholesterol level 
≥ 6.2 mmol/l associated with NNRTI (OR=1.79; 95% CI: 1.45-2.22; p=0.0001), PI 
(OR=2.35; 95% CI: 1.92–2.87; p=0.0001) and NNRTI and PI combined (OR=5.48; 
95% CI: 4.34–6.91; p=0.0001). In addition, an HDL lower than 0.9 mmol/l was 
associated with NRTI (OR=1.35; 95% CI: 1.06–1.71; p=0.02) and PI (OR=1.46; 
95% CI: 1.20–1.77; p=0.001). Lastly, a TG greater than 2.3 mmol/l was associated 
with all drug classes: NRTI (OR=1.48; 95% CI: 1.22–1.79; p=0.0001), NNRTI 
(OR=2.06; 95% CI: 1.73–2.45; p=0.0001), PI (OR=2.90; 95% CI: 2.47–3.40; 
p=0.0001) and NNRTI and PI combined (OR=4.66; 95% CI: 3.82–5.67; p=0.0001). 
Thus the development of diabetes and an altered lipid profile could be risk factors 
for IHD in PLWHA, and require monitoring and management in the HAART era. 
Section 2.3.3.2.8 consists of an explanation of the inflammatory risk factor marker 
hs-CRP, and why this marker can be used to monitor risk for IHD. 
 
2.3.3.2.8  Inflammatory risk factor marker: Hs-CRP  
Systemic inflammation plays an important part in the pathophysiology of IHD, and is 
stimulated by certain risk factors for IHD. A summary of these risk factors is 
presented in Figure 2.2 below. 
 
 
 
 
 
            
 
(Smith et al., 2012; Das and O’Keefe, 2008; Mora et al., 2007; Ambrose and Barua, 2004; 
Spranger et al., 2003). 
 
Figure 2.2:  Risk Factors for IHD that Stimulate Systemic Inflammation 
 
High-sensitivity CRP is a marker of inflammation with predictive abilities for 
cardiovascular events in the general population (Pearson et al., 2003), and also in 
PLWHA (De Luca et al., 2013; Triant, Meigs and Grinspoon, 2009). The suggested 
categories of hs-CRP as risk for cardiovascular events are as follows: low risk (less 
than 1.0 mg/l), average risk (1.0-3.0 mg/l) and high risk (Hs-CRP>3.0 mg/l) 
(Pearson et al., 2003). For PLWHA De Luca et al. (2013) indicated that a high hs-
CRP value was independently associated with a cardiovascular event (OR=1.69; 
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Abdominal 
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95% CI: 1.09–2.64; p=0.02). Furthermore, Triant, Meigs and Grinspoon (2009) 
showed that both an elevated Hs-CRP value (OR=2.13; 95% CI: 1.92–2.37; 
p<0.0001) and HIV status (OR=1.93; 95% CI: 1.21–2.93; p=0.004) were 
independently associated with AMI when adjusting for age, sex, race, HTN, 
diabetes and dyslipidaemia. Masia et al. (2007) investigated the relationship of 
known IHD risk factors with CRP in PLWHA. They found that CRP levels correlated 
positively with total cholesterol (p=0.01), LDL (p=0.001), TG (p=0.04) and the 
Framingham Risk Score (FRS) (p=0.006) and negatively with HDL (p=0.004) during 
univariate analysis. In multivariate analysis factors independently associated with 
CRP were LDL (p<0.001), HDL (p=0.001), cigarette smoking (p=0.019) and HAART 
(p=0.021). Managing risk factors for IHD at primary care level that could influence 
Hs-CRP and potentially decrease the risk for IHD should therefore be a priority. 
Section 2.3.4 provides information regarding IHD risk calculation as a means of 
evaluating individuals’ 10-year relative risk of developing IHD. 
 
2.3.4  IHD Risk Calculation 
Once individuals have been screened for risk factors of IHD the information can be used to 
calculate an individual’s absolute risk of developing IHD by using a prediction equation. IHD 
prediction equations specific to PLWHA are not available for use, and the FRS is suggested 
as an effective alternative at present (Schambelan et al., 2008). When comparing FRS of 
PLWHA with non-infected individuals findings suggest PLWHA have higher scores. De 
Socio et al. (2007) evaluated the estimated IHD risk in PLWHA compared to a general 
population. The authors found the FRS to be higher (7 [±5]) in PLWHA than non-infected 
individuals (6.3 [±5]). In contrast, Hadigan et al. (2003) indicated that the FRS for HIV-
infected subjects (with fat redistribution) compared with age, sex and BMI matched non-
infected participants was significantly different (p=0.002) at 7.4 (±0.6) compared to 5.3 
(±0.3). An interesting additional finding was that FRS differed according to pattern of fat 
redistribution in PLWHA: lipoatrophy (9.2 [±1.8]), lipohypertrophy (4.3 [±0.7]) and mixed 
lipodystrophy (7.6 [±0.8]). This is therefore an additional component specific to PLWHA that 
can further influence their 10-year risk of IHD. Section 2.3.5 consists of information 
pertaining to individuals’ self-perception of IHD risk as a means of providing information 
regarding subjectively perceived mediated risk for IHD. 
 
2.3.5  Self-Perception of IHD Risk 
Perceptions of own risk of developing IHD is a factor that could influence individuals’ health 
behaviour, and may impede preventive efforts of lowering individuals’ IHD risk. Perceptions 
of IHD are reported to be often underestimated by individuals (Ansa, Oyo-Ita and Essien, 
2007; Hart, 2005; Avis, Smith and McKinlay, 1989). Factors said to influence these 
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perceptions are perceptions of generally poor health; presence of other risk factors for IHD 
and a greater knowledge regarding risk factors (Meischke et al., 2000). Only one study of 
perception of risk for IHD in PLWHA is available. Cioe, Crawford and Stein (2013) 
evaluated PLWHA’s perception regarding risk for cardiovascular disease using the 
Perception of Risk of Heart Disease Scale. They also collected data concerning individuals’ 
knowledge of cardiovascular disease using the Heart Disease Fact Questionnaire, and 
estimated individuals’ own estimate of risk with the FRS. The authors found the risk factor 
knowledge score to be fairly high (19 [±3.5]), mean total score on the Perception of Risk of 
Heart Disease Scale 53.1 (±5.9) and FRS 7.9 (±6.0). The authors found a statistically 
significant (p=0.01), though weak, association between estimated (FRS) and perceived risk 
for IHD (r=0.24). In addition, they found no significant relationship between demographic 
variables and perceived risk (p=0.98) or risk factor knowledge (p=0.21). The authors 
suggested that intervention programmes are needed in PLWHA to improve risk-perception 
of individuals by focusing on the role that risk factors, such as physical inactivity, play in 
increasing cardiovascular disease risk.  
 
Section 3 of the literature review is presented in section 2.4, and consists of information 
regarding physical activity modification as a means of influencing the risk for IHD.  
 
2.4  SECTION 3 – PHYSICAL ACTIVITY MODIFICATION AS PREVENTION STRATEGY FOR 
IHD 
 
The literature regarding physical activity modification in this section is discussed under 
headings: definition of physical activity, Public Health physical activity recommendations, 
moderate-intensity exercise effects in PLWHA, methods of promoting physical activity at 
primary care level and, lastly, home-based pedometer walking programmes.  
  
2.4.1  Definition of Physical Activity 
The definition of physical activity needs to be clear, in order to distinguish this term from 
fitness terminology, such as exercise and physical fitness.  Physical activity is defined as 
any body movement produced by the contraction of skeletal muscles that results in 
increased caloric requirements above resting energy expenditure (ACSM, 2010). Exercise, 
on the other hand, is a type of physical activity that is planned, structured and includes 
repetitive body movements to improve or maintain one or more components of physical 
fitness (ACSM, 2010). Physical fitness is related to ability to perform physical activity due to 
certain physical attributes (ACSM, 2010). Physical activity is related to what an individual 
does throughout the day, where exercise focuses only on a certain part of the daily routine. 
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Physical activity modification can thus be defined as an attempt to include more body 
movement in the daily routine in an effort to achieve the Public Health recommendations.  
 
2.4.2  Public Health Physical Activity Recommendations  
Public Health physical activity recommendations are available as a guide to promote health 
and prevent chronic conditions such as IHD in the general population. At conception of the 
research project the ACSM and American Heart Association’s physical activity 
recommendations (Haskell et al., 2007) were used to guide phase 2 of the research project. 
Since then additional guidelines with slight differences have been published, e.g. the British 
Association of Sport and Exercise Sciences’ ABC of Physical activity for Health (O’Donovan 
et al., 2010) and the 2011 Canadian Physical Activity Guidelines (Trembly et al., 2011). 
Table 2.3 gives a summary of the recommendations for adults 18–65 years of age from the 
ACSM and American Heart Association, as used in the walking programme formulation in 
the research project.  
 
Table 2.3: Public Health Physical Activity Recommendations for Adult 
Authority Physical activity recommendations Reference 
ACSM/AHA Adults aged 18–65 years of age 
 
Moderate-intensity aerobic physical activity for a minimum of 
30 minutes on five days each week or vigorous-intensity 
aerobic activity for a minimum of 20 minutes on three days 
each week. Combination of moderate- and vigorous-intensity 
activity can be combined to meet recommendations.  
 
Moderate-intensity aerobic activity (equivalent to brisk walking) 
with noticeable acceleration in heart rate can be accumulated 
toward the 30 minutes minimum by performing bouts each 
lasting 10 or more minutes. Vigorous-intensity aerobic activity 
(e.g. jogging) with rapid breathing and a substantial increase in 
heart rate.  
 
In addition, at least twice a week performing activities using the 
major muscles of the body that will result in muscle 
strengthening and endurance. Persons who wish to further 
improve their personal fitness, reduce risk for chronic diseases 
and disabilities, or prevent unhealthy weight gain will likely 
benefit by exceeding the minimum recommended amount of 
physical activity. 
Haskell et al. 
(2007) 
 
It is important to remember that the moderate- and vigorous-intensity physical activity 
proposed in the recommendations are in addition to the physical activity accumulated in the 
course of normal daily living. Walking more than 10 000 steps per day has also been 
suggested as recommendation to achieve health benefits by being active (ACSM, 2010). 
The physical activity recommendations for PLWHA are very similar, except that moderate-
intensity physical activity is preferred over vigorous-intensity to prevent possible immune 
suppression with more intense exercise (ACSM, 2010). This recommendation is proposed 
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by the European AIDS Clinical Society (Lundgren et al., 2008) and supported by a 
systematic review on the effects of aerobic exercise in PLWHA (O’Brien et al., 2010). That 
review included 14 randomised controlled trials, and found that performing aerobic exercise 
or a combination of resistive and aerobic exercise for at least 20 minutes, at least three 
times per week for at least five weeks, was safe for PLWHA who are medically stable.  
Table 2.4 consists of the physical activity recommendations for PLWHA as proposed by the 
European AIDS Clinical Society.  
 
Table 2.4:  Physical Activity Recommendations for PLWHA 
Authority Physical activity recommendations Reference 
EACS Promote an active lifestyle to prevent obesity, hypertension, 
and diabetes. 
 
Encourage moderate-intensity rather than vigorous exercise. 
 
Encourage self-directed moderate-intensity physical activity 
e.g. use stairs, walk to work or cycle, swim and/or hike. 
 
Achieve cardiovascular fitness, e.g. 30 minutes of brisk walking 
five days per week. 
 
Maintain muscular strength and flexibility. 
Lundgren et al. 
(2008) 
♦ EACS (European AIDS Clinical Society) 
 
Studies have evaluated the effects of moderate-intensity exercise in PLWHA, and a 
summary is set out in section 2.4.3. 
 
2.4.3  Moderate-Intensity Exercise Effects in Adult PLWHA 
Moderate-intensity exercise is beneficial in PLWHA as it is reported to influence a number 
of factors. As expressed in metabolic equivalents it is equal to 3.0-6.0 metabolic 
equivalents (Haskell et al. 2007), and can be evaluated as a percentage of heart rate 
reserve (HRR), oxygen uptake reserve (VO2R) or maximal heart rate (HRmax) (ACSM, 
2010). Moderate-intensity physical activity quantified in these parameters is 40%-59% HRR 
or VO2R or 64%-76% HRmax. A summary of moderate-intensity exercise effects on selected 
IHD risk factors in PLWHA is supplied in Table 2.5. 
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Table 2.5:  Moderate-Intensity Exercise Effects in Adult PLWHA 
Reference Population Study length Intervention Outcome 
Dudgeon 
et al. 
(2012) 
HIV-infected 
men (n=26) 
 
Mean age (yrs): 
IG (43.1 [±1.3]) 
CG (46.6 [±1.5]) 
Six weeks  IG: Supervised three to 
five minutes warm-up, 
30 minutes at 60-75% 
HRmax on stationary 
cycle or treadmill, three 
to five minutes of cool-
down. Upper and lower 
body resistance 
exercise at correct 
intensity level.  
Two times/week. 
 
CG: Did not receive 
intervention. No other 
specific instructions 
noted.  
Significant increase in 
lean tissue mass in IG 
(p<0.001). 
 
No significant change in 
physical activity in IG 
(p=0.38) or CG (p=0.42) 
and no between-group 
difference (p=0.29). 
No significant changes in 
IG or CG in the following 
measures: selected pro-
inflammatory cytokines, 
growth hormone: 
IG (p=0.3), CG (p=0.5), 
cortisol: IG (p=0.3), CG 
(p=0.1). 
No significant changes in 
anthropometric and 
strength measures. 
Ogalha et 
al. (2011) 
HIV-infected 
men (n=34) and 
women (n=29) 
 
Mean age (yrs): 
IG (42.06 
[±7.45]) 
CG (44.25 
[±11.45]) 
Six months 
 
IG: Monthly dietary 
counselling (50 
minutes). Supervised 
aerobic, resisted and 
stretching gym 
programme, one hour, 
three/week at training 
target HRmax of 75%. 
 
CG: Monthly dietary 
counselling (50 
minutes). Thirty 
minute orientation of 
benefits of regular 
physical activity. 
Encouraged to perform 
running, biking or 
walking for one hour, 
three times/ week.  
Significant decrease in 
body fat % (p=0.04), RHR 
(p=0.001), hip 
circumference (p=0.001), 
glucose level (p=0.04) in 
the IG. Significant 
increase in muscle mass 
(p=0.001) and CD4 count 
(p=0.001) in the IG. 
Significant decrease in 
BMI (p=0.02) and hip 
circumference (p=0.001) 
in the CG. 
Significant increase in 
CD4 count (p=0.04) in the 
CG. 
 
Significant changes 
occurred in QOL in both 
groups. 
Mutimura 
et al. 
(2008) 
HIV infected 
men (n=40) and 
women (n=60) 
 
Mean age (yrs): 
IG (37.8 [±5.5]) 
CG (37.5 [±6.9]) 
Six months IG: Supervised 
aerobic, resisted and 
stretching gym 
programme, three/ 
times, one and a half 
hour/sessions, 
alternating days. 
Intensity of exercise 
increased from 45% 
HRmax in the first three 
weeks to 60% HRmax in 
the next six weeks to 
75% HRmax by the end 
of study.  
 
CG: Did not receive 
exercise. No other 
specific instructions 
noted. 
Significant reduction in 
body fat redistribution 
(p<0.0001), BMI 
(p<0.05), WC (p<0.0001), 
WHR (p<0.0001), body 
fat % (p<0.0001) changes 
in IG compared to CG.  
 
Significant increase in 
VO2max (p<0.0001) and 
QOL (p<0.05) changes in 
IG compared to CG.  
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Table 2.5 continued 
Reference Population Study length Intervention Outcome 
Fillipas et 
al. (2006) 
HIV-infected 
men 
(n=40) 
 
Mean age (yrs): 
IG (43.3 [±7.7]) 
CG (43.7 [±10]) 
 
Six months IG: Supervised 
aerobic, resistance 
exercise group class, 
twice weekly. Each 
session (60 minute) 
began with five 
minutes warm-up, 
aerobic and 
strengthening routine 
and ended with five 
minutes cool-down. 
Exercise intensity 
started at 60% HRmax 
and progressed to 
75%. 
 
CG: Community 
walking 20 minutes, 
twice/weekly with 
monthly group 
sessions. Walking 
intensity 60% HRmax 
and progressed to 
75%.  
Significant improvement 
in IG’s self-efficacy 
(p<0.001), RHR 
(p<0.001), overall health 
QOL factor (p<0.05) and 
cognitive function 
(p<0.05) compared to 
CG. 
Dolan et 
al. (2006) 
HIV-infected 
women (n=40). 
 
Mean age (yrs): 
IG (43 [±2]) 
CG (40 [±2]) 
14 weeks IG: Home-based 
supervised aerobic and 
strength training 
programme, three 
times/week on 
alternating days. Each 
session started with 
five minutes warm-up, 
followed by exercise 
programme and cool-
down period. Aerobic 
exercise intensity was 
set at 60% HRmax first 
two weeks, followed by 
75% thereafter. 
 
CG: Did not receive 
exercise. No other 
specific instructions 
noted. 
Significant improvement 
in VO2 max (p<0.001), 
submaximal bike exercise 
time (p.0.001), six minute 
walk test distance 
(p=0.009), upper and 
lower body muscle 
strength measures, total 
muscle area (p=0.02) and 
muscle attenuation 
(p=0.03) in the IG 
compared to the CG. 
Significant reduction in 
WC (p=0.03) in the IG 
compared to the CG.  
♦ IG (intervention group), CG (control group), QOL (Quality of life), yrs (years) 
 
Additional benefits of moderate-intensity exercise in PLWHA include improvement in 
functional aerobic capacity, as demonstrated by increased treadmill time (Hand et al., 
2008), life satisfaction (Gomes et al., 2010) and decreased levels of depression (Neidig et 
al., 2003). No published literature is available concerning the effects of a home-based 
pedometer walking and education programme on the risk factors for IHD in PLWHA; nor is 
there any on the effects of an exercise programme on the IHD inflammatory marker Hs-
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CRP. The present research project will provide evidence for such a programme that can be 
implemented to promote physical activity in PLWHA at primary care level. 
 
2.4.4  Methods of Promoting Physical Activity at Primary Care Level 
Brisk walking is included in physical activity recommendations for incorporating moderate-
intensity activity into one’s daily routine. Ogilvie et al. (2007) investigated effective methods 
of promoting walking in adults in a systematic review consisting of 19 randomised and 29 
non-randomised controlled trials. They found that interventions tailored to participants’ 
needs, focusing on the most sedentary, and including individuals motivated to change were 
effective (Ogilvie et al., 2007).  In addition, interventions targeted at individual level by 
including advice and motivational components e.g., pedometers or telephone calls, and 
secondly through group programmes, can encourage individuals to walk more, increasing 
activity by 30 to 60 minutes per week (Ogilvie et al., 2007). A systematic review evaluating 
the characteristics of physical activity promotion programmes indicated that programmes 
done at home, unsupervised, informal and which could be done at any time, were most 
effective (Hillsdon et al., 1995). Programmes involving frequent professional contact 
(usually by telephone) and which promoted moderate-intensity exercise, such as walking, 
were also successful (Hillsdon et al., 1995). In addition, Foster, Hillsdon and Thorogood 
(2009) reiterated Hillsdon’s findings in a Cochrane review, stating that physical activity 
promotional strategies have a moderate effect on increasing self-reported physical activity 
in the short- to medium term. The authors found that a mixture of professional guidance 
with self-directed activity plus continuing professional support led to a more consistent 
result (Foster, Hillsdon and Thorogood, 2009). Thus programmes consisting of motivational 
components (professional contact or group support) and monitoring (professional contact or 
pedometers), are flexible and home-based could be possible means to promote physical 
activity effectively. 
 
2.4.5  Home-Based Pedometer Walking Programmes 
Pedometers are small calculators that can be worn to monitor walking quantity, as the 
device counts the number of steps (Tudor-Locke and Lutes, 2009). More than 10 000 
steps/day is considered “active”, 7 500 to 9 999 steps/day is “somewhat active”, 5 000 to 7 
499 steps/day is “light active”, and less than 5 000 steps/day is sedentary (Tudor-Locke 
and Bassett, 2004). Intervention studies have evaluated the effect of pedometer walking 
programmes on physical activity levels. 
 
A systematic review conducted by Bravata et al. (2007) investigated the effects of 
pedometer-based walking programmes on physical activity levels and health outcomes. 
The authors found that programmes were beneficial in promoting physical activity (p<0.00) 
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and participants on average increased their steps/day by 26.9% above baseline. A 
reduction in BMI was possible (p=0.03), and was related to age (p=0.00) and having a step-
count goal (p=0.04). Participants could also significantly reduce their SBP (p<0.00), and 
this was related to a higher baseline blood pressure value (p=0.00) and increase change in 
steps/day (p=0.08). In addition, Richardson et al. (2008) investigated the effect of a 
pedometer-based walking programme on weight loss in a meta-analysis of which nine 
studies met the specific inclusion criteria. The median duration of studies ranged from four 
weeks to one year, with a median of 16 weeks. The pooled estimation of weight change 
possible with such programmes was a loss of 1.27 kg (95% CI: -1.85 to -0.70 kg), with 
longer intervention having greater effect (Richardson et al., 2008). Providing a pedometer 
as a self-monitoring tool while walking is therefore a possible means of promoting 
increased activity and gaining health benefits that could influence IHD risk.  
 
To assist in meeting the Public Health physical activity recommendation of 30 minutes of 
moderate-intensity brisk walking while using a pedometer, walking has been translated to 
steps. Marshall et al. (2009) and Tudor-Locke et al. (2005) indicated that walking at a 
speed of 100 steps/minute was found to be approximately equal to moderate-intensity 
walking. To meet the physical activity recommendations individuals are therefore 
encouraged to walk a minimum of 3 000 steps in 30 minutes, or alternatively, three bouts of 
1 000 steps in 10 minutes (Marshall et al., 2009; Tudor-Locke et al., 2005).  
 
The effects of pedometer walking programmes on selected IHD risk factors in the general 
population have been evaluated by a number of authors. Table 2.6 is a summary of such 
programmes. Studies presented were not included in the systematic review of Bravata et al. 
(2007) or the meta-analysis of Richardson et al. (2008). 
 
Information presented in the table provides evidence regarding the following: 
 
 The influence of pedometer exercise prescription on the outcome (risk factors for IHD) 
of a pedometer walking programme.  
 
 The difference in result between several short bouts of walking (10 minutes three times 
per day) compared to a single long one (30 minutes).  
 
 The difference in result between accumulating 10 000 steps per day compared to 30 
minutes of additional walking per day. 
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 The contrasting results between participating in a programme which progresses 
incrementally to achieve a 3 000 step increase in step-count compared to a programme 
starting with the 3 000 step goal.  
 
 The added benefit of prescribing a walking programme according to heart rate levels or 
asking individuals to document their daily step-count or dyspnoea level in a physical 
activity diary.    
 
 The effect of a pedometer walking programme on inflammatory markers, as conducted 
by Gray et al. (2009). 
 
 Dropout rates of home-based pedometer walking programmes and information 
regarding adherence to pedometer exercise prescriptions.  
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Table 2.6: Pedometer-Based Walking Programmes Focusing on Achieving Physical Activity Recommendations as Prevention Strategy 
for IHD Risk Factors 
Study Methods Participants Interventions Outcomes Adherence  
Serwe et al.  
(2011) 
 
Total population: 
60 participants 
Randomised controlled 
trial with two walking 
groups (walking bouts 
differed) and control 
group 
60 inactive 
premenopausal 
healthcare women self-
reported not to engage 
in ≥ 30 minutes of 
physical activity on 
more than two 
days/week for the past 
three months. 
 
Mean age: 
Walking group #one 
(38.2 [±7.3]) 
Walking group #two 
(37.1 [±7.2]) 
Control group  
(36.3 [±8.1]) 
Eight weeks home-based 
pedometer walking programme.  
 
(Both walking groups consisted 
of n=20) 
Intervention group (IG):  
The intervention participants 
received a pedometer, walking 
log and were instructed not to 
change their diet. IGs were 
instructed to walk for 30 minutes 
daily at 60%-70% HRR five 
days/week.  
 
Walking group #one performed 
three x 10 minutes of walking 
five days/week. Walking group 
#two completed the prescribed 
walking in one continuous 30-
minute bout five days/week. 
Walking logs were returned 
weekly, and participants 
received biweekly telephone 
calls for monitoring purposes. 
Control group (CG): 
 
Asked to maintain normal 
physical activity and diet during 
intervention period 
Significant increase in 
pedometer steps per day in 
both walking groups 
(p<0.001) from baseline, 
but no significant 
differences between the 
two groups.  
 
Significant reduction in hip 
circumference (p<0.05), 
SBP (p<0.05) and DBP 
(p<0.01) in walking group 
#one from baseline. 
Significant increase in six-
minute walk test distance 
(p<0.05) in walking group 
#one from baseline. 
 
Significant decrease in hip 
circumference (p<0.001) 
and DBP (p<0.05) in 
walking group #two from 
baseline. Significant 
increase in six-minute walk 
test distance (p<0.01) in 
walking group two from 
baseline. 
 
No significant changes 
noted in control group. 
Fifty-three of the original 60 
participants completed the 
study. Dropout rate at eight 
weeks was thus 12%. 
 
Lost to follow-up: 
CG (n=1) 
Walking group #one (n=3) 
Walking group #two (n=3) 
 
Reasons for lost to follow-
up not supplied. 
 
Adherence to walking 
programme was calculated 
as a percentage of total 
prescribed sessions 
completed. Adherence in  
walking group #one  was 
69% and 80% in walking 
group #two. Adherence was 
not significantly different 
between groups (p=0.239). 
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Study Methods Participants Interventions Outcomes Adherence  
Zoelliner et al. 
(2010) 
 
Total population: 
83 participants 
Longitudinal feasibility 
study 
83 vulnerable African-
Americans of whom 
94% were female.  
 
Mean age: 
44 [±13] years 
 
Six months community 
pedometer walking programme 
led by community coaches. 
 
All participants received a 
pedometer diary and 
pedometer, and were instructed 
on the proper use of the device 
and instructed to record daily 
steps in diary. Participants 
attended weekly goal-setting 
appointments with coaches, and 
educated on the 10 000 
steps/day walking 
recommendation. 
 
Immediate aim: 
Set own realistic walking aim 
per week. No specific 
instructions regarding time 
spent walking, steps/week 
achieved or intensity level. 
63% of participants 
increased daily steps, 25% 
had no change and 12% 
regressed in activity level.  
Significant association 
between reduction in TG 
(p=0.04) and % of body fat 
(p=0.01) with physical 
activity levels. 
Sixty six of the original 83 
participants completed the 
study. Thus the dropout rate 
was 20%. 
 
Reason for loss to follow-up 
not supplied.  
Musto et al. 
(2010) 
 
Total population: 
84 participants 
Longitudinal quasi-
experimental study. 
Participants grouped 
as active or control 
following intervention. 
84 university women 
taking less than 5000 
steps/day.  
 
Mean age:  
Active group (46.3 
±10.4) years 
Control group (45.7 
±9.5) years 
 
12-week university worksite 
programme. 
 
All participants received a 
pedometer, guide to programme 
details, daily step log and an 
education booklet. The 
education booklet provided 
information regarding health 
benefits of physical activity, tips 
for increasing steps through 
lifestyle activity and basic 
nutrition information.  
Ultimate aim: 
Incremental 10% increase in 
step-count per week from 
baseline. Once a participant 
reached the 10 000 step-count 
Significant increase in 
pedometer step-count 
(p≤0.001) in active and 
control group with 
significant self-reported 
activity (SUAQ) (p≤0.001) 
in activity group.  
 
Significant reduction in 
weight (p≤0.001), BMI 
(p≤0.001) and RHR 
(≤0.001) in active group. 
Seventy seven of the 
original 84 participants 
completed the study. 
Dropout rate was thus 8% 
at 12 weeks.  
 
Lost to follow-up: 
(n=7) 
 
Reasons for lost to follow-
up: personal reasons. 
 
Twenty control participants 
did not log their weekly 
steps in their daily step log. 
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Study Methods Participants Interventions Outcomes Adherence  
goal, weekly progression 
reduced to three percent. 
Gray et al. (2009) 
 
Total population: 
66 participants 
Randomised control 
trial with walking and 
control group 
66 participants (gender 
distribution not 
specified) self-classified 
as not meeting PA 
recommendations. 
 
Mean age: 
Walking group (48.1 
[±9.2]) years 
Control group (51.3 
[±8.3]) years 
12-week community walking 
intervention in Glasgow. 
 
Intervention group (IG) (n=32): 
One physical activity 
consultation combined with 
pedometer-based walking 
programme.  
 
Ultimate aim: 
Gradually increase mean step 
count by 3 000 steps/day on at 
least five days of the week over 
first six weeks. Remaining six 
weeks instructed to maintain 
walking aim.   
 
Control group (CG) (n=34): 
Asked to maintain normal 
walking levels. 
Significant increase in IG’s 
pedometer step-count 
(p<0.001) by 3 300 (±2 
215) steps/day. No 
significant change in CG 
activity level. 
 
No significant changes in 
weight, BMI, % body fat, 
waist:hip ratio, blood 
pressure, fasting glucose 
and insulin, homeostatic 
model assessment of 
insulin resistance, hs-CRP 
and selected pro-
inflammatory cytokines of 
IG or CG.  
Forty eight of the original 66 
participants completed the 
study. Dropout rate was 
thus 27%.  
 
Lost to follow-up: 
IG (n=8)  
CG (n=10) 
 
Reasons for lost to follow-
up: injury, personal 
reasons, failed to turn up, 
not contactable, other 
commitments, randomised 
to control group, 
dissatisfaction with 
pedometer and inability to 
fast. 
Baker et al. (2008) 
 
Total population: 
79 participants 
Randomised control 
trial with walking and 
control group 
63 women and 16 men 
from lower 
socioeconomic group 
self-classified as not 
meeting PA 
recommendations. 
 
Mean age: 
47.3 (±9.3) years 
12-week community walking 
intervention in West of Scotland. 
 
Intervention group (IG) (n=39): 
One physical activity 
consultation with 12-week 
unsupervised home-based 
incremental pedometer walking 
programme. 
 
Ultimate aim: 3000 steps from 
baseline on five days per week. 
 
Control group (CG) (n=40): 
Asked to maintain normal 
walking levels. 
Significant increases in IG’s 
pedometer step count 
(p<0.001), leisure-time 
walking (IPAQ) (p=0.02) 
and positive effect 
(PANAS) (p=0.027). Mean 
between-group different 
change in step-count was 
3022 per day (p < 0.001). 
Significant decrease in time 
in weekday (p=0.03), 
weekend (p=0.001) and 
total sitting (p=0.001) as 
measured with IPAQ. No 
overlapping changes in CG. 
 
No significant changes in 
PANAS negative, EQ-5D 
Sixty-four of the original 79 
participants completed the 
study. Dropout rate was 
thus 19%. 
 
Lost to follow-up: 
IG (n=7)  
CG (n=8) 
 
Reasons for lost to follow-
up: injury, personal 
reasons, not contactable, 
other commitments, 
dissatisfaction with 
pedometer. 
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Quality of life, BMI, waist 
and hip circumference, 
WHR, % body fat, blood 
pressure, heart rate, total 
cholesterol, HDL, 
cholesterol: HDL ratio. 
Tully et al. (2007) 
 
Total population: 
106 participants 
Randomised control 
trial with two walking 
groups (differing in 
frequency per week) 
and a control group 
64 women and 42 men 
sedentary adults (not 
more than one 
moderate-intensity 
exercise per week in 
the last six months). 
 
Mean age: 
Walking group #one 
(47.80 [±5.97]) years 
Walking group #two 
(46.37 [±4.76]) years 
Control group 
(49.05 [±6.31]) years 
12 week unsupervised home-
based pedometer walking 
programme. 
 
Intervention groups (IG) 
(Walking group #one: n=44), 
(Walking group #two: n=42): 
Participants received a 
pedometer and diary. They were 
asked to document steps, 
duration of the walk, level of 
dyspnoea and any comments or 
difficulties experienced during 
each walk. Every two weeks 
dairies were returned and new 
diaries were posted to 
participants. The researcher 
phoned the participants every 
two weeks to resolve difficulties. 
 
Immediate aim:  
Walk briskly for 30 minutes for 
12 weeks. Participants could 
choose to do a long bout of 30 
minutes or 10 minutes three 
times/day. 
Walking group #one: frequency 
three times/week. 
Walking group #two: 
frequency five times/week. 
 
Control group (CG) (n=18): 
Maintain lifestyle for 12 weeks. 
Given a diary and asked to 
Walking group #one: 
Significant decrease in 
weight (p=0.02), BMI 
(p=0.03), waist (p<0.001) 
and hip (p=0.004) 
circumference, SBP 
(p=0.002), log transformed 
TG (p=0.002), total 
cholesterol: HDL (p<0.001), 
distance walked with the 10 
meter shuttle walk test 
(p<0.001).  
 
Walking group #two: 
Significant decrease in 
waist (p<0.001) and hip 
(p=0.02) circumference, 
SBP (p<0.001) and DBP 
(p=0.01) and distance 
walked with the 10 meter 
shuttle walk test (p<0.001). 
 
Small percentages of both 
walking programmes were 
completed in multiple bouts 
(three day: 2.7% and five 
day: 6.5%) 
 
CG: 
No significant changes 
observed in CG. 
 
Significant differences in 
distance walked with the 10 
Ninety three of the original 
106 participants completed 
the study. Dropout rate was 
thus 12%. 
Walking group #one: 
Completed (n=39) 
Withdrew (n=5) 
Ill health (n=2) 
Lack of time (n=3) 
 
Walking group two: 
Completed (n=36) 
Withdrew (n=6) 
Ill-health (n=3) 
Lack of time (n=2) 
Walking-induced injury 
(n=1) 
 
CG: 
Completed (n=18) 
Withdrew (n=2) 
Ill health (n=2) 
 
Walking adherence was 
defined as number of days 
completed as a percentage 
of number of days 
prescribed. 
Adherence was 89.3% in 
walking group one and 
82.6% in walking group two. 
No significant difference 
observed between groups 
(p=0.42). 
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document any exercise that they 
did above their normal activity. 
After 12 weeks they were given 
a pedometer and invited to 
begin their own walking 
programme. 
 
IG and CG were asked not to 
change their diet during the 12 
weeks. 
meter shuttle walk test 
(p=0.04) and TC: HDL 
(p=0.04).  
 
Significant between group 
differences observed in 
walking groups for time 
spent walking (p=0.04): 
Significant differences 
between walking groups for 
time spent walking 
(p=0.04): walking group 
#one (29.5 ±10.5) and 
walking group #two (26.9 
±10.8).  
Tully et al. (2005) 
 
Total population: 
31 participants 
Randomised control 
trial with walking and 
control group 
18 women and 13 men 
sedentary adults (taking 
less than 20 minutes of 
moderate intensity on 2 
days or less per week in 
the last six months). 
 
 
 
Mean age: 
Walking group (55.52 
[±3.99]) years   
Control group (57.75 
[±4.64]) years 
12 week unsupervised home-
based pedometer walking 
programme. 
 
Intervention group (IG) (n=12): 
Participants received a 
pedometer and diary. 
Follow-up telephone calls every 
two weeks to encourage 
compliance and assess any 
difficulties. 
 
Immediate walking aim:  
Walk briskly for 30 minutes, five 
days/week for 12 weeks. 
Participants could choose to do 
a long bout of 30 minutes or 10 
minutes three times/day 
 
Control group (CG) (n=10): 
Maintain habitual lifestyle and 
not to change their activity. 
Significant increase in 
distance walked with the 10 
meter shuttle walk test 
(p=0.015) in IG compared 
to CG. 
 
Significant decrease in SBP 
(p=0.02), DBP (p=0.0001) 
and 10-year risk estimate 
for stroke based on SBP 
(p=0.00) in IG. Significant 
decrease in 10-year risk 
estimate for IHD based on 
SBP in IG (p=0.032) and in 
CG (p=0.00). No 
differences between groups 
for above. 
 
Only four individuals 
performed walking 
programme in multiple 
bouts per day. The majority 
(n = 17) preferred a 30-
minute stint. Mean time 
spent walking per day was 
Twenty-six of the original 31 
participants completed the 
study. Dropout rate was 
thus 16%. 
 
Lost to follow-up:  
IG (n=4)  
CG (n=1) 
 
Reasons for lost to follow-
up: ill health and lack of 
time. 
 
Walking adherence was 
defined by expressing the 
number of minutes walked 
as a percentage of the 
number of minutes 
prescribed. Adherence was 
90.3%. 
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27.72 (±9.79) minutes. 
 
No significant changes in 
weight, BMI, WC, WHR and 
lipid profile.  
Tudor-Locke et al. 
(2002) 
 
Total population: 
9 participants 
Observational pilot 
study 
Six women and three 
men, recently 
diagnosed with type two 
diabetes, accumulating 
less than one hour of 
physical activity per 
week. 
 
Mean age: 
53 (±6) years 
All participants received 
education regarding diabetes 
self-management: nutrition, 
blood glucose monitoring, 
medication and exercise. 
 
Initial eight-week First Step 
Programme included one month 
of weekly meetings and 
unsupervised home-based 
pedometer walking. The 
following month participants 
continued with walking without 
contact from programme staff.  
Significant changes were 
observed in WC (p=0.005), 
resting SBP (p=0.02), and 
walking time (22.6 minutes 
per day) 
 
No significant changes in 
weight, WHR, hip 
circumference, RHR and 
DBP. 
Adherence issues not 
reported and all participants 
completed assessments at 
baseline, four and eight 
weeks. 
♦ SUAQ (Stanford Usual Activity Questionnaire), PANAS (Positive and Negative Affect Schedule), IPAQ (International Physical Activity Questionnaire), EQ-5D (Euro 
Quality of Life), RHR (resting heart rate), SBP (systolic blood pressure), DBP (diastolic blood pressure), WC (waist circumference) and WHR (waist:hip ratio). 
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The walking programme in study four was structured using the findings of Table 2.6 as 
guide. The programme’s weekly step count increased incrementally and frequency per 
week started at three times per week and then progressed over time to ultimately reach five 
times per week as a means to maintain participants’ adherence to the programme.  
Participants had the freedom of performing their walking in short bouts or one long bout 
while monitoring breathlessness and heart rate. The specifics regarding the intervention 
programme is available for review in Appendix 47. 
 
2.5  CONCLUSION  
Human immunodeficiency virus infection is a significant health burden in SA, with 
prevalence higher in women and affecting both genders between 15-49 years of age more 
frequently. With local HAART initiation guidelines now being aligned with those 
recommended internationally, the future causes of mortality in PLWHA in SA could shift to 
non-AIDS-related conditions, such as IHD. Risk factors for IHD are already reported to be 
increasing in the South African public. International data suggests that PLWHA are at a 
higher risk of IHD due to HIV infection-mediated factors, traditional risk factors for IHD and 
HAART exposure. The need for rehabilitation services to prevent, manage and control risk 
factors for IHD - that could also lead to disability - is therefore extremely important in the 
general population, as well as in the emerging chronic disease era of HIV. Healthcare 
workers such as physiotherapists will have to consider innovative ways to offer 
rehabilitative services, as the burden related to HIV is greater in SA than other parts of the 
world. A home-based walking programme, including a self-monitoring tool such as a 
pedometer could be one such intervention, promoting walking amongst PLWHA and 
thereby decreasing the risk of IHD, and promoting general health.  
 
Chapter 3 consists of the literature related to the instrumentations and outcome measures 
used in the research project. 
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CHAPTER 3 
3.  INSTRUMENTATION FOR TESTING AND MEASURING OUTCOMES  
 
3.1  INTRODUCTION 
This chapter discusses the instruments and outcome measures used in the data collection 
process. Justification of their choice will also be discussed. The instruments and outcome 
measures are linked to the study objectives of each aim of the research. The project was 
divided into two phases: Phase 1 consisted of an observational study (1) and a qualitative 
study (2), the two running concurrently. Both provided support for the material for the 
education physical activity diary. This diary was developed in study 3 before phase two, as 
it was used in the intervention. Phase 2 consisted of an intervention that was evaluated with 
a randomised controlled trial (study 4). Table 3.1 is a representation of the instruments or 
outcome measures used to evaluate a specific variable related to an aim or objective of a 
particular study in the research project.  
 
Table 3.1: Overview of Instruments and/or Outcome Measures and the 
Relationship with the Specific Objectives and Aims 
Aim/objective Variable Instrument/Outcome measure 
Phase 1: Study 1 
To determine physical activity 
levels, in individuals living with 
HIV (on HAART). 
Physical activity levels Demographic questionnaire (1) 
Yamax SW200 pedometer 
To determine perceived stress 
levels, in individuals living with 
HIV (on HAART). 
Perceived levels of stress Cohen’s Perceived Stress Scale-10 (PSS-
10) 
To determine selected known 
associated risk factors for IHD, 
in individuals living with HIV 
(on HAART). 
Smoking history 
 
Diet 
 
RHR and Blood pressure 
 
Waist and hip 
circumference 
 
WHR 
 
BMI (kg/m2) 
 Weight 
 
 Height 
Demographic questionnaire (1) 
 
Demographic questionnaire (1) 
 
Microlife BP A100 automated 
sphygmomanometer 
Butterfly non-stretch tape measure 
 
Calculation: 
Waist (m)/Hip (m) 
 
Simple Choice portable electronic scale 
Poster paper, Fagram non-stretch tape 
measure, non-flexible ruler, clinic wall 
Phase 1: Study 2 
To determine the nature of the 
individual’s self-perception and 
behaviour in relation to the risk 
for IHD. 
Self-perception and 
behaviour 
Semi-structured interview questionnaire 
Card sort with placement sheet 
Olympus VN-5500PC Digital voice 
recorder 
Nikon camera 
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Table 3.1 continued 
Aim/objective Variable Instrument/Outcome measure 
Phase 1: Study 3 
To create an education 
physical activity diary. 
Record of events Methodological and procedural processes 
explained in chapter 6a.  
Education physical activity diary 
Phase 2: Study 4 
To determine physical activity 
levels in individuals at a higher 
risk of IHD as determined by 
study 1. 
Physical activity levels Demographic questionnaire (2) 
Yamax SW200 pedometer 
Six minute walk test (6MWT) 
To determine perceived levels 
of stress in individuals at a 
higher risk of IHD as 
determined by study 1. 
Perceived levels of stress Cohen’s Perceived Stress Scale-10 
(PSS-10) 
To determine selected known 
associated risk factors for IHD 
in individuals living with HIV 
(on HAART). 
RHR and Blood pressure 
 
Waist and hip 
circumference 
 
WHR 
 
BMI (kg/m2) 
 Weight 
 
Height 
Microlife BP A100 automated 
sphygmomanometer 
Butterfly non-stretch tape measure 
 
Calculation: 
Waist (m)/ Hip (m) 
 
Simple Choice portable electronic scale 
Micro Health Stadiometer 
To determine Hs-CRP, lipid 
profiles and glucose levels in 
individuals at a higher risk of 
IHD, as determined by study 1. 
 
 
 
 
Hs-CRP 
 
Lipid profiles  
 Total cholesterol 
 HDL 
 TG 
 
Glucose levels 
LDL 
 
Roche/Hitachi cobas c 501 analyser 
using the following tests respectively: 
 
Cardiac C-Reactive Protein (Lasex) High 
Sensitive test 
 
Cholesterol Gen.2 test 
HDL-Cholesterol plus 3rd generation test 
Triglycerides test 
Glucose HK, Gen.3 test 
LDL was calculated using the Friedewald 
equation 
To calculate the ten-year 
relative risk of IHD events in 
individuals living with HIV/AIDS 
using the Framingham Risk 
equation.  
Ten-year relative risk of 
IHD events 
Framingham Risk Score 
♦ RHR (resting heart rate), WHR (waist: hip ratio), BMI (body mass index), Hs-CRP (high sensitivity 
C-reactive protein), HDL (high density lipoprotein), LDL (low density lipoprotein) and TG 
(triglycerides). 
 
3.2 INSTRUMENTATION, OUTCOME MEASURES AND TOOLS 
A full description, based on literature of each of the instruments/outcome measures, their 
properties, and validity and reliability, is discussed below. 
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3.2.1 For the Objectives of Aim 1: To determine, in individuals living with HIV (on HAART):  
 physical activity levels  
 perceived levels of stress 
 non-invasive known associated risk factors for IHD  
 
A pedometer was chosen to assess the level of physical activity as the interest of this study 
was to evaluate the amount of walking done by individuals, measured in steps.  Walking is 
often given as a functional activity to address the risk of IHD and gain health benefits to 
manage IHD (Murtagh et al., 2010; Balady et al., 2007; Haskell et al., 2007; Giannuzzi et 
al., 2003). An objective way of measuring walking was selected to minimise the influence of 
education level and home language of study participants on reliability of data collected, had 
reported data been used. Two questions related to physical activity were added to the 
demographic questionnaire (1) to determine whether study participants did any form of 
formal (supervised) exercise and/or exercised on their own when entering the research 
project. The questionnaire provided information regarding participants’ baseline motivation 
to be physically active and their preferred method of exercise.   
 
i) Yamax SW200 pedometer 
The Yamax SW200 pedometer detects each step taken, and is useful to evaluate 
ambulation activities. It is an objective, low-cost tool when compared to an 
accelerometer (Berlin, Storti and Brach, 2006). The cost of a Yamax SW200 
pedometer range between 20-25 US dollars compared to an accelerometer at 50-400 
US dollars per device (Tudor-Locke et al., 2002). It provides information regarding the 
quantity of ambulation, activity and is not specific to intensity level. The pedometer 
contains a horizontal spring-suspended lever arm that deflects with the up-and-down 
motion of the leg in hip movement when walking. An electrical circuit opens and closes 
with each detected leg motion, and an accumulated step count is displayed digitally on 
a small screen (Tudor-Locke and Lutes, 2009). The Yamax pedometer requires a force 
of ≥ 0.35 gram to register and record a movement (Tudor-Locke and Lutes, 2009). This 
force sensitivity threshold censors out “non-step activity”, such as vibrations in a car 
journey (Tudor-Locke and Lutes, 2009).  
 
Validity and reliability of the Yamax SW200 pedometer 
The Yamax SW200 pedometer is considered valid for assessing physical activity 
involving ambulation in free-living physical activity (Schneider, Crouter and Bassett, 
2004; Tudor-Locke et al., 2002). It is often used as the criterion when evaluating other 
pedometers (Tudor-Locke and Lutes, 2009; Schneider, Crouter and Bassett, 2004). 
The convergent validity of this pedometer with a dual-mode accelerometer was noted 
to be strong at r=0.74–0.86 (Tudor-Locke et al., 2002) but only fair at r=0.32–0.44 
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when comparing four different physical activity questionnaires with the pedometer in 
healthy volunteers (De Cocker, De Bourdeaudhuij and Cardon, 2008). It has been 
reported that overestimation of physical activity can occur when using a questionnaire 
compared to an objective measure such as the pedometer or an accelerometer (Tutor-
Locke et al., 2002). The Yamax SW200 pedometer has been used in the HIV research 
sphere to evaluate individuals’ physical activity levels. Ramirez-Marrero et al. (2008) 
demonstrated a strong relationship between that brand of pedometer and the moderate 
physical activity category of the IPAQ (r=0.76, p=0.04) and fair correlation between it 
and an Actigraph accelerometer (r=0.46, p=0.0004) in Hispanic individuals infected 
with HIV. The agreement between the Actigraph and pedometer was significant (61%, 
kappa=0.25, p=0.01) and the sensitivity of the device was high (96%).  
 
Swartz et al. (2003) reported that the BMI category did not significantly influence 
pedometer step counts at any walking speed when the pedometer was used to 
measure step-count in a group of healthy volunteers. Individuals were included in this 
study if they were normal weight, overweight or obese. The findings of BMI influence 
on pedometer step-count at different walking speeds were as follows: 54 m x min-1, 
p=0.991; 67 m x min-1, p=0556; 80 m x min-1, p=0.591; 94 m x min-1, p=0.426 and 107 
m x min-1, p=0.869. The researchers concluded that this particular pedometer had 
similar accuracy in groups differing in WC and BMI. This particular study’s findings 
were of noteworthy interest, as PLWHA are reported to develop varying degrees of 
lipodystrophy on HAART that could influence WC and/ or BMI. Thus, using the 
pedometer in PLWHA that might have lipodystrophy would still produce reliable walking 
activity findings.  
 
No data is available concerning the reliability of using the Yamax SW200 pedometer in 
the South African context. It has been used in a rural South African population (Cook et 
al., 2010; Cook, Alberts and Lambert, 2008) and in South African individuals with 
diabetes (Van Rooijen, Viviers and Becker, 2010) to evaluate individuals’ physical 
activity levels. Concerns about reliability were not reported in these studies.  
 
Number of pedometer assessment days 
Variability of step-count exists between days of the week, with the lowest step-counts 
registered on a Sunday (Clemes and Griffiths, 2008; Tudor-Locke et al., 2005). A 
common protocol used when evaluating pedometer physical activity is to ask 
individuals to wear a pedometer for seven days, and calculate the average number of 
steps per day (total steps divided by the number of days) (Berlin, Storti and Brach, 
2006). Tudor-Locke et al. (2005) reported that a minimum of three days of observation 
are necessary to achieve an intra-class correlation coefficient of 0.80. Clemes and 
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Griffiths (2008) later recommended using a seven-day assessment period for a reliable 
estimate of habitual activity, including Sundays, considering that variability is noted 
between days of the week, gender, BMI and age. The authors also noted that when 
using seven days of assessment there was a significant relationship between the mean 
step-count and the criterion (adjusted R2=0.91, p˂0.001). It was therefore decided to 
use a seven-day pedometer assessment period in this research project.  
 
Reactivity to pedometer physical activity assessment 
Reactivity is defined as a change in behaviour that could occur due to an individual 
wearing a measuring instrument – in this case the pedometer - for physical activity 
assessment (Clemes, Matchett and Wane, 2008). Conflicting literature is available 
dealing with this concern when using a pedometer to assess physical activity. Eastep 
et al. (2004) reported no reactivity in their study participants when they wore a sealed 
pedometer for a three-week period following a non-sealed three week period of 
assessment. On the other hand, two similar studies, by Clemes, Matchett and Wane 
(2008) and Clemes and Parker (2009) reported that reactivity occurs when individuals 
wear an unsealed pedometer and are also asked to log their daily step-count. Both 
these studies reported that the probability of reactivity is higher in studies where less 
than seven days of pedometer assessment is involved. Owing to these contrasting 
findings, reactivity was evaluated in pilot study 2 of this project before study 1 to 
determine if a sealed or open pedometer should be used.   
 
ii)  Cohen’s Perceived Stress Scale-10 (PSS-10) 
Cohen’s Perceived Stress Scales were created by Dr Sheldon Cohen of the 
Psychology Department of Carnegie Mellon University. Three scales are available for 
use; PSS-14, PSS-10 and PSS-4. Permission to use the PSS-10 scale was received 
from Dr Cohen (Appendix 9). It was decided to use the PSS-10 scale, as it had been 
used previously in SA (Hamad et al., 2008) and also in an international HIV 
population group (Paddison et al., 2009; Koopman et al., 2000). This scale was also 
recently included in a proposed protocol for evaluating perceived stress in conjunction 
with physical activity levels in an American HIV population (Jaggers et al., 2013).  
 
The PSS-10 measures the degree to which a person perceives their life as having 
been stressful in the past month. The instrument was designed to evaluate stress in 
communities with at least a junior high school educational level. It consists of 10 
questions, rated on a 5-point Likert scale that ranges from “0 = never” to “4 = very 
often”. The scale consists of four positive (4, 5, 7, and 8) and six negative questions 
(1, 2, 3, 6, 9, and 10). Scoring for the positive questions is obtained by reversing 
responses e.g. 0=4, 1=3 and 2=2 and calculating a value. Scoring for the negative 
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questions is calculated adding the values in the following manner e.g. 0=0, 1=1, 2=2, 
3=3 and 4=4. Scores range from 0 to 40 with a higher score indicating a higher 
degree of perceived stress (Cohen and Williamson, 1988). Normative data for the 
PSS-10 is available for a large probability sample of USA adults (Cohen et al., 2012). 
As no normative data are available for South Africans, a strategy of setting the 75th 
percentile as a cut-off to signify a “high” stress level was used in this project. This 
procedure was previously suggested by Hamad et al. (2008) when reviewing South 
African PSS-10 information. 
 
Validity and Reliability of the PSS-10 
The scales are considered valid instruments for assessing perceived stress (Cohen et 
al., 1988; Cohen, Kamarck and Mermelstein, 1983). The internal reliability of the 
PSS-10 was noted to have a Cronbach’s alpha coefficient of 0.78 compared to the 
PSS-14 at 0.75 and the PSS-4 at 0.60 in a large adult USA population (Cohen and 
Williamson, 1988). This finding suggests that the PSS-10 is a slightly more reliable 
instrument, due to the higher internal consistency than the other PSS scales. This 
scale has previously been used in international studies conducted in PLWHA 
(Paddison et al., 2009; Koopman et al., 2000). Koopman noted a strong internal 
reliability of α=0.88 when using the PSS-10 to evaluate perceived stress and the 
relationship with coping strategies, attachment styles and social support in PLWHA in 
California. The PSS-10 was used by Hamad et al. (2008) and Fernald et al. (2008) to 
evaluate the perceived levels of stress in low-income South Africans living in Cape 
Town, Port Elizabeth and Durban. The internal reliability of the PSS-10 was reported 
as Cronbach’s alpha of α=0.72. Owing to the suggested validity of the PSS-10 and 
the high internal reliability of this scale when assessing perceived levels of stress in 
PLWHA - and also in a South African group - it was decided to use the PSS-10 as 
outcome measure in this study.  
 
iii)  Demographic questionnaire (1) 
Demographic variables such as age and gender are known risk factors for IHD, and 
always collected in large-cohort IHD studies (Steyn et al., 2005; Yusuf et al., 2004; 
NCEP ATP-III, 2002). In the South African context the distribution of non-
communicable diseases shows inequality according to socio-economic status, with 
the heaviest burden identified in poor communities in urban settings (Mayosi et al., 
2009; Schneider et al., 2009). It is also reported that a poorer health status is often 
found in SA in less-educated persons (Mfenyana et al., 2006). These factors 
necessitated including questions regarding participants’ age, gender, educational 
level and employment status on the demographic questionnaire. The questionnaire 
thus consisted of questions in four categories: personal background; exercise, as 
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reported above; HIV history and IHD risk factors. Two questions were added to 
provide information regarding when the HIV-positive status was diagnosed and when 
antiretroviral therapy was initiated. This feedback was collated, by reviewing the 
participants’ clinic files. Information pertaining to medical and surgical history was 
received from the participants, and again, by review of the participants’ clinic files. 
  
The WHO Step Surveillance Manual (2008), the INTERHEART study (Yusuf et al., 
2004) and the INTERHEART Africa study (2005) were reviewed to assist with the 
selection of questions pertaining to risk factors, including smoking and diet. The 
literature reported that a diet low in vegetable and fruit intake is considered a risk 
factor for IHD, and so questions pertaining to vegetable and fruit intake were added. 
A diet high in alcohol and low in fish intake is also reported to increase one’s risk for 
IHD (Artalejo et al., 1996), so relevant questions were added. Lipodystrophy is 
reported to develop over time in PLWHA on antiretroviral therapy (Hurley et al., 2011; 
George et al., 2009; Pujari et al., 2005), and is also said to increase risk of IHD 
(NCEP ATP-III, 2002). Questions pertaining to perception regarding weight gain, 
weight loss or changes in body shape were added to the questionnaire to facilitate 
subjective screening for lipodystrophy. The personal background pertaining to risk of 
IHD included questions related to family history of IHD, as this is again said to 
increase risk of IHD (NCEP ATP-III, 2002). Symptom-specific screening questions for 
shortness of breath, fatigue and chest pain were included as they are known IHD 
symptoms (Collins and Dias, 2009), and also often experienced by PLWHA (Myezwa 
et al., 2009; Van As et al., 2009). Information on risk facilitated identification and 
clarification of when such symptoms were first experienced, and assisted with 
deciding whether a participant should be referred to a clinic medical practitioner.  
 
Information regarding smoking, diet, weight and body shape changes also enhances 
the trustworthiness of the second study. That study assessed the nature of the 
individual’s self-perception and behaviour in relation to the risk of IHD, and thus 
triangulation was achieved, by using both the quantitative and qualitative data to 
confirm the presence of risk factors.  
 
iv)  Automated sphygmomanometer 
A new, portable, Microlife BP A100 automated blood pressure sphygmomanometer 
was used in this project to assess RHR and blood pressure. Details of this device 
were: model number BP A100; width 151 cm x length 115 cm x height 88 cm; gross 
weight 610 g with batteries, and blood pressure range 30-280 mmHg. This device is 
of Swiss design, and the manufacturers report that it has been tested according to the 
protocol of the British Hypertension Society, and provides the highest possible 
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grading for systolic and diastolic measurement accuracy.  It consists of a small 
display monitor with a cuff attachment. It calibrates automatically after a pause of one 
minute after each blood pressure measurement.  
 
Validity and reliability related to using an automated sphygmomanometer 
Using an automated blood pressure device is said to be a valid means of assessing 
blood pressure, and less “white coat effect” occurs when using this instrument than 
the conventional mercury sphygmomanometer (Myers et al., 2011). Pavan et al. 
(2012) evaluated the correlation and agreement between blood pressure 
measurements when using an automated digital device compared to the conventional 
auscultatory sphygmomanometer. The authors noted that the mean difference was 
only 1.9 mmHg in SBP and 0.5 mmHg in DBP when the two different devices were 
compared. The Pearson correlation coefficients between these two devices when 
evaluating SBP and DBP were r=0.97 and r=0.91 (p=0.001) respectively indicating 
high association. The Bland-Altman method to test agreement between the two 
devices also indicated less than 1% of measures fell outside the two standard 
deviation ranges when assessing SBP and DBP reflecting good agreement (Pavan et 
al., 2012). Thus the authors concluded that an automated device is a valid tool for 
evaluating blood pressure in an adult population. The Microlife blood pressure 
technology complies with international guidelines for blood pressure devices, and is 
recommended for clinical use in an adult population (Saladini et al., 2011; Stergiou et 
al., 2008; Cuckson et al., 2002).  
 
v)  Non-stretch tape measure 
A non-stretch, commercially available Butterfly brand tape-measure was used for 
waist and hip circumference measurements. The range of the measuring tape was 0 
to 150 cm. An additional Fragram tape-measure was available for use in individuals 
where the Butterfly length was insufficient. The Fragram tape measure was sufficient 
for up to three meters.  
 
Validity and reliability of tape-measure  
A non-stretch tape measure is advocated in the ACSM Guidelines for exercise testing 
and prescription (2010) as a means of assessing waist and hip circumference 
measurements, and this technique was used clinically in a number of projects (Canoy 
et al., 2007; Mosca et al., 2006; Dalton et al., 2003). The non-stretch characteristic 
reduces variability and improves reliability when performing the technique, simply 
because it is unable to stretch.  
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vi) Portable electronic scale 
A Simple Choice portable electronic scale was used for assessing weight. Details for 
this bathroom scale were: weight capacity 150 kg; mass graduation 100 g; 25 mm 
LCD display and lithium battery-operated. The device calibrated before each weight 
measurement when the researcher tapped the right corner of the scale. This device 
was selected as it was easy to transport. The physiotherapy room in Themba Lethu 
clinic was used for research sessions. This space was also used by Helen Joseph 
hospital physiotherapists intermittently to treat outpatients. Research equipment could 
not be stored in the room for lack of space. An easily transportable device for use was 
thus needed, and the scale was selected. 
 
Validity and reliability of portable scales      
Portable scales are commercially available to the public for self-monitoring of weight. 
They are often used in studies when evaluating self-reported- against measured 
weight (Lawler et al., 2002; Schmidt et al., 1993). It is thus a clinically valid means of 
determining weight, and using the same instrument and standardised assessment 
procedure in the research project improved its reliability.  
 
vii)  Height measurement instruments phase 1: non-stretch tape measure, poster 
paper, non-flexible ruler and clinic wall 
 
The height of study participants in study 1 was measured using white poster paper 
taped to the wall of the physiotherapy room, the Fragram tape measure, a non-
flexible ruler and a pen. A stadiometer to measure height was not available in study 1 
because clinic stadiometers were in use by nursing staff for clinic activities, the 
physiotherapy department of Helen Joseph hospital did not have a stadiometer, all 
Wits physiotherapy department stadiometers were in use by other researchers, and 
this researcher had not yet acquired enough additional funding to purchase her own. 
In study 4 a Micro Health stadiometer became available, and was put to use. 
 
Validity and reliability of using a non-stretch tape measure, poster paper and non-
flexible ruler for height measurement 
 
Valid means of making standing height measurements are a stadiometer, or if that is 
not available, a tape measure, with the subject standing against a wall (Hall, 2006). 
Using this equipment, with a standardised assessment procedure, ensured that 
reliable height data was collected. 
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3.2.2  For the Objective of Aim 2: To determine the nature of the individual’s self-perception and 
behaviour in relation to the risk of IHD.  
 
Data was generated in study 2 using a qualitative design. The following instruments were 
used: a semi-structured interview questionnaire; flash cards (used in card-sort in the 
interview); a digital voice recorder for taping the interviews and a conventional Nikon 
camera for photographing the cards selected by participants in the card-sort technique. 
  
i) Semi-structured interview questionnaire 
The questionnaire was divided into two sections: questions pertaining to living a 
healthy lifestyle and others that focused on IHD. These sections contained key 
primary questions and follow-up questions to prompt respondents. Space was made 
available for the researcher for field notes. 
 
Content validity of the semi-structured interview questionnaire 
The questionnaire was constructed according to the aim of the study. The 
questionnaire was reviewed by the Faculty of Health Sciences Postgraduate Protocol 
Assessors group and the University of the Witwatersrand Ethics committee. Both 
groups consisted of experienced researchers, whose suggestions were incorporated. 
The content validity of the questionnaire was further evaluated by sending it to four 
qualitative researchers for review in relation to the study objectives. One researcher 
declined participation in the process due to other obligations. The remaining three 
researchers’ suggestions were implemented.  
  
ii)  Flash card for card-sort technique 
The card-sort technique is associated with the constructivist approach, specifically 
Kelly’s Personal Construct Theory: “they assume that people make sense of the world 
by categorising it, and that people can describe their own categorisation of the world 
with reasonable validity and reliability” (Rugg and McGeorge, 1997; p.81).  Another 
explanation is: “Personal Construct Theory is based on the belief that different people 
categorize the world differently, but with enough commonality to let us understand 
each other but enough differences to make us individuals” (Fincher and Tenenberg, 
2005; p.89). Thus the card-sort’s advantages are that it can elicit our individual 
understanding about topics and their relationships with each other. It is systematic 
and easy to use for both respondents and researchers (Fincher and Tenenberg, 
2005; Rugg and McGeorge, 1997).  
 
Several varieties of sorting techniques are available: closed-card sort technique (e.g. 
Q sorts), hierarchical sorts; open card-sort (e.g. “all-in-one sorts”) and repeated 
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single-criterion sorts (Kerr, Hilari and Litosseliti, 2010; Rugg and McGeorge, 1997). In 
open card-sort techniques cards are usually given for participants to categorise. This 
might be done once, as in the case of “all-in-one sorts”, or a number of times, as with 
repeated single-criterion sorts (Rugg and McGeorge, 1997). Performing a sort 
involves several cognitive processes: creating a category for each card, recall of 
categories already created, rejecting or accepting categories, generating new 
categories and moving cards from one category to another (Kerr, Hilari and Litosseliti, 
2010). This card-sort technique might be difficult for individuals from a lower 
educational level or for those with a medical condition that might affect cognitive 
function. In a multi-cultural population a wide variety of response categories might be 
generated, due to different socio-cultural beliefs that could make data analysis very 
difficult when an open card-sort is used. In closed card-sort participants are given the 
cards to sort according to pre-determined categories e.g. from most important to least 
important or into specific clusters (Kerr, Hilari and Litosseliti, 2010). Thus, fewer 
cognitive processes are involved, making it easier to perform, and data analysis might 
also be less problematic for the researcher.  
 
Card-sort is a qualitative data-collection technique that has been used in the Social 
Sciences (Ernest, 2011; Saunders and Thornhill, 2011; Whaley and Longoria, 2009) 
and Health Sciences (Killam et al, 2012; Kerr, Hilari and Litosseliti, 2010; Lugina et al, 
2004). Three examples of a closed card-sort method used in the Health Sciences are 
worth reviewing. Lugina et al. (2004) used semi-structured interviews and card-sort to 
evaluate postpartum concerns of women in Dar-es-Salaam, Tanzania. Participants 
had to have a minimum of seven years of primary school education to participate in 
this study. They were required to sort cards into three predetermined clusters: worry, 
interest and confidence. The authors noted that the card-sort technique was more 
sensitive in obtaining information about areas of concerns than the results of the 
semi-structured interviews. Killam et al. (2012), on the other hand, used a card-sort 
method to evaluate nursing students’ viewpoints on the most unsafe aspects of the 
clinical setting. In data-collection study participants were asked to rank 43 cards with 
statements from “most disagree” to “most agree” on a template. Due to the large 
number of cards, students often requested additional time to sort them. This suggests 
using fewer cards in the card-sort when constructing a research project. Kerr, Hilari 
and Litosseliti (2010) conducted focus groups with individuals living with stroke to 
determine what information they would want to have included on a website for stroke 
survivors. The authors requested the participants to sort cards according to five 
clusters to explore preferences for structuring information on the website: equipment, 
keeping well, home and money, out-and-about and friends, and family. The authors 
created cards consisting of pictures and words in order to exploit reading and visual 
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recognition, that they proposed would increase semantic knowledge of the particular 
idea. The cards were of the same size, and were numbered so as not to bias 
participants in any way. Information from these three studies supported the use of the 
card-sort technique in study 2. In addition, the studies provided information regarding 
things to consider when constructing and using flash cards.  
 
Content validity of study flash cards used in the card-sort technique    
A review of the literature was carried out regarding aspects of living a healthy lifestyle 
and IHD, as in the objectives of study 2, that needed to be included on the flash 
cards. Focus areas were identified: infection control, sexual practices, sleep, diet, 
physical activity, smoking, stress and adherence to prescribed medication. This 
information was used in creating the sentences/phrases on the flash cards. The cards 
thus created could support or refute the above categories, thus ensuring participants 
had to evaluate each one according to their own knowledge, attitudes and beliefs, 
before making a selection. A copy of the set of cards thus created was sent to the 
qualitative researchers, together with the semi-structured interview, for content 
validity review. Following a suggestion received in feedback, sentences on the cards 
were translated into isiZulu, and pictures explaining the statements were added to 
provide a visual depiction of the sentence on each card. This method is supported by 
Kerr, Hilari and Litosseliti (2010) to enhance semantic knowledge of each particular 
idea. Each card thus consisted of a picture with accompanying English and isiZulu 
sentences. The sentences or phrases on the cards were short, and in layman’s 
English and isiZulu, to ensure participants would find it easy to understand. The cards 
were identical in size and writing font to ensure uniformity. Twenty four cards were 
created, 23 with pictures and sentences or phrases, and one blank. This was for each 
participant to elaborate on other aspects of living a healthy lifestyle in his/her opinion. 
The inclusion of this blank card was suggested by an expert clinician with experience 
in using card-blank card-sort methodology. 
 
iii)  Olympus VN-5500PC digital voice recorder 
A battery-operated Olympus VN-5500PC digital voice recorder was used in qualitative 
interviews for verbatim transcription at a later stage. That particular voice recorder 
had computer connection capability for downloading files onto the researcher’s 
computer for safekeeping. Recording interviews by means of an audiotape recorder is 
a recognised method of collecting qualitative data (Dicicco-Bloom and Crabtree, 
2006). 
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iv) Conventional Nikon camera 
Triangulation is commonly used in qualitative research to enhance quality and 
credibility of data collected (Patton, 1999). One such method is triangulation of 
sources: “examining the consistency of different data sources within the same 
method” (Patton, 1999; p. 1193). A conventional Nikon camera was used to 
photograph the card-sort layout of each participant for record-keeping and analysis. 
The photographs facilitated triangulation of sources, with the field notes regarding 
cards selected being reviewed together with the photographs.  
 
3.2.3 For the objectives of aim 3:  
1) To determine, in individuals at a higher risk of IHD as determined by study 1: 
 physical activity level 
 perceived level of stress 
 RHR and blood pressure 
 waist and hip circumference, WHR and BMI 
 Hs-CRP 
 lipid profiles (total cholesterol, HDL, LDL, and TG level) 
 glucose levels 
 
2) To create an education physical activity diary.  
 
3) To implement an individualised education and home-based walking exercise 
programme, and monitor adherence to the programme. 
 
4) To determine if an education and home-based walking programme has an effect on the 
physical activity level, perceived stress level, RHR, blood pressure, WC, WHR, BMI, 
Hs-CRP, lipid profile and glucose levels of affected individuals. 
 
5) To determine whether a correlation exists between hs-CRP and evaluated related IHD 
risk markers. 
 
6)  To calculate the ten-year relative risk of IHD events in individuals living with HIV/AIDS 
using the Framingham Risk equation, and determine whether the education and home-
based walking programme had an effect on the relative risk. 
 
Phase 1 was concerned with pre-participation screening of IHD risk factors for study 4, 
which consisted of an intervention focusing on physical activity modification. The physical 
activity levels of participants were evaluated with the Yamax SW200 pedometer and the 
six-minute walk test (6MWT) in study 4. Exercise testing for all risk stratification categories 
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is suggested as good practice before the implementation of an intervention, as this 
establishes safe and effective exercise prescription (ACSM, 2010; Noonan and Dean, 
2000). A sub-maximal exercise test, the 6MWT, was selected. The 6MWT is a self-paced 
functional outcome measure, and aligns with the specific intervention where self-monitored 
moderate intensity walking is encouraged. The sub-maximal exercise test was added to 
evaluate the presence and severity of cardiovascular symptoms e.g. shortness of breath, 
fatigue, dizziness and/or chest pain when performing a focused walk. The cardiopulmonary 
response and distance walked provided information on exercise tolerance in individuals. It 
was necessary, as the intervention of study 4 focused on increasing step-count by means 
of an incremental walking programme that might have had an effect on exercise tolerance 
of participants. Pre- and post-6MWT heart rate and oxygen saturation values were 
evaluated with a digital finger probe, the 9550 Onyx II Nonin pulse oximeter. Pre- and post-
6MWT perceived breathlessness and fatigue was measured with the Borg scale as 
suggested by the American Thoracic Society statement (ATS) (2002).  
 
In the course of study 1 it became apparent that certain social factors could influence 
physical activity levels, e.g. the type of housing would influence the number of steps taken 
at home.  This information was not formally collected in study 1, but was gleaned in 
informal discussion with participants. The researcher needed to be aware of these social 
factors when implementing the home-based education and walking programme, and 
demographic questionnaire (2) was created to standardise questions posed to participants 
in study 4.  
 
i) Six-minute walk test (6MWT) 
The 6MWT is a self-paced sub-maximal exercise test that provides information 
regarding physical function capacity and change in that capacity in individuals without 
health problems, and also those with moderately severe impairments due to a variety 
of conditions (Chang, 2006; Noonan and Dean, 2000). The test involves study 
participants walking as far as possible in six minutes, between two points 30 meters 
apart, with standardised prompts issued intermittently (ATS statement, 2002). The 
outcomes measured with this test are distance walked, cardiopulmonary variables 
and perceived breathlessness and fatigue (Rasekaba et al, 2009; ATS statement, 
2002). The 6MWT is also reported to be a moderate-to-vigorous intensity exercise 
test when reviewed against VO2 max in healthy working-aged adults (Burr et al., 
2011).  
 
The distance findings obtained from the 6MWT can be compared with predicted 
normal values of an individual, and it is suggested that percentage change could be a 
valuable clinical parameter to review (Seale, 2006). A number of predictive equations 
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for 6MWT distance in individuals are available for use in clinical research (Dourado, 
2010). Predictive equations in healthy individuals are, however, often limited in their 
application to the suggested age ranges of such equations. For example, the 
equation by Gibbons et al (2001) can be used in individuals 22 to 79 years of age, 
while, on the other hand, that of Enright and Sherrill (1998) can be used in individuals 
40 to 80 years of age. When reviewing 6MWT distance findings against the predicted 
value it is suggested that a value less than 82% should be considered as abnormal 
(Troosters, Gosselink and Decramer, 1999). There is at present no specific predictive 
6MWT equation available for use in individuals living with HIV. The Gibbons et al. 
(2001) 6MWT predictive equation for healthy individuals over 20 years of age was 
used to calculate study 4 participants’ predicted 6MWT distance, as it aligned with the 
age inclusion criteria of the research project.  
 
The 6MWT work (6MWORK) is a product of body weight times distance walked, as 
body weight directly affects the work, or energy, required to perform the walk (Carter 
et al., 2003; Chuang, Lin and Wasserman, 2001). Authors suggest including this 
calculation when reviewing findings from the 6MWT to enhance understanding of 
functional capacity (Carter et al., 2003; Chuang, Lin and Wasserman, 2001). 
Considering that overweight and obesity are an increasing cause for concern in 
individuals living with HIV (Crum-Cianflone et al., 2010), it is possible that participants 
in study 4 could have been overweight or obese. For that reason the 6MWORK 
calculation was incorporated in the study. 
  
Validity and reliability of the 6MWT 
The study focused on physical activity modification in relation to IHD risk 
management in an HIV population, and information pertaining to the 6MWT validity 
and reliability in a cardiac and HIV setting was therefore sought. The validity, 
reliability and responsiveness of the 6MWT in outpatient cardiac rehabilitation 
programmes were reviewed by Bellet, Adams and Morris (2012) in a systematic 
review. The analysis noted that the 6MWT was responsive to clinical change in 
individuals following cardiac rehabilitation. An estimated mean difference of 60.43 
meters (95% CI: 54.57-66.30; p˂0.001) was noted following cardiac rehabilitation 
interventions (12 trials, with a total of 2 487 subjects). Percentage change was 10% to 
28%. The repeatability of the 6MWT in cardiac rehabilitation (two trials with a 
combined number of 103 subjects) indicated a 2% to 8% test-retest change, with a 
correlation of 0.97. No information pertaining to inter- or intra-rater reliability was 
available. Reliability between the 6MWT and other symptom- limited exercise tests 
ranged from r=0.58 to r=0.69.  
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Shoemaker et al. (2013) evaluated the minimum detectable difference and minimum 
clinically important difference when conducting the 6MWT in 22 individuals living with 
chronic heart failure. They reported a minimum detectable difference of 32.4 meters 
at the 95% CI, and minimum clinically important difference as 30.1 meters (95% CI: 
20.8-39.4). In this study the researchers reported the test-retest reliability of the 
6MWT to be excellent with r=0.99 (95% CI: 0.97-0.99). In contrast, Gremeaux et al. 
(2011) estimated the minimum clinically important difference in patients with coronary 
artery disease in a cardiac rehabilitation programme of eight weeks, and reported a 
minimum clinically important difference of 25 meters for the 6MWT.  
 
Suitability for using the 6MWT in PLWHA 
The 6MWT has been used in a few studies evaluating individuals living with HIV, and 
provide support for its inclusion for evaluating functional exercise capacity in PLWHA, 
as was done in study 4. Neumann et al. (2007) included the 6MWT in the HIV-HEART 
study protocol to evaluate functional exercise capacity in outpatient HIV-infected 
individuals with suspected heart failure diagnosis. Dolan et al. (2006) used it as an 
outcome measure to evaluate the effects of a home-based exercise programme in a 
group of HIV-infected women in Boston. The baseline 6MWT distance in the 
intervention group was 489 meters and in the control group 474 meters. The authors 
noted a change of 34 meters in the intervention group after the four-month period. 
Mbada et al. (2013) compared quality of life, 6MWT and 6MWORK between 37 HIV+ 
and 37 HIV- individuals in Nigeria. The authors reported that the 6MWT and 
6MWORK findings in the HIV- group were significantly higher (p=0.001) than the HIV+ 
group. The actual 6MWT mean values were not reported in the article. Oursler et al. 
(2009) investigated the utility of the 6MWT in an older HIV+ population (age=57.5 
[±6.5]) consisting of 97 individuals in Baltimore, USA. A moderate correlation of 
r=0.60 (p<0.001) was found between 6MWT distance and the VO2 peak collected in a 
treadmill exercise test. The mean 6MWT distance reported in this sample was 514 (± 
91) meters.  Information pertaining to intra-rater and inter-rater reliability of assessors 
when performing the 6MWT in these studies was not reported in the relevant articles.  
 
ii) Digital finger probe 9550 Onyx II Nonin pulse oximeter 
Peripheral pulse oximetry is a monitoring modality to facilitate review of non-invasive 
oxyhaemoglobin saturation levels of patients in many clinical health care settings 
(Milner and Mathews, 2012). The pulse oximeter works in the following way: “a probe 
with an electro-optical sensor is placed on a finger and emits two wavelengths of light 
to differentiate oxygenated from deoxygenated hemoglobin” (West, 2009; p. 449). 
The ATS guidelines on the 6MWT support the inclusion of pulse oximetry as a means 
of evaluating pulse rate and oxygen saturation levels (2002). The digital finger probe 
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9550 Onyx 11 Nonin pulse oximeter was included in a few studies related to patients 
living with chronic obstructive pulmonary disease (COPD). Schermer et al. (2009) 
used this device when evaluating patients with stable and acute exacerbation of 
COPD by general practitioners (Schermer et al., 2009). Majewski, Rozek and Alawale 
(2010) included this device to evaluate pulse oximetry in a pulmonary rehabilitation 
programme. No problems were reported by the authors.  
 
Validity and reliability of pulse oximetry 
The accuracy of pulse oximeters used in adults was evaluated against arterial oxygen 
saturation levels in a meta-analysis done by Jensen, Onyskiw and Prasad (1998). 
The authors found that pulse oximeters are accurate within 2% (±1) to 5% (±2) of in 
vitro oximetry when arterial oxygenation was 70% to 100%. The authors also noted 
that finger probes were more accurate than ear probes. They also noted, however, 
that accuracy could be lost when the patient experienced severe or rapid 
desaturation, hypotension or hypothermia. Given the inclusion and exclusion criteria 
of study 4, none of the participants would have fallen into these categories.  
 
 iii)  Demographic questionnaire (2) 
Demographic factors are known to be associated with physical inactivity (Linetzky et 
al., 2013; Bauman et al., 2012; Allen and Morey, 2010). These include age, female 
gender, non-white ethnicity, low socioeconomic status and lower educational level. In 
low- and middle income countries social support, such as support of family, is also 
reported to be positively associated with physical activity levels (Bauman et al., 2012). 
In sub-Saharan Africa urbanization often leads to significant growth in cities, leading 
to informal settlements that may lead to deterioration in health (Belue et al., 2009). 
This consequence was confirmed in research done by Belue et al. (2008) in 
Khayelitsha, SA. Khayelitsha is a partial informal settlement in the Western Cape. 
The researchers noted that the lack of potable water in the home and the inability to 
depend on a partner had the strongest association with perceived stress. Mobility and 
transport stress often occurs in informal settlements (Belue et al., 2009; Belue et al., 
2008). It is therefore to be expected that environmental factors such as transport are 
associated with physical activity levels in individuals living in low- and middle income 
countries (Bauman et al., 2012). Owing to these factors the following questions were 
added to the demographic questionnaire (2): question pertaining to current 
employment status, as this could have changed since study 1; monthly income and/or 
grants received by participants; marital status for information regarding support; 
housing environment for an estimation of size of housing and transport.  
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iv) Laboratory analysis of collected blood samples 
A primary prevention strategy for non-communicable diseases such as IHD is 
identifying risk factors for the disease in individuals (Hsue et al., 2008; Mensah, 2008; 
WHO STEPS Surveillance, 2008). The WHO STEPS surveillance programme 
suggests that identification of risk factors in individuals should occur according to 
three progressive steps: step one: gathering information regarding demographics and 
behaviour; step two: physical measurements, and step three: collecting blood 
samples for biochemical review (WHO STEPS Surveillance, 2008). Not all individuals 
who are screened undergo blood sampling, but only those individuals that were 
identified in steps one and two.  
 
Biochemical screening of glucose level and cholesterol profile (total cholesterol, HDL, 
LDL, TG) is recommended for IHD risk factor screening, as these tests identify 
individuals with diabetes mellitus and hyperlipidemia (Klug et al., 2012; NCEP ATP-III, 
2002). C-reactive protein is considered an independent predictor of increased 
coronary risk, as demonstrated in a systematic review and meta-analysis (Buckley et 
al., 2009). High-sensitivity CRP is a novel IHD risk biomarker (Pearson et al., 2003) 
that could be included to evaluate IHD risk, as it provides information regarding 
inflammation in otherwise healthy individuals (Center for Devices and Radiological 
Health, 2005). In this study, participants underwent non-invasive IHD risk factor 
screening in phase 1 and were included in phase 2 if they presented with an IHD risk 
factor. In phase 2 blood sampling for glucose, cholesterol profile (total cholesterol, 
HDL, LDL, TG) and Hs-CRP were added to conclude IHD risk factor screening and 
also to evaluate the effects of the intervention on these parameters.  
 
Validity and reliability of laboratory analysis of collected blood samples 
Laboratory analysis of blood samples was carried out at Contract Laboratory Services 
at the main chemistry laboratory in Johannesburg, SA - practice number 5204240, 
and registration number 1997/015443/07 (Appendix 11). Contract Laboratory 
Services is an accredited laboratory with the South African National Accreditation 
board - facility accreditation number: M0074 (Appendix 11).  
 
Laboratory analysis was done with the Roche/Hitachi Cobas C system using a 501 
analyzer, according to the set protocols for this system. The Roche system was 
indicated as one of the two most reliable systems according to analytical performance 
in a study evaluating five different blood glucose monitoring systems in four hospitals 
in Paris (Daly et al., 2011). It has also been used as the criterion against which other 
systems are evaluated e.g. measuring viral load assays (Katsoulidou et al., 2011).  
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Low density lipoprotein levels of participants were calculated using the Friedewald 
equation. This is said to be valid when calculating LDL specifically for the use of 
cholesterol risk classification (Warnick et al., 1990).   
 
Quality assurance strategies at Contract Laboratory Services 
Contract Laboratory Services has internal and external quality control strategies to 
ensure that valid and reliable results are obtained. An example of internal quality 
control strategy is the availability of manufacturer-suggested result values for assays 
assessed. The laboratory uses a standard deviation of ± two in analysis, and if 
results fall beyond this range the machine automatically calibrates for normalisation.  
A second example is the systematic tracking of specimen samples throughout the 
analysis process from delivery to the laboratory to the final electronic report being 
produced. This is possible because the Roche Cobas C system is interfaced with 
the Disa laboratory computer system in use at the laboratory.   
 
External quality assurance strategies for Contract Laboratory Services include: 
 Frequently audited by large research studies to ensure laboratory practices are 
followed.  
 Assessed by the South African National Quality Assurance Council in terms of 
assessment frequency required by the organisation. 
 Belongs to Patient Safety Monitoring in International Laboratories that monitors 
the laboratory analysis results against other international laboratories that also 
use the Hitachi/ Roche Cobas C system. 
 
v)  Education physical activity diary 
Physical activity diaries, or physical activity logs, have been used extensively for 
assessing physical activity in various populations. In such literature individuals are 
often asked to document time spent in a specific activity or to document motion 
sensor readings. Examples of studies that have used diaries are: Moore et al. 
(2009) used a pedometer and activity diary when measuring physical activity in 
individuals living with COPD. The authors reported the daily diary to be more 
effective in this population due to slower walking speeds caused by physical 
complications, such as shortness of breath. Saves and Ades (2008) determined 
walking levels of individuals by pedometer when entering a cardiac rehabilitation 
programme, comparing non- rehabilitation days with rehabilitation days. Individuals 
were required to document their daily step-counts in an activity log every day for 
seven days. The participants’ step-counts on cardiac rehabilitation days were 
significantly higher (p<0.0001). Similarly, Butler et al. (2009) followed the same 
physical assessment method in individuals when evaluating baseline pedometer 
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activity levels before instituting a post-cardiac rehabilitation maintenance 
programme. Saunders et al. (2013), on the other hand, evaluated physical activity in 
the six-year longitudinal Quebec family study by asking study participants to 
document time spent performing a specific activity in an activity diary over a three-
day period. Activities were organised according to specific categories. The 
relationship between sedentary behaviour and cardio-metabolic parameters were 
evaluated.  
 
Physical activity diaries are also used as self-monitoring tools to enable individuals 
to log activity levels when participating in physical activity-promoting programmes. 
In the Cochrane review by Foster, Hillsdon and Thorogood (2009) interventions 
promoting physical activity were reviewed. The studies included in this review often 
provided participants with an education diary (verbal or written) for self-monitoring. 
Likewise, Richardson et al. (2008) demonstrated that diaries or logs used for 
recording step-count, together with education of participants, were the norm in 
studies in the meta-analysis of pedometer-based walking programmes where weight 
loss was the primary aim. 
 
Literature is available supporting what patients diagnosed with IHD would wish to 
have included in an education diary tailored for them. Redfern et al. (2006) 
assessed the expressed requirements of patients with IHD of what should be 
included in education leaflets. Patients reported that they would appreciate space to 
document their own particular values, e.g. blood pressure measurement, and 
information regarding the recommended levels of risk factors, and how those risk 
factors affected the heart. Regarding physical inactivity, the patients requested 
information regarding duration and frequency, and suggested a chart for motivation. 
The findings of these studies clearly support the use of the education physical 
activity diary in study 4 as an education and self-monitoring tool; and findings from 
Redfern et al. (2006) were considered in its design.   
 
vi)  Framingham Risk Score (FRS) 
The Framingham Heart study was the first to evaluate the causal relationship 
between IHD risk factors and IHD, and consisted of 5209 men and women living in 
Framingham, Massachusetts, in 1948. The researchers enhanced risk assessment 
by formulating the Framingham IHD risk prediction equation. This equation 
determines absolute global risk for IHD by using prominent risk factors together with 
the cause of cardiovascular disease; thus it is a multifactorial equation (D’Angostino, 
2012; Bitton and Gaziano, 2010). Since the Framingham Heart study in 1948 the 
research entity has continued with research in the cardiovascular field with an 
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Offspring Cohort, initiated in 1971 (2489 males and 2646 females), and the Third-
Generation Cohort initiated in 2001 (more than 4 000 participants) (D’Angostino, 
2012). The Framingham IHD risk prediction equation incorporates the following 
facets to calculate an individual’s 10-year RR for cardiovascular disease: gender, 
age, total cholesterol level, smoking status, high HDL level and SBP value (Blom, 
2011; NCEP ATP-III, 2002).  
 
Validity of the FRS 
The FRS is often used as the criterion against which other scores are tested, e.g. 
the Reynolds Risk Score (Cook et al., 2012). It has been validated in various ethnic 
groups with gender-specific categories, performing well in white and black 
participants in different settings (D’Argostino et al., 2001). The FRS was also 
validated in the developing world, specifically China (Liu et al., 2004). For these 
reasons the South African Dyslipidaemia Guidelines supports the use of the FRS 
when estimating cardiovascular risk in South African individuals (Klug et al., 2012). 
There are no validated IHD risk prediction equations available for use in an HIV 
population. The State of the Science Conference that focused on initiatives to 
decrease cardiovascular disease in individuals living with HIV suggested that the 
FRS could be used in the interim (Grinspoon et al., 2008). The FRS tables were 
used in this study to assist with calculating participants’ IHD risk.  
 
Chapter 4 consists of an explanation of the methodology, procedures, results and 
discussion related to study 1 of phase 1 of this project. The focus of study 1 was to 
screen the physical activity levels and other known non-invasive risk factors for IHD 
in PLWHA attending the Themba Lethu clinic in Johannesburg, SA. This provided 
information regarding the extent of the behavioural and clinically-assessed IHD risk 
factor status in PLWHA at an outpatient clinic level.   
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CHAPTER 4 
4. STUDY 1:  SCREENING OF NON-INVASIVE RISK FACTORS FOR IHD 
 
4.1  INTRODUCTION 
A lifestyle disease such as IHD is becoming a concern in PLWHA due to HIV having 
progressed to a chronic disease state, as well as side-effects of HAART. International data 
suggest that the predominant causes of mortality in PLWHA are shifting towards non-
communicable diseases e.g. IHD (Grinsztejn et al., 2013; French et al., 2009; Palella et al., 
2006). Screening and monitoring risk factors for IHD in PLWHA are thus considered an 
important management strategy (Grinspoon et al., 2008). Published information regarding 
the physical activity levels and non-invasive risk factor status of IHD in PLWHA at primary 
care level in SA is lackng. This study set out to provide information regarding these risk 
factors for IHD in PLWHA at a primary care level in SA. This information is important in 
providing support for preventive management strategies. This chapter consists of an 
explanation of the methodology, procedures, results, and discussion related to study 1 of 
phase 1 of the research project.  
 
4.2  STUDY 1 
4.2.1  Aim and Objectives 
Aim:  
To determine the associated risk factors for IHD in HIV+ individuals (on HAART) in 
Johannesburg, SA. 
 
Objectives: 
To determine, in individuals infected by HIV and on HAART:  
 current physical activity levels  
 perceived levels of stress 
 the presence of selected known associated risk factors for IHD (smoking history, diet, 
RHR, blood pressure, WC, WHR and BMI) 
 
4.3  METHODOLOGY  
4.3.1  Study Design 
An observational quantitative study was conducted from October 2010 to June 2012. 
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4.3.2  Sample Size 
No prevalence rates for IHD were available in the South African context at the start of this 
research project, either for the general or the HIV+ population. Hypertension is said to be a 
significant risk factor for IHD in the black African group of the INTERHEART Africa study 
(Steyn et al., 2005). The client base at Themba Lethu clinic was mostly of black African 
origin. Prevalence rates of HTN in the general South African population were used to 
calculate the sample size of study 1. Data available from Steyn (2008) indicated a 
prevalence rate of 55% in a study sample of 9 731. The sample size of study 1 was 
estimated at 195 subjects, with alpha set at 5% and the power set at 80%. The sample was 
increased by 5% for allowance of attrition rate during the data-collection period. The final 
sample size for study 1 was therefore 205 participants. A statistician assisted with sample 
size calculation for this study.    
 
4.3.3  Study Subjects 
The study participants were individuals infected with HIV, on HAART, living in 
Johannesburg and attending the Themba Lethu HIV clinic at the Helen Joseph hospital. A 
consecutive sampling method was used, according to the following inclusion and exclusion 
criteria: 
 
4.3.3.1  Inclusion criteria 
The following individuals were included: 
 Those infected with HIV. 
 On HAART. 
 Attending Themba Lethu clinic at Helen Joseph hospital in Johannesburg, SA. 
 Aged between 20 and 65 years.  
 Those on HAART for ≥ six to 12 months. 
 Those with HIV on HAART who were ambulatory without an assistive device. 
 
4.3.3.2  Exclusion criteria 
The following individuals were excluded from participation in the study: 
 Pre-existing history of angina, myocardial infarction, stroke and peripheral vascular 
disease. 
 Acute infection or active/current opportunistic AIDS-defining illness. 
 Pre-existing history of dementia, confusion, psychosis or current signs of emotional 
distress. 
 Known diagnosed peripheral neuropathy or a physical complaint of “sore” or “burning 
feet” influencing walking ability.  
 Pregnant or breast-feeding women. 
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4.3.4  Measuring Instruments 
The following instruments were used: demographic questionnaire (1) referred to in this 
chapter below as “the questionnaire (1)” (Appendix 12), PSS-10 (Appendix 10), phase 1 
evaluation form (Appendix 13), Yamax SW200 pedometer, with pedometer activity walking 
log sheet (Appendix 14), pedometer accuracy sheet (Appendix 15), Microlife BP A100 
automated sphygmomanometer, Butterfly non-stretch tape measure, Simple Choice 
portable weight scale, poster paper, clipboards and pens. The literature review and 
justification for the use of these measuring instruments are provided above (chapter 3, 
section 3.2.1).  
 
4.3.5  Translation Considerations  
4.3.5.1 Gauteng language review  
South Africa has 11 official languages: Afrikaans, English, isiNdebele, isiXhosa, isiZulu, 
Sesotho sa Leboa, Sesotho, Setswana, siSwati, Tshivenda and Xitsonga. English is the 
country’s lingua franca, due to it being the language of business, politics and media (Stats 
SA, 2011). Languages most frequently spoken in Gauteng province where this study was 
conducted were isiZulu (19.8%), English (13%), Afrikaans (12.4%) and Sesotho (11.6%) 
(Stats SA, 2011). Unpublished data from two PhD theses at the University of the 
Witwatersrand (Ballington et al., 2012; Wood et al., 2010) reported that participants in 
research studies in Gauteng province, very rarely select information in their home 
language, their preference most often being English. English and isiZulu were therefore 
chosen as the languages considered for translation. 
  
4.3.5.2 Documents considered for translation 
Content validity of the questionnaire was established by giving it, together with the study 
objectives, to two physiotherapists for review: one with clinical and academic experience in 
the HIV population, and the other with experience in cardiopulmonary physiotherapy. Their 
suggestions were implemented, and minor adjustments made accordingly. The 
questionnaire was also reviewed by the Faculty of Health Sciences Postgraduate Protocol 
Assessors group and the University of the Witwatersrand Ethics committee. The Ethics 
committee suggested minor alterations, such as removing “relationship status” from the 
questionnaire, which were implemented.   
 
The following documents pertaining to study 1 were translated into isiZulu: information 
document (Appendix 16), consent form (1) (Appendix 17), the questionnaire (1) (Appendix 
18) and the pedometer activity walking log (Appendix 19). These documents were 
forwarded for translation from English to isiZulu by one translator, and then back-translated 
from isiZulu to English by a second translator. This was done to ensure objectivity in the 
translation process, and to ensure consistency of English and isiZulu formats. The 
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translations were performed by Bangula Translation Services.  The researcher reviewed 
the original English versions against the back-translated versions of the documents to 
identify any discrepancies that might have occurred. The documents were very similar, and 
no significant alternations were noted that could affect understanding.  
 
4.3.6  Orientation of Research Assistants 
Study 1 included two research assistants that worked as physiotherapists at Helen Joseph 
hospital. The home language of one was English, though she could also speak Afrikaans. 
That of the second was isiZulu and he was also fluent in English. Their function was to 
obtain informed consent from eligible study participants. They were briefed about the aims 
of the study and their role in it, and were given a document with the most important facts to 
remember. They were also given copies of the information document and consent forms 
(English and isiZulu versions). A third research assistant was a “runner/place-keeper” in the 
clinic queue while testing was under way. The need for the “runner” had become apparent 
in pilot study 2, and the same person became part of study 1. She was fluent in English and 
isiZulu, and knew the logistics of the clinic, having attended as a patient there. She had 
received HAART for many years, so could not participate as a subject in the project. She 
assisted with translation in consultation sessions where participants had difficulty 
understanding English. The researcher’s first language was Afrikaans but she was fluent in 
English.  
 
4.3.7  Pilot Studies of Study 1 
Two pilot studies were conducted before the main study to assist with selection of the 
Yamax pedometer and review the intra-rater reliability of tools and the researcher when 
assessing participants. Details of these pilot studies will be presented in section 4.3.7.1 and 
4.3.7.2.  
 
4.3.7.1 Pilot study 1 
The physiotherapy department of the University of the Witwatersrand had access to two 
types of Yamax pedometers: the Yamax SW200 and the Yamax CW600. In pilot study 1 
the differences between these two devices when conducting physical activity assessment 
were determined. 
 
4.3.7.1.1 Aim and objectives: Pilot study 1 
Aim:  
To determine the instrument intra- and inter-rater reliability of the Yamax SW200 
and Yamax CW600 pedometer in physical activity assessment.  
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Objectives: 
To determine, in full-time University of the Witwatersrand staff: 
 physical activity, as measured with the Yamax SW200 and CW600 pedometers, 
 the relationship between the Yamax SW200 and Yamax CW600 pedometers in 
physical activity assessment, 
 the extent of agreement between these pedometers, 
 whether there were any difficulties related to physical activity assessment over a 
period of seven days with these pedometers.  
 
 4.3.7.1.2  Study design: Pilot study 1 
An observational quantitative study was undertaken in June and July 2010. 
 
4.3.7.1.3  Sample size: Pilot study 1 
A sample size of ten participants was selected to compare step-count between the 
two pedometers. Schneider et al. (2004) used 20 participants to evaluate 13 models 
of pedometers in free-living activity. It was thus concluded that 10 participants to 
compare one variable between two pedometers should be adequate to provide 
statistically significant findings. 
 
4.3.7.1.4  Study participants: Pilot study 1 
Twelve physiotherapy and two occupational therapy department staff members from 
the School of Therapeutic Sciences of the University of the Witwatersrand were 
invited to participate in the study. They were invited because they available in the 
time set aside for this pilot study. The only requirements for participation were that 
they be independently mobile without a mobility aid, willing to wear both pedometers 
for seven days and document pedometer step-count findings daily on a physical 
activity log sheet. Two declined participation, resulting in a sample size of 12 
participants. The participants were sampled consecutively. 
 
4.3.7.1.5  Measuring instruments: Pilot study 1 
Of the two pedometers, the SW model offered a step-count function only, whereas 
the CW model included a clock, physical activity time function, a seven-day memory 
and a two-week accumulated memory function. The last two functions were 
considered beneficial in the research environment where participants could easily 
forget to record their daily information on the activity log. The participants were 
asked to document their pedometer findings on a physical activity log sheet 
(Appendix 14). The procedure involved, and the results, with a brief discussion and 
conclusion, are presented in Appendix 20. 
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4.3.7.1.6  Key recommendations: Pilot study 1 
The pilot study supplied valuable information in preparation for study 1. It found that 
the accuracy of the SW200 model was greater (r=0.96; p<0.00) than the CW600 
(r=0.82; p<0.00). The study also highlighted that the CW600 tended to 
underestimate pedometer steps when compared to the SW200. These findings 
supported the use of the SW200 pedometer in the project.  
 
The pilot study also highlighted potential difficulties, requiring correcting strategies: 
 
 Participants might be predominantly female and only wear dresses. In that case 
a belt would need to be available for mounting the device. Alternative pedometer 
placements, such as wearing it on tights underneath a dress, might be 
suggested in a seven-day assessment. 
 
 Participants with children would need to ensure that they did not carry a child on 
their hip where the pedometer was positioned, as it might influence readings.  
 
4.3.7.2 Pilot study 2 
Pilot study 2 followed pilot study 1, and was conducted at Themba Lethu clinic with the 
research population of interest: individuals living with HIV and on HAART. The inclusion 
and exclusion criteria, as well as the measuring instruments, were the same as in study 1 
(4.3.3 and 4.3.4. above).  
 
4.3.7.2.1  Aims and objectives: Pilot study 2 
Aim 1:  
To determine the reliability of the Yamax SW200 pedometer in physical activity 
assessment. 
 
Objectives of aim 1:  
To determine, in affected individuals: 
 physical activity with the pedometer. 
 accuracy of the pedometer. 
 reactivity between first and last day of physical activity assessment. 
 
Aim 2:  
To determine researcher intra-rater reliability in vital signs- and anthropometric 
measurement assessments in individuals that are HIV+ (on HAART). 
 
  
81 
 
Objectives of aim 2:  
To determine: 
 vital signs: RHR and blood pressure. 
 anthropometric measurements: WC, hip circumference, height and weight. 
 
Aim 3: 
To evaluate the utility of the demographic questionnaire (1) and PSS-10. 
 
Objectives of aim 3:  
To determine: 
 the internal consistency of the PSS-10 
 any problems experienced in completing the demographic questionnaire (1) 
 
4.3.7.2.2  Study design: Pilot study 2 
An observational quantitative study was undertaken from October to December 
2010. 
 
4.3.7.2.3  Sample size: Pilot study 2 
The sample size for the pilot study (n = 21) was calculated at 10% of that of the 
larger main study one (n = 205), as suggested in the literature (Hertzog, 2008). 
Twenty-four individuals were assessed and included. The procedure, with results 
and brief discussion and conclusion are given in Appendix 21.  
 
4.3.7.2.4  Key recommendations: Pilot study 2 
The pilot study yielded valuable information on clinical research in PLWHA at clinic 
level. The most pertinent difficulties encountered included: 
 
 Participants stood in the clinic queue for a long time when attending 
appointments, and were thus not willing to leave their place in the queue to 
attend research sessions. To overcome this, a “runner” was recruited (research 
assistant three) to keep participants’ place in the queue.  
 
 The cue used in the pedometer accuracy test: “walk at a normal comfortable 
pace” resulted in slower walking speeds than what was found with pilot study 1 
participants. The cue was changed to: “walk at a normal fast pace as if you are 
trying to catch a taxi”. 
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 Acquiring the participants’ file for review was often difficult, due to it being in use 
in the clinic at the time. The researcher therefore relied on subjective feedback 
from participants when reviewing the inclusion and exclusion criteria. 
Information on participants’ blood results in clinic files was often absent or very 
old (>1 year). The manager of the clinic allowed the researcher to review blood 
results from the National Health Laboratory database system, to which the clinic 
had access. Further explanations of the obstacles are offered in Appendix 21. 
 
Pilot study 2 found that the intra-rater reliability of the researcher when 
evaluating participants’ body measurements (height, waist and hip 
circumference) was excellent (r=0.99; p<0.00 to r=1.00; p<0.00). The intra-rater 
reliability of the sphygmomanometer (r=0.82; p<0.00 to r=0.93; p<0.00) and the 
weight scale (r=1.00; p<0.00) was also excellent, indicating that the equipment 
was reliable. No significant reactivity (p=0.40) occurred when participants wore 
the pedometer and recorded their findings on the log sheet. The Cronbach’s 
alpha of the PSS-10 was 0.82, indicating internal consistency when assessing 
perceived stress levels with the PSS-10. It was therefore concluded that the 
measuring equipment and instruments were reliable, and could be used for the 
procedures in main study 1.  
 
4.4  PROCEDURE  
Knowledge gained from the pilot studies was incorporated in the procedure of study 1. 
Patients attending Themba Lethu clinic at Helen Joseph hospital were approached while 
they were queuing. Eligible participants were identified at this stage by the researcher. 
Each eligible participant was introduced to a research assistant (Helen Joseph hospital 
physiotherapist) who then explained the study and obtained informed consent.  Once the 
consent had been obtained a third research assistant (“runner”) kept the participant’s place 
in the queue while the researcher conducted the first interview (on the same day as 
recruitment). 
 
Participants provided information regarding their time on HAART, and this information was 
checked with the file, as well as the type of HAART medication prescribed. Information 
regarding CD4 count, viral load and liver function tests was collected from clinic files and/or 
the National Health Laboratory database. At the first interview the demographic 
questionnaire (1) and PSS-10 were completed, with the researcher at hand for any 
questions that might have arisen.  
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A. Procedure for testing pedometers 
The pedometer and physical activity log sheet were then explained to the participant. 
Factors relating to use of the pedometer covered in this training session included: how 
to open and close it, how to reset it, and when and where to wear the waist-mounted 
instrument. Participants were requested to continue with their daily life as normal for the 
seven consecutive days of wearing the pedometer, and asked to wear it from the time 
they got up in the morning until they went to bed at night. They were instructed not to 
wear the pedometer when bathing, showering, swimming or sleeping. Before fitting the 
pedometer each morning, they had to reset the counter to zero. They were asked to 
document the step-count recorded on the log sheet in the evening when they removed 
the device. 
 
An accuracy test was done with each participant as the pedometer was issued at the 
first session.  Accuracy was determined by demarcating a 10-meter distance in a quiet 
corridor outside the physiotherapy room. Participants were instructed to wear the 
pedometer on the right side of the body, at waist level. Pedometer placement in each 
participant was standardised by instructing the participants always to wear the 
pedometer anterior to the right hip, in approximately mid-thigh position. The researcher 
checked the pedometer placement for correctness. This position was suggested by the 
manufacturers (Yamax, 2011). The participants were instructed to walk at a normal fast 
pace “as if they were trying to catch a taxi” over the 10-meter distance, starting with the 
right leg. The researcher counted the actual steps taken by the participant, remaining 
positioned at a distance behind the participant so as not to influence the walking speed. 
This procedure was followed twice. The counted steps were evaluated against the 
pedometer reading, and the findings documented on a pedometer accuracy sheet. A 
follow-up appointment was then scheduled for 10 to 14 days later. One day before the 
second appointment, the researcher sent each participant a reminder cellphone short 
message service (SMS) regarding their physiotherapy appointment the next day. 
 
B. Procedure for body measurements 
In the return appointment the pedometer and activity log were returned. The 
participants were asked whether they experienced any problems related to the 
pedometer or their health since the last session.  
 
Positioning of participants 
This discussion took place while participants were resting comfortably in an office chair. 
They were asked if they had drunk any coffee, Coca-Cola or smoked a cigarette in the 
previous half-hour, as these could have influenced their vital signs. None of them had. 
Vital signs and anthropometric measures were then assessed by the researcher.  
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Test Procedures 
 
a)  Heart rate and blood pressure 
The participants were asked to expose their arms and remove any tight-fitting 
clothes that could affect circulation in the upper extremities during blood pressure 
evaluation. Each participant sat quietly for approximately five minutes on a 
comfortable office chair with his/her back supported by a pillow.  The cuff of the 
sphygmomanometer was positioned, firstly on the left upper arm approximately two 
to three centimeters above the elbow joint, as recommended by the manufacturers, 
with the limb resting pointing forwards at heart level on the table. Two readings were 
taken on the left arm. The procedure was repeated on the right arm. The device was 
used and cared for in accordance with the manufacturer’s instructions. Once the 
start button had been activated the cuff inflated, and an automatic measurement 
was made. The values were displayed for one minute on the display monitor before 
disappearing. After each reading a minute elapsed before the sphygmomanometer 
automatically re-calibrated to zero, and a follow-up reading could be done. Pulse 
rate and blood pressure values were collected with the Microlife BP A100 
automated sphygmomanometer. The measuring unit for pulse rate was bpm, and 
for blood pressure mmHg. 
 
b) Respiratory rate 
In the cardiovascular assessment the researcher observed participants’ chest rise 
and fall to determine the respiratory rate. This was to provide information regarding 
relaxation level, and was not part of risk factor screening for IHD. The measuring 
unit for respiratory rate was breaths per minute.  
 
c) Weight, height, waist and hip measurements 
The participants were then instructed to remove their shoes, hats and any bulky 
clothing, as well as any articles in their pockets e.g. wallet or cellphones. Their 
weight was measured twice with the portable scale. The scale was calibrated before 
each assessment in accordance with the manufacturer’s guidelines, and a minute 
elapsed between readings. Participants were then instructed to stand upright 
against a wall in the physiotherapy room facing the researcher with their head in a 
neutral resting position. A ruler was positioned against the top of the head normal to 
the wall. A mark was made on the poster paper. The participant stepped aside and 
the researcher measured the distance from the mark to the floor to determine 
height. This procedure was followed twice. Weight and height were measured to the 
nearest 0.1 kg and 0.1 cm respectively.  
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Waist and hip circumferences were measured with a Butterfly non-stretch tape 
measure according to the ACSM Guidelines for anthropometric measurements 
(2010). Waist circumference was measured at the narrowest circumference halfway 
between the lowest ribs and iliac crests with the arms of participants lowered next to 
their sides and feet placed together. The participants were encouraged to exhale 
gently, and measurements were then taken to ensure the abdomen was relaxed. A 
horizontal measure was taken at the narrowest portion of the trunk (above the 
umbilicus but below the xiphoid process). Hip circumference was measured at the 
broadest circumference of the buttocks with participants’ feet placed together while 
standing upright. Two measurements of waist and hip circumference were taken. 
The measuring unit for weight was kg and height, waist and hip circumference were 
measured in cm. 
 
d) WHR and BMI 
Body mass index was calculated with the following equation: kilograms divided by 
height in meters squared (WHO, 2004). The WHR of study participants was 
calculated by dividing the WC by the hip circumference, both in meters (ACSM, 
2010). At completion of the session participants received feedback concerning their 
findings and were informed regarding normal values of each parameter. If 
parameters suggested an increased risk of IHD the participants were invited to 
participate in study 4 that followed study 1. If an individual had difficulty 
understanding information research assistant three acted as translator. She was 
instructed to translate word-for-word, or as close as possible, depending on the 
availability of the word in the vernacular. 
 
All the assessed variables were recorded on the phase 1 evaluation form of the 
study for data capture at a later stage. Blood pressure and pulse rate were 
measured twice on each arm, resulting in four blood pressure and four pulse rate 
measurements. The South African Hypertension Society Guidelines suggest that 
when measuring blood pressure it should be assessed on both arms, and an 
average of two readings should be taken (Seedat et al., 2006). The means of these 
variables were calculated in statistical analysis. Anthropometric measurements 
resulted in two measurements of each variable. The means of these variables were 
calculated in statistical analysis.   
 
4.5  STATISTICAL ANALYSIS  
Data collected in study 1 were captured in Microsoft Excel 2007 spread sheets. The data 
sheets were reviewed to highlight any anomalies or absences of data, and corrected 
accordingly. Data analysis was done with STATA 12 by an external statistician, and IBM 
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SPSS 20 by the researcher. Data were evaluated for normal distribution. Continuous data 
were summarised as means and standard deviations. Categorical data were summarised 
as frequencies and percentages. Demographic data of the study sample was assessed as 
a whole, but smoking status, physical activity levels, perceived levels of stress and 
anthropometric measurements were also reviewed by gender groups, as literature supports 
gender differences in these variables (ACSM, 2010; Peer et al., 2009; Guthold et al., 2008; 
Hamad et al., 2008). This was also observed in pilot study 2. Bivariate analysis was carried 
out to determine which variables - physical inactivity (step-count ≤ 9 999 steps/day), 
overweight/obesity (BMI ≥ 25 kg/m2) or RHR (≥ 80 bpm) - had an association as abnormal 
values. These were noted in these sample mean variables. Univariate logistic regression 
analysis was then done to explain the odd ratios between physical inactivity, RHR and BMI 
with their independent variables. The odd ratios were adjusted for age and gender in further 
logistic regressions. Findings were significant, with p ˂ 0.05. Data are represented up to 
one decimal value. The results are presented in section 4.6. 
 
4.6  RESULTS  
The results of study 1 are reported in six sections: Socio-demographic profile, HIV-related 
profile, physical activity levels, perceived stress levels, other non-invasive IHD risk factors 
screened, and lastly logistic regression analysis findings. Figure 4.1 is a flow diagram of the 
representation of the number of participants, from interest to participation to second session 
assessment in study 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Flow Diagram to Illustrate Participants’ Retention from Interest to 
Assessment in Study 1 
 
  
n=296 
Individuals who indicated interest. 
n=14 (4.5%) 
Individuals excluded. 
n=282 
Individuals recruited and consented 
n=77 (27.3%) 
Lost to follow-up due to following 
reasons: 
 unable to attend due to work 
 unable to attend due to 
financial constraints 
 individuals travelling outside 
the Gauteng province 
 unable to contact telephonically 
 
n=205 (100%) 
First session assessment 
n=11 
Lost to follow-up due to same reasons 
n=194 (94.6%) 
Second session assessment 
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Fourteen individuals were excluded from participation in the study because: two would be 
travelling outside Gauteng Province, and were unsure of their return; eight had been on 
HAART for more than 12 months, two were pregnant, one had a history of myocardial 
infarction and one had TB myopathy.  
 
4.6.1 Socio-Demographic Profile of Study 1 Participants 
Table 4.1 provides information on socio-demographic profile, as obtained through the 
questionnaire.  
 
Table 4.1:  Socio-Demographic Information of Study 1 Participants (N = 205) 
Variable N n (%) or Mean (±SD) 
Age (years) 205 38.2 (±9.5) 
Gender 
 Male 
 Female 
205  
   47 (22.9) 
 158 (77.1) 
Educational level 
 None 
 Primary  
 Secondary  
 Post-secondary  
205  
6 (2.9) 
50 (24.4) 
95 (46.3) 
54 (26.3) 
Employment status 
 Unemployed 
 Employed 
 Self-employed 
205  
   83 (40.5) 
  115 (56.1) 
   7 (3.4) 
Participants who had dependants 
 
205   158 (85.4) 
 
The majority of participants were female (n=158; 77.1%), had a secondary education 
(n=95; 46.3%), were employed (n=115; 56.1%) and supporting dependants (n=158; 
85.4%).  
 
The occupation (where employed), was as follows: domestic worker (n=46; 22%), 
administrative (n=25; 12%), handyman-type (n=18; 8%), cashier or sales person (n=18; 
8%), cook or waiter (n=12; 6%), security officer (n=6; 3%), street vendor (n=6; 3%), 
teaching assistant or nanny (n=6; 3%), taxi- or truck driver (n=3; 1.5%), cleaner (n=3; 
1.5%), auxiliary nurse (n=3; 1.5%), counsellor (n=3; 1.5%), carer (n=2; 1%), hairdresser 
(n=2; 1%), student (n=2; 1%) and jockey (n=1; 0.5%).  
 
Table 4.2 provides information regarding previous medical information. 
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Table 4.2:  Past Medical Information of Study 1 Participants (N = 205) 
Variable n (%) 
Respiratory history 
 Pulmonary TB 
 Upper respiratory tract infection 
 Pneumonia 
 Asthma 
 Sarcoidosis 
 Pneumocystosis 
 
55 (27) 
17 (8) 
15 (7) 
9 (4) 
1 (0.5) 
1 (0.5) 
Neurological history 
 Shingles 
 Meningitis 
 Bell’s palsy 
 Unspecified polyneuropathy 
 Epilepsy 
 HIV encephalopathy 
 
9 (4) 
5 (2) 
2 (1) 
2 (1) 
1 (0.5) 
1 (0.5) 
Musculoskeletal history 
 General or specific joint discomfort 
 Gout 
 Headache 
 Myalgia 
 
14 (7) 
1 (0.5) 
1 (0.5) 
1 (0.5) 
Dermatological history 
 Acne and rashes 
 
12 (6) 
Gastric history 9 (4) 
Genitalia history 
 Genital warts 
 
13 (6) 
Extra-pulmonary TB 
 Meningitis 
 Abdominal cavity 
 
4 (2) 
2 (1) 
Renal dysfunction 3 (1.5) 
Wasting syndrome 1 (0.5) 
Malnutrition 1 (0.5) 
Thyroid dysfunction 1 (0.5) 
Lipodystrophy 1 (0.5) 
Hyperlipidaemia 1 (0.5) 
Depression 1 (0.5) 
♦ TB (tuberculosis) 
 
The condition most often identified in previous medical history was pulmonary TB (n=55; 
27%). Unspecified polyneuropathy was noted in 2 (1%) files, but was not reported verbally 
as factors influencing their health and walking ability. 
 
Table 4.3 provides information regarding surgical history. 
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Table 4.3:  Surgical History of Study 1 Participants (N = 205) 
Variable n (%) 
Abdominal wall surgery 
 Caesarian section 
 Laparotomy 
 Hysterectomy 
 Mini-laparotomy for ectopic pregnancy 
 Appendicectomy 
 
27 (13) 
9 (4) 
8 (4) 
4 (2) 
3 (1.5) 
Musculoskeletal surgery 10 (5) 
Biopsy 
 Breast biopsy 
 Uterus biopsy 
 
4 (2) 
2 (1) 
Head and neck surgery 
 Dental surgery 
 Tonsillectomy 
 Eye procedure  
 
2 (1) 
2 (1) 
1 (0.5) 
Procedures performed on the genitalia 
 Genital wart removal 
 Circumcision 
 
4 (2) 
1 (0.5) 
Dermatological procedures 
 Repair of skin lacerations 
 Removal of wart on hand 
 
3 (1.5) 
1 (0.5) 
Chest wall procedures 
 Intercostal drain insertion 
 
1 (0.5) 
Removal of varicose veins 1 (0.5) 
 
The majority of surgical interventions performed in participants were confined to the 
abdominal cavity, and were mostly obstetric and gynaecological.   
 
Medication, excluding HAART, included: anti-hypertensive (n=9; 4%), collected from the 
local clinic in their community; bronchodilator therapy through metered-dose inhalers (n=2; 
1%); statin therapy and aspirin (n=1; 0.5%); Glucophage (n=1; 0.5%); anti-depressants 
(n=1; 0.5%), and one participant (0.5%) was taking thyroxin sodium for thyroid dysfunction. 
No participant reported using recreational drugs; nor was any such history established in 
their file review. Section 4.6.2 contains information regarding participants’ HIV-related 
profile. 
 
4.6.2 HIV-Related Profile 
Table 4.4 provides information regarding the HIV-related profile of participants’ defining 
parameters, screened by the questionnaire.  
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Table 4.4: Information of HIV Characteristics of Study 1 Participants (N = 205) 
Variable N n (%) or Mean (±SD) 
Time on HAART (months) 205 8.7 (±2.3) 
Confirmed to have HIV 
 Before 2005 
 2005 - 2008 
 2009 - 2011 
205  
25 (12) 
44 (22) 
136 (66) 
HAART categories 
 Lamivudine, Efavirenz, Tenofovir  
 Lamivudine, Efavirenz, Stavudine 
 Other                         
205  
139 (67.8) 
38 (18.5) 
28 (13.6) 
Perceived health perception 
 Poor 
 Average 
 Good 
 Excellent 
205  
5 (2.4) 
40 (19.5) 
120 (58.5) 
40 (19.5) 
Body shape changes in last six months 205 123 (60) 
Weight gain in last six months 205   132 (64.4) 
Weight loss in last six months 
 
205 49 (23.9)  
 
The majority of participants (n=136; 66%) were confirmed as having HIV between 2009 and 
2011, and received the previous first line HAART regimen. The “other” HAART category 
contained alternative combinations of drugs e.g. Nevirapine and/or Zidovudine, and were 
collapsed into an “other” category for ease of data analysis.  
 
The majority (n=120; 58.5%) perceived their health as good, and reflected on how their 
health had improved since initiation of HAART. The majority also reported weight gain 
(n=132; 64.4%) and body shape changes (n=123; 60%). The body shape changes were 
explained as: general weight gain or general weight loss or gaining weight centrally (around 
the abdomen, or at the breasts, or at both abdomen and breasts, or around the hips and 
buttocks, or at the breasts and buttocks).  
 
Table 4.5 provides information regarding the immune parameters and liver function test 
results.  
 
  
91 
 
Table 4.5:  Results of immune parameters and liver function tests of study 1 
participants (N = 205) 
Variable N n (%) or Mean (± SD) Normal range 
CD4 count (cells/mm3) 205 285.1 (±157.9) 
600-1500 
(Van Dyk, 2008) 
Viral load (copies/ml) 
▪ < 400 170 * 133 (64.9)  
Full liver function (U/L) 
 ALT 
 AST 
 GGT 
  110 *  
           35.1 (±42.7) 
           42.2 (±34.7) 
         101.6 (±127.5) 
 
7 – 56  
0 – 35  
9 – 85  
(Gowda et al., 2009) 
Isolated ALT (U/l)   188 *            31.6 (±24.3) 7 – 56  
(Gowda et al., 2009) 
Isolated AST (U/l)     25 *               47 (±54.0) 0 – 35  
(Gowda et al., 2009) 
♦ Cells/mm3 (cells per cubic millimeters of blood), copies/ml (copies of HIV RNA in milliliters of 
blood), U/l (units per liter), ALT (Alanine transaminase), AST (Aspartate transaminase) and GGT 
(Gamma glutamyl transpeptidase). 
 
* No results of viral load and liver function tests available in all of the study participants. 
 
The sample cohort’ CD4 count was below the suggested normal range. Viral load was 
available in only 170 individuals from review of their clinic files and the National Health 
Laboratory database, and the majority of participants had a value less than 400 copies/ml.  
 
Abnormal mean values were noted in aspartate transaminase (AST) and gamma glutamyl 
transpeptidase (GGT) liver function findings of the sample. It is important to note that full 
liver function tests were most often older than six months. No results of liver function 
assessments were available for all study 1 participants.  
 
Section 4.6.3 answers objective 1 of study 1: 
 To determine, in affected individuals (on HAART), their physical activity level with the 
Yamax SW200 pedometer. 
 
4.6.3  Physical Activity Levels of Study 1 Participants 
Physical activity data for 195 participants were available for analysis. Three were excluded 
in analysis due to not completing seven days of pedometer assessment. Furthermore, one 
of those three left her pedometer and log sheet with a staff member for collection, and did 
not attend her second assessment session. Seven participants did not attend their second 
visit or return their pedometer and log sheet. Three participants could not attend their 
second session, and sent a friend or family member to return their pedometer and physical 
activity log sheet.  
 
The mean pedometer step-count finding was 7 673.2 (±4 017.7), with women (n=152) 
walking less [6 993.3 (±3 462.6)] than men (n=43) [10 076.3 (±4 885.6)]. The sample as a 
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whole was therefore “somewhat active”, as the mean steps per day were between 7 500 – 
9 999. Table 4.6 is a representation of the pedometer physical activity categories of 
participants. 
  
Table 4.6: Pedometer Physical Activity Categories of Study 1 Participants 
(N = 195) 
Pedometer physical activity categories† N n (%) 
Sedentary: less than 5 000 steps per day 195 52 (26.7) 
Light active: 5 000 to 7 499 steps per day 195 57 (29.2) 
Somewhat active: 7 500 to 9 999 steps per day 195 41 (21.0) 
Active: 10 000 to 12 499 steps per day 195 23 (11.8) 
Very active: more than 12 500 steps per day 195 22 (11.3) 
† Pedometer physical activity categories as per Tudor-Locke and Bassett (2004) 
 
The majority fell into categories less than “active”, walking less than 10 000 steps per day - 
indicating room for improvement. This finding is similar to those of pilot study 2. Physical 
activity preferences concerning mode of activity as determined by the questionnaire are 
depicted in Table 4.7. 
 
Table 4.7: Physical activity preferences of study 1 participants (N = 205).   
Physical activity mode N n (%)  
Formal sporting activities 
 Aerobic exercise 
 Soccer 
 Basketball 
 Netball 
 Running group 
 Horse racing (jockey) 
205 8 (3.9) 
2 (25.0)  
2 (25.0)  
1 (12.5)  
1 (12.5)  
1 (12.5)  
1 (12.5)  
Self-initiated exercise 
Individual exercise 
 Walking 
 Running 
 Strengthening exercises 
 Own aerobics 
 Stretching 
 Dancing 
 Jumping 
 Cycling 
 Yoga 
 Vibration machine 
Social exercise 
 Netball 
 Soccer 
 Squash 
Physical activity through home-related activities 
 Housework 
 Gardening 
Physical activity through work-related activities 
 Active at work 
205 123 (60) 
 
56 (45.5)  
33 (26.8)  
19 (15.4)  
6 (4.8)  
3 (2.4)  
3 (2.4)  
2 (2.0)  
2 (2.0)  
1 (1.0)  
1 (1.0)  
 
3 (2.4)  
2 (2.0)  
1 (1.0)  
 
1 (1.0)  
2 (2.0)  
 
1 (1.0)  
 
Eight (3.9%) participants reported participating in a supervised formal sporting activity. One 
hundred and twenty three (60%) participants incorporated exercise in their lives. Walking 
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(n=56; 45.5%) and running (n=33; 26.8) were most often reported as the preferred activity 
that individuals performed individually. Soccer (n=2; 2%) and netball (n=3; 2.4%) were most 
often reported as the activities that individuals engaged in a group situation.  
 
Section 4.6.4 answers objective 2 of study 1:  
 To determine, in affected individuals (on HAART), their perceived levels of stress. 
 
4.6.4  Perceived Levels of Stress of Study 1 Participants 
Table 4.8 is a representation of the perceived levels of stress of the participants.  
 
Table 4.8:  Perceived Levels of Stress of Study 1 Participants (N = 205) 
Variable N Mean (±SD) 
Perceived stress level 
 Men 
 Women 
205 
47 
158 
19.2 (±7.8) 
16.9 (±9.1) 
 20 (±7.1) 
 
Women (20 [±7.1]) reported higher perceived stress levels than men (16.9 [±9.1]). The 75th 
percentile value for the perceived stress rating of the sample was 25. Thus the perceived 
stress level of the sample as a whole, and women particularly, was moderately high.  
 
Section 4.6.5 answers objective 3 of study 3:  
 To determine, in individuals infected by HIV and on HAART: the presence of non-
invasive known associated risk factors for IHD (smoking history, diet, RHR, blood 
pressure, WC, WHR and BMI) 
 
4.6.5  Non-Invasive IHD Risk Factors Screening of Study 1 Participants 
The questionnaire provided information regarding general symptoms experienced by 
participants, and the findings are presented in section 4.6.5.1 for review.  
  
4.6.5.1 Screening of general symptoms  
Symptoms of shortness of breath (SOB), fatigue and chest pain were screened in the 
questionnaire. One hundred and sixteen (56.6%) reported feeling fatigued. Their 
explanations included: very busy at work, feeling tired when waking up in the morning, or 
when walking a lot or when the weather was hot. 
 
Fifty nine (28.8%) participants complained of often feeling SOB. Explanations included:  
physical activity, e.g. walking, running, walking uphill or working a lot; emotional factors, 
e.g. being angry, feeling stressed or panicking; hot weather; talking a lot; respiratory illness 
or being in enclosed spaces. Three individuals (2%), however, reported SOB when 
sleeping flat, and they required additional pillows, perhaps indicating that they suffered from 
orthopnoea.  They were advised to consult their medical doctor.  
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Fifty two (25.4%) reported previous chest pain. They linked it to respiratory illness and 
severe coughing; musculoskeletal complaints that diminished when oral analgesia or 
creams were applied to the area; heartburn. One participant, however, complained of left-
sided chest pain, had difficulty sleeping flat, regular heart palpitations and a family history of 
heart disease. Her resting heart rate was above 115 bpm on examination, and she was 
referred to a medical doctor at the clinic for further investigation.  
 
4.6.5.2 Results of non-invasive risk factor screening for IHD 
Table 4.9 consists of a representation of family, diabetes and HTN history, smoking status, 
diet, RHR and blood pressure. 
 
Table 4.9:  Family, Diabetes and HTN History, Smoking Status, Diet, RHR and 
Blood Pressure of Study 1 Participants (N = 205) 
Variable N n (%) or Mean (±SD) Normal range 
Family history of IHD 205 29 (14.2)  
History of diagnosed diabetes mellitus  205 1 (0.5)  
History of diagnosed HTN 205        19 (9)  
Smoking status 
 Current smokers 
 Men 
 Women 
 Former smokers 
205  
33 (16.1) 
19 (40.4) 
       14 (8.9) 
53 (25.9) 
 
 
Diet 
Alcohol consumption 
 None  
 Monthly  
 Weekly  
 Daily  
 
Fish consumption 
 No weekly  
 Once weekly  
 Twice or three times weekly  
 Do not eat fish 
 
Vegetable and fruit consumption 
 Weekly  
 Daily  
 Daily consumption of three to five fruit and 
vegetables combined  
205  
 
177 (86.3) 
18 (8.8) 
  9 (4.4) 
     1 (0.5) 
 
114 (55.6) 
  36 (17.6) 
  22 (10.7) 
  33 (16.1) 
 
 
 
110 (53.7) 
  95 (46.3) 
  68 (33.2) 
 
 
PLWHA should  not 
drink alcohol 
(Maartens et al., 
2012) 
 
Emphasise 
consumption of fish 
as primary source of 
protein 
(Alpert, 2011; 
Lundgren et al., 
2008) 
Consumption of a 
minimum of five fruit 
and vegetables 
combined daily 
(WHO, 2013) 
Resting heart rate (bpm) 194 * 82.7 (±11.4) Less than 80 
(Palatini, 2007) 
Blood pressure (mmHg) 
 SBP 
 DBP 
194 *  
118.6 (±13.0) 
77.8 (±9.9) 
 
Less than 120 
Less than 80 
(Collins and Dias, 
2009) 
* n = 194 participants attended their second assessment session where these parameters were 
assessed. 
The number of current smokers was low (n=33; 16.1%), with more men (n=19; 40.4%) than 
women (n=14; 8.9%). Reasons for stopping smoking were: being diagnosed as HIV+; own 
choice; family requested they stop, and health reasons.  
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The prevalence of medically-diagnosed diabetes mellitus (n=1; 0.5%) and HTN (n=19; 9%) 
was low. Only 9 of the 19 participants were on antihypertensive medication. One additional 
participant reported having had HTN in her pregnancy.  Family history of heart disease was 
low (n=29; 14.2%), with 27 (13.2%) reporting that the history of heart disease involved their 
parents and/or grandparents.  
 
The majority (n=177; 86.3%) did not consume alcoholic beverages. One (0.5%) reported 
consuming one to two units of alcoholic beverages per day. The majority (n=114; 55.6%) 
were not able to eat fish weekly. All reported a diet that contained vegetables and fruit, but 
110 (53.7%) consumed it weekly, and only 95 (46.3%) were able to obtain it daily. The 
majority (n=137; 66.8%) were unable to obtain three to five vegetables and fruit combined 
daily. 
 
Resting heart rate was above the recommended normal range, and mean blood pressure 
values were normal. Individual patients were referred to the medical team of the clinic due 
to blood pressure and heart rate values being significantly above normal. A number of 
these also reported palpitations.  
 
Table 4.10 provides information regarding the anthropometric body measurements of 
participants. 
 
Table 4.10:  Anthropometric Body Measurements of Study 1 Participants (N = 194) 
Variable n Mean (±SD) Normal ranges 
Waist circumference (cm) 
 Men 
 Women 
194 
44 
150 
 84.9 (±11.1) 
82.7 (±9.6) 
  68.7 (±14.3) 
 
Less than 102  
Less than 88  
(ACSM, 2010) 
Hip circumference (cm) 194 103.5 (± 11.6) None available 
Waist:hip ratio 
 Men 
 Women 
194 
44 
150 
  0.8 (±0.1) 
  0.9 (±0.1) 
  0.8 (±0.1) 
 
Less than 0.95 
Less than 0.86 
(ACSM, 2010) 
Body mass index (kg/m2) 
 Men 
 Women 
194 
44 
150 
 25.6 (±1.4) 
 22.3 (±3.1) 
 26.6 (±5.5) 
 
18.5 to 24.9  
(WHO, 2004) 
♦ cm (centimeters), kg/m2 (kilograms per square meter)  
 
The anthropometric values were within acceptable normal ranges, except that the BMI 
finding for the sample was overweight (25–29.99 kg/m2), due to the women in the 
overweight category (WHO, 2004).  
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4.6.6  Independent Predictors at Univariate Logistic Regression of Physical Inactivity, 
Increased Resting Heart Rate and BMI  
 
Findings are presented in the tables below, firstly without adjustment for age and gender 
and then with adjustment. The variables are those identified in bivariate analysis and found 
to be significantly related to the specific variable of interest, namely physical inactivity, RHR 
and BMI. Findings are presented up to two decimal values. 
 
Table 4.11:  Independent Predictors of Physical Inactivity 
Variable n Odds ratio 95% CI p-value 
Unadjusted univariate analysis 
 Gender (female) 
 Resting heart rate 
 Waist circumference 
 
205 
194 
194 
 
3.33 
1.03 
1.04 
 
1.67 – 6.64 
1.00 – 1.06 
1.01 – 1.08 
 
<0.00 
0.04 
0.02 
Adjusted univariate analysis 
 Resting heart rate 
 Waist circumference 
 
194 
194 
 
1.02 
1.04 
 
0.99 – 1.06 
1.00 – 1.08 
 
0.11 
0.03 
 
Female gender, RHR and WC were found to be significantly associated with being 
physically inactive (less than 10 000 steps per day) before adjustment for age and gender. 
After adjustment WC was still significantly associated with physical inactivity. If WC 
increased by 1 cm he/she had a 4% probability of taking fewer than 10 000 steps per day.  
 
Table 4.12:  Independent Predictors of Increased RHR 
Variable n Odds ratio 95% CI p-value 
Unadjusted univariate analysis 
 Diastolic blood pressure 
 Physical activity level 
 Active category 
 
194 
195 
195 
 
1.04 
0.99 
0.34 
 
1.00 – 1.07 
0.99 – 0.99 
0.12 – 0.94 
 
0.03 
0.01 
0.04 
Adjusted univariate analysis 
 Diastolic blood pressure 
 Physical activity level 
 Active category 
 
194 
195 
195 
 
1.07 
0.99 
0.38 
 
1.03 – 1.11 
0.99 – 0.99 
0.13 – 1.11 
 
<0.00 
0.02 
0.08 
 
Diastolic blood pressure was found to be significantly associated with a RHR ≥ 80 bpm 
before adjustment. Physical activity level and the “active” physical activity category (10 000-
12 499 steps per day) were also found to be significantly associated with a RHR ≥ 80 bpm. 
This association was, however, inversely related to an elevated RHR. After adjustment the 
relationship persisted. Thus, if DBP increased by 1 mmHg the individual had a 7% chance 
of having a RHR ≥ 80 bpm. In contrast, with one extra step per day RHR was 99% less 
likely to be elevated ≥ 80 bpm. 
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Table 4.13:  Independent Predictors of Increased BMI 
Variable n Odds ratio 95% CI p-value 
Unadjusted univariate analysis 
 Gender (female) 
 SBP 
 Waist circumference 
 Hip circumference 
 Physical activity level 
 Very active category 
 CD4  
 Current smoking status 
 Former smoking status 
 Daily intake of fruit and vegetables 
 
205 
194 
194 
194 
195 
195 
205 
205 
205 
205 
 
7.16 
1.04 
1.26 
1.56 
0.99 
0.29 
1.00 
0.46 
0.42 
1.84 
 
3.14 – 16.33 
1.01 – 1.06 
1.18 – 1.35 
1.36 – 1.78 
0.99 – 0.99 
0.09 – 0.92 
1.00 – 1.01 
0.20 – 0.97 
0.22 – 0.80 
1.06 – 3.21 
 
<0.00 
<0.00 
<0.00 
<0.00 
<0.00 
0.04 
<0.00 
0.04 
0.01 
0.03
Adjusted univariate analysis 
 SBP 
 Waist circumference 
 Hip circumference 
 Physical activity level 
 Very active category 
 CD4 
 Current smoking status 
 Former smoking status 
 Daily intake of fruit and vegetables 
 
194 
194 
194 
195 
195 
205 
205 
205 
205 
 
1.07 
1.34 
1.53 
0.99 
0.60 
1.00 
0.90 
0.80 
1.80 
 
1.04 – 1.10 
1.22 – 1.46 
1.38 – 1.75 
0.99 – 0.99 
0.17 – 2.11 
1.00 – 1.01 
0.36 – 2.25 
0.38 – 1.70 
0.99 – 3.27 
 
<0.00 
<0.00 
<0.00 
0.05 
0.42 
0.01 
0.83 
0.56 
0.05 
 
Female gender, SBP, WC, hip circumference, CD4 count and daily fruit and vegetable 
intake were found to be significantly associated with a BMI ≥ 25 kg/m2 before adjustment. A 
“very active” physical activity category (taking more than 12 500 steps per day), and current 
and former smoking status were found to be significantly associated with, but inversely 
related to, a BMI ≥ 25 kg/m2 before adjustment. After adjustment SBP, WC, hip 
circumference and CD4 count were still significantly associated with a BMI ≥ 25 kg/m2. If 
SBP increased by 1 mmHg a 7% likelihood existed of a BMI ≥ 25 kg/m2. In addition, if a 
participant’s WC or hip circumference increased by 1 cm a 34% and 53% chance of a BMI 
≥ 25 kg/m2 existed respectively.  
 
A discussion of the results of study 1 is provided in section 4.7. 
 
4.7  DISCUSSION  
The aim of study 1 was to screen physical activity levels and other selected risk factors for 
IHD in individuals living with HIV and on HAART for six to 12 months. This particular period 
of HAART exposure was selected for the following reasons: firstly, the researcher wished to 
initiate contact with participants who had been monitored for adherence to HAART 
treatment for a reasonable period. This period was considered essential for them to have 
effectively implemented HAART into their lives and adjusted to the effects of therapy.  
 
Secondly, at conceptualisation of the project, literature indicated that 87% of deaths occur 
in the pre- and early HAART period amongst PLWHA in the South African context (Lawn et 
al., 2006). Mortality in this early period was independently related to advanced 
immunodeficiency at initiation of HAART. Early HAART in this study was defined as the first 
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four months of treatment. The authors reported few late deaths, and that these were related 
to the patient’s response to HAART at four months. Hence the decision to select 
participants after six months on HAART to ensure improved immune function at entry to the 
project and reduce the likelihood of loss to follow-up due to death.  
 
Thirdly, two research groups evaluated anthropometric body changes that occurred in 
PLWHA when initiated on HAART containing Stavudine in the South African context 
(Hurley et al., 2011; George et al., 2009). Hurley et al. (2011) reviewed participants at three 
intervals: baseline, six and 12 months following HAART initiation. George et al. (2009) 
reviewed study participants over the first two years of therapy. The current study thus 
provides additional information regarding IHD risk factors status in the early part of HAART 
exposure. This additional information highlights what education and intervention 
programmes are required at primary care level to improve health, and thus reduce IHD risk.  
 
4.7.1  Review of Socio-Demographics and HIV-Related Profiles 
The participants in the study were mostly female. Bias towards the female gender is 
expected, as prevalence of HIV infection in women in SA is higher than men (Stat SA, 
2013; Rehle et al., 2010). More women are also reported to access HAART in sub-Saharan 
Africa (Braitstein et al., 2008). Similar findings were reported in the South African context: 
gender differences in survival on HAART were evaluated in a multicentre study consisting 
of 58 124 adults (Cornell et al., 2012). Cornell et al. (2012) reported a finding of 65% 
women and 35% men. Hurley et al. (2011) had a similar gender distribution of 37.4% men 
and 62.6% women. In the current study the distribution was more for women (77.9%) than 
men (22.1%), but similar with regards to gender distribution compared to Cornell et al. 
(2012) and Hurley et al. (2011). The information collected in this study provides a picture of 
the general type of population attending an outpatient HIV clinic in Johannesburg, SA in the 
early part of HAART exposure. It also highlights selected risk factors for IHD in this 
particular population that require management. 
 
The majority of participants were in their thirties (mean age: 38.2 [±9.5] years), employed 
(n=115; 56.1%), had a secondary education (n=95; 46.3%) and supported dependants 
(n=158; 85.4%). Similarly, Hurley et al. (2011) found the same demographics in their study 
participants (n=230) attending a semi-private urban outpatient clinic in Durban, Kwa-Zulu 
Natal when evaluating anthropometric body measurements over the first year of HAART 
exposure. It is of interest to note that the demographics of individuals accessing HIV clinics 
in these two studies are similar, irrespective of province or health care spectrum (public 
sector vs semi-private). It also highlights the fact that the population initiated on HAART is 
individuals with family responsibilities, and form part of the workforce as demonstrated by 
the current study and the study conducted by Hurley et al (2011). This finding could 
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possibly explain the problem of dropout experienced later in the research project in terms of 
work or family obligations. International clinical exercise trials in the HIV field often report 
family responsibility and sessions clashing with work schedules as reasons for non-
adherence to exercise programmes (O’Brien et al., 2010). Ability to attend consultation 
sessions was already hindered by some participants’ work obligations. On the other hand, 
this finding implies that if participants’ adherence to HAART and episodic disability is 
managed, they have the potential to contribute to their community and the larger society for 
a satisfactory length of time.  
 
A positive finding was that the majority of participants (n=120; 58.5%) perceived their health 
status as good, even though their immune parameters were not yet optimal. The CD4 value 
in this study was slightly less than that reported by Cornell et al. (2012) in individuals after 
12 months’ exposure to HAART. The median CD4 value in that study was 294 (204–403) 
cells/mm3 (women) and 239 (164–337) cells/mm3 (men). The lower CD4 count in this study 
might be because the mean time on HAART was only 8.7 (±2.3) months and not yet 12. 
Despite the CD4 count, most participants reflected that the pre-treatment period was the 
one when they had been ill. A review of the medical histories reinforced the fact that 
participants had been ill previously, and now noted their health as better. Conditions noted 
were illnesses associated with WHO Clinical Staging of HIV II, III and IV (Van Dyk, 2008; 
WHO, 2005). Thus, reviewing the participants’ past illnesses in conjunction with immune 
parameters, it could be suggested that participants were initiated on HAART when 
advanced immunodeficiency was present. This finding is supported by literature stating that 
individuals in sub-Saharan Africa are often initiated on HAART when already presenting at 
an advanced stage of HIV (Peltzer et al., 2011; Braitstein et al., 2008; Lawn et al., 2008; 
Lawn et al., 2006).  
 
Physical activity has the ability to influence the immune system positively or negatively 
depending on the intensity of exercise. In the general population moderate-intensity 
exercise is reported to aid in immune stimulation and reduce disease risk.  Intense, 
vigorous exercise, on the other hand, could suppress the immune system, and increase 
disease risk (Rosa Neto et al., 2011). Moderate-intensity exercise in the general population 
has also been shown to improve immune function and lower the risk and severity of 
respiratory viral infections (Martin, Pence and Woods, 2009). In PLWHA an inverse 
relationship is reported to exist between viral load and physical activity levels, but this 
relationship does not extend to CD4 counts (Bopp et al., 2004). Promoting an increase in 
physical activity levels of participants could therefore lower viral loads and counteract 
disease progression. Bopp et al. (2004) noted that intensity of physical activity did not 
specifically correlate with CD4 or viral load values in their study population. This might be 
due to the authors reviewing participants’ normal daily activity, and not when they were 
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performing higher-intensity activity, such as formal exercise. In contrast, randomised control 
trials included in a systematic review done by O’Brien et al. (2010) found that structured 
exercise that consist of aerobic and resistance training tend to increase CD4 counts in 
exercise participants. The degree of increase differed among studies included in this review 
and findings were not always statistical significant when compared to non-exercise 
participants. Additionally, viral load response in exercise participants differed between 
studies: increased or decreased. The finding of Bopp et al. (2004) is beneficial, as it 
suggests that including low- to moderate-intensity physical activity in participants’ daily 
routine would not have a detrimental outcome on immune parameters.  
  
Consequently, the immune parameter findings in this study highlighted the need to design 
the physical activity programme in such a way as to improve, and not further impair, 
immune function. This could possibly be achieved if intensity and frequency were to begin 
at a low level and be gradually increased to a moderate level, in order to monitor how 
participants react functionally to this activity change. Achieving a moderate intensity level of 
physical activity, such as brisk walking, would be the ultimate goal, as suggested by the 
European AIDS Clinical Society Guidelines as a means to manage cardiovascular disease 
in PLWHA (Lundgen et al., 2008). 
 
Most participants (n=123; 60%) perceived a change in their body shape in the previous six 
months. This shape change was attributed more to weight gain than to weight loss. Body 
mass index is reported to change with HAART exposure over time in the South African 
context (Hurley et al., 2011; George et al., 2009). The mean change in BMI in the first year 
of HAART exposure is reported to be 2.4 kg/m2 in men and 2.2 kg/m2 in women (Hurley et 
al., 2011). In the study conducted by Hurley et al. (2011) male participants’ BMI changed 
more in the observation period, but were always within the normal BMI category. On the 
other hand, women at baseline were already overweight and progressed further into this 
category in the year of observation. In this study female participants, when assessed, were 
overweight compared to male participants, who had a normal BMI. Thus it seems that 
weight gain to the extent of being overweight or obese is more likely to affect women than 
men in the South African HIV context. 
 
An important factor to consider when evaluating weight is individuals’ perception of their 
weight status. Hurley et al. (2011) formally investigated PLWHA’s perception of weight in a 
South African cohort. The authors noted that individuals often perceived their weight to be 
less than the actual objective measured value. A perception of ideal weight could influence 
individuals’ acceptance of education strategies regarding ideal body weight, as they might 
not agree with a health care provider’s evaluation of a particular risk factor for IHD. The 
authors also noted that weight loss in communities in SA is seen as a sign of HIV/AIDS, 
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and encourages stigmatisation. This belief is corroborated by comparable international data 
(Reynolds et al., 2006). This belief could result in reduced compliance with counsel to 
reduce weight, as it could lead to compromising the confidentiality of status. In this study 
the majority of participants reported an increase in weight, and women often reported 
wishing to lose weight in answer to this question. Thus, with motivation for weight-loss 
present, implementing a weight-loss programme in this study might be better-accepted.  
 
A portion of the sample reported centralisation of weight around their trunk area in their 
explanations of body shape change. This phenomenon is a component of lipodystrophy 
(Grinspoon and Carr, 2005), a condition reported to develop in 69% of PLWHA when on 
HAART for more than 72 weeks. It is then that weight gain around the abdominal area is 
most often reported (Mutimura et al., 2007). George et al. (2009) noted that those who 
developed lipodystrophy in the first two years of HAART were more likely to have had a 
higher BMI at baseline than others.  In this particular study the BMI at baseline of 
individuals who developed lipodystrophy was 23.6 (±3.5) kg/m2, compared to 22.0 (±2.2) 
kg/m2 in those who did not. It should be noted that the study cohorts of George et al. (2009) 
and Hurley et al. (2011) were on a regimen containing Stavudine. Weight gain in the study 
conducted by Hurley et al. (2011), however, was related, not to HAART, but positively 
related to age, and negatively to TB status. The majority of participants (81%) included by 
Mutimura et al. (2007) were also on a regimen containing Stavudine. In the current study 
only a small proportion of the study cohort was on Stavudine (n=38; 18.5%). It is also 
important to remember that a relationship is reported between Stavudine and the risk of 
diabetes mellitus (RR=1.13; 95% CI: 1.08–1.15; p=0.0001) over time (De Wit et al., 2008). 
Screening these participants regularly to determine their glucose level as a monitoring 
method for diabetes mellitus is therefore indicated as a means of reducing their risk of 
developing IHD. 
 
International data on anthropometric changes in individuals living with HIV produced 
findings contrasting with South African data. Brown et al. (2006) reported no significant 
change in BMI in HIV-infected men who, in 1999-2003, were in three antiretroviral 
treatment groups: no treatment, monotherapy or combination therapy and, lastly, HAART. 
Similarly, Justman et al. (2008) reported no significant change in BMI in HIV-infected 
women in 1999-2004. They also reported that HAART was not an independent predictor of 
BMI or WHR. This contrasting finding might be due to black South African women being 
reported as more likely to be overweight or obese, irrespective of HIV status (Kruger et al., 
2012). Kruger et al. (2012) suggested that this gender difference in BMI might be due to 
molecular variances, and thus not specific to socio-demographic and/or health-related 
behaviours in the South African context. Considering that more women in SA access 
HAART at clinics and are also more likely to be overweight, monitoring of weight and 
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weight management strategies should therefore be one of the core focus areas at HIV 
clinics in SA. A discussion regarding participants’ pedometer physical activity and how it 
relates to risk of IHD is presented below. 
 
4.7.2  Screening of Physical Activity Levels 
The aim of physical activity screening in the study was, firstly, to determine the physical 
activity level of a cohort of South African individuals living with HIV and on HAART, and, 
secondly, to evaluate their physical activity preferences in order to provide information on 
modes of activity. Findings of the study contribute to the body of knowledge regarding 
ambulation physical activity, and provide information of a South African group of individuals 
living with HIV and on HAART.  The physical activity levels are very similar to international 
data on pedometer step-count findings in individuals living with HIV (Santos-Lozano and 
Garatachea, 2011; Ramirez–Marrero et al., 2008). The mean pedometer step-count finding 
in this study was 7 673.2 (±4 017.7) with women walking less than men. Ramirez-Marrero 
et al. (2008) investigated the physical activity levels in 58 Hispanic adults living with HIV in 
San Juan, Puerto Rico. They reported a mean of 7 418 (±2 714) steps per day, with men 
accumulating slightly fewer steps than the men in the present study (7 594 [±2 817]). 
Women in their study were slightly more active at 7 151 (±2 589) steps per day. Fillipas et 
al. (2010) reported the mean step-count finding in their Australian cohort to be 7 594 steps 
per day. This trial formed part of a systematic review (Santos-Lozano and Garatachea, 
2011). The slightly higher step-count finding in this study could be explained in part by the 
age variances in the three samples, since an inverse relationship between age and 
pedometer physical activity step-count is known to exist (Tudor-Locke et al., 2008). The 
mean age of the three cohorts was: South African 38.2 (±9.5) years, Puerto Rican 45.9 
(±9.3) years and Australian 53.2 (±10.2) years. In addition, not all individuals in the study 
conducted by Ramirez-Marrero et al. (2008) were on antiretroviral therapy, and it is known 
that physical activity and functional status improves when individuals are on HAART 
(Kinsey, 2007).  
 
Gender discrepancy concerning physical activity levels in this study compared to 
international data could be explained if one reviews physical activity data from the general 
South African population. The World Health Survey reported crude prevalence rates for 
physical inactivity in SA to be 43% for men and 47% for women in 2002–2003 (Guthold et 
al., 2008). Thus it seems to be the norm for women in SA to be less active than men, 
irrespective of HIV status, and that they therefore require more motivation and formal 
programmes to address this risk factor for IHD.   
 
In the South African context objective assessment of physical activity levels with 
pedometers was previously done by Cook et al. (2010, 2008) in healthy black South 
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Africans living in a rural community, and by Van Rooijen et al. (2010) in diabetic patients 
attending an outpatient hospital clinic in an urban setting. The pedometer step-count in the 
present study was less than that reported by Cook et al. (2010). The average step-count in 
their sample was 12 471 steps/day. Cook (2012) also reported that the average daily step 
range in a rural community was between 1 048–35 534 steps per day with an age range of 
14–96 years. The differences between this study and that rural study could be explained in 
the following manner: it is well known that epidemiological transition, of which urbanisation 
is a part, results in behavioural change, due to industrialisation and economic development 
(Mensah, 2008; Vorster et al., 2007; Gaziano, 2005). The change is often noted in diet and 
physical activity levels. The different settings could have influenced the physical activity 
levels due to factors such as differences in transportation, geographical location and living 
environment. The HIV status of the rural population in Cook’s study was not mentioned. 
The differences in immune function between the two study populations could offer a 
possible explanation for the different step-count findings.  
 
The pedometer step-count findings in this study showed that 75% (n=150) of the sample 
walked fewer than 10 000 steps per day, and that the majority of these individuals were 
sedentary or lightly active. This objective finding conflicted with verbal feedback on their 
performance of exercise on their own. Sixty percent of the sample (n=123) reported that 
they exercised on their own. The reported activity preference was first, walking, and second 
running. Both involve ambulation activity, and are ideal for assessing and monitoring with a 
pedometer. If participants had performed either of these activities regularly in the seven 
days of assessment, it would have been reflected in their pedometer findings. It could 
therefore be argued that they reported some healthy activity, but that actual implementation 
was lacking.  
 
One possible reason for this poor implementation could be explained in relation to their 
expressed occupations. These occupations included jobs involving manual labour, rather 
than prolonged sedentary behaviour, such as sitting. With these occupations their 
perceived need for additional regular focused exercise might have been diminished, 
resulting in lower recorded step-counts. The lower step-count in the majority of participants 
could also be due to physical symptoms. Fatigue and SOB are reported as symptoms 
limiting physical function in PLWHA in SA in both in- and out-patient contexts (Myezwa et 
al., 2009; Van As et al., 2009). In this study a common explanation for fatigue and SOB was 
related to physical activity – in most cases, increased activity.  
 
The proportion of low recorded step-count in this study is of clinical significance, and also a 
cause for concern. Fewer pedometer steps per day are associated with increased BMI, WC 
and DBP in a general population (Chan et al., 2003). Hence it is understandable that this 
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population was overweight, considering their low mean recorded step-count. An increased 
WC in the general population is also significantly correlated with FRS (r=0.24, p˂0.001), 
indicating a higher risk of developing IHD (Mosca et al., 2006). In this study the univariate 
logistic regressions analysis, after adjusting for gender and age, revealed that WC was 
significantly associated with walking less than 10 000 steps per day. This finding is 
supported by Cook et al. (2010) when using a pedometer in a general rural black South 
African cohort. They reported the association between physical activity and BMI to be      
r=-0.08 (p˂0.03), and between WC and physical activity to be r=-0.12 (p˂0.03). The 
relationship between increased WC and lower activity levels has also been established 
when using other activity surveillance methods, e.g. the physical activity diary (Saunders et 
al., 2013). Study 1 therefore highlighted the need for an intervention to assist individuals in 
implementing increased activity levels as a possible means of reducing their WC, and 
influencing their IHD risk.  
 
This study is of clinical significance, as it has demonstrated that most study participants 
reported attempting to increase their activity level by performing some type of exercise on 
their own. It suggests that they knew that it was important to try to exercise, and also a 
motivation to becoming active, even though the level of actual physical activity measured 
was modest. Published information on physical activity preferences in a HIV population 
could not be found, and information for a general population is also scarce. The information 
on the physical activity method of choice in a cohort of individuals living with HIV provided 
in this study, is thus a significant contribution. Burton, Khan and Brown (2012) evaluated 
physical activity preferences in adults at risk of being inactive in a general Australian 
population. The format (how), location (where) and social setting (with whom) of the 
physical activity preferences were assessed. The researchers noted that more than 75% of 
respondents preferred activities at no or limited financial cost, 80% preferred activities that 
could be done close to home, and 75% preferred activities that could be done alone. 
Similarly, in this study the majority of participants performed exercise that was not 
supervised, and could also be done on their own: most often walking or running. Walking 
has often been reported as the preferred mode of activity in individuals with type two 
diabetes (Forbes et al., 2010) and sedentary individuals (Booth et al., 1997). This might be 
due to the fact that the ability to walk does not require learning a new skill, has no cost 
implications, is not dependent on belonging to an exercise group, and can be done close to 
home. Even though participants reported walking and running as their preferred activities, 
the majority of the sample still accumulated fewer than 10 000 steps per day. Thus the 
need for education on frequency and, possibly, intensity of walking has been highlighted in 
this study.  
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4.7.3  Non-Invasive Risk Factor Screening for IHD 
Non-modifiable non-invasive risk factors for IHD include age, gender and family history. 
The risk of IHD is reported to be higher in men, occurs more often in the age range above 
45 years, and in individuals with a direct family history of IHD, when using general 
population information as guide (NCEP ATP-III, 2002). Only a small proportion of 
participants in this study had a direct family history of IHD, reflecting a generally low family 
history risk. The age guide for reviewing IHD risk in the general population should not, 
however, be followed strictly when reviewing PLWHA. Currier et al. (2003) reported that the 
incidence of IHD in young men (up to age 34) and young women (up to age 44) with HIV 
was significantly higher than non-infected individuals. In the South African context Sliwa et 
al. (2012) noted that PLWHA admitted to Chris Hani Baragwanath hospital in Johannesburg 
due to cardiac symptoms were often younger  (39 [±13] years compared to 53 [±17] years) 
than non-infected individuals.  The similarity in mean ages between this study and 
information from Sliwa et al. (2012) cannot be ignored. PLWHA, when screened by nursing 
staff or physiotherapists for risk factors for IHD at primary care level, with suspect 
symptoms and signs, should be referred for medical review to ensure early detection and 
appropriate management of such cardiac symptoms. This was the procedure followed with 
this project when individuals complained of, or presented with, suspect symptoms or signs 
for IHD.  
 
Non-invasive modifiable risk factor screening for IHD provided valuable information 
regarding what risk factors for IHD are of greater concern at primary care level in SA. The 
non-invasive modifiable risk factors for IHD will be discussed, firstly, according to 
behavioural aspects, history of diabetes and/or HTN, and then findings related to body 
measurements. 
 
4.7.3.1 Screening of behavioural risk factors  
Smoking was present in the study population, but was not as prevalent as noted by 
international authors in HIV populations. Smoking prevalence in PLWHA internationally is 
estimated to range between 50-70% (Reynolds, 2009) and contributes significantly to the 
risk of IHD. Saves et al. (2003) reported a high prevalence of smoking in their cohort of 
French PLWHA, noting the frequency as 65% in men and 29% in women towards the five-
year RR for IHD. Smoking status was also strongly associated with mortality from 
cardiovascular disease in PLWHA, as determined by the Data Collection on Adverse 
Events of Anti-HIV Drugs Study Group (2010). A possible reason for the lower level of 
smoking in this study is that the study population consisted mostly of women and 
individuals of black ethnic origin. Research indicates that South African women are less 
likely to smoke than their male counterparts (Peer et al., 2009), and that black men and 
women smoke significantly less than other population groups in SA (Sitas et al., 2013; Peer 
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et al., 2009). The gender difference in smoking history in an HIV population in SA is 
supported by findings from Sliwa et al. (2012) and recently by Waweru et al. (2013). They 
reported that men were more likely to be smokers than women. Waweru et al. (2013) noted 
23.2% of men and 7.4% of women of a sample of 207 individuals attending an HIV-clinic at 
Charlotte Maxeke Johannesburg Academic Hospital were current smokers. Smoking 
cessation in PLWHA is important, due to the known association between smoking and 
several pathologies, namely, cardiovascular disease (Data Collection on Adverse Events of 
Anti-HIV Drug Study Group, 2010), obstructive pulmonary disease (Morris et al., 2011), 
community-acquired pneumonia and pneumocystis carinii pneumonia (Miquez-Burbano et 
al., 2005). However, in the South African context, where HIV prevalence remains 
disproportionally high in females in comparison to males, it might be suggested that more 
focus is needed, at primary care level, on education and interventions to address physical 
inactivity and BMI, as opposed to smoking cessation. 
 
A diet low in vegetable and fruit intake is known to increase risk of IHD. A diet consisting of 
at least five fruits and vegetables combined per day (400 grams) is suggested by the WHO 
as a means of preventing the risk of non-communicable diseases (WHO, 2013). A 
Mediterranean diet consisting of regular fish intake is said to have IHD-preventative 
properties (Artalejo et al., 1996). The majority of participants in this study were unable to 
partake in daily fruits and vegetables, and also less likely to partake in three to five fruit and 
vegetables daily. They were also less likely to eat fish every week. They were therefore at 
an increased risk of developing IHD. In SA prevalence of insufficient fruit and vegetable 
intake in older adults is estimated at 68.5%, with men noted to be more compliant (64.8%) 
than women (71.4%) (Peltzer and Phaswana-Mafuya, 2012). The authors reported that 
being of Black or Coloured ethnic group, having lower educational level and daily smoking 
habits were associated with inadequate fruit and vegetable intake (Peltzer and Phaswana-
Mafuya, 2012).  In a general adult rural and semi-urban black South African population 7% 
of villagers and none of the semi-urban participants were able to partake in five fruit and 
vegetables per day (Peltzer and Promtussananon, 2004). The cost of purchasing fruit and 
vegetables is an obstacle that inhibits adequate fruit and vegetable intake for a large 
number of South Africans (Faber, Laubscher and Laurie, 2013; Peltzer and 
Promtussananon, 2004). In this study the majority of participants were employed, but in 
poorly-remunerated manual occupations. A large portion of the sample was also 
unemployed. Participants frequently expressed financial constraints as a reason for 
inadequate dietary intake, when completing the demographic questionnaire. A solution for 
this risk factor would therefore require education regarding diet in relation to risk for IHD, 
but more importantly, attention needs to be given to the wider addressing of social 
problems in SA. That includes unemployment. Lastly, community-wide responses that 
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include land availability that might enable a community to grow their own fruit and 
vegetables could be another avenue.  
 
Perceived stress has many health implications. The current study’s objective was to assess 
perceived stress levels as a means of screening this risk factor for IHD. It was, however, 
done in an HIV+ population, where elevated stress levels have even wider health 
implications. Perceived stress is a risk factor for IHD, and reported to be associated with 
other IHD risk factors. Rod et al. (2009) found that individuals with high levels of stress 
were less likely to stop smoking (OR=0.58; 95% CI: 0.41–0.83) and were more likely to 
become physically inactive (OR=1.90; 95% CI: 1.41–2.55). Women were more likely to 
become overweight (OR=1.55; 95% CI: 1.12–2.15) and men were twice as likely to develop 
diabetes (OR=2.36; 95% CI: 1.22–4.59). The perceived stress levels of study 1 participants 
were moderately high, with women showing higher levels than men. The interactive 
relationship reported to exist between stress, physical inactivity and overweight could 
therefore partially explain why women in this study were overweight and also less active.  
 
This gender difference in stress levels is supported in findings from a general South African 
cohort of individuals applying for small loans (Hamad et al., 2008). The current study’s PSS 
scores were, however, higher than what was found by Hamad et al. (2008): mean sample 
score 18.6 (±6.7); women 19.6 and men 17.5. This higher level of stress is to be expected, 
as the study cohort was HIV+, and therefore possibly dealing with additional factors related 
to stigmatisation, having to use chronic medication such as HAART and insecurity about 
their future. HIV status is also reported to be an independent predictor of PSS scores, as 
assessed in a peri-urban population of infected women living with HIV (Mkandawire-Valhmu 
et al., 2013). Hamad et al. (2008) found that PSS scores were related to female gender, 
being multiracial, increased household members, decreased subjective social status and 
lastly, a recent birth or catastrophe. The authors did report, however, that information 
regarding HIV status was not collected in their study, and that this finding could have 
influenced their results significantly.  
 
Considering wider health implications relevant to the study population, a relationship is 
reported to exist between PSS scores and CD4 count in individuals living with HIV, as 
evaluated by Remor et al. (2007). The authors noted that perceived stress levels 
significantly predicted CD4 count (ß=0.74, p=0.000) and that an increase of one in PSS 
score increased the likelihood of a reduction of 4.82 in CD4 cell count, as assessed in their 
Spanish cohort over a six month period. Fatigue is often reported by individuals living with 
HIV, and in this study this symptom was frequently expressed by participants. A 
relationship between depression and anxiety on the one hand, and perceived stress and 
fatigue on the other, is reported to explain 25% to 75% of fatigue ratings in a psychiatric 
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HIV cohort (Paddison et al., 2009). Considering the relationship between perceived stress, 
CD4 count and fatigue, the high levels of stress in this study might have influenced CD4 
values and subjective feelings of fatigue. The current sample is at an increased risk of 
developing IHD due to these high levels of stress, and this symptom could have wider 
negative health implications concerning their immune function over time. Screening 
participants’ history of diabetes mellitus and HTN formed part of non-invasive risk factors 
for IHD assessment, and results regarding these findings are discussed below. 
 
4.7.3.2 Screening of history for diabetes and HTN 
The study population did not present with a high prevalence of known diabetes mellitus or 
HTN, as assessed by the demographic questionnaire. Only one individual had diabetes, 
and 19 had HTN. Causative factors for HTN in an international HIV population are reported 
to be related to age, length of duration of HIV infection, increased BMI, history of diabetes 
mellitus, and shows a trend with African-American ethnicity (Medina–Torne et al., 2012). 
The small number of individuals that presented with a history of HTN in this study could be 
explained by the sample’s young age and relatively short duration of HIV positivity with time 
since diagnosis as reference point. Of concern in the screening process was that when a 
history of HTN was reported or documented it became clear that not all participants were 
receiving pharmacological treatment.  
 
Hypertension management in the general South African context at primary care level has 
been reported to be less than optimal (Ntusi, 2011). Steyn et al. (1999) reported that only 
42.1% of individuals had a blood pressure reading below 140/90 mmHg in a sample of 220 
individuals at a centre in Cape Town, SA. Similar findings were reported by Rayner et al. 
(2007), where only 39.8% of HTN patients at two Cape Town health centres achieved 
optimal blood pressure readings of below 140/90 mmHg. Patient adherence to HTN 
medication was reported as a problem that hindered optimal management, as reflected by 
study subjects’ feedback (Rayner et al., 2007). They reported that 61.7% of patients self-
reported no missed doses of medication and 37.4% of patients noted more than one 
medication dose missed per week. When medical doctors were interviewed to assess the 
nature of hindrances to effective management, they reported poor patient adherence to 
prescribed medication, language difficulties, heavy patient load, medical staff shortages 
and patient loss to follow-up as significant difficulties (Parker et al., 2011). Disturbingly, 
medical doctors showed a lack of knowledge of the South African guidelines for HTN 
management and indications for treatment (Parker et al., 2011). Advice given to study 
participants concerning modification of lifestyle was lacking in all reports (Parker et al., 
2011; Rayner et al., 2007; Steyn et al., 1999).  
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Participants in this study who took HTN medication received it from their local primary care 
clinic. The additional individuals not on HTN medication might either not have adhered to 
their treatment or not even started on treatment as per medical doctor prescription. A 
change in care model might be suggested as a means to improve HTN management in 
PLWHA in SA in favour of holistic management of patients instead of condition-specific 
silos e.g. HIV and HTN managed separately by HIV and HTN clinics.  Holistic management 
would also reduce the time required for individuals to manage their different conditions. 
They would spend less time travelling to the different clinics, less cost in transport, less time 
off work and, almost certainly, less stress would be involved. All these factors could 
ultimately improve patient adherence to HTN treatment and improve prevention 
management of stroke and IHD in PLWHA in SA. 
 
4.7.3.3 Body measurements review 
An increased BMI was identified as a significant risk factor for IHD in this study cohort, as 
the majority of participants were overweight (mean BMI: 25.6 [±1.4] kg/m2). Variables 
associated with overweight in the sample when adjusting for age and gender included: 
behavioural aspects e.g. physical activity level and daily fruit and vegetable intake; 
anthropometric measurements, e.g. waist and hip circumference; SBP and CD4 count.  It is 
important to note that female gender increased the likelihood of being overweight by 7.16 
(95% CI: 3.14–16.33; p=0.00), as demonstrated by the odds ratios before adjusted 
analysis.  
 
These gender differences in BMI in sub-Saharan Africa are well documented (Kruger et al., 
2012; Finucane et al., 2011; Belue et al., 2009; Cappuccio et al., 2008). It is salutary to be 
aware of the high global statistics: Southern African women have the highest prevalence 
rate for obesity, and only a slightly lower rate for being overweight (Finucane et al., 2011).  
Kruger et al. (2012) suggested the gender difference in BMI status in black South African 
adults to be multifactorial, of which three biological factors may play a significant role: the 
female sex hormone estrogen and its influence in weight regulation; the effect of higher 
anxiety levels in women, and the influence on the short allele of the serotonin transporter 
gene. The authors noted that the black South African population belongs to macrohaplo-
group L, which has the highest level of genetic variations, that could further influence BMI 
status. Behavioural aspects should not, however, be excluded when evaluating gender 
differences in BMI, as reduced physical activity levels (Guthold et al., 2008), reduced 
smoking status (Peer et al., 2009) and increased stress levels (Hamad et al., 2008) in 
South African women could possibly further add to the higher BMI values.  
 
In this study smoking status reduced the probability of being overweight or obese before 
adjusting for age and gender. Justman et al. (2008) also noted that, in their international 
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cohort, PLWHA who smoked were more likely to have lower BMI values. An increase in 
SBP increased participants’ chances of being overweight. International data suggests a 
positive relationship between BMI and blood pressure, but the extent of the relationship 
weakens as BMI increases in the general population (Cappuccio et al., 2008). In the 
general South African population anthropometric measures such as BMI, WC, hip 
circumference and WHR were reported to relate positively to SBP and DBP in women 
(Mkhonto, Labadarios and Mabaso, 2012). Findings in men were only significant for WHR, 
thus again underscoring the important relationship between anthropometric measures and 
blood pressure. Individuals who walked more than 10 000 steps per day in this study were 
also less likely to be overweight or obese. An inverse relationship between BMI and 
pedometer physical activity levels is known to exist, and a step-count of 12 000 per day is 
reported to be associated with a healthy body-weight category of BMI < 25 kg/m2 in the 
general population (Tudor-Locke et al., 2008).  
 
Interestingly, a diet with daily fruit and vegetable intake in this study increased individuals’ 
chances of being overweight. The focus of this study was not to evaluate general diet, 
however, but the more important factor of fruit and vegetable intake (or lack thereof) as a 
risk factor for IHD. In view of reports that purchasing of fruit and vegetables is often 
hindered in SA by financial limitations (Faber, Laubscher and Laurie, 2013; Peltzer and 
Promtussananon, 2004), those in this study who were able to consume this produce daily 
might have enjoyed less financial constraint, leading to a greater food security. Thus these 
individuals might have consumed a diet high in fat, sugar and starch, that might have 
predisposed them to being overweight. International data suggests that PLWHA that are 
overweight often consume a diet high in fat and low in fibre, that could indicate poor diet 
quality (Duran et al., 2008; Hendricks et al., 2006). It is therefore suggested that further 
investigation is warranted to evaluate the general diet and its components of PLWHA and 
its relationship to BMI.   
 
An increase in CD4 count was associated with being overweight in this sample of individuals 
on HAART. Justman et al. (2008) found that a lower CD4 count was independently related 
to smaller BMI, but did not specifically find that the reverse applied. Crum-Cianflore et al. 
(2010), on the other hand, did note that a higher CD4 value was associated with increased 
BMI values in the US Military HIV Natural History Study. The authors also noted a higher 
weight-gain in participants with a lower BMI value at diagnosis (Crum-Cianflore et al., 
2010). In addition, Palermo et al (2011) noted that higher BMI values at baseline predicted 
higher CD4 count findings at 96 and 144 weeks after initiation of antiretroviral therapy. Thus 
the finding in this study related to increased likelihood of being overweight as immune 
parameters improve is congruent with that of Crum-Cianflore et al. (2010) and Palermo et al 
(2011).  
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The mean gender WC and WHR of the sample were within normal values, but individual 
participants had abnormal values and yet also complained of weight gain centrally around 
the trunk area. Waist and hip circumference was associated with overweight. Waist 
circumference measurement is of clinical value, as it provides information on visceral 
adipose tissue accumulation (Katzmarzyk, Heymsfield and Bouchard, 2013), which is 
known to be associated with insulin resistance, altered cholesterol profiles and raised 
inflammatory markers in the general population (Smith et al., 2012). An increased WC 
measurement is therefore also known to increase one’s risk for IHD (Smith et al., 2012; 
Yusuf et al., 2004). The association of increased BMI with these anthropometric 
measurements may suggest that waist- and hip circumference measurements and WHR 
calculation should be included in general HIV management to monitor individuals at risk of 
IHD due to the development of abdominal obesity. 
 
The study cohort’s mean RHR value was slightly increased when evaluating risk for IHD 
(Palatini, 2007). An elevated RHR is reported to be an independent predictor of myocardial 
infarction in women (Hsia et al., 2009; Greenland et al., 1990) and in men (Greenland et al., 
1999) in a general population. In the present study, even though the mean RHR value was 
in the normal range, individual participants who complained of palpitations had abnormal 
RHR values. Sliwa et al. (2012) noted that individuals infected with HIV had higher RHR 
values (99 [±22] bpm) than non-infected individuals (84 [±19] bpm) when admitted to Chris 
Hani Baragwanath hospital with cardiac symptoms. The authors noted that HIV-related 
cardiomyopathy was the most frequently diagnosed condition, pericarditis and pericardial 
effusion second, and IHD less often diagnosed. An elevated heart rate (above 80 bpm) in 
this study was associated positively with DBP and physical activity level, which had an 
inverse relationship with RHR after adjustment for age and gender. Similarly, Hsia et al. 
(2009) reported an inverse relationship between physical activity level and RHR in an 
international cohort of women. Resting heart rate and blood pressure are routinely 
monitored in PLWHA at primary care clinics. With HIV-related cardiomyopathy reported to 
be a common condition noted in PLWHA in SA, symptoms such as palpitations and raised 
RHR values should be seriously considered for management. Further medical review 
seems indicated to evaluate the specific cardiac condition present in such individuals. The 
conclusions of study 1 are summarised in section 4.8. 
 
4.8 CONCLUSION  
Study 1 highlighted the type of population attending a primary care clinic in Johannesburg 
SA, in the early period of HAART initiation, namely women who are part of the workforce 
and have dependants. It also provided information on the presence of risk factors for IHD in 
this population. Reduced physical activity levels and the presence of other non-invasive risk 
factors for IHD, such as increased perceived stress levels, diet low in fruit and vegetables, 
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elevated BMI and RHR values in the study cohort builds on the body of knowledge related 
to IHD in PLWHA in SA. These risk factors could possibly be influenced by education and 
intervention programmes, such as a physical activity modification programme at primary 
care level. However, social factors such as financial constraints could influence adequate 
implementation of dietary guidelines in PLWHA in SA. Furthermore, family responsibility or 
work obligations may influence adherence to exercise programmes.  
 
The study found that the risk of IHD was reduced when considering family history related 
this condition, as only a few participants reported such a history. Other risk factors for IHD 
such as smoking were also less prevalent in the study cohort than indicated in international 
data, and this might be due to population particulars, e.g. females being less likely to 
smoke than South African men. Diagnosed diabetes and HTN were also less prevalent in 
the study cohort, but management of reported HTN leaves room for improvement. Even 
though a low prevalence of these known risk factors for IHD was present in the sample, 
aggressive management is still of extreme importance to reduce the absolute risk of 
cardiovascular disease in PLWHA (Lundgren et al., 2008). 
 
This study is the first to report on the physical activity preferences of PLWHA in SA, and 
provides information specific to the mode of activity. Walking and running were most often 
reported as means by which participants included exercise in their lives. The study found 
that participants reported implementing their own exercises, but that those assertions were 
not adequately reflected in their pedometer physical activity findings. It is therefore 
suggested that the study cohort would need education regarding an adequate frequency, 
and possibly the correct intensity level, of physical activity to gain added health benefits and 
reduce their risk of IHD. 
 
Weight gain and increased BMI were noted in this study as a significant risk factor for IHD, 
and the parameters associated with an elevated BMI were found to be more extensive in 
this study than other national data, such as that found by Hurley et al. (2011).  The results 
of this study provide additional South African information to build on the available 
international data related to overweight and obesity in PLWHA.  
 
Subjective symptoms such as fatigue, SOB and chest pain were reported by some study 
participants. A review of the explanations of when such symptoms were experienced 
provided screening information for IHD, and also reinforced the fact that fatigue and SOB 
were most often experienced when performing physical activity or when an increase in 
physical activity was required. The influence of these symptoms on physical activity levels 
should therefore not be ignored, but instead could also be used as self-monitoring methods 
for participants to evaluate their tolerance for exercise and effort during exercise.   
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It was disturbing to note that individual participants presented with suspect signs and 
symptoms (palpitations, sinus tachycardia at rest and chest pain with cardiogenic referral 
pattern) that had not been identified or managed in standard clinic care.  Screening these 
individual signs and symptoms added clinical importance to the screening process for IHD 
risk factors in the study cohort.  
 
Chapter 5 consists of an explanation of the methodology, procedures, results and 
discussion of study 2 of phase 1.  The focus of study 2 was to investigate study 
participants’ self-perception and behaviour towards IHD. The information obtained from this 
study described their knowledge and understanding regarding IHD and their insight into 
their own risk of IHD.  
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CHAPTER 5 
5. STUDY 2: SELF-PERCEPTION AND BEHAVIOUR TOWARDS IHD 
 
5.1  INTRODUCTION 
With IHD becoming an increasing cause for concern in PLWHA, health promotion and 
prevention of IHD by screening, identifying and treating modifiable risk factors for IHD are 
becoming important. A factor that might influence individuals’ compliance with such 
prevention strategies is their perception regarding their own risk of IHD. Research indicates 
that “perceived susceptibility” for a condition is likely to influence preventive health 
behaviours (Janz and Becker, 1984).  Self-risk perception of IHD is often underestimated in 
the general population (Hart, 2005; Meischke et al., 2000), as well as in PLWHA (Cioe et 
al., 2013). It is not known if PLWHA in SA perceive themselves at risk of IHD.  Study 2 set 
out to answer this research question.  
 
5.2  STUDY 2 
5.2.1  Aim 
The aim of study 2 was to determine the nature of the self-perception and behaviour of 
PLWHA’S in relation to the risk of IHD. 
 
5.3  METHODOLOGY  
5.3.1 Study Design 
A qualitative study design was chosen. Qualitative inquiry provides the ideal means to 
describe the complex nature of humans and how individuals perceive their own 
experiences within a particular social context (Portney and Watkins, 2009). The study 
perspective was ethnographic: ethnography is the study of attitudes, beliefs and behaviours 
of a group of people within their cultural environment (Portney and Watkins, 2009).  
 
5.3.2 Sample Size 
The sample size depended on when information gathered in the interview process was 
considered saturated. Saturation was the point at which no new or relevant information 
emerged. In this study data saturation occurred when 30 study participants completed their 
interviews.  
 
5.3.3  Study Subjects 
Study 2 was conducted simultaneously with the larger study 1 that sought to determine the 
prevalence of non-invasive risk factors for IHD in PLWHA, as described in chapter 4. Hence 
an overlap between the two studies, as the first 30 study participants of study one who also 
consented to participate in study two were interviewed. 
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5.3.4  Measuring Instruments  
The instruments used to gather the qualitative data were the semi-structured interview 
questionnaire (Appendix 22), flash cards used in the card-sort method (Appendix 23) with 
poster board for placement, Olympus VN-5500PC digital voice recorder and conventional 
Nikon camera. The literature review and justification for the use of these measuring 
instruments are provided in chapter 3: 3.2.2.  
 
5.3.5  Translation Considerations  
The questionnaire (Appendix 24) was translated into isiZulu for use in case individuals had 
difficulty understanding the English questions. The consent form (2) for study 2 was also 
available in isiZulu (Appendix 25). The translation of the documents was done by Bangula 
Translation Services as described in chapter4: 4.3.5.  
 
5.3.6  Pilot Study of Study 2 
Pilot study 3 was conducted before study 2, in order to evaluate the instruments planned for 
use in study 2. Details pertaining to this pilot study are presented in section 5.3.6.1. 
 
5.3.6.1 Pilot study 3  
5.3.6.1.1 Aim and objectives: Pilot study 3 
Aim:  
To test the feasibility of the card-sort method applied in the qualitative interviews. 
 
Objectives: 
 To determine whether the questions in the semi-structured interview 
questionnaire were understood by participants. 
 To determine whether the sentences and pictures on the flash cards were 
understood by participants. 
 To facilitate training of the researcher to improve her interview skills. 
 To evaluate the feasibility of using the method in interviews with PLWHA. 
 
5.3.6.1.2  Study subjects: Pilot study 3 
Four individuals were invited to participate: two lay persons and two senior 
qualitative researchers and academics in the School of Therapeutic Sciences at the 
University of the Witwatersrand. One researcher declined participation due to other 
professional obligations.  
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5.3.6.1.3 Measuring instruments: Pilot study 3 
The tools used were: the semi-structured questionnaire, flash cards for card-sort 
technique with poster board for placement and the Olympus VN-5500PC digital 
voice recorder. The procedure in pilot study 3 and the results are detailed in 
Appendix 26. 
 
5.3.6.1.4  Key recommendations made and adopted: Pilot study 3 
The senior qualitative researcher provided the following feedback and suggestions: 
 
1. Adding the card-sort technique to the interview made it interactive and 
interesting. The number of flash cards included was appropriate (23 with 
phrases, and one blank), as it allowed the participant to think about what she 
wanted to select, and the number of cards was not overwhelming. Adding the 
blank card was also reported to be beneficial as it allowed the participant to add 
her own contribution to what was considered “living a healthy lifestyle”.  
 
2. A positive interview skill of the researcher was reminding the participant what 
she had said earlier when she became confused. This was appropriate, as the 
participant could easily forget what he or she had said previously, and it also 
demonstrated that the researcher was listening attentively to the conversation.  
 
3. It is important for the researcher to create an informal atmosphere, especially in 
the particular study population involved. This was essential, as participants 
might be nervous about giving an ‘incorrect’ answer, or might feel ill-at-ease if 
they feel uncertain about their answer. They might feel a need to please the 
researcher in their feedback. Putting a participant at ease, and assuring at the 
start of the interview that the researcher is interested in his or her thoughts, 
could overcome this obstacle. 
 
4. It was suggested that the researcher give more time for thought between 
questions. If participants get ‘stuck’, they could be reassured by eye contact, a 
nod of the head, and a murmuring sound, e.g. mm... instead of a prompting 
question. This would show that the researcher was engaged in the conversation, 
and was giving the participant freedom in the interview. If, after a few minutes, 
the participant could not produce an answer, a prompting question would give a 
helpful lead. This would make for an “open” interview rather than one in which 
the participant was led along.  
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5. Field notes should be limited during the interview, as excessive note-taking 
could become a barrier. Better rather to focus on the participant and make eye 
contact to demonstrate involvement in what is being said. The tape recorder can 
be used for collecting data. 
 
6. In the card-sort exercise, hand the cards to the participant in a stack and let 
them shuffle through them, instead of placing them spread out on a table. This 
would give the participant control, and also help where space is limited.  
 
These comments were implemented in the first interview of a Themba Lethu 
participant, and worked well. The participant had no difficulty understanding the 
questions, and also read the English and isiZulu phrases on the flash cards with 
ease. The same procedure was therefore followed with the remaining participants of 
the study. 
 
5.4  PROCEDURE  
The qualitative interviews were held in the first contact session with the study participants in 
the private physiotherapy room in Themba Lethu clinic one-on-one. The participant and 
researcher sat on comfortable office chairs at a table for the interview.  
 
The questionnaire was followed as a guide in the process to keep the questions 
standardised. The card-sort technique was done at the appropriate time according to the 
guide. The stack of flash cards was handed to the participant to peruse and select those 
that they associated with living a healthy lifestyle. The participant then placed them on the 
poster board in descending order, with what they considered most important to the left, and 
least important to the right. Thus the cards were ranked according to importance. The 
participants were allowed to stack cards on the line if they felt them to be equally important. 
They could also choose as many cards as they liked. A discussion based on their selection 
and arrangement followed, in line with the questionnaire guide. After this discussion the 
interview continued, in keeping with the interview questionnaire.  
 
All interviews were tape-recorded for record keeping and accuracy, to allow for verbatim 
transcription at a later stage. The researcher made some field notes in the interviews on the 
participant’s copy of the questionnaire. A photograph of selected cards on the poster board 
was taken at the end of the interview to ensure trustworthiness of note-taking and to assist 
with analysis of card-sort data. Figure 5.1 is an example of a photograph taken of 
participant’s (number 30) selected flash cards. 
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Figure 5.1: Photograph of Card Selection of Participant Number 30 of Study 2 
 
5.5  ANALYSIS OF TRANSCRIBED DATA  
An inductive approach to data analysis was followed, using conventional content analysis 
(Thomas, 2006; Hsieh and Shannon, 2005). As stated by Thomas (2006: 238): “inductive 
analysis refers to approaches that primarily use detailed readings of raw data to derive 
concepts, themes or a model through interpretation made from the raw data by an 
evaluator or researcher”. All interviews were transcribed by the researcher, in full and 
verbatim, using Microsoft Word 2007. This allowed the researcher to review the collected 
data. Codes and keywords were identified that had been repeated by study participants, 
and the content of the transcribed interviews was analysed to identify codes (keywords) for 
each question. The codes were sorted in table format with the participant number. The 
frequency of appearance of codes was analysed question-by-question (Smith, 2000). Data 
analysis thus occurred vertically and then horizontally. To reduce the data, the codes were 
collapsed, first into subcategories, then categories and, lastly, themes (Thomas, 2006; 
Smith, 2000).  
 
The cards selected in the card-sort technique were visually presented in diagram format as 
in the photograph, and field notes made according to what cards were chosen, and, if cards 
were stacked into piles how many, and where they were placed. The diagram below (Figure 
5.2) is an example of this procedure. It represents the flash cards selected in the interview 
with participant number 30, as in the photograph above (Figure 5.1). 
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         Pile one        Pile two           Pile three           Pile four           Pile five         Pile six       
  
  
  
 
Most important                                                                                                                Least important 
Figure 5.2: Visual Presentation of Diagram Format of Selected Cards 
 
A Microsoft Excel 2007 spread sheet was created to systematically quantify 1) each 
participant, 2) separate piles created by the participant, and the presence or absence of a 
unique statement in a particular pile. If a statement was present it was captured as one, 
and if absent, as zero. The diagram below (Figure 5.3) explains this Microsoft Excel data-
capturing procedure for participant 30.  
 
Id Pile No of cards in pile Card 1 Card 2 Card 3 Card 4 Card 5 etc.
30 1 2 0 0 0 0 0
30 2 2 0 0 0 0 0
30 3 2 0 1 0 0 0
30 4 1 0 0 0 0 0
30 5 1 0 0 0 0 0
30 6 1 0 0 0 0 0  
Figure 5.3: Microsoft Excel Data-Capturing Procedure 
 
The frequency of occurrence of a statement and the position of each statement on the 
continuum line (pile number) were then analysed with IBM SPSS 20. The procedure of 
systematically collapsing and organising cards selected by study participants to enable 
analysis is supported by Whaley and Longoria (2009).   
 
The participants’ demographic and non-invasive risk factors screened were collected from 
study 1 and analysed by quantitative analysis on SPSS IBM 21. Categorical data are 
presented as frequencies and percentages. Numerical data are expressed as median 
(interquartile range) or mean (±SD) dependent on skewness. If the skewness falls outside 
the +1 to -1 range, findings are presented as median (interquartile range).  
 
5.6  TRUSTWORTHINESS  
5.6.1 Credibility 
Strategies were implemented throughout the qualitative research process to enhance 
credibility, as suggested by Patton (1999). The researcher received advice from a senior 
qualitative researcher to assist her with interview skills in pilot study 3 as preparation for the 
main study. She also attended qualitative research workshops to improve her 
understanding of the qualitative research process. In the course of the study three senior 
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qualitative researchers provided guidance with the analysis process. Triangulation 
strategies were also implemented to enhance credibility of data-collection and analysis.  
 
a) Methods triangulation 
Information such as smoking and diet history collected in study 1 (quantitative study) 
enhanced and supported some findings of qualitative study 2.  
 
b) Triangulation of sources 
Different data-gathering techniques were used: observations with field notes, tape-
recordings, card-sort technique, and flash cards selected in the card-sort technique 
were photographed and compared with field notes. Different data analysis sources 
enhanced credibility: thematic content analysis findings were enhanced with 
frequencies of codes and frequencies of flash cards selected in the card-sort activity.  
 
c) Analyst triangulation 
The dependability of transcribed interviews was reviewed by a portion of the study 
sample. The researcher telephoned participants to invite them to a follow-up session, 
where their transcribed interviews were reviewed. Six participants (20% of the sample) 
consented to this session. There they listened to their interview, read the transcribed 
interview, clarified any information and commented on the accuracy of transcribed 
interviews.  
 
A portion of the transcribed interviews and code analysis was reviewed by a second 
senior qualitative researcher to allow for member checks. Another researcher analysed 
six participants’ (20% of the sample: participants 5, 10, 15, 20, 25, 30) interviews in line 
with the procedure stated above. Every fifth interview was selected for sampling to 
provide the researcher with an evenly distributed sample of interviews for analysis. Two 
sessions were held between the researcher and the three senior qualitative 
researchers, where data analysis was reviewed and possible themes suggested. 
 
5.6.2  Transferability 
The study was conducted in PLWHA in the South African context. A detailed description of 
the data-collection procedure and analysis process is provided for review. Both these 
methods are supported by the literature (Whaley and Longoria, 2009; Thomas, 2006; Hsieh 
and Shannon, 2005; Smith, 2000). Explanatory quotations from the raw data are provided 
to enhance understanding of participants’ viewpoint and background. The reader needs to 
judge the transferability to other populations and/or situations.  
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5.6.3  Dependability 
Transparent coding process and inter-coder verification added to the dependability of the 
research findings (Thomas, 2006; Patton, 1999). 
 
5.6.4  Confirmability 
Determining the confirmability of all research findings of this study is difficult, as only one 
other study has been published related to PLWHA and their perception regarding their risk 
for IHD. Cioe, Crawford and Stein (2013) conducted a cross-sectional study in a USA 
cohort, and found that individuals had a fair degree of knowledge related to IHD, but a weak 
correlation of perceived self-risk to individual estimated risk was noted.  
   
The results of study 2 are presented in section 5.7. 
 
5.7  RESULTS  
The results of study 2 are presented according to the following sections: demographic 
characteristics; screening results of risk factors for IHD; participants’ self-perception 
regarding risk of IHD and living a healthy lifestyle; card-sort technique results and themes 
from content analysis.  
 
5.7.1  Demographic Characteristics of Study 2 Participants 
The first 30 study participants of study 1 who also consented to participate in study 2 were 
interviewed. Data saturation occurred when 30 participants were interviewed. The general 
and HIV demographic characteristics are depicted in Table 5.1, as obtained from study 1.  
 
  
122 
 
Table 5.1:  Demographic Characteristics of Study 2 Participants (N = 30) 
Variable N 
n (%) or 
Median 
(Interquartile range) 
Normal range 
Age (years) 30 36.5 (31.8–45.0)  
Gender 
 Male 
 Female 
30  
  5 (16.7) 
25 (83.3) 
 
Educational level 
 None 
 Primary  
 Secondary  
 Post-Secondary  
30  
1 (3.3) 
  5 (16.7) 
16 (53.3) 
8 (26.7) 
 
Employment status 
 Unemployed 
 Employed 
 Self-employed 
30  
12 (40.0) 
17 (56.7) 
1 (3.3) 
 
Participants with dependants 30   26 (86.7)  
Perception of health status 
 Average 
 Good 
 Excellent 
30  
8 (26.7) 
17 (56.7) 
5 (16.7) 
 
Confirmed to have HIV 
 Before 2005 
 2005 - 2008 
 2009 - 2010 
30  
3 (10.0) 
6 (20.0) 
21 (70.0) 
 
HAART categories 
 Lamivudine, Efavirenz, Tenofovir  
 Lamivudine, Efavirenz, Stavudine 
 Other                         
30  
10 (33.3) 
13 (43.3)  
7 (23.3) 
 
Time on HAART (months) 30 10.5 (7.0–12.0)  
CD4 count (cells/mm3) 30 282 (211.0–357.5) 
600-1500 
(Van Dyk, 2008) 
Viral load (copies/ml) 
▪ < 400 28 * 26 (86.7)  
♦ Cells/mm3 (cells per cubic millimetre of blood), copies/ml (copies of HIV RNA per millilitre of blood) 
* Viral load blood results were available for 28 participants. 
 
Most participants were female (n=25; 83.3%), employed (n=17; 56.7%), had a secondary 
educational level (n=16; 53.3%) and were supporting dependants (n=26; 86.7%). Just over 
half of participants (n=17; 56.7%) perceived their general health as good. The median time 
on HAART was 10.5 (7.0–12.0) months, most participants were on a Stavudine-containing 
regimen (n=13; 43.3%) and confirmed to have HIV in 2009-2010 (n=21; 70%). The median 
CD4 count of the sample was less than the suggested normal range for CD4 count. The 
majority of participants had a viral load of less than 400 copies/ml. Viral load findings of two 
participants had not been noted in the hospital records. The IHD risk factor screening 
results of study 2 participants are presented in section 5.7.2. 
 
5.7.2 Screening Results of Risk Factors for IHD of Study 2 Participants 
The screening results of non-invasive risk factors for IHD of study 2 participants are 
depicted in Table 5.2, as deduced from study 1.  
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Table 5.2:  Non-invasive Risk Factors for IHD of Study 2 Participants (N = 30) 
Variable N n (%) or Mean (±SD) or  Median (Interquartile range) Normal range 
Smokers 30 3 (10)  
History of hypertension 30 3 (10)  
Vegetable and fruit intake 
 Daily 
 Weekly  
30 
 
 
16 (53.3) 
14 (46.7) 
Daily intake 
(WHO, 2013) 
Vegetable and fruit intake daily 
(three to five) 
 Yes 
 No 
30 
 
 
 
 
10 (33.3) 
20 (67.3) 
At least five fruit and 
vegetables 
combined 
(WHO, 2013)  
Perceived stress level 30 19.6 (±9.1) 75
th Percentile 
(Hamad et al., 2008) 
RHR (bpm)   29 *   82.2 (±13.3) Less than 80 (Palatini, 2007)  
Blood pressure (mmHg) 
 SBP 
 DBP 
  29 *  
     115.8 (106.9–122.4) 
   74.3 (69.3–81.3) 
 
Less than 120 
Less than 80 
(Collins and Dias, 
2009) 
WC (cm) 
 Men 
 Women 
 29 * 
4 
25 
 83.4 (±11.5) 
83.4 (±5.9) 
  83.4 (±12.3) 
 
Less than 102 
Less than 88 
(ACSM, 2010) 
WHR 
 Men 
 Women 
 29 * 
4 
25 
0.8 (±0.1) 
0.9 (±0.1) 
0.8 (±0.1) 
 
Less than 0.95 
Less than 0.86 
(ACSM, 2010) 
BMI (kg/m2) 
 Men 
 Women 
 29 * 
4 
25 
23.9 (21.5–28.3) 
21.9 (21.4–23.1) 
25.2 (21.5–28.6) 
18.5 – 24.9 
(WHO, 2004) 
Physical activity level (steps/day)  29 * 10 087.4 (±4 818.9) More than 10 000 (ACSM, 2010) 
Physical activity categories 
 Sedentary 
 Light active 
 Somewhat active 
 Active 
 Very active 
 29 *  
3 (10.3) 
7 (24.1) 
7 (24.1) 
5 (17.2) 
7 (24.1) 
 
Less than 5000 
5000 – 7499 
7500 – 9999 
10000 – 12499 
More than 12500 
(Tudor-Locke and 
Bassett, 2004) 
♦ RHR (resting heart rate), SBP (systolic blood pressure), DBP (diastolic blood pressure), WC (waist 
circumference), WHR (waist: hip ratio), BMI (body mass index), bpm (beats per minute), mmHg 
(millimetres mercury), cm (centimetres), kg/m2 (kilograms per square metre), steps/ day (steps per 
day). 
* One individual did not attend second study 1 session. 
 
The body measurements and physical activity levels of 29 participants were available due 
to one participant failing to return for his second study 1 appointment, where these data 
were collected. 
 
Only three individuals (10%) were smokers, and had a known history of HTN. The majority 
of participants (n=16; 53.3%) were eating fruit and vegetables daily, but were not able to 
partake in three to five vegetables and fruit combined daily (n=20; 67.3%). The 75th 
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percentile for perceived stress was 26.3 indicating that the cohort had a moderately high 
stress level at a mean of 19.6 (±9.1). 
 
The mean RHR was slightly elevated when considering risk of IHD. Women were 
considered overweight, deduced from an increased BMI value (BMI ≥ 25 kg/m2).  
 
Waist circumference, WHR and pedometer physical activity step-count mean values were 
all within the normal ranges. The standard deviations of these parameters, however, 
indicated that a portion of the sample had abnormal values. Seventeen individuals (58.6%) 
had a pedometer physical activity level of less than 10 000 steps per day, indicating less-
active categories.  
 
5.7.3  Participants’ Self-Perception Regarding Risk for IHD (Frequency Data) 
The majority of participants (n=15; 50%) did not perceive themselves at risk of developing 
IHD, as demonstrated in Figure 5.4.  
 
 
Figure 5.4:  Participants’ Self-Perception Regarding the Risk of IHD (N = 30) 
 
Twelve participants (40%) did perceive themselves to be at risk of developing IHD, and 
three (10%) were unsure. Twenty-six individuals (87%) thought one could prevent IHD from 
occurring. Two (6.6%) considered it unavoidable, and two (6.6%) additional individuals 
were unsure.  
 
5.7.4  Participants’ Self-Perception Regarding Living a Healthy Lifestyle (Frequency Data) 
The majority of participants (n=27; 90%) perceived themselves as living a healthy lifestyle, 
as shown in Figure 5.5.  
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Figure 5.5:  Participants’ Self-Perception Regarding Living a Healthy Lifestyle 
(N = 30) 
 
Two participants (6.7%) did not perceive themselves to be living a healthy lifestyle and one 
(3%) was unsure. 
 
5.7.5  Card-Sort Technique  
The card-sort technique results are presented in the following sections: the behaviours 
and/or components related to living a healthy lifestyle; most important behaviours and/or 
components related to living a healthy lifestyle, and participants’ suggestions regarding 
behaviours and/or components related to living a healthy lifestyle.  
 
The median number of flash cards selected by participants in the semi-structured interview 
was 12 (10.0–14.3). The lowest number of cards selected was three, and the highest 17. 
The participant who selected only three cards was the one who reported no schooling 
education.  
 
5.7.5.1 Behaviours and/or components related to living a healthy lifestyle  
Figure 5.6 is a representation of the frequency of lifestyle behaviours and activities selected 
in the card-sort technique when components of living a healthy lifestyle were discussed.  
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Figure 5.6:  Behaviours and/or Components Related to Living a Healthy Lifestyle. 
 
The two most frequently selected cards were card 19: drinking 5 – 8 glasses of water daily 
and card seven: eating fruit and vegetables daily. Both were selected by 29 participants 
(96.6%). The second-most frequent card selected was card 23: eating fish regularly during 
the week, and was selected by 28 participants (93.3%). The third most frequently selected 
cards were card two: washing hands regularly, card nine: using your prescribed medication 
and card five: knowing your HIV status. These three cards were selected by 27 participants 
(90%).  
 
The least-frequently selected card was card 22: sitting a lot during the day. Four 
participants (13.3%) reckoned this to be part of living a healthy lifestyle, as it allowed them 
to rest. Interestingly, five participants (16.6%) selected card four: blowing a vuvuzela daily 
as part of living a healthy lifestyle. A vuvuzela is a plastic horn that makes a monotone note 
when one blows into the instrument. Participants explained that this behaviour formed part 
of recreation and socialising, and could also influence one’s lung function. 
 
5.7.5.2 Most important behaviours and/or components related to living a healthy lifestyle  
In the interview participants stacked their chosen cards from most to least important on a 
continuous line, and they were allowed to overlap cards into piles if they thought them 
equally important. The frequency of piles, with number of participants who created them, 
was as follows: pile one (n=30), pile two (n=30), pile three (n=27), pile four (n=22), pile five 
(n=17), pile six (n=9), pile seven (n=3) and pile eight (n=2).  
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Specifics pertaining to pile one will be presented in this chapter, but information related to 
the other piles is available for review in Appendix 27. Figure 5.7 is a representation of the 
cards that participants stacked into pile one, indicating that they considered those cards as 
most important when considering behaviours or activities related to living a healthy lifestyle. 
 
 
Figure 5.7:  Most Important Behaviours and/or Components Related to Living a 
Healthy Lifestyle (N = 30). 
 
Card nine: using your prescribed medication was selected by 17 participants (56.6%) as the 
most important component related to living a healthy lifestyle. Secondly, 14 participants 
(46.6%) selected card five: knowing your HIV status. Interestingly, unhealthy lifestyle 
components also featured in pile one: sitting frequently (n=1), prolonged television watching 
(n=1), cooking with oil and fat (n=1) and eating pap and meat 3 – 5 times per week (n=4).   
 
5.7.5.3 Participants’ suggestions regarding behaviours and/or components related to living 
a healthy lifestyle  
 
Participants provided additional information in the blank card discussion concerning what 
they considered important to live a healthy lifestyle that was not adequately included in the 
picture flash cards. They could mention more than one factor. Figure 5.8 is a representation 
of the frequency information regarding their suggestions. 
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Figure 5.8: Participants’ Suggestions Regarding Behaviours and/or Components 
Related to Living a Healthy Lifestyle. 
 
Six participants (20%) had nothing to add, and 24 (80%) provided additional material. They 
considered financial independence by being employed (n=5), having a supportive family 
(n=5) and interacting socially (n=5) as important additional components of a healthy 
lifestyle.  
 
Section 5.7.6 provides the theme results from the content analysis of the study two 
interviews. 
 
5.7.6  Themes Identified from Semi-Structured Interviews 
Three themes were identified in the course of content analysis of transcribed interviews: 
knowledge and understanding related to IHD, insight into own risk of IHD and health 
character in the HIV context. 
 
5.7.6.1 Theme 1: Knowledge and understanding related to IHD 
Causes, consequences and prevention strategies for IHD were recognised as categories of 
participants’ knowledge and understanding related to IHD (theme 1). Table 5.3 is a 
representation of this. Selected quotations to illustrate are added for review.  
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Table 5.3: Theme 1: Knowledge and Understanding Related to IHD (Causes). 
Category Sub-category Codes/Keywords Code frequency    n (%) Quotes to illustrate 
Causes Psychological 
 
Stress 
‘Thinking too much’ (brooding, 
worrying) 
13 (43) 
  7 (23) 
“Mostly thinking, when you are thinking a lot you are not giving 
your heart a chance to function well. You are most of the time 
panicking. When you panic a lot, I used to even feel like something 
is piercing me through the heart, I feel a pain,that means I am 
panicking a lot. You know when you are relaxing you are just okay 
you feel even you are calm. When you are thinking a lot you are 
like the kind of life you are living you are stressed mostly you 
develop heart disease” (Participant 2: Quote 1). 
 Nutrition Eating habits 
Alcohol abuse 
16 (53) 
3 (10) 
“When you are eating too much fat, the fat clots the heart. 
Pumping of the heart is not good. When it is very bad your heart 
can fail” (Participant 11: Quote 2). 
 
“I have thought a lot that drinking a lot of tea like my dad can 
cause heart problems. My dad also liked a lot of sweet cookies. 
Sweets and cold drinks. I think sweet things” (Participant 9: Quote 
3). 
 
“When you are eating mostly fatty things, too much fatty things or 
drinking too much also. People are drinking too much alcohol you 
eat less you are going to develop heart disease” (Participant 2: 
Quote 4). 
 Structure and function 
 
 
Heart pump abnormal 
Blood flow abnormal 
Fatty heart 
8 (27) 
4 (13) 
1 (3) 
“The fat closes the veins and then there is not enough blood going 
through the heart then the heart stops when the veins are blocked 
then the heart don’t get enough blood and the heart won’t pump” 
(Participant 16: Quote 5).  
 
“When you have a heart attack then the heart is beating fast” 
(Participant 27: Quote 6).  
 
“I don’t have a lot of history and maybe your heart with too much 
fat on it” (Participant 1: Quote 7). 
 Behaviour Smoking 
Not exercising 
Not living healthy  
 4 (13) 
2 (7) 
1 (3) 
“It is being inactive number one, not eating fruits, if you think too 
much and stress a lot you get it. Those are the main things” 
(Participant 8: Quote 8). 
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Category Sub-category Codes/Keywords Code frequency    n (%) Quotes to illustrate 
 Emotional Keeping problems inside 
Anger 
Not accepting HIV 
 3 (10) 
1 (3) 
1 (3) 
“When one has a lot of problems that you can’t solve on your own 
that you keep on yourself, inside that can cause heart disease” 
(Participant 6: Quote 9). 
 
 “I think it means it is because they don’t accept that they are sick 
and also don’t tell people close to them that they are sick” 
(Participant 14: Quote 10).  
 
 “Causes of heart disease…like when you talk too much with your 
heart it cause heart disease. When you take something little like 
and get so angry every day it causes heart problems. Like you put 
the pain things in your heart. Like the heart will be affected” 
(Participant 10: Quote 11). 
 Physical 
 
 
Heart disease when body big 
Hypertension 
Cholesterol 
Inherited heart disease 
1 (3) 
1 (3) 
1 (3) 
1 (3) 
“I think it starts with stress because you will be stressed and 
stressed etc. and maybe you will start having high blood pressure 
that will lead you to heart attack” (Participant 3: Quote 12). 
 
Stress and ‘thinking too much’ were codes that presented most frequently (n=20; 66%) as causes of IHD. ‘Thinking too much’ was an 
frequently-reported concept, and included aspects of worrying, panicking and not allowing the mind to rest, resulting in increased stress levels. 
Participants explained it as follows: “It means worrying. When I sit I often worry about how long I will live and have time to spend with my child. 
And who will look after my child and what sort of life he will have if I am not there” (Participant 9: Quote 13); “If you are thinking too much you 
can’t rest, you can’t have a peace, your mind is always busy, and you worry this is what is happening now, you are always worried” 
(Participant 13: Quote14).  
 
The second-most common cause of IHD was reported to be nutrition, as reflected by specifics related to diet (n=16; 53%). Third was impaired 
structure and function of the heart (n=13; 43%). Only a few participants reported the effects of smoking (n=4; 13%) and not being active (n=2; 
7%). Emotional factors, such as anger (n=1; 3%), not accepting one’s HIV status (n=1; 3%) and keeping problems to themselves (n=3; 10%) 
were least-often mentioned. A few participants related the causes of IHD to physical changes as a risk factor for IHD (n=4; 12%).  
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The consequences of IHD were highlighted by participants’ knowledge and understanding regarding the signs and symptoms of IHD, and the 
fact that this disease could be fatal. Table 5.4 is a representation of the knowledge and understanding regarding the consequences of IHD, 
with selected explanatory quotations added. 
 
 Table 5.4:  Theme 1: Knowledge and Understanding Related to IHD (Consequences). 
Category Sub-category Codes/Keywords Code frequencies n (%) Quotes to illustrate 
Consequences Signs and 
symptoms 
Chest pain 
Breathing problems 
Feeling tired 
Sweating 
Swollen feet 
Collapse 
Anger 
Can’t talk properly 
Feel dizzy 
Feeling weak 
Losing weight 
13 (43) 
11 (37) 
8 (27) 
4 (13) 
3 (10) 
2 (7) 
2 (7) 
2 (7) 
1 (3) 
1 (3) 
1 (3) 
“I think swelling because the circulation is not well. Sweating and 
breathing problems and chest pains most of the time” (Participant 8: 
Quote 15). 
 
“Some of them collapse, complaining of pain in the heart and you will see 
that a person is shrinking, shrinking” (Participant 7: Quote 16). 
 
“The person won’t breathe well. The heart is paining” (Participant 27: 
Quote 17). 
 
“Feel numb, tired and sometimes the hearts beats faster” (Participant 20: 
Quote 18).
 Mortality Heart disease can kill 8 (27) “If someone is having heart disease they can die from heart disease or if 
they take care of themselves they can live long. Heart disease is not very 
nice” (Participant 29: Quote 19). 
 Morbidity Does not start 
immediately  
1 (3) 
 
“The little that I understand about heart disease it’s a disease that does 
not start immediately it starts with small things like stress” (Participant 1: 
Quote 20). 
 
Participants identified chest pain (n=13; 43%), breathing problems (n=11; 37%) and feeling tired (n=8; 27%) as the most common symptoms 
of IHD. Signs such as sweating (n=4; 13%), swelling (n=3; 10%) and collapsing (n=2; 7%) were noted to accompany IHD, though to a lesser 
extent. One participant was aware of the insidious onset of IHD, and a number (n=8; 27%) were aware of the serious nature of IHD and that it 
could result in death. IHD also elicited emotions of anxiety and nervousness in participants: “It makes me scared, because the heart is 
important in our body. So if you have a problem with your heart you have a problem with your life” (Participant 19: Quote 21). 
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IHD was viewed as a serious condition, and participants had knowledge and understanding regarding prevention strategies that could 
influence the risk of its developing. Table 5.5 is a representation of the knowledge and understanding regarding prevention strategies of IHD, 
with selected explanatory quotations added.  
 
Table 5.5:  Theme 1: Knowledge and Understanding Related to IHD (Prevention) 
Category Sub-category Codes/Keywords Code frequency n (%) Quotes to illustrate 
Prevention 
strategy 
Lifestyle change Eating healthy diet 
Don’t stress 
Exercise 
Healthy lifestyle 
Don’t smoke 
Reduce alcohol 
Sleep enough 
14 (47) 
7 (23) 
6 (20) 
2 (7) 
2 (7) 
1 (3) 
1 (3) 
“Yes, if you do all the right things like not eating fatty food not using 
cooking oil, if you don’t smoke if you do your exercises and eat your 
vegetables and fruit. Healthy balanced life; drink enough water, sleep 
enough and don’t stress too much. You always make sure that you are in 
the middle and level” (Participant 29: Quote 22). 
 
“Ja, I do think so reducing fats there are things when we were growing up 
like eating atcher like chacalekka in my community my culture there is a 
whole lot of oily stuff that you eat. Not to leave them but to reduce the 
amount of fat you are using every time” (Participant 1: Quote 23). 
 Coping behaviour Share problems 
Don’t think too much 
Don’t overreact 
Forget the past 
Socialise 
2 (7) 
2 (7) 
2 (7) 
1 (3) 
1 (3) 
“Yes a person can by not keeping your problems inside always but share 
with someone” (Participant 6: Quote 24).  
 
“Prevent…we can’t stop problems from happening but you need to take it 
normally. When things happen it happens but you must go on” (Participant 
13: Quote 25). 
 Health-seeking 
behaviour 
Consult a doctor 
Hospital attendance 
1 (3) 
1 (3) 
“Yes, they must come to the clinic to the hospital to get treatment. Only the 
hospital can make the heart disease right… A person can’t help 
themselves they can’t do something the hospital must help” (Participant 26: 
Quote 26). 
 Medical management Heart operation 
New heart 
2 (7) 
1 (3) 
“Yes you can…like an operation to your heart. I don’t know anything else 
that will help” (Participant 10: Quote 27). 
 
“Yes, a lot of people can go for heart operations and maybe get another 
heart” (Participant 9: Quote 28).
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Changing one’s lifestyle as a means to achieve a balanced and healthy lifestyle was considered essential for preventing IHD. Participants 
reported following a healthy diet (n=14; 47%); reducing stress levels (n=7; 23%); exercising (n=6; 20%) (less important than diet modification); 
coping strategies; health-seeking behaviour all as ways of preventing IHD. Then three individuals reported medical management in the form of 
surgical intervention as the sole way of preventing IHD.  
 
Although participants demonstrated knowledge and understanding regarding components of IHD, it was important to identify whether they 
were able to apply this knowledge and determine their own risk of IHD in self-assessment. Section 5.7.6.2 provides the results regarding 
participants’ insight into their own risk of IHD. 
 
5.7.6.2 Theme 2: Insight into own risk of IHD 
Insight into own risk of IHD was identified as theme no. two, with self-perception as its main category. Table 5.6 is a representation of 
participants’ insight into their own risk for IHD findings.  
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Table 5.6:  Theme 2: Insight into Own Risk of IHD 
Category Sub-category Codes/Keywords Code frequency n (%) Quotes to illustrate 
Self- perception Lifestyle Living a healthy lifestyle 
Exercise 
2 (7) 
1 (3) 
“No, at the moment with HIV and the life I have been leading 
before, it has been a healthy life throughout and I have never 
thought that I could get heart disease, but in the course of time 
you are no longer as young and fit as you used to be you can 
come across a lot of problems and could get heart disease, but at 
the moment I don’t think so” (Participant 28: Quote 29). 
 Coping behaviour Share problems 
Take everything as it comes 
Avoid anything that can 
cause pain  
1 (3) 
1 (3) 
 
1 (3) 
 
“No, because something that can cause a painful heart I try and 
take away or leave alone” (Participant 21: Quote 30). 
 
“No because I share my problems always” (Participant 6: Quote 
31). 
 HIV influence Better since ARVs 2 (7) “No since I am taking ARVs I am healthy” (Participant 14: Quote 
32). 
 Possibility for IHD 
risk 
- Behaviour 
Diet 
Stress 
Thinking too much 
Lack of exercise 
Smoking 
Lack of awareness 
  5 (17) 
2 (7) 
2 (7) 
2 (7) 
1 (3) 
1 (3) 
“Sometimes, because of the stress and unhealthy diet and not 
exercising. I think sometimes I can feel my heart tension that is 
not normal. Maybe you feel that you are stressed and angry. 
Anger causes your high blood to go higher and you can even feel 
that your heart is not klopping normal. You feel that it is beating 
faster. It feels like you can hold it then you feel the short breath 
and everything” (Participant 3: Quote 33). 
 Possibility for IHD 
risk 
- Physical 
symptoms 
Chest pain 
Heart beating fast 
Heart beat abnormal 
2 (7) 
1 (3) 
1 (3) 
“I think so, because when I am worried there is pain straight in the 
heart. Sometimes I feel weak and the pain goes to my back” 
(Participant 7: Quote 34). 
 
“Yes I think so, because sometimes when I am sitting I am scared 
and I feel my heart is going fast” (Participant 17: Quote 35). 
 
Fifteen participants (50%) did not perceive themselves at risk of IHD, due to reporting living a healthy lifestyle, exhibiting coping behaviour and 
reporting that their health had improved since being on HAART. Twelve (40%) perceived a possibility of risk of IHD due to specific behaviours 
and physical symptoms. Participants linked their own risk for IHD most often to behavioural factors, such as following an unhealthy diet (n=5; 
17%), psychological factors, such as stress (n=2; 7%) and “thinking too much” (n=2; 7%). Lack of exercise (n=2; 7%) and smoking (n=1; 3%) 
were less often cited.   
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A third, final, theme: health character in the HIV context, was identified in content analysis of the transcribed interviews. It became apparent 
that when participants were providing information regarding living a healthy lifestyle, they were doing so from their HIV perspective. This data 
is presented in section 5.7.6.3. 
 
5.7.6.3 Theme 3: Health character in the HIV context  
Three categories were identified regarding participants’ health character in the HIV context: knowledge and understanding regarding HIV, 
coping with HIV and applications to manage HIV. Table 5.7 is a representation of participants’ knowledge and understanding regarding HIV, 
with selected quotes to illustrate added. 
 
 
  
136 
 
Table 5.7:  Theme 3: Health Character in the HIV Context (Knowledge and Understanding regarding HIV) 
Category Sub-category Codes/Keywords Code frequency n (%) Quotes to illustrate 
Knowledge and 
understanding 
regarding HIV 
HIV 
- Self-care 
 
Protect yourself when having sex 
Take your treatment 
Look after self 
Don’t deny that you are ill 
Know your CD4 count  
Can’t smoke 
7 (23) 
4 (13) 
4 (13) 
1 (3) 
1 (3) 
1 (3) 
“Live a positive life by taking care of yourself. Protecting 
yourself when having sex or abstaining. Take care of 
yourself now that you know you are HIV positive how to 
protect yourself from getting other infections and all that” 
(Participant 3: Quote: 36). 
 
“To live longer that is way I am taking ARVs so that I live 
longer for my children. I know that the ARVs are helping 
me to keep the sickness down but not to prolong my life” 
(Participant 6: Quote 37). 
 HIV 
- Remission 
Immune system 
Not taking medication 
6 (20) 
3 (10) 
“Ja, they might have re-infection with the HIV virus and 
their immune system will be getting weak and they will 
be prone to getting infections” (Participant: 18: Quote 
38). 
 HIV 
- Co-morbidities 
Tuberculosis 
Mind gets disturbed 
5 (17) 
1 (3) 
“TB, losing weight, skin can change, some people get a 
rash or get sores in the mouth” (Participant 22: Quote 
39). 
 
“Especially the mind can get disturbed, losing your mind, 
not communicating with the people well, sometimes they 
speak to you and you are not even there. It is not a 
disease as such, but it becomes a disease if you begin 
to worry what is going on in your life” (Participant 28: 
Quote 40). 
 Healthy lifestyle Diet 
Exercise 
Limit stress 
Don’t smoke 
Don’t drink 
Sleep 
Don’t do drugs 
Drink water 
19 (63) 
14 (47) 
11 (37) 
7 (23) 
7 (23) 
1 (3) 
1 (3) 
1 (3) 
“Taking care of themselves, their bodies, trying to give 
their bodies a fair way of living…we need to eat good 
food as well there is good food and we also need to 
exercise, which I believe gives energy it gives the mind 
clarity to think very clearly” (Participant 1: Quote: 41). 
 
“Can’t smoke or drink when on ARVs; smoke damages 
the lungs and beer damages the liver; you deteriorate 
faster and will die faster” (Participant 11: Quote 42). 
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Participants’ knowledge and understanding about how to manage their health, knowing they were HIV+, was frequently reported when 
answering what they understood about living a healthy lifestyle. Wearing a condom to protect themselves when having sex (n=7; 23) and 
adhering to their HAART (n=4; 13%) were important aspects of self-care knowledge. Not taking their HAART medication was known to have 
detrimental consequences, as it could result in remission and development of co-morbidities. Knowledge concerning the importance of 
incorporating healthy lifestyle choices to manage HIV was reported. 
 
Coping with HIV was considered an important facet influencing health, and coping beliefs and certain coping behaviours were identified as 
ways in which they attempted to live a healthy lifestyle. Table 5.8 is a representation of participants’ coping with HIV. 
 
Table 5.8:  Theme 3: Health Character in the HIV Context (Coping with HIV) 
Category Sub-category Codes/ Keywords Code frequency n (%) Quotes to illustrate 
Coping with HIV Coping beliefs Supportive family 
Share with people 
To be happy 
Ignore gossip 
5 (17%) 
3 (10%) 
1 (3%) 
1 (3%) 
“Okay…like…let me think first…It is important to have support from my 
family, especially my mother, because in many ways she supported me in 
my life; if I am sick she was there for me” (Participant 10: Quote 43). 
 Coping behaviour Watch television 
Using a cell phone 
Socialise 
Sleep 
Doing yard work 
Prayer 
7 (23%) 
4 (13%) 
2 (7%) 
2 (7%) 
2 (7%) 
1 (3%) 
“Me at home I can sit and watch TV and then the stress is gone. Sitting and 
watching TV helps to decrease my stress. If I am thinking about my child, 
my child passed away of HIV, but when I watch TV I can smile and forget 
and I can tell myself I must not stress myself” (Participant 13: Quote 44). 
 
“I enjoy doing yard work. I don’t have a lot of flowers in the garden but I 
enjoy working in the yard. When I do yard work I forget about my problems 
and physically my body feels relaxed and it feels like my problems are gone. 
It is a way I handle my stress. Eating sweets and cookies are my best 
friends. I like eating it and it makes me feel relaxed within me. I can eat a 
whole bag of cookies or bag of sweets. My favourite is Romany Creams. It 
gives me the same feeling as if when I work in the garden” (Participant 9: 
Quote 45). 
 
“Personally I think prayer. Your religion. In order for me to do all of these 
things, I feel I can’t do them on my own. I pray to God and believe that God 
will help me to do all the things I have to do” (Participant 8: Quote 46). 
 
138 
 
The importance of having a supportive family (n=5; 17%) was considered an essential coping belief, as well as sharing problems with others 
(n=3, 10%).  Certain pastimes, such as watching television (n=7; 23%) as a form of escape; and interacting with others by cell phone (n=4; 
13%) were all ways of coping with HIV. Spirituality played an important role in one participant’s ability to cope. A healthy lifestyle was often 
hindered by environmental factors beyond their control. Despite this reality, their ability to take responsibility for their health and self-regulate 
their behaviour were important components to function. Table 5.9 is a representation of their applications to manage HIV as part of their health 
character. 
 
Table 5.9:  Theme 3: Health Character in the HIV Context (Applications to Manage HIV) 
Category Sub-category Codes/Keywords Code frequency n (%) Quotes to illustrate 
Applications to 
manage HIV 
Self-regulation Adherence to HAART 
Knowing HIV status 
Protected sex 
Control reactions 
CD4 count evaluation 
Don’t rush things 
17 (56.7) 
13 (43.3) 
  7 (23.3) 
2 (6.6) 
1 (3) 
1 (3) 
“You need to know your HIV status. You, if are living and you don’t know your 
status you don’t know where you belong. If you know, you know sometimes 
some people look healthy, when you ask them if they know their status, they 
say why should I know my status I am healthy. I don’t do these things with men 
but maybe if you tried once you catch that disease. It is better to know your 
status and keep it that way. If you know your status, eat healthily and have less 
stress you will know you will be okay. You know now how you are going to live. 
If you don’t know your status you are living anyhow” (Participant 2: Quote 47). 
 
“I think to take my medication at the right time. Not to take my medication at 
any time. If I take my medication at eight o’clock I need to take my medication 
at the same time. It is very important and healthy” (Participant 14: Quote 48). 
 
“You have to protect yourself from STI’s, HIV and unexpected pregnancies. 
Sometimes people are throwing the babies in the dustbins because they did not 
use protection or anything” (Participant 16: Quote 49). 
 
“You must always know your CD4 count, how much is the level of your CD4 
count. CD4 count tells you how much is the virus active in you. The CD4 count 
must be 200 and upwards and not less than that. We want it high and level” 
(Participant 6: Quote 50).  
 
 Behaviour Drinking water 
Exercise 
Eating vegetables and 
fruit 
10 (33) 
  9 (30) 
     7 (23.3) 
 6 (20) 
“I think I am doing half of it and not a 100% of what I should do. I need to 
exercise and eat healthy more often. That is the important thing. I can’t afford to 
buy food I should eat. My work is not paying a lot. Such as vegetables and 
fruits and healthy food that I might need. I would eat anything at the moment 
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Category Sub-category Codes/Keywords Code frequency n (%) Quotes to illustrate 
Washing hands 
Eating fish 
Sleep enough 
Gardening 
Washing fruit and 
vegetables 
Eating pap and meat 
Time for relaxation 
     5 (16.7) 
  3 (10) 
  3 (10) 
    2 (6.6) 
 
1 (3) 
1 (3) 
because I don’t have the income to buy healthy food. Exercising; I am trying by 
working hard, like cleaning/ scrubbing/ cleaning the floor/ bending/ washing and 
everything and at least not to sit down but to do something. Just to be active” 
(Participant 3: Quote 51). 
 
“Doing your own yard work and housework is important if you have the 
strength. Some people are too sick and can’t do their own house or yard work 
and just sit. If you can, it is important, and it is part and parcel of exercises, and 
you will grow your own vegetables in your own yard. The vegetables will be 
fresh out of your garden, unlike buying vegetables from the market. Because 
now other people don’t have money to buy vegetables because if you have 
vegetables in your yard you can cook the spinach and cabbage from your yard” 
(Participant 12: Quote 52). 
 
“Most of we black people prefer eating pap because we don’t have money to 
buy rice every day and spaghetti or macaroni or buying take-away. It is starch 
food” (Participant 16: Quote 53).
 Environment Job 
Family 
   5 (16.7) 
3 (10) 
“Yes it is important to have a job so that you will be able to buy food to be able 
to take your medication” (Participant 25: Quote 54).  
 
“Fruits I don’t eat every day because sometimes we don’t have money. Fruits 
are the same price as vegetables but vegetables you can cook; cabbage you 
eat today and put it in the fridge and tomorrow again. Sometime you buy five 
apples or oranges - after two days they start to rot. The vegetables last longer 
than the fruit” (Participant 30: Quote 55). 
 
“If I have a job I will buy myself Flora for my heart and olive oil and I would not 
use normal oil. I can’t afford them at the moment and are taking the cheaper 
option” (Participant 19: Quote 56). 
 
“I don’t have family support. No one knows I am HIV positive. If they know they 
would not be supportive. They do not like my boyfriend, and said that if he 
brings me into trouble they will not help me. That is why I don’t tell them that I 
am positive” (Participant 18: Quote 57). 
 
“I work in Jo-burg, but my house is far away in Kimberley. Sometimes I want to 
go home because I miss my family, but I need to work to earn money. I would 
want to see my family more and earn more money to be more financially 
independent” (Participant 21: Quote 58). 
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Knowing their HIV status (n=13; 43.3%) was an important component to self-regulation, as 
it represented responsible behaviour and facilitated action by adhering to HAART (n=17; 
56.7%) and taking responsibility for their health.  Unemployment was an environmental 
factor that prevented participants from living a healthy lifestyle. It had a severe effect on 
stress levels, diet and, possibly, their adherence to HAART. Family dynamics (being a 
single parent, non-disclosure to family members or living far from family) were an 
environmental factor that influenced health character, as it affected their support structure. 
Participants were applying healthy lifestyle choices in their lives by performing certain 
behaviours as they were able 
 
Section 5.8 consists of a discussion of the results found in study 2, evaluating participants’ 
self-perception and behaviour towards IHD. 
 
5.8  DISCUSSION  
The aim of the study was to determine the nature of the participants’ self-perception and 
behaviour in relation to the risk of IHD. This is said to depend on knowledge and 
understanding of IHD (Meischke et al., 2000). Participants had fair knowledge and 
understanding relating to IHD, as they demonstrated positive knowledge of risk factors, 
signs and symptoms, and prevention strategies for IHD. They also had some understanding 
regarding the pathophysiology of IHD, as they reported that it could change blood flow and 
develop due to arteriosclerosis. Only one other published study that investigated the 
knowledge of risk factors for IHD and self-perception for the risk of developing IHD in 
PLWHA is available for comparison, namely, that of Cioe, Crawford and Stein (2013).   
 
Cioe, Crawford and Stein evaluated IHD risk factor knowledge and risk perception in a 
cohort of HIV-infected adults in the USA. A cross-sectional study was done with 130 
individuals where risk factor knowledge was assessed with the Heart Disease Fact 
Questionnaire. The sample achieved a mean value of 19 (±3.5), reflecting a fair knowledge 
of IHD. The demographics of the study were different from the current study: mean age (48 
[±8.4] years), consisted mostly of male patients (62%), had more smokers (56%) and 
participants had had longer HIV exposure (14.7 years). The current study, being qualitative 
in nature, provides information regarding perspectives in a South African context of HIV, 
and highlights social difficulties encountered on a day-to-day basis. Background information 
regarding social impediments is helpful for planning an intervention to manage specific IHD 
risk factors. In-depth information is more difficult to collect with quantitative research, and 
absent from the study conducted by Cioe, Crawford and Stein (2013). Thus the two studies 
consider the topic (providing information regarding PLWHA’s self-perception regarding the 
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risk for IHD) from different perspectives. Participants in this study demonstrated knowledge 
of IHD, as evidenced by their understanding of risk factors for IHD.  
 
Participants described causes of IHD in relation to known risk factors for IHD. Stress, diet, 
HTN, cholesterol, being overweight and a family history of IHD were mentioned. Being 
overweight was reported as a cause, but by only one individual. The lack of understanding 
among participants of the causative role that overweight or obesity play in relation to IHD is 
of concern, considering that the cohort was overweight. Participants did not report being 
overweight or obese as part of their explanation of why they perceived themselves at risk 
for IHD. Thus it could imply either that they did not perceive themselves as overweight or 
that they did not view being overweight as a problem, or both. This finding is in contrast to 
international data regarding perceptions or beliefs regarding contribution of overweight to 
IHD risk (Pace et al., 2008).  
 
Pace et al. (2008) reported that African-American individuals in rural areas in Alabama 
noted that being overweight or obese increased one’s chances for IHD by 71.3%. The 
participants in their study also had knowledge of the link between overweight and obesity 
with high blood pressure (71.3%), diabetes (71.1%) and cancer (53.5%). In the West Africa 
region, Ansa, Oyo-Ita and Essien (2007) evaluated the knowledge of risk factors for IHD in 
a cohort of university staff in Nigeria. The authors reported that smoking (70.6%), alcohol 
use (52.8%) and obesity (41.6%) were most often reported as risk factors, and sedentary 
lifestyle as less so (16.6%). Having a post-secondary school educational level in the 
reported study determined whether individuals were able to note a sedentary lifestyle as a 
risk factor for IHD. The inverse relationship between education and IHD risk factor 
knowledge is well reported in the literature (Pace et al., 2008; Potvin, Richard and Edwards, 
2000; Avis, Smith and McKinlay, 1989). Literature suggests that lower educational levels 
reduces one’s knowledge of IHD risk factors. Ansa, Oyo-Ita and Essien (2007) also 
explained that a sedentary job in the African culture is seen as an elevation in social status, 
and therefore not often associated with IHD risk by the less-educated. Performing jobs 
involving physical labour can also influence one’s perception regarding performing 
exercise.  
 
Airhihenbuwa et al. (1995) reported that African-Americans believed that, since they 
performed jobs that involved physical labour, they needed to rest in off-work time and not 
perform additional exercise. In the current study few participants (n=8; 26.6%) had post-
secondary school education that might have influenced their knowledge of the risk of a 
sedentary lifestyle for IHD. The majority of participants were employed (n=17; 56.7%) and 
performed work that involved physical labour, e.g. domestic workers or waiters. Lack of 
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exercise (n=2; 7%) and smoking (n=4; 13%) were mentioned less often than diet and stress 
as causative factors for IHD. The lower level of reporting of lack of exercise as cause for 
IHD could be due to participants not knowing the link between IHD and physical inactivity, 
or possibly to a belief that additional exercise is not necessary because of their active jobs. 
The objective in this study was not to determine beliefs regarding exercise, and further 
research is warranted to evaluate this question. The lower number of participants that 
reporting smoking as harmful is most probably due to the low number of smokers in the 
cohort (n=3; 10%). Studies have indicated that smokers more often interpret smoking as a 
risk factor for IHD than non-smokers (Hamarneh et al., 2012; Silagy et al., 1993). This could 
explain participants’ lack of belief of smoking as risk factor for IHD. Participants referred to 
diet frequently in the interview.  
 
Participants noted that diet plays a significant role in causing IHD, and a change in diet was 
reported as a prevention strategy for IHD. An unhealthy diet by eating too much or eating a 
diet high in fat and/or sugary substances was reported to increase one’s chances of 
developing IHD. The importance that participants linked to diet is understandable: firstly, 
the role that diet plays in the management of HIV has received focus from the national 
media in SA, due to sensational and controversial information provided by a previous 
Health Minister (BBC News, 2006). The information provided to PLWHA regarding diet has 
been updated since then, and education regarding a healthy diet is now often included as 
part of health programmes at HIV clinics in SA. The HIV clinic that participants frequented 
advised them to attend the clinic’s health and HAART adherence programmes on 
enrolment to the clinic. These programmes included advice on eating a healthy diet. It is 
therefore not surprising that participants considered a diet high in fruit and vegetables part 
of living a healthy lifestyle.  
 
Secondly, national advertising through television media, e.g. Flora margarine campaigns, 
often advocates low-fat options for a healthy heart. Watching television was reported by 
individuals as a coping strategy, and seeing these advertisements could have added to 
their knowledge of the topic. This was illustrated by one participant’s explanation which 
referred specifically to Flora. A noticeable lack of knowledge and understanding relating to 
salt intake and its relationship to HTN and IHD was exhibited by participants. Three 
individuals (10%) were known hypertensives, and neither they nor the other participants 
referred to salt intake in discussions on diet. The finding in the current study could be 
explained by those of Pace et al. (2008), who noted that participants in their study were 
more likely to maintain that salt intake had an effect on blood pressure or IHD risk if it was 
of concern to them, or if they had an educational level greater than high school. Additional 
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education regarding the effects of a diet high in salt on blood pressure levels, and the 
consequent risk of developing IHD could be included in health programmes for PLWHA. 
 
Participants’ diet was also given as one reason why they perceived themselves at risk for 
IHD. Disagreement was noted between dietary knowledge and practice. The majority of 
participants (n=16; 53.3%) were able to partake in daily fruit and vegetable intake, but 
unable to consume three to five vegetables and fruit combined daily (n=20; 67.3%). 
Environmental factors such as financial constraints due to unemployment, low salaries or 
absence of financial support from life-partners were offered as explanations for their dietary 
choices. Growing own produce was suggested as a solution to overcome these 
environmental problems, but physical impairment such as lack of strength were noted as 
hindrances. Participants also opted for buying produce from street vendors or made 
different dietary choices to limit cost. Dietary practices were therefore partly due to external 
factors, and not necessarily to lack of knowledge or unwillingness to change behaviour. 
Individual participants, however, did choose to follow dietary behaviours that put them at 
risk for IHD, despite knowing that it was unhealthy. IHD is said to develop due to factors 
that act synergistically, and minor adjustments in one lifestyle risk factor in the presence of 
others can have a significant effect on overall risk (Silagy et al., 1993). In these individuals, 
where education regarding diet is not effective, management of their other risk factors for 
IHD might lower their overall risk.  
 
Psychological factors, such as stress and ‘thinking too much’ were frequently reported in 
the interviews as important causative factors for IHD. An inter-relationship between 
‘thinking too much’ and stress were noted in discussions. Worry and panicking were 
concepts that included it, and were reported to result in stress or to escalate stress levels. 
The subjects of the worry included their children and what would happen when they are no 
longer there; finances and employment. Naturally, these aroused high levels of stress. The 
concept of worry is reported in literature on chronic diseases. Boutain (2001) noted that 
African-American individuals in Louisiana, living with HTN, often expressed worrying about 
their family and financial burdens. Worrying about others was also reported by women with 
IHD, and perceived to exacerbate their disease (Lisk and Grau, 1999). Angus et al. (2007) 
also noted that stress-talk in women, when evaluating risk for IHD, was often centred on 
caring for spouses and children, and balancing these with other work responsibilities. 
Stress in Boudain’s (2001) study was linked to participants having to do multiple tasks and 
confronting prejudice in the workplace and surrounding community.  
 
Prejudice against PLWHA is a reality, and one reason why individuals fear disclosing their 
status because of the uncertainty of how others might react (Bogart et al., 2013). Social 
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support, such as support from significant others and others with similar experiences are 
reported in the literature as aids in managing stress (Thoits, 2011). These stress-
management methods (Mkandawire-Valhmu et al., 2013), and also spirituality (Dalmida et 
al., 2012; Hodge and Roby, 2010), are coping strategies employed in HIV populations. 
Coping strategies for participants in the current study were: sharing with others, receiving 
support from family, socializing and prayer. Non-disclosure of status can therefore create a 
form of isolation where some coping strategies, such as sharing with others, are not 
possible, and could compound the stress, as described by one participant. Most 
participants had disclosed their status to family or friends they could trust, and used sharing 
with others as a form of coping behaviour to manage their stress levels, as well as coping 
with their HIV status in general.  
 
A number of participants perceived themselves to be at risk of developing IHD. Twelve 
participants (40%) perceived themselves to be at risk of IHD. This self-perception was due 
to a combination of behavioural aspects, and also to physical symptoms. When evaluating 
this perception it is important to remember that the current study consisted mostly of 
women participants (n=25). Literature suggests that women often underestimate their risk 
of IHD (Hart, 2005; Legato, Padus and Slaughter, 1997), but are more likely than men to 
perceive behaviours such as smoking and diet as harmful (Silagy et al., 1993). Stress in 
women less than 60 years old is also noted to be high, or very high, when evaluating risk 
perception for IHD, and is a risk factor to be monitored closely (Legato, Padus and 
Slaughter, 1997). In this regard, it is not surprising that behavioural aspects expressed by 
participants included an unhealthy diet, stressing too much, smoking and not exercising 
enough. Preferring a diet high in fat content was one such reason reported, and this could 
have been related to exposure to culture-specific food from an early age. Literature states 
that individuals often maintain that self-perceived risk of IHD due to dietary behaviour and 
dietary practices related to culture are hindrances that need to be overcome when 
addressing IHD risk (Angus et al., 2009). Insufficient exercise was another reason reported, 
and they attempted to increase activity during the day if they were not able to perform 
formal exercise. 
 
Of greater concern were the physical symptoms that a few participants experienced that 
informed their belief regarding their risk for IHD, including chest pain with referral and 
perceived alterations in heart rate. Known cardiac symptoms include chest pain, chest pain 
with referral to upper extremity or jaw or back, and, often, palpitations (Collins and Dias, 
2009). Reasons why participants had not acted on their symptoms and requested medical 
advice could be due to a number of factors. Bodily sensations provide information to the 
individual, and, depending on one’s previous experiences, a person might or might not act 
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on these experiences (Corbin, 2003). Corbin (2003) states that individuals are likely to ‘wait 
and see what happens’, and if the sensations become more frightening they will then seek 
medical advice. The Shifting Perspectives Model of chronic illness described by Paterson 
(2001) could also be used to explain the reluctance to seek medical advice. The Shifting 
Perspectives Model demonstrates that individuals living with chronic illness, e.g. HIV, 
continually shift between two states: illness-in-the-foreground or wellness-in-the-
foreground. Wellness is determined by comparing the experience, e.g. chest pain, to what 
is known and understood about the illness and vice-versa. Paterson (2001) explains that a 
perception of threat to one’s control is the major factor that will move an individual from a 
state of wellness-in-the-foreground to illness-in-the-foreground. Study 1, that determined 
the non-invasive risk factors for IHD, highlighted that participants’ medical histories included 
a number of illnesses. These previous physical experiences could have determined 
whether they considered their current symptoms frightening or not, and hence influenced 
their actions. This notion is supported by Meischke et al. (1995), as their study findings 
indicated that reasons why patients with chest pain delay seeking help were belief that 
symptoms would go away, or that the symptoms were not severe enough, or that they 
thought it was due to another illness. Individuals also perceive themselves to be at a 
greater risk of IHD if they perceive their general health as poor (Meischke et al., 2000). In 
the current study no participants held this perception, and only eight (26.7%) thought their 
general health was average. Participants also reported that their health had improved when 
they initiated HAART, and thus could not come to terms with the idea that they might now 
be at risk of another threatening disease, IHD.  
 
When contrasting participants’ self-perception for risk of IHD to their non-invasive risk 
factors screened in study 1, some agreement was noted in behavioural risk factors. Actual 
risk factors present in the study cohort included: not consuming enough daily fruit and 
vegetables; moderately high stress levels; overweight; raised RHR; not active enough (a 
portion of the sample); smoking and HTN. The number of participants that viewed their 
behaviour as reason for increased risk of IHD was less than those presenting with the 
actual risk factors screened. Cioe, Crawford and Stein (2013) had similar findings. They 
noted that smoking (56%), pre-hypertension (48.5%) and overweight (BMI 27 ± 5.5 kg/m2) 
were traditional risk factors encountered in their Boston cohort of PLWHA. Information 
relating to perceived risk of IHD was collected by participants using the Perception of Risk 
of Heart Disease Scale. The total mean score in the authors’ sample was 53.1 (±5.9). 
Estimated risk for IHD was calculated by the FRS. The authors found that estimated and 
perceived risk for IHD had a weak correlation (r=0.24; p=0.01) in their study sample. 
Further education strategies are therefore indicated to assist individuals in seeing the 
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relationship between their behaviour and risk of IHD, and to assist them in implementing 
prevention strategies. 
 
An important finding highlighted in the study was that participants did not perceive 
themselves to be at risk of IHD due to being HIV+ or using HAART. They were unaware that 
these factors could put them at risk of developing IHD over time. Their perception regarding 
HAART usage was positive, as it was seen to make them healthy and not to cause other 
ailments. Informing individuals of the effects of the virus on the cardiovascular system, and 
of the effects of different HAART regimens on their risk of IHD could improve adherence to 
behavioural lifestyle strategies. 
 
Important aspects regarding health character were identified in the course of the study that 
did not directly inform their self-perception of IHD, but did influence their general behaviour, 
and are worth mentioning. Participants presented with social difficulties in the form of 
unemployment, financial constraints and single parenthood. These difficulties were a 
significant source of stress, but did not prevent them from attempting to improve their health 
and make the most of their situation. They were actively engaged with their health 
condition. Participants were HIV+ and engaged in active management of their disease by 
attending clinic appointments, using HAART and implementing clinic advice as able. They 
were also knowledgeable about HIV; knew how to prevent re-infection, what parameters to 
monitor to evaluate their status, and had an understanding of the co-morbidities that can 
occur. This level of knowledge about HIV is supported by Mkandawire-Valhmu et al. (2013), 
as evaluated in a study where the capacity of women living with HIV in low-income areas in 
Malawi and Kenya were evaluated. A culture of responsible health behaviour was present 
in participants with regard to their HIV status. Due to the ingrained culture of going to the 
clinic and seeking medical advice, it is not surprising that visiting the clinic for medical 
advice and/or having heart surgery were prevention strategies for IHD mentioned by 
participants. Of concern was that they believed that heart surgery was the only course of 
action to take when confronted with the possibility of being diagnosed with IHD. Educating 
individuals on the other avenues available for the prevention of IHD is necessary. The 
influence of their actions through healthy behaviour should be reinforced, to emphasise to 
them that their behaviour affects their HIV condition, and also overflows, and can prevent 
IHD to some extent.  
 
5.9 CONCLUSION  
This is the first study to be conducted on PLWHA in a South African population where the 
nature of participants’ self-perception and behaviour in relation to the risk of IHD was 
investigated. It highlights the status of individuals’ perception in a South African context, 
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where the demographics related to HIV prevalence are different from the rest of the 
Western world. Women are more afflicted by HIV in the South African region, and 
internationally women often perceive their risk of IHD to be low. In the current study 40% of 
participants perceived themselves to be at risk of IHD due to behavioural aspects and 
physical symptoms. The larger portion of the sample (50%) presented with an optimistic 
bias due to not perceiving themselves at risk when they presented with risk factors. Three 
(10%) participants were unsure of their own risk.  
 
Participants presented with positive knowledge about IHD, but this knowledge was not 
often used when reviewing personal risk. Actual risk factors for IHD were present, and 
moderate agreement was noted between actual and perceived risk factors.  
 
Responsible health behaviour was noted, as reflected by active involvement in their HIV 
management and knowledge ability related to their HIV condition. Participants attempted to 
follow healthy lifestyle choices, but were often hindered by social hindrances.  Education 
strategies regarding how overweight, and a positive HIV status with treatment interventions, 
influence risk of IHD are required in PLWHA to inform their personal risk perception of IHD.   
 
Chapter 6a consists of an explanation of the development of the education physical activity 
diary. This was used in the intervention evaluating the effects of an education and home-
based walking programme on risk factors for IHD in PLWHA. Details of the intervention are 
elaborated on in study 4 (chapter 6b).   
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CHAPTER 6A 
6a. STUDY 3: DEVELOPMENT OF THE EDUCATION PHYSICAL ACTIVITY DIARY 
 
6a.1  INTRODUCTION 
Education and therapeutic exercise are recognised treatment modalities in physiotherapy 
practice to improve health. They are used as prevention strategies for medical conditions 
and to manage known pathologies present in patient populations (Dean, 2009). A 
suggested method for providing education to assist individuals in changing a specific 
behaviour - for example, physical inactivity - is through providing information material 
(Evans, 2013; Whitlock et al., 2002). This chapter outlines the development of the 
education physical activity diary that was used in the intervention in study 4.  
 
6a.2  STUDY 3 
6a.2.1 Aim and Objectives 
Aim:  
To create an education physical activity diary for use in an education and home-based 
walking programme to mitigate associated risk factors for IHD in individuals infected by HIV 
and on HAART.   
 
Objectives: 
 To create the education material for the diary. 
 To create the self-monitoring tools for the diary. 
 To validate the content of the education material for the diary. 
 To design and construct the diary. 
 
6a.3 METHODOLOGY  
The function of the education physical activity diary was twofold: it provided education 
material specific to the objectives of the intervention programme of study 4, and it was used 
as a self-monitoring tool by participants in the intervention programme. The first objective 
was thus to create the education material to be included.  
 
6a.3.1 Education Material of the Physical Activity Diary 
In the course of studies 1 and 2 differences in the level of the study participants’ 
understanding and knowledge of IHD became apparent. The ‘knowledge’ referred to the 
risk factors for IHD and why physical activity was important in reducing the risk of IHD. To 
ensure that all the participants began the intervention with a reasonable baseline 
understanding of IHD, it was decided to include relevant information in the educational 
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material. A systematic literature review was undertaken related to IHD: risk factors for IHD; 
the importance of physical activity; guidelines for physical activity in the general population; 
and the same, specific to PLWHA. The information obtained laid the groundwork for the 
education material of sections A and B of the diary. Figure 6a.1 is a representation of the 
education material for section A. 
 
Figure 6a.1: Education Material Regarding IHD Included in the Physical Activity 
Diary 
 
Figure 6a.2 is a representation of the education material included in section B. 
 
Figure 6a.2: Education Material Regarding the Physical Activity Programme 
 
Warm-up and cool-down exercises were included in the education material. This was to 
educate participants on a range of motion exercises of specific joints and muscle stretches 
of targeted muscles before performing a focused walk, as a prevention strategy for injury. 
The warm-up and cool-down exercises were included in section C. Figure 6a.3 is a 
representation of the activities included in section C. 
A. Education material regarding IHD
What is IHD?
What are risk factors for IHD?
Which risk factors of IHD  can be changed?
Are the risk factors of IHD different in people who are living with HIV? 
How can I make my lifestyle healthier?
What is physical activity?
How can being physically active reduce my risk of IHD?
B. Education material regarding the physical activity programme
How can I improve my physical activity level?
How do I know that I am doing enough physical activity?
How do I know I am exercising at a moderate intensity level?
What do I need to consider when starting my exercise programme?
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Figure 6a.3:  Education Material Regarding Warm-Up and Cool-Down Activities. 
 
Literature indicates that people who are being educated about IHD request information 
regarding how risk factors influence the heart, recommended normal values of risk factors 
and recommended duration and frequency of physical activity (Redfern et al., 2006). In 
addition, space for participants to record their values should be included (Redfern et al., 
2006). These recommendations were applied in compiling the education material, and the 
self-monitoring tools were also included. The second objective was to create the self-
monitoring tools to be included in the diary.  
 
6a.3.2 Self-Monitoring Tools of the Physical Activity Diary 
The self-monitoring tools consisted of a page where participants could document their 
assessment results. With the intervention focusing on increasing participants’ pedometer 
physical activity levels incrementally, weekly physical activity tracking sheets were created. 
These were used for participants to document their pedometer physical activity level daily, 
and they provided space for comment on how they were feeling that week. The pages also 
carried the participants’ weekly pedometer physical activity prescription, with heart rate 
intensity levels, for their knowledge and self-monitoring.  Sheets for face-to-face sessions 
with the physiotherapist were created. On these sheets participants’ suggestions regarding 
how to overcome their reported impediments to walking were documented for record and 
implementation. To remind participants of the function of the intervention, the aim and 
make-up of the physical activity programme was presented on the front of the dairy, 
together with a physiotherapy appointment schedule.  
 
 
C. Warm-up and cool-down activities
Neck exercise
Trunk exercise
Shoulder exercise
Shoulder and trunk exercise
Ankle exercise
Calf stretch
Thigh stretch one
Thigh stretch two
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6a.3.3 Message Framing of the Education Material of the Physical Activity Diary 
The message framing of the material was considered important for its influence on 
participants’ motivation (Gallagher and Updegraff, 2012; Latimer, Brawley and Bassett, 
2010). The benefits of being physically active were depicted in a gain-frame message; i.e., 
a positive, rather than negative cast, e.g. “it improves blood circulation”, instead of a loss-
frame approach. This followed literature suggesting that gain-frame messages are effective 
when promoting increased physical activity (Gallagher and Updegraff, 2012; Latimer, 
Brawley and Bassett, 2010).  
 
With the success of the intervention being dependent on participants’ willingness to change 
their behaviour by self-monitoring and increasing their daily step-count, a behavioural 
contract was added. Behavioural contracts are said to improve self-confidence regarding 
ability to perform a particular behaviour when implementing behavioural change 
interventions (Charlson et al., 2007). These contracts are said to embody the commitment 
that participants are willing to make when participating in interventions (Charlson et al., 
2007). The academic peer review panel that reviewed the diary preferred term 
“commitment” to “contract” to avoid the suggestion of a legal document. The behavioural 
commitment document was placed in the front of the diary for participant review. A copy of 
the “Commitment to Myself” document is available for review in Appendix 28.  
 
6a.3.4 Readability of the Education Material of the Physical Activity Diary 
Readability of the material was considered important to ensure comprehension. To ensure 
readability the following suggestions by Albert and Chadwick (1992) and Jamison (2010) 
were implemented: 
 Sentences were kept short. 
 Understandable layman’s language was used as much as possible. 
 Attempts were made to frame messages according to individuals’ environmental 
context. 
 Sentences were written in the active voice. 
 Attempts were made to keep the writing personal by using the words “I, me and you”.  
 Pictures were included to explain the text and to keep readers’ interest. 
 Clutter was reduced by adequate white space between writing. 
 Non-gloss paper was used.  
 Bold print was included as a typographical cue to suggest important information. 
 
The readability of the education material was evaluated using the Gunning Fog Index 
before content validation by an academic peer review panel and a Themba Lethu patient 
group. In the Gunning Fog index the average sentence length and the number of words of 
152 
 
three syllables or more per 100 words is calculated (Jamison, 2010). The result is then 
multiplied by 0.4 to get a reading score. A score of between six and ten is considered 
“easy”, and above 13 requires a reading-level of a first year university student (Jamison, 
2010). The score of these pages ranged from 4.8 to 11.4. Recommendations of the 
academic and patient groups, and also the Gunning Fog Index score, were implemented to 
improve readability.   
 
The procedure followed to assist with content validation of the education physical activity 
diary is explained in section 6a.4.   
 
6a.4  PROCEDURE  
The procedure of study 3 consisted of content validation of the education material and the 
steps taken to construct the final version. 
 
6a.4.1 Content Validation of the Education Material of the Physical Activity Diary 
The steps taken to ensure the content validity were:  
 
 The education material was developed as explained in section 6a.3. 
 
 Content validity was evaluated by peer review, as recommended by Portney and 
Watkins (2009). The peer-review panel consisted of eight academics drawn from the 
Wits Physiotherapy department, selected to include individuals with the following 
knowledge: conducting clinical research in the public health care sector of SA, 
cardiopulmonary and HIV academic background, cultural sensitivity and correct English 
grammar usage. Suggestions made by the panel were implemented. See Appendix 29 
for information regarding the suggestions made by the peer-review panel.  
 
 The education material and self-monitoring tools were translated from English into 
isiZulu by a professional translator, and then back-translated into English by a second 
professional translator. Translation services were provided by Bangula Translation 
Services.  
 
 Copies of the English and isiZulu education physical activity diaries were reviewed by a 
physiotherapist who occasionally worked at the study site and was fluent in English and 
isiZulu. His suggestions, consisting of minor language changes e.g. changing of 
particular words and isiZulu spelling corrections, were implemented.   
 
153 
 
 Copies of the English and isiZulu versions of the diary were then reviewed by five 
Themba Lethu patients voluntarily while waiting in the clinic queue for their medication. 
Their suggestions were implemented. Refer to Appendix 30 for a review of the 
background of the patients and their suggestions.  The practice of including patients in 
the review process is supported in the literature, and is part of the member check to 
improve validity and credibility (Redfern et al., 2006; Hill and Bird, 2003).   
 
Once the content validation process had been completed the education physical activity 
diary was constructed. 
 
6a.4.2 Constructing the Education Physical Activity Diary 
A graphic designer drew up the lay-out of the English and isiZulu diaries, based on 
discussions held with the researcher. The lay-out of both formats was reviewed by the 
researcher a number of times to ensure consistency between them before finalisation. 
Appendix 31 consists of a selection of pages from the final version.   
 
Figure 6a.4 shows the cover page of the final edition of the education physical activity diary.  
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Figure 6a.4:  Cover Page of the Education Physical Activity Diary  
 
Chapter 6b consists of an explanation of the methodology, procedure, results and 
discussion related to study 4 of phase 2 of the research project. The aim of this study was 
to implement and evaluate the effects of the education and home-based walking 
programme on pedometer physical activity levels and secondary IHD risk-factor outcomes 
in individuals living with HIV and on HAART in Johannesburg, SA.  
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CHAPTER 6B 
6b. STUDY 4: PHYSICAL ACTIVITY MODIFICATION AS PREVENTION STRATEGY FOR  
       IHD  
 
6b.1 INTRODUCTION 
The promotion of adequate physical activity levels by means of physical activity 
modification methods is supported as a prevention strategy for IHD in PLWHA (Lundgren et 
al., 2008). Supervised structured exercise is one such method to increase physical activity 
levels and influence some risk factors for IHD (O’Brien et al., 2010). To date the effects of a 
predominantly self-monitored home-based education and pedometer walking programme 
on known modifiable risk factors for IHD are not known. Study 4 set out to investigate the 
effects of such a programme in PLWHA in a South African context.  
 
The hypothesis statement of study 4 was as follows:  
 
An individualised education and home-based walking programme would influence the 
associated risk factors of IHD in individuals infected by HIV (on HAART). 
 
6b.2  STUDY 4  
Study 4 is the final study of the research project (as set out in section 1.8 in Figure 1.1 of 
chapter 1), and tests the effects of a physical activity modification programme on selected 
risk factors for IHD.  
 
6b.2.1 Aim and Objectives 
Aim:  
To determine the effects of a six-month individualised education and home-based walking 
programme on the associated risk factors for IHD in individuals infected by HIV, on HAART.  
 
Objectives:  
1. To determine levels of the following factors in individuals infected by HIV, on HAART: 
 physical activity  
 perceived stress 
 RHR and blood pressure 
 waist and hip circumference, WHR and BMI 
 Hs-CRP 
 lipid profiles (total cholesterol, HDL, LDL, and TG) 
 glucose 
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2. To implement an individualised education and home-based walking programme for 
affected individuals at risk of IHD, and monitor adherence to the programme. 
 
3a. To determine whether an education and home-based walking programme has an effect 
on the pedometer-determined physical activity level of affected individuals.     
   
3b. To determine whether an education and home-based walking programme has an effect 
on 6MWT distance, perceived stress level, RHR, blood pressure, WC, WHR, BMI, Hs-
CRP, lipid profile and glucose levels. 
 
4. To determine, in affected individuals, whether a correlation exists between Hs-CRP and 
evaluated related IHD risk markers. 
 
5. To calculate the 10-year relative risk of IHD events in individuals living with HIV, using 
the Framingham Risk equation, and to evaluate whether an education and home-based 
walking programme had an effect on that relative risk. 
 
6b.3  METHODOLOGY  
6b.3.1 Study Design 
A single blind randomised controlled trial was done. 
 
6b.3.2 Sample Size 
Information from a systematic review done by Ebrahim and Smith (1998) regarding the 
estimated change in SBP that occurs during an exercise programme was used as guide for 
sample size calculation. If the change in SBP is 6 mmHg (±7) with alpha set at 5% and the 
power at 80%, then the sample calculated using a sample size calculator was estimated at 
22 participants for the intervention, and 22 participants acting as controls. To account for 
loss to follow-up a challenge faced by roll-out HAART centres in South Africa (Cornell et al., 
2012) and non-adherence to exercise reported in PLWHA (O’Brien et al., 2010), 20% non-
compliance and 20% drop-out rates respectively were selected as precautions for the 
eventuality of a decreasing sample size as the study  progressed. This resulted in the 
sample used in the study: 42 control and 42 intervention participants.  
 
6b.3.3  Study Subjects 
Study 1 participants who were identified as being at risk of developing IHD were invited to 
continue with study 4. 
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6b.3.3.1 Inclusion criteria 
Inclusion rested on the following criteria: 
 Those on HAART for six months or more, aged 20 to 65 years, ambulatory without an 
assistive device and willing to accept randomised group allocation 
Plus one or more of the following: 
 A pedometer physical activity level of less than 10 000 steps per day  
 A BMI value of  ≥ 25 kg/m2   
 Increased WC (women ≥ 88cm, men ≥ 102 cm)  
 Increased WHR (women ≥ 0.85, men ≥ 0.95)   
 Blood pressure values in the high normal range (SBP 130-139 mmHg and DBP 85–89 
mmHg) or mild hypertension range (SBP 140-159 mmHg and DBP 90-99 mmHg) 
(Collins and Dias, 2009)  
 A known medical history of diabetes or HTN or dyslipidaemia (and on medical 
management)  
  
6b.3.3.2 Exclusion criteria 
The following individuals were excluded from participating: 
 If they had moved out of the Gauteng province since the screening process. 
 Noted to have a RHR ˃ 100 bpm or blood pressure ≥ 160/ 100 mmHg in the screening 
process. 
 Developed any condition or disease that was life-threatening or could be aggravated by 
exercise. 
 Known acute infections or active AIDS-defining opportunistic illnesses. 
 Were pregnant. 
 Documented new mental illness. 
 
6b.3.4 Independent and Dependent Variables 
The independent and dependent variables of the study are documented in Table 6b.1. 
 
Table 6b.1:  Independent and Dependent Variables 
Independent variable Risk of IHD 
Dependent variables Primary outcome: Pedometer-determined physical activity levels  
Secondary outcomes: Perceived stress levels, 6MWT distance, RHR, 
blood pressure, BMI, WC, WHR, Hs-CRP, lipid profile and glucose 
levels, FRS. 
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6b.3.5  Measuring Instruments 
Table 6b.2 is a representation of the measuring instruments used in the study.  The 
literature review and justification for the use of these measuring instruments is provided in 
chapter 3: sections 3.2.1 and 3.2.3. 
 
Table 6b.2:  Measuring Instruments 
Outcomes Measuring instruments 
Demographics Demographic questionnaire (2) (Appendix 32) 
Physical activity level Yamax SW200 pedometer with physical activity log sheet (Appendix 
14), pedometer accuracy test (Appendix 15), 6MWT evaluation form 
(Appendix 33), Standardised instruction in the 6MWT (Appendix 34), 
Borg scale (Appendix 35), two cones, two stools, Rolson measuring 
wheel, clipboard, pens.  
Perceived stress level PSS – 10 (Appendix 10) 
Hs-CRP level, lipid profile 
and glucose level 
Laboratory analysis of overnight fasting venous blood samples 
performed by Contract Laboratory Services. 
Blood sampling 
equipment 
Gloves, adjustable arm tourniquet, alcohol swabs, vacutainer needles, 
vacutainer holders, bar-coded grey glucose tube, bar-coded yellow 
serum-separating tube, cotton wool, plaster and medical sharps bin.  
Body measurement 
equipment 
9550 Onyx II Nonin finger probe pulse oximeter, Micro Health 
Stadiometer, Simple Choice electronic portable scale, non-stretch tape 
measure, Microlife BP A100 automated blood pressure 
sphygmomanometer, phase 2 evaluation form (Appendix 36). 
IHD risk score FRS tables (Appendix 37) 
Adherence to exercise Face-to-face session with physiotherapist contact session sheets 
(Appendix 38), photographed copies of Weekly Physical Activity 
Tracking Sheets in physical activity education diary (Appendix 39), 
Education physical activity diary, Post-Intervention Questionnaire 
(Appendix 40). 
 
6b.3.6 Randomisation Process  
The participants were randomised into either an intervention or control group with simple 
randomisation procedure using a Microsoft Excel randomisation formula to ensure chance 
allocation to groups (Schulz and Grimes, 2002). The randomisation process was done by a 
postgraduate academic, not directly involved with the project. The only restriction placed on 
the simple randomisation process was that the two groups (control and intervention groups) 
needed to consist of 42 individuals each. Refer to Appendix 41 for the randomisation list.  
 
Concealment from group allocation was achieved by the same academic placing 
allocations in sequentially numbered envelopes to reduce selection bias (Viera and 
Bangdiwala, 2007; Schultz and Grimes, 2002). A fourth research assistant was recruited for 
the study, whose responsibilities were to perform all assessments with participants. She 
was blinded to group allocation to limit assessment bias. 
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6b.3.7 Training of Research Assistants  
In the randomised controlled trial, the fourth research assistant did all baseline, six- and 12-
month assessments. She was a qualified physiotherapist with an MSc degree in 
cardiopulmonary physiotherapy with basic cardiac life support certification. She was trained 
by the researcher over two sessions before the study in the measuring instruments and 
equipment to be used. In a third session she was oriented to the study site. A qualified 
nursing sister who specialised in phlebotomy did all blood sampling procedures. She was 
oriented regarding the aim of the study, the assessment procedures to be carried out, and 
blood sampling kits.    
 
6b.3.8  Pilot Study of Study 4 
Pilot study 4 was conducted before the study to evaluate the intra-rater reliability of the 
research assistant when assessing PLWHA. Details of this pilot study are presented in 
section 6b.3.8. 
 
6b.3.8.1 Aims and objectives: Pilot study 4 
Aim 1:  
To determine the research assistant’s intra-rater reliability for vital signs, 
anthropometric measurements and pedometer accuracy testing in individuals that 
were HIV+ (on HAART) and at increased risk for IHD, as determined in study 1. 
 
Objectives of aim 1: 
1. To determine the research assistant’s intra-rater reliability when assessing, in 
affected individuals (on HAART) and at increased risk for IHD, as determined by 
study 1: 
 vital signs: RHR and blood pressure. 
 anthropometric measurements: WC, hip circumference, height and weight. 
 accuracy of the Yamax SW200 pedometer 
 
Aim 2: 
To determine, in affected individuals (on HAART) and at increased risk of IHD as 
determined by study 1: 
 the functional exercise capacity with the 6MWT 
 whether a statistically significant difference in distance walked was noted 
between the first and second 6MWT trial.  
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6b.3.8.2  Study subjects: Pilot study 4 
The participants in study 1 with an increased risk of IHD as determined by non-
invasive risk factor evaluation were invited to continue with study 4, and included in 
pilot study 4.  
 
6b.3.8.3  Sample size: Pilot study 4 
The sample size of the pilot study (n = 8) was calculated at 10% of the sample size 
of study 4 (n = 84) (Hertzog, 2008). The pilot study thus consisted of the first eight 
participants of study 4 who were willing to stay longer at their first assessment 
session to allow for two 6MWT trials. The procedure and results from pilot study 4 
with a short conclusion are available for review in Appendix 42. Key 
recommendations from the findings are outlined in section 6b.3.8.4.  
 
6b.3.8.4  Key recommendations: Pilot study 4 
Pilot study 4 found that the intra-rater reliability of the research assistant was good 
to excellent when evaluating participants’ body measurements, except for the heart 
rate and blood pressure measurements performed on participants’ left arms. The 
intra-rater reliability when assessing RHR using the left arm was r=0.79 (p=0.02), 
SBP using the left arm was r=0.70 (p=0.05) and DBP was r=0.61 (p=0.11). Because 
of the weaker correlation noted with RHR and blood pressure assessments using 
the left arm, it was suggested that she encourage participants to relax their upper 
limb and sit quietly a bit longer before the start of the assessments. This suggestion 
was implemented and changed the correlations of RHR to r=0.96 (p<0.00), SBP to 
r=0.90 (p<0.00) and DBP to r=0.89 (p<0.00).  
 
The pedometer accuracy test findings between actual counted steps and 
pedometer-counted steps were r=0.66 (p=0.77) when the research assistant 
performed this procedure. All intra-rater reliability findings were very similar to the 
findings of the researcher’s intra-rater reliability, as detailed in pilot study 2. It thus 
indicated that she followed the assessment procedure effectively, and that the 
equipment was giving reproducible results.  
 
In functional exercise testing with the 6MWT no adverse side-effects occurred, as 
assessed with objective cardiovascular parameters, perceived breathlessness and 
fatigue. The median distance walked in the first 6MWT trial was 539.30 (490.03–
572.80) meters and in the second trial 527.20 (489.48–588.40) meters. The 
correlation between the first and second 6MWT trials was excellent (r=0.95; 
p<0.00), and no statistically significant differences in distance walked between the 
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two attempts were noted (p=0.88). Due to the 6MWT finding and the difficulty 
regarding participants’ ability to attend appointments as noted in study 1, only one 
6MWT trial was done per participant in the remaining assessment periods of study 
4. The procedure followed in study 4 is detailed in section 6b.4. 
 
6b.4 PROCEDURE  
Assessments in the study were done at baseline, six and 12 months by the research 
assistant. Each assessment time-slot consisted of two sessions per participant, resulting in 
two appointments per month. Figure 6b.1 is a flow diagram depicting the assessment 
activities performed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6b.1: Flow Diagram of Activities Conducted in Assessment Sessions 
 
A. Baseline assessment 
The first session with the research assistant was scheduled for each participant at the 
physiotherapy room in Themba Lethu clinic. If research appointment dates coincided 
with regular clinic appointments, the “runner” kept participants’ place in the clinic queue 
to allow the research assistant to do their assessments.  
 
At the first session information about participants’ demographic details using 
demographic questionnaire (2) was taken. Parameters depicted in Figure 6b.1 were 
evaluated. The assessment procedures followed to evaluate body measurements, 
pedometer accuracy testing and 6MWT are available for review in Appendix 43. On 
completion of session one the researcher reminded the participants that the blood 
sampling procedure would be performed at the second session by a nursing sister who 
Session one 
Perceived stress 
Body measurements 
Pedometer accuracy test 
Pedometer physical activity assessment 
explained 
Pedometer and physical activity log sheet given 
6MWT 
Session two 
Pedometer and physical activity log sheet 
returned 
Control participants returned pedometer 
Phlebotomy blood sampling 
Delivery of blood samples to Contract 
Laboratory Services 
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specialised in phlebotomy. They also were given a verbal and written information 
reminder regarding the blood tests to be done (Appendix 44). Latest CD4, viral load and 
liver function test results of participants were obtained from the clinic’s electronic 
National Health Laboratory database system. 
 
Pedometer physical activity assessment 
In the period between the first and second assessment sessions each participant had to 
wear the pedometer for seven consecutive days and document her/his daily step-count 
on the physical activity log sheet when removing the pedometer in the evening. The 
second appointment was scheduled approximately eight to 14 days after the first. This 
was assessed at the beginning of the study, as a time lapse occurred between study 1 
and 4.  
 
The day before their second appointment a reminder SMS was sent to each participant 
of their physiotherapy appointment the next day, and that the fasting blood tests would 
be done. Participants did not have to respond to this message. If they did not have a 
cell phone, they were phoned on their land line. If they did not arrive for their second 
session, the researcher phoned them to enquire about the reason, and rescheduled the 
appointment. A maximum of two additionally-scheduled appointments was allowed 
throughout the study, before a participant was considered “lost to follow-up”.  
 
Phlebotomy blood sampling collection 
At the second baseline assessment session all participants were introduced to the 
phlebotomist. They were asked to expose their arm and sit comfortably on an office 
chair at the blood sampling set-up station. The bar-coded glucose and serum-
separating tubes were labelled with the participant’s study code and initials.  
 
Blood sampling was done through a venepuncture procedure at the median cubital 
vein. Immediately afterwards the tubes were gently mixed by inverting, as requested by 
Contract Laboratory Services. Each participant received a small fruit juice and savoury 
snack after the procedure. The nurse followed general infection control principles when 
performing the blood sampling procedure as suggested by the Program for Appropriate 
Technology in Health (2005). She: 
 wore a lab coat  
 washed her hands frequently 
 wore latex gloves and changed gloves between patients 
 disinfected the skin with alcohol wipes before blood sampling 
 covered the puncture site with cotton wool and plaster following needle removal 
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 disposed of items in appropriate containers, e.g. medical sharps bin, medical and 
general waste bins 
 
Contract Laboratory Service’s requisition form (Appendix 45), containing the following 
information, was filled in following blood sampling: blood analysis to be done; the 
participant’s study number, initials, age and gender; date and time of collection of blood 
sample and bar-coded sticker identical to that on the collection tubes. Bar-coded labels 
attached to the evacuation tubes, and relevant requisition form allowed for identification 
of equipment associated with each participant by both the laboratory and the 
researcher. The requisition form was signed by the phlebotomist and placed with the 
blood sample tubes in the individualised research kits for transport to the laboratory. 
Refer to Appendix 46 for a photograph of a study test kit and phlebotomy set-up station.  
 
Quality control of blood samples following sampling 
In the course of the study the blood sampling kits containing the blood sample tubes 
remained in the care of the researcher until she handed it over to the laboratory 
technicians. She transported the kits to Contract Laboratory Services directly on the 
same day. The time from sampling to delivery was well within that allowed for stability of 
specimens, as recommended by the laboratory. The results for electronic reports of the 
laboratory analysis were sent to the researcher within 24 hours. Hardcopy reports were 
received a few days later, and filed in the researcher’s office for safekeeping and data-
capturing.  
 
Laboratory analysis of phlebotomy collected blood samples 
Laboratory analysis of blood samples was carried out at Contract Laboratory Services, 
at the main chemistry laboratory in Johannesburg. Samples were analysed in order of 
receipt and on day of arrival at the laboratory. The analysis was conducted using the 
Roche/Hitachi Cobas C system (Roche Diagnostics, Mannheim, Germany) using the 
following tests:  
 
 Fasting glucose level was enzymatically measured on a cobas c 501 analyser using 
the Glucose HK, Gen.3 test. 
 Total cholesterol level was enzymatically measured on a cobas c 501 analyser 
using the Cholesterol Gen.2 test. 
 HDL level was enzymatically measured on a cobas c 501 analyser using the HDL-
Cholesterol plus 3rd generation test. 
 Triglycerides were enzymatically measured on a cobas c 501 analyser using the 
Triglycerides test. 
164 
 
 High-sensitivity C-reactive protein was measured using the particle-enhanced 
immunoturbidimetric assay test principle on a cobas c /501 analyser, using the 
Cardiac C-Reactive Protein (Latex) High Sensitive test.  
 
The Friedewald equation was used to calculate LDL, using the Disa laboratory 
computer system of Contract Laboratory Services. The Friedewald equation is: LDL = 
total cholesterol – HDL – (triglycerides/5). Details pertaining to the quality assurance 
strategies in place at the laboratory are outlined in chapter 3: section 3.2.3.  
 
Management of randomisation of participants: Control and intervention group 
At completion of blood sampling it was explained to participants that they had been 
allocated to the intervention or control group according to a computer-generated list, 
and that the researcher had not arranged membership of either group. At this time the 
specific participant coded envelope was opened to determine group allocation. If the 
participant was allocated to the control group the pedometer was returned, and they 
received feedback regarding their first assessment session findings. They were 
informed about management of the control group for the period between baseline and 
six-month assessments. They were telephonically contacted once per month to 
maintain contact and to determine whether any health or social (e.g. moved out of 
Gauteng province) changes had occurred. They continued with their normal Themba 
Lethu clinic management that included routine doctor consultations, nursing staff 
assessment of vital signs and collection of antiretroviral therapy from the clinic 
pharmacy. They did not receive any physiotherapy service during the study except 
scheduled research assessments. In the final monthly telephone call they were 
informed about the six-month assessment, and appointments were scheduled. 
 
Participants in the intervention group received feedback regarding their first assessment 
session findings. They kept the pedometer and received an education physical activity 
diary. Then the intervention programme was initiated. The researcher conducted it, and 
they continued with their normal Themba Lethu clinic management at the same time. 
Refer to Appendix 47 for a detailed description of the intervention programme.  
 
Monthly face-to-face sessions were held with each intervention participant and the 
researcher at the clinic. Attempts were made to schedule the research sessions to 
coincide with monthly clinic visits. In these sessions body measurements were taken to 
determine whether any physical changes had occurred. Adherence to individualised 
pedometer walking programmes was evaluated by checking whether participants had 
achieved their weekly pedometer step-count goals in the previous month. They were 
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asked to mention any obstacles to exercise they might have encountered. The 
researcher made suggestions for possibly overcoming these barriers to improve 
walking activity. The researcher used the “face-to-face contact sheet” to document the 
assessment findings and the discussions of the monthly session for her records. The 
assessment findings, barriers and suggestions to be implemented were documented on 
the “face-to-face session with physiotherapist” sheets in each participant’s physical 
activity diary for their record and self-monitoring.  Each participant gave verbal consent 
for photographing their notes made in their physical activity diary in these sessions, for 
analysis at a later stage. None of the participants withheld this consent.  
 
For each monthly appointment the researcher sent a reminder SMS the day before.  
Participants who did not attend were contacted telephonically to find out the reason, 
and the appointment was rescheduled. The intervention participants attended monthly 
face-to-face sessions with the researcher, and received monthly SMS prompts in the 
baseline-to-six-month period to encourage adherence to the programme. Refer to 
Appendix 48 for a review of the SMS prompts. At the final face-to-face session the 
participants were reminded about the approaching six-month assessment, and 
appointments were scheduled. Figure 6b.2 is a representation of the contacts made 
between the researcher and participants.  
 
Control group
 
 
Intervention group
 
 
Figure 6b.2:  Contact Sequence of Control and Intervention Group Management 
 
B. Six month assessment 
When the six-month assessments were scheduled participants were informed that the 
research assistant should not be informed about their group allocation, as she should 
remain blinded. They were therefore instructed to conceal their pedometer until they 
were seated in the research room. The researcher had a private consultation with each 
participant in the research room for five minutes before the assessment with the 
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research assistant. In this time control participants received a pedometer that was 
positioned at the waist and reset to zero. Intervention participants were instructed to 
keep their physical education diary in their bag or handbag, to prevent the research 
assistant accidentally finding out their group allocation. Their pedometer position was 
reviewed and reset to zero. These precautions were taken to ensure that the research 
assistant remained blinded to participants’ group allocation. The assessment procedure 
was followed in the same manner as with the baseline assessments.  
 
At the second assessment session, following blood sampling, intervention participants 
were requested to continue with their exercise programme in the six- to 12- month 
period. Both control and intervention participants were informed that the researcher 
would only contact participants again in the month before the 12 month appointment 
dates. If participants had any queries regarding their six month assessment findings 
they were responded to accordingly.  
 
C. Twelve month assessment 
In the six to 12 month period neither the researcher nor assistants had any contact with 
study participants. This was to determine participants’ adherence to the physical activity 
programme with no motivation from the researcher. In this period the intervention 
participants still had their pedometers and education physical activity diaries for use 
while continuing with their individualised programme. Control participants continued 
with standard clinic care. In the month preceding the twelve month assessment control 
and intervention participants alike were contacted telephonically by the researcher to 
schedule appointments. The day before their appointments they were sent a reminder 
SMS.  
 
At the last assessment session all pedometers and physical activity diaries were 
returned to the researcher. The intervention participants completed the post-
intervention questionnaire, providing information regarding their adherence to the 
exercise programme over the six- and 12-month periods. Participants’ queries 
regarding their 12th month assessment findings were answered. The participants were 
thanked for their participation in the research project at their final assessment session. 
The statistical analysis performed in the study is detailed in section 6b.5.  
 
6b.5 STATISTICAL ANALYSIS  
The data analysis was performed with the assistance of a bio-statistician using STATA 12.0 
(StataCorp, 2011), IBM SPSS 21 (IBM Corp, 2012) and IBM SPSS 22 (IBM Corp, 2013). 
Intention-to-treat (ITT) analysis was selected as the primary analysis method of the study 
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and a confirmatory per protocol analysis was done. Intention-to-treat was selected as the 
primary analysis to ensure that the original random group allocation effect would be 
maintained, as suggested by Gupta (2011). A strategy to prevent any loss of data was to 
systematically follow up all participants, as set out in the procedure in section 6b.4.2 (White 
et al., 2011).  
 
In the course of the study a number of participants dropped out. Explanations (provided in 
the results section) ensured that the missing data could be considered “missing completely 
at random” (European Medicines Agency, 2010). These “missing completely at random” 
data were managed by imputing the “last observation carried forward” of the particular 
individual (European Medicines Agency, 2010). An exception to this occurred in the case of 
three participants not returning for their second baseline assessment. Their missing 
baseline blood results were managed by imputing the mean value of the cohort’s results 
(European Medicines Agency, 2010). One of those three participants sent a friend to return 
her pedometer and baseline physical activity log sheet for use in data analysis. The two 
remaining individuals’ missing baseline pedometer data were managed by using their study 
1 findings as a source for this data to be imputed (European Medicines Agency, 2010).  
Any absences of participants’ clinic viral load and/or liver function test results that were not 
available in the National Health Laboratory database were handled by imputing the mean 
value of the cohort’s specific results. These strategies ensured a complete data set for ITT 
analysis.  
 
Evaluation of randomisation process 
Data were evaluated for normal distribution. The randomisation procedure (baseline 
characteristics of the control and intervention groups) was evaluated with a two sample/ 
independent t-test or Wilcoxon rank–sum (Mann–Whitney) test for non-normally distributed 
continuous data. Categorical data were evaluated with the Pearson Chi Square test. A p–
value less than 0.05 was considered statistically significant. Baseline characteristics of the 
intervention and control participants are presented as means (±SD) and frequencies with 
percentages. With few numbers in some categorical data, demographic categories were 
collapsed in analysis. Employment and self-employment both reflected a state considered 
employed, and so were collapsed. The last two categories of gross monthly income were 
collapsed to represent participants that earned more than R5 000 per month. Marital status 
categories were collapsed according to similar support structures, and housing according to 
similar house sizes. Lastly, transportation was collapsed into walking or wheeled 
transportation.  
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Evaluation of within-group management effect on IHD risk factors 
The within-group mean changes in risk factors assessed, at the different assessment 
periods, were determined with repeated measures ANOVA. Results are presented as 
means (±SE), p-values and 95% CI in table format.   
 
Evaluation of between-group management effect on IHD risk factors 
The between-group management effect on IHD risk factors assessed, at the different 
assessment periods, were determined with repeated measures ANCOVA with baseline 
findings as co-variates. Findings of the ANCOVA analysis are presented as adjusted 
means due to co-variate inclusion (±SE) and between-group effect output (df, F, p-value, 
partial eta-squared) in table format.  
 
Secondly, the study was of longitudinal nature, and to evaluate the associations of 
interaction effect between treatment (control or intervention group management) and time 
on the variables of interest, the generalised estimation equation (GEE) approach was used 
for between-group analyses. Three assessment intervals existed: baseline (84 individuals), 
six (84 individuals) and 12 months (84 individuals), totalling 252 assessments. To facilitate 
GEE the wide Microsoft spread-sheet format was altered to a long format, so that 
observations totalling 252 should be noted. The correlation structure selected in the GEE 
model was the exchangeable option, as this takes time into account (Ghisletta and Spini, 
2004), with the identity link function due to data being continuous (Ma, Mazumdar and 
Memtsoudis, 2012). Due to skewness of the pedometer physical activity level data, these 
data were log-transformed for statistical analysis when adjusting for the secondary 
outcomes in the univariate and multivariate logistic regression model. A mixed effects 
model (MEM) analysis was added to provide information regarding the between-group 
individual participant changes (within participant effect) over time following GEE analysis. A 
wide-format data sheet was also used with MEM. Findings from the univariate logistic 
regression analysis in the GEE and MEM models are presented as log-transformed 
coefficients of mean change, 95% confidence intervals. To illustrate if changes were 
significant a p–value less than 0.05 was considered statistically significant.  
 
The univariate logistic regression analysis was followed by multivariate logistic regression 
analysis to evaluate how the dependent variables reacted in the presence of others. The 
dependent variables that fulfilled a p–value less than 0.1 were added to the multivariate 
logistic regression model. A goodness-to-fit test was performed using Cook’s Distance to 
identify any outliers in the pedometer physical activity data that could influence analysis 
before multiple regression analysis. To limit the effect of these outliers on the multiple 
regression analysis a restriction of less than +2 and more than –2 standardised residuals 
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were implemented to the MEM model. This restriction resulted in a reduction of 
observations from 252 to 240, as 12 observations fell outside the set parameters. A 
restriction of more than -3 and less than 11 was applied to the GEE model. This restriction 
reduced the observations from 252 to 249, as three observations fell outside the set 
parameters. Findings of the multiple regression analysis are reported with and without 
restriction using log-transformed coefficients of mean change, 95% confidence intervals 
and p–values. A p–value less than 0.05 was considered statistically significant. Refer to 
Appendix 49 for graphical illustration of the goodness-to-fit testing.  
 
Evaluation of relationship between hs-CRP and evaluated IHD risk markers 
Linear correlation with the Pearson correlation coefficient was used to consider the 
relationship between Hs-CRP and evaluated IHD risk markers at baseline and with 
univariate logistic regression in MEM to highlight if within individual findings differed. Due to 
skewness of the Hs-CRP data these data were log-transformed for statistical analysis.  
 
Evaluation of participant adherence to the education and home-based walking programme 
Statistical analysis to monitor adherence to the education and home-based walking 
programme was conducted in two ways: firstly, adherence to the programme in the 
baseline to six month period was done by the researcher partly using IBM SPSS 21 (IBM 
Corp, 2012) using descriptive analysis. Adherence to the programme was evaluated by 
firstly determining their monthly attendance of face-to-face sessions, and, secondly, 
establishing whether they achieved their weekly pedometer step-count goals per month. 
These data are presented as frequencies and percentages. Reasons for non-adherence to 
face-to-face sessions as explained telephonically by participants are given for review.  
 
The barriers to, and enablers of, participants’ achieving their weekly pedometer step-count 
goals were determined following a content review of the researcher’s field notes recorded 
on participants’ monthly “face-to-face session with physiotherapist” sheets. Keywords were 
identified on each sheet. To collapse the data, the keywords were collapsed into monthly 
keywords, then to monthly categories and finally to prominent overall categories. The 
photographed weekly physical activity tracking sheets of participants’ diaries and returned 
diaries were reviewed for their explanatory quotes for categories determined.   
 
Secondly, adherence to the programme during the six to 12 month interval was partly 
explained by the Anova analysis, as noted in change of pedometer physical activity level 
findings over time. Findings from the post-intervention questionnaire provided additional 
input regarding adherence to the programme. The following facets of adherence were 
collected from the questionnaire: 
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 Whether participants used the pedometer in the six to 12 month period. 
 The frequency per week that participants performed a focus walk. 
 Whether participants documented their pedometer step-count as an aid for self-
monitoring. 
 Whether participants performed the warm-up and cool-down activities regularly. 
 How often participants performed the warm-up and cool-down activities. 
 
This information is presented as frequencies and percentages in table format following IBM 
SPSS 21 analysis done by the researcher.   
 
The results of Study 4 are presented in section 6b.6. 
 
6b.6  RESULTS  
The ITT analysis findings are presented for review in the results section. Figure 6b.3 is a 
consort diagram showing the participants’ flow throughout the study. 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n = 205) 
Excluded (n = 121) 
♦ Unable to contact (n = 40) 
♦ Declined participation 
- Work obligations (n = 38) 
- Financial constraints (n = 5) 
- No specific reason (n = 2) 
♦ Not meeting criteria (n = 17) 
♦ Living outside Gauteng (n = 16) 
♦ Other reasons 
- Death (n = 1) 
- Pregnant (n = 1) 
- In hospital (n = 1) 
Randomised (n = 84) 
Allocated to intervention (n = 42) 
♦ Received intervention (n = 40) 
♦ Did not receive intervention (n = 2) 
- Participants did not arrive for 
scheduled second baseline Ax 
(Three second baseline Ax were 
scheduled) 
Allocated to control (n = 42) 
♦ Received control management (n = 41) 
♦ Did not receive control management (n = 1) 
- Participant did not arrive for 
scheduled second baseline Ax 
(Moved to Kwa-Zulu-Natal) 
Allocation 
Enrollment 
Six month  
171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6b.3:  Consort Diagram of the Study Participants Followed Up from 2012 to 
2013 
 
6b.6.1 Baseline Characteristics of the Study Participants (N = 84). 
Tables 6b.3 – 6b.9 provide the results of the baseline levels for the socio-demographic 
profile, HIV-related clinical markers and IHD risk factors evaluated in the study. The 
♦ Lost to follow-up (n = 3) 
- Unable to attend second six month 
Ax due to finances (n = 1) 
- Unable to attend due to work (n = 1) 
- Unable to contact (n = 1) 
♦ Discontinued intervention (n = 2) 
- Unable to continue due to work  
(n = 1) 
- Unable to continue due to caring for 
ill grandmother (n = 1) 
 
♦ Lost to follow-up (n = 8) 
- Unable to attend due to work (n = 3) 
- Unable to attend due to now lives 
outside Gauteng province (n = 4) 
- Unable to contact participant (n = 1) 
♦ Discontinued as control participant (n = 1) 
- At first Ax session participant was 
diagnosed with a DVT and admitted 
to hospital for medical management 
(n = 1)  
♦ Lost to follow-up (n = 6) 
- Hospital admission for hysterectomy 
(n = 1) 
- Hospital admission for severe 
headache in Kwa Zulu-Natal (n = 1) 
- Hospital admission for severe 
headache. Diagnosed with brain 
tumour (n = 1).  
- Unable to attend due to now lives 
outside Gauteng province (n = 1) 
- Unable to attend due to work (n = 1) 
- Unable to attend due to finances 
(n = 1) 
                 ♦ Lost to follow up (n = 10) 
- Unable to attend due to now lives 
outside Gauteng province (n = 1) 
- Unable to attend due to work (n = 3) 
- Unable to contact (n = 3) 
- Unable to attend due to family 
obligations (n = 1) 
- Unable to attend second twelve 
month Ax session due to work  
(n = 2) 
Twelve month 
Analysed (Per protocol) 
♦ Six month evaluations 
- First assessment session data 
available (n = 36) 
- Second assessment session data 
available (n = 35) 
♦ Twelve month evaluations 
- First and second assessment 
session data available (n = 29) 
 
Analysed (Per protocol) 
♦ Six month evaluations 
- First assessment session data 
available (n = 33) 
- Second assessment session data 
available (n = 32) 
♦ Twelve month evaluations 
- First assessment session data 
available (n = 24) 
- Second assessment session data 
available (n = 22). Pedometer data 
is, however, n = 23 due to a 
participant returning at 17h00 to drop 
off pedometer and log sheet. 
Analysis 
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difference between the levels reported for the control and intervention groups were also 
tested and the p-values are presented for review. No significant between-group differences 
were noted. The socio-demographic profile is presented in Table 6b.3.  
 
Table 6b.3:  Socio-Demographic Profile of PLWHA (on HAART) (N = 84) 
Variable n Intervention Group 
Mean (±SD) or n (%) 
Control Group 
Mean (±SD) or n (%) 
p-value 
Age 42 38.7 (±8.9) 39.4 (±9.6) 0.7 
Gender 
 Male 
 Female 
42  
7 (16.7) 
35 (83.3) 
 
11 (26.2) 
31 (73.8) 
 
0.3 
Employment status 
 Unemployed 
 Employed and self-
employed 
 Retired and other 
42  
17 (40.5) 
19 (45.2) 
 
6 (14.29) 
 
13 (30.9) 
26 (61.9) 
 
3 (7.1) 
 
0.3 
Gross monthly income 
 Less than R500 
 R501 – R1000 
 R1001 – R2000 
 R2001 – R5000 
 More than R5000 
42  
19 (45.2) 
 7 (16.7) 
6 (14.3) 
 9 (21.4) 
1 (2.4) 
 
13 (30.9) 
9 (21.4) 
9 (21.4) 
6 (14.3) 
5 (11.9) 
 
0.3 
Marital status 
 Single/ Widowed 
 Married/ Cohabiting 
 Divorced/ Separated 
42  
23 (54.8) 
12 (28.6) 
7 (16.7) 
 
26 (61.9) 
10 (23.8) 
6 (14.3) 
 
0.8 
Housing environment 
 Share a space/ Shack 
 RDP house/ hostel/ flat 
 Town/ residential house 
 Other 
42  
10 (23.8) 
  9 (21.4) 
15 (35.7) 
 8 (19.1) 
 
11 (26.2) 
  6 (14.3) 
11 (26.2) 
14 (33.3) 
 
0.4 
Transportation  
 Walking 
 Wheeled transport 
42 
 
 
17 (40.5) 
25 (59.5) 
 
21 (50) 
21 (50) 
 
0.4 
♦ R (rands), RDP (Reconstruction and Development). 
 
The majority of participants were female (control [n=31; 73.8%] and intervention group 
[n=35; 83.3%]), employed (control [n=6; 61.9%] and intervention group [n=19; 45.2%]) and 
earned less than R500 per month (control [n=13; 30.9%] and intervention group [n=19; 
45.2%]). Most participants fell in the single/widowed marital status category (control [n=26; 
61.9%] and intervention group [n=23; 54.8%]). Intervention participants lived mostly in a 
townhouse or a residential house (n=15; 35.7%) and control participants in a room attached 
to a residential house (n=14; 33.3%), as demonstrated by the “other” category. Control 
participants mostly used walking (n=21; 50%) and intervention participants wheeled 
devices (n=25; 59.5%) as transportation methods. Fifteen (35.7%) intervention participants 
and nine (21.4%) control participants received a government child grant. Other sources of 
income included earnings from doing volunteer work, financial assistance from family 
members, pension and interest from investments. 
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Table 6b.4 summarises the HIV-related clinical markers of participants. 
 
Table 6b.4:  HIV-Related Clinical Markers of PLWHA (on HAART) (N = 84) 
Variable n Intervention GroupMean (±SD) or n (%) 
Control Group
Mean (±SD) or n (%) 
p- 
value Normal range 
Immune parameters 
 CD4 count (cells/mm3) 
- n (%): six month  
 Viral load (copies/ml) 
-      <400 
-      n (%): six month  
42  
340.3 (±132.4) 
29 (69) 
10 140 (±42 525.9) 
35 (83.3) 
35 (83.3) 
 
347.1 (±172.3) 
23 (54.8) 
2 793.9 (±15 252.2) 
35 (83.3) 
32 (76.2) 
 
0.8 
 
0.8 
 
600-1500  
(Van Dyk, 2008) 
 
Liver function parameters 
(U/L) 
 Single ALT 
- n (%): six month 
 Full liver function ALT 
 Full liver function AST 
 Full liver function GGT 
- n (%): six month 
42  
 
26.3 (±15.5) 
28 (66.7) 
29.1 (±8.7) 
30.5 (±5.2) 
56.4 (±20.6) 
1 (2.4) 
 
 
37.8 (±47.6) 
25 (59.5) 
33.2 (±24.9) 
32.7 (±10.7) 
63.4 (±52.8) 
1 (2.4) 
 
 
0.3 
 
0.9 
0.8 
0.7 
 
 
7 – 56  
(Gowda et al.,2009) 
7 – 56  
0 – 35  
9 – 85  
(Gowda et al., 2009) 
HAART exposure 
 TDF, EFV, 3TC 
 Other 
- 3TC, EFV, Stavudine 
- 3TC, TDF, Nevirapine 
- 3TC, Stavudine, 
Nevirapine 
- 3TC,Alluvia, Saquinavir 
- 3TC, TDF, Alluvia 
42  
26 (61.9) 
16 (38.1) 
 9 (21.4) 
4 (9.5) 
1 (2.4) 
 
0 (0) 
2 (4.8) 
 
32 (76.2) 
  10 (23.81) 
  5 (11.9) 
 4 (9.5) 
0 (0)  
 
 1 (2.4) 
0 (0) 
 
0.2 
 
♦ Cells/mm3 (cells per cubic millimeters of blood), copies/ml (copies of HIV RNA in milliliters of 
blood), U/L (units per liter), AST (aspartate transaminase), ALT (alanine transaminase), GGT 
(gamma glutamyl transpeptidase), TDF (tenofovir), EFV (efivarenz), 3TC (lamivudine).  
 
The control and intervention groups’ CD4 counts were both below the suggested normal 
range for this value. The mean viral load findings were elevated but the majority of the 
sample had findings less than 400 copies/ml. Liver function results were within normal 
suggested ranges. More than 50% of the participants had a CD4, viral load or single ALT 
test done in the preceding six months. Only two participants had had a full liver function 
analysis review in the six months preceding the programme.  
 
A secondary analysis was conducted on CD4 count and viral load findings of only the 
results of tests done in the clinic in the preceding six months. Findings were as follows: CD4 
count (control group: 365.3 [±169.5] cells/mm3 and intervention group: 352.9 [±121.7] 
cells/mm3) and viral load (control group: 3 435.7 [±17 459.2] copies/ml and intervention 
group: 9 882.6 [±45 269.2] copies/ml). In this analysis the CD4 count improved slightly. 
There were still no statistically significant differences between the control and intervention 
groups’ CD4 count (p=0.9) or viral load findings (p=0.8).  
 
The first-line South African HAART regimen (Tenofovir, Lamivudine, Efivarenz) was in use 
by 61.9% (n=26) of intervention and 72.2% (n=32) of control group participants 
(Department of Health, 2013). One control and two intervention group participants were on 
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a protease inhibitor-containing regimen. The remaining participants were on a HAART 
regimen containing two nucleoside reverse transcriptase inhibitors and one non-nucleoside 
reverse transcriptase inhibitor. Table 6b.5 contains the baseline physical activity level 
information. 
 
Table 6b.5:  Baseline Physical Activity Level of PLWHA (on HAART) (N = 84) 
Variable n 
Intervention 
Group 
Mean (±SD) or 
n (%) 
Control 
Group 
Mean (±SD) 
or n (%) 
p-value Normal range 
Pedometer physical 
activity level, 
steps/day 
42 6 888.1  
(±2 925.8) 
8 102.7  
(±5 395.6) 
0.8 More than 10 000 
(ACSM, 2010) 
6MWT distance, m 42 540.7 (±71.6) 547.8 (±56.9) 0.6 571 (±90) 
(Casanova et al., 2011)  
Predicted 6MWT 
distance, m 
42 690.6 (±36.5) 695.7 (±41.0) 0.5 868.8 – (age years x 2.99) – 
(sex men = 0; women = 1 x 74.7). 
(Gibbons et al., 2001) 
% Predicted 6MWT 
distance achieved  
42 78.2 (±8.8) 78.1 (±7.7) 1.0 Distance walked/predicted 
distance x 100 
More than 82% of 
predicted is normal range. 
(Troosters, Gosselink and 
Decramer, 1999). 
♦ Steps/day (steps per day), m (meters), 6MWT (six-minute walk test). 
 
Both groups’ pedometer physical activity levels were less than 10 000 steps per day. Both 
groups achieved less than 82% of their predicted 6MWT distance, indicating a reduced 
functional exercise tolerance level. The 6MWT distance was less in both groups compared 
to the proposed normal mean distance for healthy individuals. Table 6b.6 is a 
representation of the smoking, HTN and diabetes mellitus history. Prevalence of these 
modifiable risk factors for IHD was low.  
 
Table 6b.6:  Baseline smoking, HTN and diabetes history of PLWHA (on HAART)  
(N = 84) 
Variable n Intervention Group n (%) 
Control Group 
n (%) p - value 
Smokers 42   4 (9.5)   5 (11.9) 1.0 
History of hypertension 42     5 (11.9) 4 (9.5) 1.0 
History of diabetes mellitus 42 0 (0) 1 (2.4) 1.0 
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Table 6b.7 consists of the baseline information related to perceived stress levels and body 
measurements.  
 
Table 6b.7:  Baseline Perceived Stress Levels and Body Measurements of PLWHA 
(on HAART) (N = 84) 
Variable n 
Intervention 
Group 
Mean (±SD) 
Control 
Group 
Mean (±SD) 
p - value Normal range 
Perceived stress level 42 20.1 (±6.7) 20.1 (±6.4) 0.9 Normative values not 
available. 
75th percentile for cohort  
= 24 
Resting heart rate, bpm 42   80.8 (±11.6)   77.2 (±10.7) 0.1 Less than 80  
(Palatini, 2007) 
Blood pressure, mmHg 
 SBP 
 DBP 
42  
121.3 (±10.5) 
79.4 (±8.1) 
 
120.1 (±12.8) 
78.2 (±8.6) 
 
0.6 
0.5 
 
Less than 120 
Less than 80 
(Collins and Dias, 2009) 
Body mass index, kg/m2 42 25.9 (±4.0) 25.4 (±6.5) 0.9 18.5 – 24.9 
(WHO, 2004) 
Waist circumference, cm 
- Men* 
- Women** 
42 81.3 (±7.5) 
78.0 (±8.9) 
81.9 (±7.1) 
  79.8 (±12.6) 
77.4 (±10.4) 
80.7 (±13.3) 
0.5 Less than 102 
Less than 88 
(ACSM, 2010) 
Waist: hip ratio 
- Men* 
- Women** 
42   0.8 (±0.1) 
  0.8 (±0.1) 
  0.8 (±0.1) 
  0.8 (±0.1) 
  0.8 (±0.1) 
   0.8 (±0.1) 
0.5 Less than 0.95 
Less than 0.86 
(ACSM, 2010) 
♦ Bpm (beats per minute), mmHg (millimeters mercury), cm (centimeters), kg/m2 (kilograms per 
square meter), m (meters) 
* Control group men (n=11; 26.2%) and intervention group men (n=7; 16.7%). 
** Control group women (n=31; 73.8%) and intervention group women (n=35; 83.3%). 
 
The mean RHR of the intervention group was slightly elevated when considering risk for 
IHD.  Blood pressure findings for both groups were within the pre-hypertension range 
(systolic blood pressure: 120–139 mmHg; diastolic blood pressure: 80–89 mmHg) (Collins 
and Dias, 2009). Both groups were overweight (mean BMI > 25 kg/m2, but less than 30 
kg/m2) (WHO, 2004). The mean WC and WHR results were normal, but when considering 
the standard deviations, individual women in the control and intervention groups had 
above-normal WC readings. Both groups’ perceived stress levels were moderately high 
when taking into account the 75th percentile for perceived stress being a score of 24 out of 
40. Table 6b.8 is a representation of the baseline results of the biochemical IHD risk factors 
assessed. The National Cholesterol Education Programme, Adult Treatment Panel III 
Guidelines (George et al., 2009; NCEP ATP-III, 2002) were used as guide in interpretation 
of the lipid profile and glucose results.  
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Table 6b.8: Baseline biochemical risk factors for IHD of PLWHA (on HAART) (N = 84) 
Variable n Intervention 
Group 
Mean (±SD) 
Control 
Group 
Mean (±SD) 
p-value Normal range 
Glucose level, mmol/l 42 4.8 (±0.7) 5.1 (±1.8) 0.5 < 5.6 
(NCEP, 2002) 
Lipid profile, mmol/l 
 Total cholesterol 
 HDL 
- Men* 
- Women** 
 LDL 
 TG 
42  
4.3 (±0.8) 
1.4 (±0.5) 
1.1 (±0.6) 
1.5 (±0.6) 
2.5 (±0.7) 
1.0 (±0.5) 
 
4.3 (±1.1) 
1.4 (±0.4) 
1.2 (±0.2) 
1.5 (±0.4) 
2.5 (±0.8) 
1.0 (±0.4) 
 
0.9 
1.0 
 
 
0.6 
0.5 
 
< 5.0 
> 1.0 
> 1.3 
< 3.0 
< 1.7 
(NCEP, 2002) 
Inflammatory parameter, 
mg/l 
 Hs-CRP 
42  
 
8.6 (±8.4) 
 
 
5.4 (±6.6) 
 
 
0.05 
 
 
Low risk < 1.0 
Moderate risk 1.0–3.0 
High risk > 3.0 
(Pearson et al, 2003) 
♦ Mmol/l (millimoles per litre), mg/l (milligrams per litre).  
* Control group men (n=11; 26.2%) and intervention group men (n=7; 16.7%). 
** Control group women (n=31; 73.8%) and intervention group women (n=35; 83.3%). 
 
The mean glucose and lipid profile results were within normal ranges. If one takes into 
account the standard deviations, abnormal results were found in the glucose level of 
individual control participants. The mean glucose level in the control group might have been 
higher, as one individual had known diabetes mellitus. This was confirmed by secondary 
glucose analysis omitting this individual’s data. The findings then were: mean glucose level 
4.8 (±0.1) mmol/l, and no statistically significant differences were noted between the groups 
(p=0.6). In terms of the standard deviations of total cholesterol, HDL and LDL, individual 
control and intervention participants had abnormal findings. 
 
The mean Hs-CRP in both groups was above 3.0 mg/l, indicating a high risk of IHD 
(Pearson et al., 2003). The randomisation process indicated that a significant difference 
between the control and intervention group regarding Hs-CRP was borderline, as the p–
value was 0.05. Fifteen participants (control group [n=4] and intervention group [n=11]) had 
Hs-CRP values above 10 mg/l, indicating a possible active inflammatory process (Pearson 
et al., 2003). A secondary analysis without these 15 participants’ Hs-CRP findings indicated 
that participants were still at an increased risk of IHD. The Hs-CRP result in the control 
group was then 3.9 (±3.9) mg/l and in the intervention group 5.2 (±5.4) mg/l. No statistically 
significant differences were observed between the control and intervention group regarding 
Hs-CRP (p=0.3).  
 
Results showing the effect of the physical activity modification programme on pedometer-
determined physical activity levels are reported in section 6b.6.2. 
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6b.6.2 Pedometer Physical Activity Level Change Over Time in PLWHA (on HAART) 
Table 6b.9a is a representation of the within-group change in pedometer physical activity 
levels over time calculated by repeated measures ANOVA. The change in mean represents 
the change from baseline. 
 
Table 6b.9a:  Within-Group Pedometer Physical Activity Level Change Over Time in  
PLWHA (on HAART) (N = 84) 
 Control Group Intervention Group 
Baseline steps/day, mean (±SE) 8 102.67 (±832.56) 6 888.13 (±451.46) 
Change at six months, mean (±SE) 1 123.41 (±422.12) 5 935.37 (±2 186.47) 
Change at six months, 95% CI 69.71 – 2 177.11 477.52 – 11 393.22 
Change at six months, p-value 0.03* 0.03* 
Change at 12 months, mean (±SE) 817.34 (±500.86) 3 809.96 (±2 041.44) 
Change at 12 months, 95% CI -432.87 – 2 067.62 -1 285.86 – 8 905.78 
Change at 12 months, p-value 0.33 0.21 
 
* The within-group pedometer physical activity levels increased significantly from baseline 
at the six month assessment period in the control and intervention groups. The increase 
was however more in the intervention group and they exceeded the aim of the programme: 
3 000 steps above baseline finding. 
 
The increase in pedometer physical activity levels was not significant from baseline at the 
12 month assessment period in the control and intervention groups. Both groups were 
however still more active than what they were at baseline. The intervention group was still 
clinically significant at this time point as the group still exceeded the aim of the programme.    
 
Table 6b.9b is a representation of the between-group effect on pedometer physical activity 
levels after 12 months of physical activity modification expressed with baseline value as co-
variate using ANCOVA. 
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Table 6b.9b: Between-group effect on pedometer physical activity levels after 12 
months of physical activity modification (N = 84) 
 † Mean (±SE) 95% CI Between-Group Effect 
Control group (six months), 
steps/day 
8 667.44  
(±1 596.35) 
5 490.60 – 11 
844.28 
F(1,80)=0.48, p=0.49, np2=0.01
Control group (12 months), 
steps/day 
8 395.06  
(±1 511.73) 
5 386.62 – 11 
403.50 
 
Intervention group (six 
months), steps/day 
13 718.34 
(±1 620.71) 
10 493.02 – 16 
943.66 
 
Intervention group (12 
months), steps/day 
11 385.25  
(±1 534.80) 
8 330.90 – 14 
439.60 
 
† Co-variate appearing in the model is evaluated at the following value: pedometer physical activity 
level (baseline) = 7495.39 steps/ day. 
 
No statistically significant between-group effect occurred in pedometer physical activity 
level. The adjusted mean values at the six and 12 month assessment periods where 
however higher in the intervention than the control group and represented the “active” 
category (> 10 000 steps/ day).   
 
6b.6.3 Effect of the Physical Activity Modification Programme on Risk Factors for IHD in 
PLWHA (on HAART) 
 
The effect of the physical activity modification programme on risk factors for IHD was 
evaluated by repeated measures ANCOVA and secondly the GEE and MEM analysis. The 
results of the between-group differences are presented in section 6b.6.3.1, and within-
group differences in section 6b.6.3.2.  
 
6b.6.3.1 Between-group differences of the effect of the physical activity modification 
programme 
 
Table 6b.10 is a representation of the between-group effect on 6MWT and 
perceived stress expressed respectively with baseline values as co-variates using 
ANCOVA. 
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Table 6b.10:  Between-Group Effect on 6MWT and Perceived Stress after 12 Months  
of Physical Activity Modification (N = 84) 
 † Mean (±SE) 95% CI Between-Group Effect 
6MWT distance 
Control group (six months), m 
Control group (12 months), m 
Intervention group (six months), m 
Intervention group (12 months), m 
 
543.78 (±6.62) 
541.89 (±7.73) 
562.30 (±6.62) 
554.78 (±7.72) 
 
530.60 - 556.96 
526.53 - 557.27 
549.13 - 575.47 
539.42 - 570.14 
F(1,80)=7.83, p=0.01, 
np2=0.09* 
Perceived stress 
Control group (six months) 
Control group (12 months) 
Intervention group (six months) 
Intervention group (12 months) 
 
18.18 (±0.96) 
19.16 (±0.88) 
18.36 (±0.96) 
18.01 (±0.88) 
 
16.27 - 20.10 
17.42 - 20.90 
16.44 - 20.28 
16.26 - 19.75 
F(1,80)=0.26, p=0.61, 
np2=0.00 
†  Co-variates appearing in the model are evaluated at the following values: baseline SMWT = 
544.26m and perceived stress = 20.13.♦ M (meters) 
 
* A statistically significant between-group effect occurred in 6MWT distance as 
demonstrated by the higher adjusted mean findings in the intervention group at six and 12 
months compared to baseline co-variate. The 6MWT distance in the control group lowered 
progressively at each time point. 
 
No statistically significant between-group effect occurred in perceived stress levels but the 
adjusted mean findings at six and twelve months progressively lowered in the intervention 
group compared to control findings.  
 
Table 6b.11 is a representation of the between-group effect on clinical physiological 
measures expressed with baseline values as co-variates using ANCOVA. 
 
Table 6b.11: Between-group Effect on Physiological Measures after 12 Months of 
Physical Activity Modification (N = 84) 
 † Mean (±SE) 95% CI Between-Group Effect 
Resting heart rate 
Control group (six months), bpm 
Control group (12 months), bpm 
Intervention group (six months), bpm 
Intervention group (12 months), bpm 
 
78.39 (±1.40) 
78.90 (±1.23) 
78.48 (±1.39) 
78.45 (±1.23) 
 
75.61 - 81.17 
76.46 - 81.35 
75.71 - 81.25 
76.01 - 80.89 
F(1,80)=1.14, p=0.29, 
np2=0.01 
SBP 
Control group (six months), mmHg 
Control group (12 months), mmHg 
Intervention group (six months), mmHg 
Intervention group (12 months), mmHg 
 
116.26 (±1.35) 
118.82 (±1.29) 
115.74 (±1.35) 
118.20 (±1.29) 
 
113.58 - 118.94 
116.26 - 121.38 
113.06 - 118.43 
115.64 - 120.76 
F(1,80)=2.22, p=0.14, 
np2=0.03  
DBP 
Control group (six months), mmHg 
Control group (12 months), mmHg 
Intervention group (six months), mmHg 
Intervention group (12 months), mmHg 
 
76.14 (±1.03) 
77.61 (±1.05) 
76.79 (±1.03) 
77.82 (±1.05) 
 
74.09 - 78.18 
75.51 - 79.71 
74.75 - 78.85 
75.72 - 79.91 
F(1,80)=1.31, p=0.26, 
np2=0.02 
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† Co-variates appearing in the model are evaluated at the following values: baseline resting heart 
rate =78.99 bpm, SBP = 120.70 mmHg and DBP = 78.79 mmHg. ♦ Bpm (beats per minute) and 
mmHg (millimeters mercury). 
 
No statistically significant between-group effect occurred in resting heart rate, systolic and 
diastolic blood pressure. 
 
Table 6b.12 is a representation of the between-group effect on anthropometric measures 
with baseline values as co-variates using ANCOVA. 
 
Table 6b.12:  Between-Group Effect on Anthropometric Measures after 12 Months of 
Physical Activity Modification (N = 84) 
 † Mean (±SE) 95% CI Between-Group Effect 
Weight 
Control group (six months), kg 
Control group (12 months), kg 
Intervention group (six months), kg 
Intervention group (12 months), kg 
 
70.35 (±0.49) 
70.95 (±0.66) 
70.55 (±0.49) 
71.08 (±0.66) 
 
69.37 - 71.34 
69.63 - 72.27 
69.57 - 71.54 
69.76 - 72.39 
F(1,80)=2.39, p=0.13, 
np2=0.03 
Body mass index 
Control group (six months), kg/m2 
Control group (12 months), kg/m2 
Intervention group (six months), kg/m2 
Intervention group (12 months), kg/m2 
 
26.53 (±0.21) 
27.04 (±0.29) 
26.48 (±0.21) 
27.18 (±0.30) 
 
26.11 - 26.94 
26.44 - 27.63 
26.06 - 26.90 
26.58 - 27.78 
F(1,80)=0.95, p=0.33, 
np2=0.01 
Waist circumference 
Control group (six months), cm 
Control group (12 months), cm 
Intervention group (six months), cm 
Intervention group (12 months), cm 
 
79.60 (±0.64) 
80.62 (±0.62) 
80.09 (±0.65) 
81.02 (±0.62) 
 
78.32 - 80.89 
79.39 - 81.84 
78.81 - 81.38 
79.79 - 82.25 
F(1,80)=2.89, p=0.09, 
np2=0.04 
Hip circumference 
Control group (six months), cm 
Control group (12 months), cm 
Intervention group (six months), cm 
Intervention group (12 months), cm 
 
103.37 (±0.58) 
103.39 (±0.59) 
104.14 (±0.58) 
104.48 (±0.59) 
 
102.21 - 104.53 
102.21 - 104.59 
102.98 - 105.29 
103.29 - 105.67 
F(1,80)=13.86, p<0.00, 
np2=0.15* 
Waist: hip ratio 
Control group (six months) 
Control group (12 months) 
Intervention group (six months) 
Intervention group (12 months) 
 
0.77 (±0.01) 
0.78 (±0.01) 
0.77 (±0.01) 
0.78 (±0.01) 
 
0.76 - 0.79 
0.77 - 0.80 
0.76 - 0.79 
0.77 - 0.79 
F(1,80)=32.35, p<0.00, 
np2=0.29* 
† Co-variates appearing in the model are evaluated at the following values: baseline weight = 70.01 
kg, body mass index = 25.62 kg/m2, waist circumference = 80.55 cm, hip circumference = 103.77 cm 
and waist: hip ratio = 0.78. ♦ Kg (kilogram), kg/m2 (kilograms per square meter), cm (centimetres). 
 
No statistically significant between-group effect occurred in weight, BMI and WC. Slight 
increases in these parameters occurred overtime when reviewing the adjusted mean 
values. 
 
* A significant between-group effect occurred in hip circumference due to the intervention 
group’s hip circumference increasing slightly more than the control group. 
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* A significant between-group effect occurred in waist: hip ratio due to the intervention 
group’s waist: hip ratio reducing slightly more than the control group. 
 
Table 6b.13 is a representation of the between-group effect on biochemical measures with 
baseline values as co-variates using ANCOVA. 
 
Table 6b.13:  Between-Group Effect on Biochemical Measures After 12 Months of 
Physical Activity Modification (N = 84) 
 † Mean (±SE) 95% CI Between-subject effect 
Glucose 
Control group (six months), mmol/l 
Control group (12 months), mmol/l 
Intervention group (six months) mmol/l 
Intervention group (12 months), mmol/l 
 
4.89 (±0.07) 
4.81 (±0.07) 
4.72 (±0.08) 
4.74 (±0.08) 
 
4.75 - 5.04 
4.66 - 4.96 
4.57 - 4.87 
4.59 - 4.89 
F(1,80)=15.56, p<0.00, 
np2=0.16* 
Total cholesterol 
Control group (six months), mmol/l 
Control group (12 months), mmol/l 
Intervention group (six months), mmol/l 
Intervention group (12 months), mmol/l 
 
4.23 (±0.10) 
4.13 (±0.08) 
4.32 (±0.10) 
4.30 (±0.08) 
 
4.03 - 4.43 
3.97 - 4.28 
4.12 - 4.52 
4.15 - 4.45 
F(1,80)=2.68, p=0.11, 
np2=0.03 
High density lipoprotein 
Control group (six months), mmol/l 
Control group (12 months), mmol/l 
Intervention group (six months), mmol/l 
Intervention group (12 months), mmol/l 
 
1.39 (±0.04) 
1.43 (±0.04) 
1.45 (±0.04) 
1.50 (±0.04) 
 
1.32 - 1.46 
1.35 - 1.50 
1.38 - 1.53 
1.43 - 1.58 
F(1,80)=7.71, p=0.01, 
np2=0.09*  
Low density lipoprotein 
Control group (six months), mmol/l 
Control group (12 months), mmol/l 
Intervention group (six months), mmol/l 
Intervention group (12 months), mmol/l 
 
2.38 (±0.06) 
2.26 (±0.06) 
2.52 (±0.06) 
2.35 (±0.06) 
 
2.26 - 2.50 
2.14 - 2.38 
2.39 - 2.64 
2.23 - 2.47 
F(1,80)=0.32, p=0.57, 
np2=0.00 
Triglycerides 
Control group (six months), mmol/l 
Control group (12 months), mmol/l 
Intervention group (six months), mmol/l 
Intervention group (12 months), mmol/l 
 
1.06 (±0.04) 
1.04 (±0.05) 
0.99 (±0.04) 
1.01 (±0.05) 
 
0.98 - 1.14 
0.93 - 1.14 
0.91 - 1.06 
0.91 - 1.12 
F(1,80)=0.46, p=0.50, 
np2=0.01 
High sensitivity-CRP 
Control group (six months), mg/l 
Control group (12 months), mg/l 
Intervention group (six months), mg/l 
Intervention group (12 months), mg/l 
 
7.25 (±0.78) 
6.68 (±0.85) 
7.23 (±0.77) 
8.26 (±0.84) 
 
5.71 - 8.79 
4.50 - 8.37 
5.71 - 8.76 
6.59 - 9.93 
F(1,80)=3.16, p=0.08, 
np2=0.04  
† Co-variates appearing in the model are evaluated at the following values: baseline glucose = 4.95 
mmol/l, total cholesterol = 4.33 mmol/l, HDL = 1.41 mmol/l, LDL = 2.49 mmol/l, triglycerides = 1.00 
mmol/l and Hs-CRP = 7.01 mg/l. ♦ Mmol/l (millimoles per litre) and mg/l (milligrams per litre).  
 
No significant between-group effect occurred in total cholesterol, LDL, triglycerides and Hs-
CRP. 
 
* A significant between-group effect occurred in HDL due to the adjusted mean values in 
the intervention group increased progressively more overtime than the control group. 
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* A significant between-group effect occurred in glucose level as indicated by lower 
adjusted mean values (95% CI) in the intervention group compared to the control group. 
 
Tables 6b.14–6b.27 provide information regarding the pedometer physical activity level 
changes with interaction effect (time and treatment) when adjusting for secondary 
outcomes, as assessed in the log-transformed model with univariate logistic regression 
analysis performed in GEE and MEM. The univariate analysis was followed by multivariate 
logistic regression analysis to evaluate how the dependent variables reacted in the 
presence of others. The multivariate logistic regression also consisted of a log-transformed 
model. Table 6b.28 provides information regarding the multiple regression analysis of GEE 
and MEM, with specific restrictions applied as indicated by the goodness-to-fit evaluations. 
Table 6b.29 provides the information without the restrictions applied.  
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Table 6b.14:  Physical Activity Levels Adjusted for Perceived Stress Level in PLWHA (on HAART) (Observations = 252) 
 
Group and  
Ax period 
GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx effect) 
Log-adjusted Coef. of mean 
change (95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean change 
(95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx effect) 
Log-adjusted Coef. of 
mean change (95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.16 (8.91 – 9.40) 
0.11 (-0.03 – 0.24) 
0.08 (-0.05 – 0.21) 
 
-0.10 (-0.33 – 0.12)
0.35 (0.13 – 0.58) 
0.19 (-0.04 – 0.41) 
 
 
 0.11 
 0.30 
 
0.36 
  <0.00 * 
0.10 
 
PSL 
-0.02 (-0.03 - -0.01) 
<0.00 * 
 
9.14 (8.88 – 9.39) 
0.11 (-0.12 – 0.33) 
0.08 (-0.15 – 0.30) 
 
-0.10 (-0.33 – 0.12) 
0.35 (0.13 – 0.58) 
0.19 (-0.04 – 0.42) 
 
 
0.35 
0.50 
 
0.36 
  <0.00 * 
0.09 
 
PSL 
-0.02 (-0.02 - -0.01) 
 <0.00 * 
 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), PSL (perceived stress level). 
 
* Significance noted in physical activity levels when adjusted for perceived stress level at six months: intervention group versus baseline 
control group (GEE and MEM). A significant association between the interaction and perceived stress levels at group (GEE) and individual 
level (MEM) were also observed. 
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Table 6b.15:  Physical Activity Levels Adjusted for 6MWT Distance in PLWHA (on HAART) (Observations = 252). 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx effect) 
Log-adjusted Coef. of mean 
change (95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean change 
(95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx effect) 
Log-adjusted Coef. of 
mean change (95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.17 (7.56 – 8.78) 
0.14 (0.00 – 0.27) 
0.09 (-0.04 – 0.23) 
 
-0.10 (-0.32 – 0.13) 
0.37 (0.14 – 0.59) 
0.22 (-0.01 – 0.44) 
 
 
 0.04* 
0.17 
 
0.41 
 <0.00* 
0.06 
 
6MWT distance 
0.00 (0.00 – 0.00) 
0.03* 
 
7.96 (7.41 – 8.51) 
0.14 (-0.09 – 0.36) 
0.09 (-0.13 – 0.32) 
 
-0.09 (-0.32 – 0.13) 
0.36 (0.14 – 0.58) 
 0.21 (-0.01 – 0.44) 
 
 
0.23 
0.41 
 
0.42 
 <0.00* 
0.06 
 
6MWT distance 
0.00 (0.00 – 0.00) 
<0.00* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), 6MWT (six minute walk test).  
 
* Significance noted in physical activity levels when adjusted for 6MWT at six months control group (GEE) and at six months intervention 
group versus baseline control group (GEE and MEM). A significant association was also noted between the interaction and 6MWT distance at 
group (GEE) and individual level (MEM).  
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Table 6b.16:  Physical Activity Levels Adjusted for RHR in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE 
Variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM 
Variable 
(Time and Rx effect) 
Log-adjusted Coef. 
of mean change  
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.97 (8.46 – 9.48) 
0.14 (0.00 – 0.27) 
0.09 (-0.04 – 0.22) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.16 – 0.61) 
0.23 (-0.00 – 0.46) 
 
 
0.04 
0.18 
 
0.40 
 <0.00* 
0.05 
 
RHR 
-0.00 (-0.01 – 0.01) 
0.61 
 
 
8.88 (8.39 – 9.37) 
0.14 (-0.09 – 0.36) 
0.09 (-0.14 – 0.32) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.61) 
0.22 (-0.01 – 0.45) 
 
 
0.24 
0.43 
 
0.38 
 <0.00* 
0.05 
 
RHR 
-0.00 (-0.01 – 0.01) 
0.87 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), RHR (Resting heart rate). 
 
* Significance noted in physical activity level when adjusting for RHR at six months intervention group compared to control group in the GEE 
and MEM.  
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Table 6b.17:  Physical Activity Levels Adjusted for SBP in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log - PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE 
Variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM 
Variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.18 (8.44 – 9.91) 
0.12 (-0.01 – 0.26) 
0.09 (-0.05 – 0.21) 
 
-0.10 (-0.33 – 0.13) 
0.37 (0.14 – 0.59) 
0.22 (-0.01 – 0.45) 
 
 
0.07 
0.20 
 
0.39 
 <0.00* 
0.06 
 
SBP 
-0.00 (-0.01 – 0.00) 
0.35 
 
9.20 (8.52 – 9.87) 
0.12 (-0.10 – 0.35) 
0.09 (-0.14 – 0.31) 
 
-0.10 (-0.33 – 0.13) 
0.37 (0.14 – 0.59) 
0.22 (-0.01 – 0.45) 
 
 
0.29 
0.46 
 
0.39 
 <0.00* 
0.06 
 
SBP 
-0.00 (-0.00 – 0.00) 
0.29 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), SBP (systolic blood pressure). 
 
* Significance noted in physical activity level when adjusting for SBP at six months intervention group compared to baseline control in the GEE 
and MEM. 
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Table 6b.18:  Physical Activity Levels Adjusted for DBP in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE 
Variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM 
Variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.16 (8.53 – 9.79) 
0.13 (-0.01 – 0.26) 
0.09 (-0.05 – 0.22) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.60) 
0.22 (-0.01 – 0.45) 
 
 
0.06 
0.20 
 
0.39 
 <0.00* 
0.05 
 
DBP 
-0.00 (-0.01 – 0.00) 
0.31 
 
9.14 (8.52 – 9.76) 
0.13 (-0.10 – 0.36) 
0.09 (-0.14 – 0.32) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.61) 
 0.22 (-0.01 – 0.45) 
 
 
0.28 
0.45 
 
0.39 
 <0.00* 
0.05 
 
DBP 
-0.00 (-0.01 – 0.00) 
0.33 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), DBP (diastolic blood pressure). 
 
* Significance noted in physical activity levels when adjusting for DBP at the six months intervention group baseline control in the GEE and 
MEM. 
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Table 6b.19:  Physical Activity Levels Adjusted for Weight in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.36 (8.89 – 9.83) 
0.14 (0.01 – 0.27) 
 0.10 (-0.03 – 0.23) 
 
-0.10 (-0.33 – 0.12) 
0.39 (0.16 – 0.61) 
0.23 (0.01 – 0.46) 
 
 
  0.04* 
 0.15 
 
0.37 
  <0.00* 
   0.04** 
 
Weight 
-0.01 (-0.01 - -0.00) 
0.02* 
 
9.33 (8.99 – 9.67) 
0.14 (-0.08 – 0.36) 
0.10 (-0.13 – 0.32) 
 
-0.10 (-0.33 – 0.12) 
0.39 (0.16 – 0.61) 
0.23 (0.00 – 0.45) 
 
 
0.22 
0.39 
 
0.37 
 <0.00* 
   0.04** 
 
Weight 
-0.01 (-0.01 - -0.00) 
<0.00* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model). 
 
* Significance noted in physical activity levels when adjusted for weight at six months for control group (GEE) and intervention group versus 
baseline control (GEE and MEM). A significant association between the interaction and weight was also noted at group (GEE) and individual 
level (MEM). 
 
** Significance noted in physical activity levels when adjusted for weight (GEE and MEM) at 12 months intervention group versus baseline 
control.  
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Table 6b.20:  Physical Activity Levels Adjusted for BMI in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean change 
(95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted 
Coef. of mean 
change (95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean change 
(95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.23 (8.79 – 9.67) 
0.15 (0.02 – 0.28) 
 0.11 (-0.02 – 0.25) 
 
-0.10 (-0.32 – 0.13) 
0.40 (0.18 – 0.63) 
0.25 (0.03 – 0.48) 
 
 
0.03* 
     0.10 
 
     0.40 
<0.00* 
 0.03** 
 
BMI 
-0.02 (-0.03 – 0.00) 
0.06 
 
9.29 (8.96 – 9.62) 
0.15 (-0.07 -0.38) 
0.12 (-0.11 – 0.34) 
 
-0.10 (-0.32 – 0.13) 
0.41 (0.18 – 0.63) 
0.26 (0.04 – 0.48) 
 
 
0.18 
0.31 
 
0.41 
 <0.00* 
  0.02** 
 
BMI 
-0.02 (-0.03 - -0.01) 
<0.00* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), BMI (body mass index). 
 
* Significance noted in physical activity levels when adjusted for BMI at six months control (GEE) and intervention group (GEE and MEM) 
versus baseline control. A significant association between the interaction and BMI was also noted at individual level (MEM). 
 
** Significance noted in physical activity levels when adjusted for BMI (GEE and MEM) at 12 months intervention group versus baseline 
control. 
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Table 6b.21:  Physical Activity Levels Adjusted for WC in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted 
Coef. of mean 
change (95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.58 (8.91 – 10.26) 
0.13 (-0.01 – 0.26) 
0.09 (-0.04 – 0.22) 
 
-0.09 (-0.31 – 0.13) 
0.39 (0.16 – 0.61) 
0.24 (0.02 – 0.46) 
 
 
0.06 
0.18 
 
0.43 
 <0.00* 
  0.04** 
 
WC 
-0.01 (-0.02 - -0.00) 
0.03* 
 
 
9.72 (9.21 – 10.23) 
0.13 (-0.10 – 0.35) 
0.09 (-0.13 – 0.31) 
 
-0.09 (-0.31 – 0.13) 
0.39 (0.17 – 0.61) 
0.24 (0.02 – 0.47) 
 
 
0.27 
0.42 
 
0.44 
  <0.00* 
   0.03** 
 
WC 
-0.01 (-0.02 - -0.01) 
<0.00* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), WC (waist circumference). 
 
* Significance noted in physical activity levels when adjusted for WC at six months intervention group versus baseline control (GEE and MEM). 
A significant association between the interaction and WC was noted at group (GEE) and individual level (MEM).  
 
** Significance noted in physical activity levels when adjusted for WC at 12 months intervention group versus baseline control (GEE and 
MEM). 
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Table 6b.22:  Physical Activity Levels Adjusted for WHR in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted 
Coef. of mean 
change (95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.00 (8.22 – 9.78) 
0.14 (0.00 – 0.27) 
 0.09 (-0.04 – 0.22) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.61) 
 0.22 (-0.00 – 0.45) 
 
 
0.05 
0.18 
 
0.39 
 <0.00* 
0.05 
 
WHR 
-0.21 (-1.19 – 0.78) 
0.68 
 
9.11 (8.40 – 9.82) 
0.13 (-0.09 – 0.36) 
0.09 (-0.14 – 0.32) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.61) 
 0.22 (-0.00 – 0.45) 
 
 
0.25 
0.43 
 
0.40 
 <0.00* 
0.05 
 
WHR 
-0.35 (-1.23 – 0.54) 
0.44 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), CI (confidence interval), Rx 
(treatment), MEM (mixed effects model), WHR (waist: hip ratio). 
 
* Significance noted in physical activity level when adjusted for WHR at six months intervention group versus baseline control (GEE or MEM). 
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Table 6b.23:  Physical Activity Levels Adjusted for Glucose in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.94 (8.55 – 9.33) 
0.13 (0.00 – 0.27 
  0.09 (-0.05 – 0.22) 
 
-0.11 (-0.34 – 0.12) 
 0.37 (0.14 – 0.60) 
  0.21 (-0.02 – 0.44) 
 
 
0.05 
0.20 
 
0.35 
 <0.00* 
0.07 
 
Glucose 
-0.02 (-0.09 – 0.05) 
0.59 
 
8.95 (8.60 – 9.30) 
0.13 (-0.09 – 0.36) 
0.09 (-0.14 – 0.32) 
 
-0.11 (-0.34 – 0.12) 
0.37 (0.14 – 0.60) 
0.21 (-0.02 – 0.44) 
 
 
0.25 
0.46 
 
0.35 
 <0.00* 
0.07 
 
Glucose 
-0.02 (-0.08 – 0.04) 
0.48 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model). 
 
* Significance noted in physical activity levels when adjusted for glucose level at six months intervention group versus baseline control (GEE 
or MEM). 
 
  
193 
 
Table 6b.24: Physical Activity Levels Adjusted for Total Cholesterol in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean change 
(95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean change 
(95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.06 (8.68 – 9.43) 
0.13 (-0.00 – 0.27) 
0.08 (-0.05 – 0.22) 
 
-0.11 (-0.33 – 0.12) 
0.38 (0.15 – 0.60) 
0.22 (-0.00 – 0.44) 
 
 
0.05 
0.24 
 
 
<0.00* 
0.06 
 
TC 
-0.05 (-0.13 – 0.03) 
0.22 
 
 
9.31 (8.97 – 9.64) 
0.13 (-0.10 – 0.35) 
0.07 (-0.16 – 0.29) 
 
-0.11 (-0.33 – 0.12) 
0.38 (0.15 – 0.60) 
 0.22 (-0.01 – 0.44) 
 
 
0.27 
0.55 
 
0.35 
  <0.00* 
 0.06 
 
TC 
-0.11 (-0.18 - -0.04) 
  <0.00 * 
 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), CI (confidence interval), Rx 
(treatment), MEM (mixed effects model), TC (total cholesterol). 
 
* Significance noted in physical activity levels when adjusted for total cholesterol at six months intervention group versus baseline control 
(GEE and MEM). A significant association was also noted between the interaction and total cholesterol at individual level (MEM). 
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Table 6b.25:  Physical Activity Levels Adjusted for HDL and LDL Levels in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.88 (8.57 – 9.19) 
0.14 (0.00 – 0.27) 
 0.09 (-0.04 – 0.22) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.15 – 0.61) 
 0.22 (-0.00 – 0.45) 
 
 
0.05 
0.18 
 
0.37 
<0.00* 
0.05 
 
HDL 
-0.03 (-0.22 – 0.16) 
0.78 
 
8.95 (8.66 – 9.23) 
0.14 (-0.09 – 0.36) 
0.09 (-0.14 – 0.32) 
 
-0.10 (-0.33 – 0.13) 
0.38 (0.16 – 0.61) 
0.23 (0.00 – 0.46) 
 
 
0.25 
0.43 
 
0.38 
<0.00* 
0.05 
 
HDL 
-0.07 (-0.24 – 0.09) 
0.38 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.95 (8.63 – 9.27) 
0.13 (-0.00 – 0.27) 
0.08 (-0.06 – 0.22) 
 
-0.11 (-0.33 – 0.12) 
0.39 (0.15 – 0.61) 
0.21 (-0.01 – 0.44) 
 
 
0.05 
0.24 
 
0.35 
<0.00* 
0.06 
 
LDL 
-0.04 (-0.15 – 0.07) 
0.44 
 
9.11 (8.83 – 9.38) 
0.13 (-0.10 – 0.35) 
0.07 (-0.16 – 0.29) 
 
-0.11 (-0.33 – 0.11) 
0.38 (0.15 – 0.60) 
 0.20 (-0.03 – 0.43) 
 
 
0.28 
0.57 
 
0.33 
 <0.00* 
0.08 
 
LDL 
-0.11 (-0.19 - -0.02) 
 0.02* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), HDL (high density lipoprotein), LDL (low density lipoprotein). 
 
* Significance noted in physical activity levels when adjusted for HDL and LDL respectively at six months intervention group versus baseline 
control group (GEE and MEM). A significant association between the interaction and LDL was also noted at individual level (MEM). 
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Table 6b.26:  Physical activity Levels Adjusted for TG in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.97 (8.74 – 9.20) 
0.14 (0.01 – 0.28) 
0.09 (-0.04 – 0.23) 
 
-0.11 (-0.34 – 0.12) 
0.37 (0.15 – 0.60) 
0.21 (-0.01 – 0.44) 
 
 
0.04 
0.16 
 
0.34 
 <0.00* 
0.06 
 
TG 
-0.13 (-0.29 – 0.04) 
0.13 
 
9.06 (8.84 – 9.28) 
0.15 (-0.08 – 0.37) 
0.10 (-0.13 – 0.32) 
 
-0.11 (-0.34 – 0.11) 
0.37 (0.14 – 0.59) 
0.22 (-0.01 – 0.44) 
 
 
0.19 
0.39 
 
0.32 
 <0.00* 
0.06 
 
TG 
-0.21 (-0.36 - -0.07) 
 <0.00* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), TG (triglycerides). 
 
* Significance noted in physical activity levels when adjusted for TG at six months intervention group versus baseline control group (GEE and 
MEM). A significant association between the interaction and TG was also noted at individual level (MEM). 
  
196 
 
Table 6b.27:  Physical Activity Levels Adjusted for Hs-CRP in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.87 (8.70 – 9.05) 
0.14 (0.00 – 0.27) 
0.09 (-0.04 – 0.23) 
 
-0.09 (-0.32 – 0.14) 
0.39 (0.17 – 0.62) 
0.24 (0.00 – 0.47) 
 
 
 0.04* 
0.18 
 
0.45 
 <0.00* 
0.41 
 
hs-CRP 
-0.01 (-0.01 – 0.01) 
0.31 
 
8.89 (8.73 – 9.06) 
0.14 (-0.08 – 0.37) 
0.09 (-0.13 – 0.32) 
 
-0.07 (-0.30 – 0.15) 
0.41 (0.18 – 0.63) 
0.26 (0.03 – 0.48) 
 
 
0.22 
0.42 
 
0.53 
  <0.00* 
    0.03** 
 
hs-CRP 
-0.01 (-0.02 - -0.00) 
 0.04* 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), CI (confidence interval), Rx 
(treatment), MEM (mixed effects model), Hs–CRP (high sensitivity C-reactive protein). 
 
* Significance noted in physical activity levels when adjusted for Hs-CRP at six months control (GEE) and intervention group (GEE and MEM) 
versus baseline control group. A significant association between the interaction and Hs-CRP was also noted at individual level (MEM). 
 
** Significance noted in physical activity levels when adjusted for Hs-CRP at twelve months intervention group versus baseline control group 
(MEM).  
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Table 6b.28:  Physical Activity Levels Adjusted for Perceived Stress Levels, BMI, LDL and TG in PLWHA (on HAART) with 
Restrictions Applied (GEE and MEM) 
Group and Ax period ♦GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
♦GEE 
Log-PA 
p-value 
♦GEE variables 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
♦♦MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
♦♦MEM 
Log-PA 
p-value 
♦♦MEM variables 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.78 (9.28 – 10.28) 
0.13 (0.01 – 0.25) 
 0.10 (-0.03 – 0.22) 
 
-0.12 (-0.32 – 0.08) 
0.32 (0.12 – 0.52) 
 0.16 (-0.04 – 0.37) 
 
 
  0.04* 
 0.13 
 
 0.26 
  <0.00* 
 0.11 
 
 PSL  
-0.01 (-0.02 - -0.01) 
 <0.00 * 
 
 BMI 
-0.02 (-0.03 - -0.002)  
 0.02 * 
 
LDL 
-0.04 (-0.14 – 0.06) 
0.41 
 
TG 
-0.15 (-0.30 – 0.002) 
 0.05 
 
9.96 (9.59 – 10.33) 
0.09 (-0.08 – 0.27) 
0.08 (-0.10 – 0.25) 
 
-0.06 (-0.06 – 0.09) 
 0.24 (0.24 – 0.09) 
 0.14 (0.14 – 0.09) 
 
 
0.31 
0.40 
 
0.53 
  0.01** 
0.11 
 
PSL  
-0.02 (-0.02 - -0.009) 
 <0.00 ** 
 
BMI  
-0.01 (-0.02 - -0.01) 
  <0.00 ** 
 
LDL  
-0.10 (-0.18 - -0.03) 
 0.01 ** 
 
TG  
-0.17 (-0.29 - -0.1) 
 0.01 ** 
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity level), Coef. (coefficient), Rx (treatment), 
MEM (mixed effects model), PSL (perceived stress level), BMI (body mass index), LDL (low density lipoprotein), TG (triglycerides).  
♦ GEE observations = 249 ♦♦ MEM observations = 240 
 
* Significance noted in physical activity levels when adjusted for perceived stress level, BMI, LDL and TG at six month control and intervention 
group versus baseline control (GEE).  A significant association between the interaction and perceived stress levels (p < 0.00) and BMI (p = 
0.02) was still highlighted in the multiple regression analysis at group level (GEE).  
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** Significance noted when adjusted for perceived stress level, BMI, LDL and TG at six month intervention group versus baseline control 
(MEM). A significant association between the interaction and perceived stress levels (p < 0.00), BMI (p < 0.00), LDL (p = 0.01) and TG (p = 
0.01) was still highlighted with the multiple regression analysis at individual level (MEM).  
 
Table 6b.29:  Physical Activity Levels Adjusted for Perceived Stress Levels, BMI, LDL and TG in PLWHA (on HAART) without 
Restrictions Applied (GEE and MEM) (observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean 
change (95% CI) 
GEE 
Log-PA 
p-value 
GEE Variables 
(Time and Rx 
effect) 
Lof-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean 
change (95% CI) 
MEM 
Log-PA 
p-value 
MEM variables 
(Time and Rx 
effect) 
Log-adjusted Coef. 
of mean change 
(95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
9.78 (9.24 – 10.32) 
0.12 (-0.02 – 0.25) 
0.09 (-0.05 – 0.22) 
 
-0.11 (-0.32 – 0.11) 
0.36 (0.15 – 0.58) 
0.20 (-0.02 – 0.42) 
 
 
0.08 
0.21 
 
0.34 
 <0.00* 
0.07 
 
  PSL 
-0.02 (-0.03 - -0.01) 
    <0.00 * 
 
BMI  
-0.02 (-0.03 – 0.001) 
 0.07 
 
LDL 
-0.05 (-0.16 – 0.06) 
 0.35 
 
TG 
-0.11 (-0.27 – 0.05)  
0.17 
 
10.02 (9.57 – 10.46) 
0.11 (-0.10 – 0.33) 
0.07 (-0.14 – 0.29) 
 
-0.11 (-0.33 – 0.10) 
0.36 (0.14 – 0.57) 
 0.19 (-0.03 – 0.41) 
 
 
0.31 
0.51 
 
0.30 
   <0.00** 
0.09 
 
PSL 
-0.02 (-0.03 - -0.01) 
      <0.00 ** 
 
BMI  
-0.02 (-0.03 - -0.004) 
     0.01 ** 
 
LDL 
-0.11 (-0.20 - -0.02) 
     0.02 ** 
 
TG  
-0.16 (-0.30 - -0.02) 
    0.03 **  
♦ Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity level), Rx (treatment),  
MEM (mixed effects model), PSL (perceived stress level), BMI (body mass index), LDL (low density lipoprotein), TG (triglycerides).  
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* Significance noted in physical activity levels when adjusted for perceived stress level, BMI, LDL and TG at six month intervention group 
versus baseline control (GEE). A significant association between the interaction and perceived stress level (p < 0.00) was still observed in the 
multiple regression analysis at group level (GEE).  
 
** Significance noted in physical activity levels when adjusted for perceived stress level, BMI, LDL and TG at six month Intervention group 
versus baseline control (MEM). A significant association between the interaction and perceived stress level (p < 0.00), BMI (p = 0.01), LDL (p 
= 0.02) and triglycerides (p = 0.03) were still observed in the multiple regression analysis at individual level (MEM).  
 
Section 6b.6.3.2 consists of the ANOVA findings related to the within-group changes on the secondary outcomes assessed that occurred in 
the control and intervention group in the physical activity modification period.  
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6b.6.3.2  Within-group differences of the effect of the physical activity modification programme 
Table 6b.30 represents the control group’s findings of the secondary outcomes assessed with repeated measures ANOVA. The mean 
change reported is the change from baseline. 
 
Table 6b.30 Risk Factor Changes within the Control Group in the Year of Physical Activity Modification (N = 42) 
 Baseline 
(Mean [±SE]) 
Mean 
change six 
months 
(Mean [±SE]) 
Mean change 
six months 
(95% CI) 
Mean 
change six 
months 
(p-value) 
Mean 
change 12 
months 
(Mean [±SE]) 
Mean change 
12 months 
(95% CI) 
Mean 
change 12 
months 
(p-value) 
6MWT distance, m 547.82 (±8.77) -0.41 (±5.66) -14.53 - 13.72 1.00 -2.15 (±4.83) -14.21 - 9.91 1.00 
Perceived stress 20.14 (±0.99) -1.95 (±1.14) -4.80 - 0.89 0.28 -0.98 (±1.00) -3.48 - 1.53 1.00 
Physiological measures 
RHR, bpm 
SBP, mmHg 
DBP, mmHg 
 
77.17 (±1.65) 
120.11 (±1.98) 
78.21 (±1.34) 
 
-0.14 (±1.32) 
-4.24 (±1.58) 
-2.45 (±1.19) 
 
-3.43 - 3.14 
-8.18 - -0.31 
-5.41 - 0.52 
 
1.00 
0.03* 
0.14 
 
0.38 (±1.22) 
-1.71 (±1.49) 
-0.94 (±1.15) 
 
-2.66 - 3.41 
-5.42 - 1.99 
-3.82 - 1.94 
 
1.00 
0.77 
1.00 
Anthropometric 
measures 
Weight, kg 
BMI, kg/m2 
WC, cm 
HC, cm 
Waist: hip ratio 
 
 
69.92 (±2.89) 
25.36 (±1.00) 
79.83 (±1.94) 
103.51 (±2.46) 
0.77 (±0.01) 
 
 
0.34 (±0.41) 
0.89 (±0.19) 
-0.94 (±0.52) 
-0.41 (±0.50) 
-0.01 (±0.01) 
 
 
-0.67 - 1.35 
0.41 - 1.37 
-2.24 - 0.36 
-1.67 - 0.84 
-0.02 - 0.01 
 
 
1.00 
 <0.00* 
0.23 
1.00 
0.56 
 
 
0.94 (±0.58 ) 
1.39 (±2.51) 
0.03 (±0.51) 
-0.39 (±0.49) 
0.00 (±0.00) 
 
 
-0.51 - 2.37 
0.77 - 2.02 
-1.25 - 1.31 
-1.62 - 0.85 
-0.01 - 0.01 
 
 
0.34 
 <0.00* 
1.00 
1.00 
1.00 
Biochemical measures 
Glucose, mmol/l 
TC, mmol/l 
HDL, mmol/l 
LDL, mmol/l 
TG, mmol/l 
Hs-CRP, mg/l 
 
5.10 (±0.27) 
4.35 (±0.16) 
1.41 (±0.06) 
2.53 (±0.13) 
1.02 (±0.07) 
5.45 (±1.02) 
 
-0.12 (±0.15) 
-0.10 (±0.08) 
-0.02 (±0.03) 
-0.11 (±0.07) 
0.06 (±0.04) 
0.57 (±0.60) 
 
-0.49 - 0.24 
-0.31 - 0.11 
-0.09 - 0.05 
-0.28 - 0.06 
-0.04 - 0.15 
-0.93 - 2.08 
 
1.00 
0.70 
1.00 
0.34 
0.43 
1.00 
 
-0.18 (±0.10) 
-0.21 (±0.08) 
0.01 (±0.03) 
-0.24 (±0.07) 
0.03 (±0.05) 
0.21 (±0.59) 
 
-0.43 - 0.06 
-0.40 - -0.01 
-0.07 - 0.09 
-0.39 - -0.07 
-0.10 - 0.16 
-1.28 - 1.70 
 
0.21 
0.04* 
1.00 
<0.00* 
1.00 
1.00 
♦ 6MWT (six-minute walk test), RHR (resting heart rate), SBP (systolic blood pressure), DBP (diastolic blood pressure), BMI (body mass index), WC 
(waist circumference), HC (hip circumference), TC (total cholesterol), HDL (high density lipoprotein), LDL (low density lipoprotein), TG (triglycerides), 
Hs-CRP (high sensitivity C-reactive protein). 
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* A significant within-group change occurred in SBP at six months compared to baseline due to a reduction in SBP. The 12 month 
finding was still lower than the baseline value but it was not significant. 
 
* A significant within-group change occurred in BMI at six and 12 months compared to baseline respectively due to an increase in BMI. 
 
* A significant within-group change occurred at 12 months in total cholesterol and LDL compared to baseline due to a reduction in 
these two parameters respectively. 
 
A reduction in 6MWT distance, perceived stress, diastolic blood pressure, hip circumference and glucose level occurred at each 
assessment time point when compared to baseline findings respectively. These changes were however not statistically significant.  
 
Table 6b.31 represents the intervention group’s findings of the secondary outcomes assessed with repeated measures ANOVA. The 
mean change reported is the change from baseline. 
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Table 6b.31:  Risk factor Changes within the Intervention Group in the Year of Physical Activity Modification (N = 42) 
 Baseline 
(Mean [±SE]) 
Mean change 
six months 
(Mean [±SE]) 
Mean change 
six months 
(95% CI) 
Mean change 
six months 
(p-value) 
Mean change 
12 months 
(Mean [±SE]) 
Mean change 
12 months 
(95% CI) 
Mean change 
12 months 
(p-value) 
6MWT distance, m 540.69 (±11.05) 19.55 (±8.66) -2.07 - 41.17 0.09 11.71 (±10.32) -14.05 - 37.48 0.79 
Perceived stress 20.12 (±1.03) -1.76 (±1.02) -4.30 - 0.78 0.27 -2.12 (±1.01) -4.63 - 0.39 0.12 
Physiological measures 
RHR, bpm 
SBP, mmHg 
DBP, mmHg 
 
80.79 (±1.79) 
121.29 (±1.62) 
79.36 (±1.25) 
 
-1.36 (±1.69) 
-5.07 (±1.26) 
-2.13 (±0.98) 
 
-5.58 - 2.85 
-8.22 - -1.91 
-4.57 - 0.31 
 
 
1.00 
<0.00* 
0.11 
 
 
-1.18 (±1.39) 
-2.52 (±1.17) 
-1.05 (±1.07) 
 
-4.67 - 2.31 
-5.44 - 0.41 
-3.73 - 1.62 
 
1.00 
0.11 
0.99 
Anthropometric measures 
Weight, kg 
BMI, kg/m2 
WC, cm 
HC, cm 
Waist: hip ratio 
 
70.10 (±1.39) 
25.88 (±0.62) 
81.26 (±1.14) 
104.02 (±1.52) 
0.78 (±0.02) 
 
0.54 (±0.57) 
0.87 (±0.23) 
-0.54 (±0.75) 
0.33 (±0.69) 
-0.01 (±0.01) 
 
-0.88 - 1.96  
0.29 - 1.45 
-2.40 - 1.33 
-1.39 - 2.05 
-0.04 - 0.02 
 
1.00 
<0.00* 
1.00 
1.00 
1.00 
 
1.06 (±0.75) 
1.56 (±0.35) 
0.38 (±0.71) 
0.65 (±0.78) 
-0.01 (±0.01) 
 
-0.81 - 2.93 
0.69 - 2.42 
-1.40 - 2.16 
-1.31 - 2.60 
-0.04 - 0.02 
 
0.49 
<0.00* 
1.00 
1.00 
1.00 
Biochemical measures 
Glucose, mmol/l 
TC, mmol/l 
HDL, mmol/l 
LDL, mmol/l 
TG, mmol/l 
Hs-CRP, mg/l 
 
4.81 (±0.11) 
4.31 (±0.13) 
1.42 (±0.08) 
2.45 (±0.10) 
0.98 (±0.08) 
8.58 (±1.29) 
 
-0.13 (±0.11) 
-0.01 (±0.12) 
0.04 (±0.05) 
0.04 (±0.06) 
-0.01 (±0.05) 
-0.43 (±1.04) 
 
-0.39 - 0.13 
-0.31 - 0.29 
-0.09 - 0.17 
-0.11 - 0.18 
-0.13 - 0.11 
-3.02 - 2.16 
 
0.68 
1.00 
1.00 
1.00 
1.00 
1.00 
 
-0.11 (±0.12) 
-0.02 (±0.09) 
0.09 (±0.05) 
-0.13 (±0.07) 
0.02 (±0.06) 
0.31 (±1.29) 
 
-0.40 - 0.19 
-0.24 - 0.19 
-0.05 - 0.22 
-0.29 - 0.04 
-0.12 - 0.16 
-2.93 - 3.55 
 
1.00 
1.00 
0.34 
0.21 
1.00 
1.00 
♦ 6MWT (six-minute walk test), RHR (resting heart rate), SBP (systolic blood pressure), DBP (diastolic blood pressure), BMI (body mass index), WC 
(waist circumference), HC (hip circumference), TC (total cholesterol), HDL (high density lipoprotein), LDL (low density lipoprotein), TG (triglycerides), 
Hs-CRP (high sensitivity C-reactive protein). 
 
* A significant within-group change occurred in SBP at six months compared to baseline due to a reduction in SBP. The 12 month 
finding was still lower than the baseline value and more so when compared to the within-group control findings but it was not 
statistically significant. 
 
* A significant within-group change occurred in BMI at six and 12 months compared to baseline respectively due to an increase in BMI. 
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An increase in 6MWT distance occurred at six and 12 month compared to baseline but a 
reduction was noted at 12 months compared to the six months findings. Findings for these 
increases in 6MWT distance were however not statistically significant. 
 
A progressive reduction in perceived stress was noted at each assessment period when 
compared to baseline findings. These reductions were however not statistically significant.  
 
A reduction in RHR, DBP, WHR, glucose and total cholesterol levels occurred at each 
assessment time point when compared to baseline findings respectively. These changes 
were however not significant. In all of these parameters except WHR and total cholesterol a 
greater reduction was noted at the six month period. 
 
A progressive increase in HDL was noted at each assessment period when compared to 
baseline findings. These changes were however not statistically significant. 
 
Section 6b.6.4 provides the results concerning the effect of the physical activity modification 
programme on the FRS.  
 
6b.6.4 Effect of the Physical Activity Modification Programme on Framingham Risk Score in 
PLWHA (on HAART) 
 
Table 6b.32 provides information regarding the baseline FRS of participants. 
 
Table 6b.32:  Baseline FRS of PLWHA (on HAART) (N = 84) 
Variable n Intervention Group Mean (±SD) n 
Control Group 
Mean (±SD) p-value 
Framingham Risk Score points 
- Men* 
- Women** 
42 2.5 (±6.5) 
4.1 (±5.6) 
2.1 (±6.7) 
42 3.3 (±6.5) 
4.1 (±8.3) 
3.1 (±5.9) 
0.5 
* Men: control group (n=11) and intervention group (n=7) 
**Women: control group (n=31) and intervention group (n=35) 
 
The FRS points were slightly higher in the control than the intervention group. This might be 
due to the control group participants being slightly older and having more smokers.  
 
The men in the control and intervention groups had a mean FRS of 4.1 points, that is, equal 
to a 1% 10-year risk of IHD (Blom, 2011). The women in the control (3.1 [±5.9]) and 
intervention (2.1 [±6.7]) groups had a mean FRS of less than nine points, also indicating a 
1% 10-year risk for IHD (Blom, 2011). With a 10-year risk of IHD of less than 3%, the study 
cohort had a low risk of IHD when using only the FRS as guide (Klug et al., 2012).  
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To evaluate whether the physical activity modification programme had an effect on the FRS, repeated measures ANCOVA was performed to 
evaluate between-group effect and repeated measures ANOVA for within-group effect. The between-group result is presented in Table 6b.33 
and within-group result in Table 6b.34.   
 
Table 6b.33:  Between-group effect on FRS after 12 months of physical activity modification (N = 84) 
 † Mean (±SE) 95% CI  † Mean (±SE) 95% CI Between-subject effect 
Control group  
(six months) 2.11 (±0.49) 1.147 - 3.08 
Intervention group  
(six months) 2.48 (±0.49) 1.51 - 3.44 
F(1,80) = 0.09, p=0.78, 
np2=0.00 
Control group  
(12 months) 1.97 (±0.53) 0.92 - 3.02 
Intervention group 
(12 months) 1.94 (±0.53) 0.90 - 2.99  
† Co-variate appearing in the model is evaluated at the following value: baseline FRS = 2.89. 
 
No significant between-group effect was observed in FRS after 12 months of physical activity modification. The adjusted mean values of both 
the control and intervention groups decreased overtime. 
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Table 6b.34:  Within-Group Effect on FRS after 12 Months of Physical Activity Modification (N = 84) 
 Baseline 
(Mean [±SE]) 
Mean change 
six months 
(Mean [±SE]) 
Mean change 
six months 
(95% CI) 
Mean change 
six months 
(p-value) 
Mean change 
12 months 
(Mean [±SE]) 
Mean change 
12 months 
(95% CI) 
Mean change 
12 months 
(p-value) 
Control group 3.33 (±1.00) -0.86 (±0.60) -2.36 - 0.65 0.49 -1.00 (±0.61) -2.52 - 0.52 0.32 
Intervention group 2.45 (±1.00) -0.38 (±0.36) -1.27 - 0.51 0.88 -0.86 (±0.49) -2.09 - 0.37 0.27 
 
No significant within-group effect was observed in the control and intervention groups after 12 months of physical activity modification. The 
mean change increased progressively at each assessment period when compared to baseline findings in the control and intervention group 
respectively.  
 
Table 6b.35 provides the results of the pedometer physical activity levels when adjusting for the FRS with the interaction effect (time and 
treatment effect), as assessed in the log-transformed model with univariate logistic regression analysis performed in GEE and MEM. 
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Table 6b.35:  Physical Activity Levels Adjusted for FRS in PLWHA (on HAART) (Observations = 252) 
Group and Ax period GEE 
Log-PA 
Coef. of mean change 
(95% CI) 
GEE 
Log-PA 
p-value 
GEE variable 
(Time and Rx 
effect) 
Log-adjusted 
Coef. of mean 
change (95% CI) 
p-value 
MEM 
Log-PA 
Coef. of mean change 
(95% CI) 
MEM 
Log-PA 
p-value 
MEM variable 
(Time and Rx 
effect) 
Log-adjusted 
Coef. of mean 
change (95% CI) 
p-value 
Control group 
 Baseline 
 Six months 
 Twelve months 
Intervention group 
 Baseline 
 Six months 
 Twelve months 
 
8.88 (8.72 – 9.05) 
0.13 (-0.01 – 0.26) 
0.08 (-0.06 – 0.21) 
 
-0.12 (-0.34 – 0.11) 
0.36 (0.14 – 0.59) 
 0.19 (-0.02 – 0.42) 
 
 
0.07 
0.25 
 
0.31 
<0.00* 
0.08 
 
FRS 
-0.01 
(-0.03 – 0.00) 
0.05 
 
 
8.90 (8.74 – 9.06) 
0.12 (-0.10 – 0.34) 
0.07 (-0.15 – 0.29) 
 
-0.12 (-0.34 – 0.10) 
0.36 (0.13 – 0.58) 
0.19 (-0.03 – 0.41) 
 
 
0.29 
0.52 
 
0.29 
 <0.00* 
0.09 
 
FRS 
-0.02 
(-0.03 - -0.01) 
   <0.00* 
♦ Abbreviations: Ax (assessment), GEE (generalised estimation equation), Log–PA (log-transformed pedometer physical activity levels), Coef. (coefficient),  
Rx (treatment), MEM (mixed effects model), FRS (Framingham Risk Score). 
 
* Significance noted in the physical activity levels when adjusted for the FRS at six months intervention group versus baseline control group 
(GEE and MEM). The association between FRS and the interaction was borderline at group-level (GEE), with a p-value of 0.05.  
 
A statistically significant association was observed between the interaction and the FRS at individual-level (MEM).  
 
Section 6b.6.5 provides the results concerning the inflammatory marker (hs-CRP) correlations with IHD risk markers evaluated. 
 
6b.6.5 Inflammatory Marker (Hs-CRP) Correlations with IHD Risk Markers Evaluated 
This objective was met with the Pearson correlation coefficient and univariate logistic regression in MEM to highlight within individual findings. 
Table 6b.36 provides information regarding the linear correlations between log-transformed Hs-CRP and IHD risk markers assessed at 
baseline.   
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Table 6b.36:  Baseline IHD Risk Marker Correlations with Log-Transformed Hs-CRP in PLWHA (on HAART) (N = 84) 
Variable n r-value p-value MEM Coefficient 95% CI p-value 
Perceived stress level 84 0.23   0.03* 0.04 0.004 – 0.08 0.03* 
Physical activity level 
 Pedometer physical activity  
 6MWT distance 
84  
-0.06 
-0.12 
 
0.58 
0.26 
 
0.00 
-0.00 
 
-0.00 – 0.00 
-0.01 – 0.00 
 
0.57 
0.25 
Physiological measures 
 Resting heart rate 
 Systolic blood pressure 
 Diastolic blood pressure 
84  
0.13 
0.13 
0.15 
 
0.23 
0.23 
0.17 
 
0.01 
0.01 
0.02 
 
-0.01 – 0.04 
-0.01 – 0.03 
-0.01 – 0.05 
 
0.22 
0.22 
0.16 
Anthropometric measures 
 Weight 
 BMI 
 Waist circumference 
 Hip circumference 
 Waist: hip ratio 
84  
0.28 
0.35 
0.28 
0.28 
0.01 
 
    0.01* 
<0.00* 
0.01* 
0.01* 
            0.96 
 
0.02 
0.07 
0.03 
0.02 
0.07 
 
0.01 – 0.04 
         0.03 – 0.12 
         0.06 – 0.36 
         0.01 – 0.04 
        -2.87 – 3.00 
 
0.01* 
<0.00* 
0.01* 
0.01 
0.96 
Biochemical measures 
 Glucose 
 Total cholesterol 
 HDL 
 LDL 
 Triglycerides 
84  
0.12 
0.06 
0.11 
0.03 
-0.01 
 
0.29 
0.58 
0.32 
0.82 
0.94 
 
0.09 
0.08 
0.29 
0.04 
-0.02 
 
-0.08 – 0.28 
-0.19 – 0.34 
-0.27 – 0.85 
-0.29 – 0.37 
-0.55 – 0.51 
 
0.28 
0.57 
0.31 
0.81 
0.94 
Framingham Risk Score 84 0.06 0.59 0.01 -0.03 – 0.05 0.59 
♦ 6MWT (six-minute walk test), BMI (body mass index), HDL (high density lipoprotein), LDL (low density lipoprotein), MEM (mixed effects model).  
* A statistically significant association was observed between perceived stress levels, weight, BMI, waist and hip circumference and Hs-CRP 
at baseline.  
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The following section consists of the results pertaining to objective 3 of the study that 
focused on the evaluation of participants’ adherence to the intervention programme.  
 
6b.6.6 Adherence to the Education and Home-Based Walking Programme in PLWHA (on 
HAART) 
 
The results regarding participants’ adherence to the education and home-based walking 
programme are presented, firstly according to the baseline to six month timeframe, and 
then the six to 12 month timeframe below. 
 
6b.6.6.1 Adherence to the physical activity modification programme (baseline to six 
 month interval) 
 
Forty-two participants were randomised into the intervention group. Two of them did 
not receive the intervention programme because they did not return for their second 
baseline assessment (despite a number of attempts to reach them). Two additional 
participants dropped out at the start of the intervention: one moved to Zimbabwe to 
care for an ailing family member, and the second did not attend her first session 
despite a number of attempts to contact her. Adherence analysis of the baseline to 
six month interval was therefore calculated on the remaining intervention group 
participants (n=38). Table 6b.37 consists of information regarding the monthly 
adherence of participants to the intervention programme.  
 
Table 6b.37:  Adherence to the Physical Activity Modification Programme 
(Baseline to Six Months Interval) 
Variable n 
Session  
One 
n (%) 
Session 
Two 
n (%) 
Session 
Three 
n (%) 
Session 
Four 
n (%) 
Session 
Five 
n (%) 
Attendance of sessions 38 37 (97.4) 36 (94.7) 36 (94.7) 36 (94.7) 34 (89.5) 
Achieved pedometer goal 38 14 (36.8) 26 (68.4) 28 (73.7) 28 (73.7) 20 (52.6) 
Identified barriers 38 26 (68.4) 15 (39.5) 9 (23.7) 9 (23.7) 14 (36.8) 
Physical complaints 38 22 (57.9) 9 (23.7) 9 (23.7) 5 (13.2) 9 (23.7) 
Psychological complaints 38 7 (18.4) 11 (28.9) 6 (15.8) 4 (10.5) 7 (18.4) 
Implemented strategies 38 25 (65.8) 34 (89.5) 30 (78.9) 34 (89.5) 28 (73.7) 
 
Monthly contact sessions were not 100%-attended in the baseline to six month 
period. Reasons included financial constraints, work obligations and being out of 
Gauteng province in a specific month. Another participant dropped out at session 
two due to work obligations.  
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The lowest achievement of monthly pedometer step-count goals was noted in the 
first month. This was due to the highest percentage of participants experiencing 
barriers such as physical complaints. More participants achieved their monthly 
pedometer step-count goals at sessions two to four. The frequency of reports of 
barriers such as physical and/or psychological complaints decreased as the 
programme progressed. At session five a drop in the percentage of participants 
achieving their monthly pedometer step-count goal was again noted.  
 
From content analysis the barriers preventing participants from achieving their 
monthly pedometer step-count goals and enablers could be grouped into two broad 
categories: individual and contextual factors.  
 
Table 6b.38 outlines the individual, and Table 6b.39 the contextual factors that 
influenced ability to adhere to the physical activity modification programme in the 
baseline to six month period.  
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Table 6b.38: Individual Barriers Influencing Participants’ Adherence to the 
Physical Activity Modification Programme (Baseline to Six 
Month Interval) 
Sub-category Keywords/Key phrases Explanatory quotation/Information given in monthly sessions. 
Physical complaints 
Respiratory ailments 
“My day was not well and I had a rough day. My 
head was paining and I had flu” (Participant 30: 
Quote 1). 
Intestinal tract ailments “I was not feeling good. My stomach was very sore” (Participant 5: Quote 2). 
Dermatological ailments “Thursday too tired, my lower body itches (forgot about allergy)” (Participant 36: Quote 3). 
Low energy levels “I was so weak, I feel like sleeping because of tiredness” (Participant 57: Quote 4). 
Psychological 
complaints 
Poor motivation 
“My spirit was down. I just felt tired. Even my 
body was not okay. I just felt sick and I had 
stress” (Participant 6: Quote 5). 
Worrying about family  
“I was sad for that my mother is sick and I may 
lose her…I did not put my pedometer” 
(Participant 5: Quote 6). “I was worried because 
my daughter was sick since giving birth. She 
never stops bleeding and she is feeling very 
weak” (Photograph 23: Quote 7). 
Stress 
“I didn’t experience any problems, only pressure 
from the college. Just had a lot on my mind that 
kept me occupied” (Participant 64: Quote 8).  
Family 
responsibility 
Being the primary care 
giver 
“I was not feeling good as my son was sick, so I 
could not cope. But even though I did try my 
best” (Photograph 4: Quote 9). 
Travelling to family 
members 
“I was working very hard at home in Eastern 
Cape preparing for the funeral” (Participant 29: 
Quote 10). 
Significant family events 
“I did not have the chance/time to do my road 
works, because on Tuesday I lost my granddad” 
(Participant 84: Quote 11).  
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Table 6b.39: Contextual Barriers Influencing Participants’ Adherence to the 
Physical Activity Modification Programme (Baseline to Six 
Month Interval). 
Sub-category Keywords/ Key phrases Explanatory QUOTATION/Information GIVEN in Monthly Sessions 
Workplace 
Sedentary job 
“The week was challenging in that I was working 
shifts and I have to sit on a chair the whole shift 
and I then go home with transport” (Participant 50: 
Quote 12).  
Change in working hours or 
working activity 
“Tired after I was doing the housework and 
working in the shop the whole weekend” 
(Participant 29: Quote 13). 
Time of year Christmas “I could not reach my daily step-count because of Christmas things” (Participant 9: Quote 14).  
Physical 
environment Weather 
“It was not easy this week because it was very 
cold” (Photograph 229: Quote 15).  
 
“I am fine the weather is the problem” (Participant 
9: Quote 16).  
 
“The rain made it so hard for me” (Participant 42: 
Quote 17). 
 
“Tuesday and Wednesday my legs got swollen 
because of the heat and they were not painful. 
Very lazy I think because of the heat temperature” 
(Photograph 678: Quote 18). 
Social 
environment 
Domestic abuse 
“I was physically abused so I couldn’t do anything. 
I did nothing as I was not feeling well this week” 
(Participant 6: Quote 19). 
Incidences of crime 
No explanatory quotes noted, but information 
disclosed to researcher in discussion. One 
participant assaulted while walking home from 
wedding. One mugged and assaulted while 
walking in community. Handbag with diary and 
pedometer stolen in the incident. Burglary at 
participant’s home in which clothing with 
pedometer stolen.  
 
Table 6b.40 outlines the individual enablers that assisted participants to achieve 
their step-count goals in the programme.   
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Table 6b.40:  Individual Enablers Enhancing Participants’ Adherence to the 
Physical Activity Modification Programme (Baseline to Six 
Month Interval) 
Sub-category Keywords/Key phrases Explanatory quotation/Information given in monthly sessions. 
Family and 
friends 
involvement 
Motivation 
Active participation 
Support and 
encouragement 
“My husband helps me with walking. I was very 
happy and everything was going my way” 
(Photograph 38: Quote 18). 
 
“In the morning I walk a long distance with my 
child” (Participant 5: Quote 19). 
 
Family motivate participants not to sit too long and 
to go for walks so pedometers can register steps 
mentioned in discussions. 
 
Walking with friends and neighbours reported in 
discussions.  
 
Friends and family members attended monthly 
sessions with participants. 
Family 
responsibility Primary care giver duty 
Walking children to school and back a means of 
increasing step count mentioned in monthly 
discussions. 
Religion Church worship “We went to church and we danced a lot. I was feeling good” (Photograph 317: Quote 20). 
Home 
Housework Participants reported doing own housework as means of increasing step-counts. 
Indoor exercise Participants reported doing indoor exercises when it was raining outside. 
Dedicated 
walking 
Allocated time 
Participants allocated a time for walking after work 
and altered walking time to suit weather, e.g. early 
in morning before it becoming hot. 
Walking bouts 
Participants reported doing short bouts of walking 
in morning and afternoon and including it in daily 
activity. 
 
Table 6.41 outlines the contextual enablers that assisted participants to achieve 
their step-count goals in the programme.  
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Table 6b.41:  Contextual Enablers Enhancing Participants’ Adherence to the 
Physical Activity Modification Programme 
Sub-category Keywords/Key phrases Explanatory quotation/Information given in monthly sessions. 
Environment 
Rural community “We go for long distance to fetch water and wood” (Photograph 314: Quote 20). 
Community environment 
“After the ups and downs of the past weeks, I 
decided to go for a long walk to church and to 
gym. I felt good, happy and relief” (Participant 6: 
Quote 21). 
 
“I was walking around the field about 20 minutes” 
(Participant 5: Quote 22). 
Workplace logistics 
Transportation to work Walking to work as transportation reported in discussions. 
Increased activity at work Participants reported when very busy at work it was easy to attain step count goal. 
 
Section 6b.6.6.2 provides information regarding intervention participants’ adherence 
to the education and home-based walking programme in the six to 12 month 
interval, during which neither the researcher nor research assistants had any 
contact with participants. 
 
6b.6.6.2 Adherence to the education and home-based walking programme (six to 12 
month interval) 
 
Twenty-nine intervention participants attended the twelve month assessment and 
completed a post-intervention questionnaire.  
 
Fourteen (48.3%) of the 29 intervention participants signed the behavioural contract 
at the start of the programme and fifteen participants (51.7%) did not. Reasons for 
not signing were that participants felt it was not important (n=3; 20%) or forgot to 
sign (n=12; 80%).  
 
All the intervention participants (n=29; 100%) felt that wearing the pedometer 
motivated them to increase their physical activity level, and would advise others to 
use a pedometer if they too wished to increase their activity levels.  
 
They all found the monthly contact sessions in the baseline to six month period 
beneficial. They enjoyed the programme overall, and would recommend the 
programme to others.  
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Information from the post-intervention questionnaire provides explanations for their 
adherence to the education and home-based walking programme in the six and 12 
month period. Table 6b.42 is a representation of this adherence information 
supplied. 
 
Table 6b.42:  Adherence to the Physical Activity Modification Programme (Six 
to 12 Month Interval) 
Variable n (%) 
Participants who used the pedometer in this period 
 No 
 Yes 
 
8 (27.6) 
21 (72.4) 
Frequency of pedometer use and walking programme execution 
 One to three times per week 
 Four times per week 
 Five times per week 
 Daily usage of pedometer 
 Infrequent use of pedometer 
 Unable to use the pedometer due to equipment problems 
 Non-adherence to pedometer usage 
 
5 (17.2) 
4 (13.8) 
4 (13.8) 
6 (20.7) 
2 (6.9) 
1 (3.4) 
 7 (24.1) 
Pedometer step-count documentation in their diary in this period 
 No 
 Yes 
 
10 (34.5) 
19 (65.5) 
Participants who performed the warm-up and cool-down exercises regularly 
 No 
 Yes 
 
6 (20.7) 
23 (79.3) 
Performance frequency of warm-up and cool-down exercises 
 Daily 
 Weekly 
 Monthly 
 
13 (44.8) 
14 (48.3) 
2 (6.9) 
Participants who did not encounter programme difficulties in this period 
 No 
 Yes 
 
5 (17.2) 
24 (82.8) 
 
Eight (27.6%) participants did not continue with the pedometer-based walking 
programme in the six to 12 month interval. One of them could not do so as it fell to 
the floor and broke. The remaining participants who continued with the pedometer-
based walking programme did so at varying frequencies per week. The majority 
(n=19; 65.5%) continued to document their pedometer step-count in their education 
physical activity diary. Those who used the pedometer and did the walking 
programme, but did not document their pedometer step-counts, explained that they 
no longer had pages left in their diaries to use. The majority (n=23; 79.3%) 
continued with the warm-up and cool-down exercises and did these exercises 
mostly (n=14; 48.3%) weekly. Nine (31%) participants found palpating their pulse 
rate difficult and 12 (41.4%) did not monitor their pulse rate during exercise, but 
rather evaluated their breathing and/or ability to speak as means to monitor their 
exercise level.  
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Appendix 50 provides information regarding what information participants found 
most helpful in the monthly education sessions, as well as what they enjoyed most 
about the whole education and home-based walking programme.  
 
6b.6.7  Medication Changes During the Study 
At the 12 month assessment control and intervention participants were asked whether they 
had been started on additional medication or whether their current medication had been 
changed during the study. The following changes were reported, and could have influenced 
participants’ assessment findings: 
 
 One control participant who had diabetes mellitus reported that his daily dose of 
Glucophage had been reduced.  
 One intervention participant reported that her Statin dose had been reduced.  
 Two control participants had been initiated on Statin therapy.  
 
The medication of participants who had known hypertension did not change in the course of 
the physical activity modification period, and no-one was initiated on antihypertensive 
medication.  
 
Regarding HAART, all participants reported that they had used their medication as 
instructed by the clinic, but six reported that their medication had been changed in the 
course of the physical activity modification period.   
 
Section 6b.7 consists of a discussion of the results of the study, and is structured in the 
following way in relation to the objectives: 
 
 Risk of IHD among PLWHA (on HAART). 
 Effect of the education and home-based walking programme on the FRS of PLWHA (on 
HAART). 
 Effect of the education and home-based walking programme on behavioural risk factors 
for IHD among PLWHA (on HAART). 
 Effect of the education and home-based walking programme on clinical risk factors of 
IHD among PLWHA (on HAART). 
 Effect of the education and home-based walking programme on biochemical risk factors 
of IHD among PLWHA (on HAART). 
 Adherence to the education and home-based walking programme among PLWHA (on 
HAART). 
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6b.7  DISCUSSION 
The primary aim of study 4 was to implement a home-based pedometer physical activity 
modification programme in PLWHA at primary care level, as prevention strategy for IHD, 
and to evaluate the effects of that programme. The participants of the study were screened 
for the presence of risk factors of IHD in study 1 and included in the study if they had one or 
more risk factors of IHD present. The causes of cardiovascular disease are multifactorial, 
and risk factors are said to act together to increase overall risk (Silagy et al., 1993). 
Because of this interplay of risk factors, small adjustments in one, e.g. physical inactivity in 
the presence of the others, could possibly reduce the overall risk of IHD significantly (Sliagy 
et al., 1993). The aim was thus to look at the effects of the physical activity programme on 
pedometer physical activity level, and also to observe whether any changes occurred in 
secondary known modifiable risk factors for IHD. Findings would therefore shed light on 
whether a home-based pedometer physical activity modification programme would be able 
to influence a range of IHD risk factors, and, if so, could contribute to designing a low-cost 
programme to be implemented at primary care level.  
 
6b.7.1  Risk for IHD among PLWHA (on HAART) 
The FRS indicated that participants were at a low 10-year relative risk of IHD. This finding 
contrasted to findings reported by Cioe, Crawford and Stein (2013), where the risk of IHD 
was evaluated in a HIV population in Rhode Island, USA. The mean FRS in the authors’ 
study was 7.9 (±6.0), with 67%, 21% and 12% of study participants scoring in the low-, 
moderate- and high-risk categories respectively. The higher mean score and presence of 
individuals in the moderate- to high-risk categories could have been due to a number of 
reasons:  
 
Firstly, the authors’ sample consisted mostly of men (n=81; 62.3%), smokers (n=73; 56.2%) 
and relatively older individuals (47.9 [±8.4] years of age). The Framingham risk equation 
incorporates gender, age, smoking status, SBP, total cholesterol and HDL to calculate an 
individual’s score (Blom, 2011). A positive smoking status and advancing age result in 
higher scores when evaluating risk of IHD. Our study cohort, on the other hand, consisted 
mostly of women (n=66; 78.6%), non-smokers (n=75; 89.3%) and was a fairly young 
population (intervention group 38.7 [±8.9] years and control group 39.4 [±9.6] years). These 
differences might well have resulted in lower FRS. 
  
Secondly, PLWHA on HAART are said to have an increased risk of IHD, but the relative 
risk is reported to be stable up to eight years of treatment (Obel et al., 2007). The risk of 
IHD is also thought to increase when individuals are on a protease inhibitor-containing 
regimen, such as lopinavir-ritonavir (Worm et al., 2010). The population in Cioe, Crawford 
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and Stein’s study (2013) had been living with HIV for 14.6 (±7.9) years since diagnosis, and 
41.5% (n=54) of them were on a protease inhibitor-based antiretroviral regimen. In the 
current study time since diagnosis and length of HAART was much less, and only three 
individuals were on a protease inhibitor regimen. These additional differences could have 
resulted in the lower mean FRS, due to HAART having had less time to influence 
cholesterol profile. HAART is known to alter cholesterol profile unfavourably, with a 
protease inhibitor having the largest effect on the different parameters (Friis-Møller et al., 
2003).  
 
Lastly, the mean SBP, total cholesterol and HDL levels of the control and intervention 
groups were normal, and would therefore have had minimal influence on the FRS. When 
considering the relative risk of IHD it should be noted that risk factors that were more 
pronounced in the sample are generally not included in the FRS when assessing risk. Risk 
factors that were more pronounced were increased stress levels, BMI, physical inactivity 
and elevated Hs-CRP levels. It is thus understandable that the 10-year risk of IHD 
according to the FRS in the study cohort was low. The FRS is the recommended risk 
scoring system in the South African context, since it is a validated tool for a developing 
country and a multi-ethnic population (Klug, 2012). The Reynolds Risk Score might be 
suggested as an alternative IHD risk scoring system, as it incorporates hs-CRP (Ridker et 
al., 2007). The Reynolds Risk Score could also be beneficial in the South African HIV 
population where prevalence is higher among women, as it was developed for women, and 
has been validated in a multi-ethnic female population (Cook et al., 2012). A concern with 
this scoring system, however, would be that it was developed for women 45 years and 
older (Ridker et al., 2007). It can therefore not be used in younger women, where HIV 
prevalence is reported to be higher in the South African context (Stats SA, 2013). The need 
for an HIV-specific risk prediction tool that includes inflammatory parameters has been 
suggested as a means of improving IHD risk assessment in PLWHA (D’Angostino, 2012). 
Such a scoring system, incorporating Hs-CRP findings, could provide different relative risk 
results.  
 
The Hs-CRP level of the sample was elevated, the control group having a mean of 5.4 
(±6.6) mg/l and intervention group a mean of 8.6 (±8.4) mg/l at baseline (high risk of IHD: 
Hs-CRP > 3 mg/l). The secondary analysis, excluding the 15 individuals with the Hs-CRP 
values above 10 mg/l, still resulted in mean baseline values higher than 3 mg/l. A number 
of factors might have contributed to the elevated Hs-CRP value: an elevated CRP value is 
reported to indicate HIV disease progression, as it is linked with poorer immune parameters 
and inflammatory processes. Chaudhary et al. (2008) and Lau et al. (2006) both reported 
an inverse relationship between CD4 count and CRP values. Chaudhary et al. (2008) 
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reported that CRP results were highest where CD4 counts were less than 200 cells/mm3, 
and the authors considered it probably related to disease progression. Lau et al. (2006) 
likewise noted a positive relationship between increased viral load and CRP findings. They 
also found a progressive increase in CRP values over time regardless of whether 
individuals progressed to AIDS.  Noursadeghi and Miller (2005) also considered that the 
higher CRP values in PLWHA without intercurrent infections could indicate a sustained 
inflammatory response as a specific consequence of HIV infection. This finding is 
significant when one considers the relationship between chronic inflammation and the risk 
of IHD development over time. The findings with regard to the association of CD4 count and 
viral load with Hs-CRP in our study were, however, different from the literature (Chaudhary 
et al., 2008; Lau et al., 2006).  
 
In the current study the correlation at baseline between CD4 count and Hs-CRP was r=0.11 
(p=0.31), and between viral load and Hs-CRP was r=-0.12 (p=0.27), indicating no 
statistically significant relationship. The direction of the correlations, however, suggests that 
improved immune parameters could relate to higher Hs-CRP values. This finding, of no 
relationship between Hs-CRP and immune parameters, is supported by Guimaraes et al. 
(2008), as assessed when they evaluated cardiovascular and HIV infection factors. They 
reported that Hs-CRP was associated with traditional risk factors for IHD: WC (p=004), 
WHR (p<0.001), SBP (p=0.05), DBP (p=0.03), glucose (p<0.001), TG (p=0.001) and total 
cholesterol (p=0.01). In the current study a positive association between Hs-CRP and the 
following IHD risk factors were found: perceived stress levels, weight, BMI, waist and hip 
circumference.  
 
A positive association is known to exist between CRP values and anthropometric 
measures. Yudkin et al. (1999) noted that positive relationships exist between BMI, WHR 
and CRP respectively in healthy subjects. The association between WHR and CRP was 
supported by Dolan et al. (2005) when evaluating cardiovascular disease risk parameters in 
HIV-infected women compared to non-infected women. The authors noted that HIV-infected 
women had higher CRP values than non-infected women, but among all participants a 
strong association was found with WHR. Guimaraes et al. (2008) also reported that hs-CRP 
values were higher in PLWHA on HAART than HAART-naïve patients. The authors also 
confirmed the relationship between Hs-CRP and waist: hip ratio and, in addition, WC.  
 
An Hs-CRP above 3 mg/l is reported to indicate a high risk of IHD in the general population, 
due to the presence of chronic inflammation (Pearson et al., 2003). In the general 
population the risk ratio for IHD per one SD higher log-CRP concentration is 1.44 (1.32–
1.57) when adjusted for age, gender and conventional risk factors for IHD (Emerging Risk 
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Factors Collaboration, 2010). This increased risk of IHD with elevated Hs-CRP values is 
supported in an HIV population, as demonstrated by De Luca et al. (2013). These authors 
found that an Hs-CRP > 3 mg/l was independently associated with cardiovascular disease 
risk (De Luca et al., 2013). Triant, Meigs and Grinspoon (2009) also demonstrated that a 
raised CRP value and a positive HIV status were independently associated with AMI. The 
authors reported that the risk of AMI is increased four-fold in patients with HIV and an 
elevated CRP value when compared to patients without HIV infection and a normal CRP 
value. It can therefore be suggested that the study 4 cohort, with their elevated Hs-CRP 
values, is at an increased risk of IHD due to the presence of inflammation.  
 
The effect of the education and home-based walking programme on the FRS of PLWHA 
(on HAART) is discussed in section 6b.7.2.  
 
6b.7.2 Effects of the Education and Home-Based Walking Programme on the Framingham 
Risk Score of PLWHA (on HAART) 
 
The mean change in the FRS from baseline reduced progressively during the study in the 
control (six months: -0.86 [±0.60] and 12 months: -1.00 [±0.61]) and intervention groups (six 
months: -0.38 [±0.36] and 12 months: -0.86 [±0.49]). A significant between-group effect was 
however not observed (p=0.78). In the log-transformed univariate model a statistically 
significant (p<0.00) inverse association was noted between the interaction (time and 
treatment effect) and the FRS at the six month interval in individual intervention 
participants, compared to baseline control findings (MEM analysis). In the GEE analysis 
this association was noted to be borderline (p=0.05). An inverse association was therefore 
found between the education and home-based walking programme and FRS at the six 
month period.  
 
Literature regarding the effect of exercise on FRS in a HIV population is not available, and 
so information regarding such programmes in a general population is presented. Tully et al. 
(2005) conducted a 12-week pedometer walking programme in physically inactive 
individuals. Participants were given a pedometer with a diary and phoned every two weeks 
for motivation. The aim was to walk for 30 minutes five times per week. The authors found 
a significant decrease in the 10-year risk estimate for IHD based on SBP in both the 
intervention (p=0.032) and in the control groups (p<0.00). No between-group differences 
were noted. The authors used the FRS, but in analysis only the effect on blood pressure 
was used to evaluate effect. If the same type of analysis was done in the current study, 
similar results might have been found considering the significant within-group changes that 
occurred in the SBP in both the intervention and control groups. 
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On the other hand, Meikle et al. (2013) evaluated the effect of exercise in the Healthy Heart 
programme, as conducted at a prevention clinic in Vancouver, Canada. Individuals were 
referred to this clinic for preventative or secondary management of IHD. The study 
consisted of a retrospective chart review of a large sample (n=300) who attended the clinic 
six-monthly over a period of 4.9 years. The authors found that a significant reduction in 
RHR and FRS occurred if individuals were compliant with exercise suggestions and 
increased their frequency of performing 30 minutes of exercise per week. Resting heart rate 
in compliant individuals decreased by 5.9 bpm compared to 0.3 bpm in the “no exercise 
change” group. A reduction of 15.7% to 13.4% was observed in the 10-year FRS. Similarly, 
Richardson et al. (2008) found a reduction of 13.1% to 12.3% in the 10-year FRS in a 12-
month community behavioural intervention, consisting of smoking cessation, exercise and 
diet changes. Both these studies had higher mean baseline FRS results and a larger scope 
for improvement than the current study.  
 
Section 6b.7.3 consists of a discussion of the effects of the education and home-based 
walking programme on the behavioural risk factors assessed in the study.  
 
6b.7.3 Effects of the Education and Home-Based Walking Programme on Behavioural Risk 
Factors for IHD among PLWHA (on HAART) 
 
This study is the first to provide information regarding the effects of a home-based 
education and pedometer physical activity programme on IHD risk factors in PLWHA on 
HAART. The effects of the education and home-based walking programme on the following 
behavioural risk factors for IHD will be discussed in this section: pedometer-determined 
physical activity, 6MWT distance and perceived stress levels.  
 
The education and home-based walking programme resulted in statistically significant 
(p=0.03) within-group increases in pedometer-determined physical activity levels in the 
control (mean change: 1 123.41 [±422.12] steps/day) and intervention (mean change: 
5 935.37 [±2 186.47] steps/day) groups at the six month assessment period. No statistically 
significant changes were however observed at the 12 month assessment period: control 
group (mean change: 817 [±500.86]; p=0.33) and intervention group (mean change: 
3 809.96 [±2 041.44]; p=0.21). The change in the intervention group at this time point was 
however still clinically significant as the change in step count from baseline exceeded the 
aim of the programme: 3 000 steps from baseline value. No statistically significant between-
group change (p=0.49) occurred during the programme as assessed with the repeated 
measure ANCOVA.  
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No published information regarding the effects of a pedometer walking programme in 
PLWHA is available, and findings from studies conducted in a general population are 
therefore presented for comparison. Access to a pedometer while performing a walking 
programme is reported to be effective in increasing ambulation physical activity levels. In a 
systematic review Bravata et al. (2007) found that pedometer use was associated with 
significant increases in physical activity levels. The magnitude of step-count change 
differed between the various clinical trials, but ranged from 395 to 5 066 steps per day. 
Including a step-count goal or step diary were key motivating factors in clinical trials. In 
trials where participants received a specific goal, e.g. walk more than 10 000 steps per day, 
or an individualised step goal, significant increases in physical activity levels occurred. 
Trials in which this was absent showed no statistically significant change in physical activity 
level from baseline (Bravata et al., 2007). Musto et al. (2010) likewise found that 
implementing a step-count goal in sedentary overweight women where the goal was to 
increase incrementally resulted in significant changes in pedometer-determined step-
counts. The incremental step-count programme implemented in the authors’ study was an 
increase of 10% of baseline step-count weekly. The authors observed a change of 5 646 (± 
1 328) steps per day in intervention participants over their 12-week physical activity 
programme.  In the current study the intervention group improved their step count more 
than the control group. This increase in pedometer-determined step-count at six months 
could therefore be the result of having had an individualised incremental step-count goal 
combined with the step diary, as supported by Musto et al. (2010) and Bravata et al. (2007). 
The beneficial effect of receiving the education material and its motivating effect on 
increasing physical activity levels should also not be excluded. 
 
Vallance et al. (2007) evaluated the effects of different motivation methods for promoting 
physical activity amongst breast cancer survivors over a 12-week programme. The clinical 
trial had four management arms: individuals who received standard verbal recommendation 
to perform 30 minutes of moderate activity per week; those who received printed education 
material regarding breast cancer; those who received a pedometer, and, lastly, those who 
received printed material and a pedometer. The physical activity time increase from 
baseline to the 12-week assessment per group was: standard advice, 30 minutes per week; 
printed material, 70 minutes per week; pedometer, 89 minutes per week and the combined 
group, 87 minutes per week. Receiving education material compared to standard advice 
more than doubled the effect, but was less effective than combining the education material 
with a pedometer. It is, however, interesting that providing a pedometer was the most 
effective in increasing physical activity levels. The influence of the education physical 
activity diary combined with the pedometer would thus also have contributed to the 
increase in pedometer step-count observed in the current study.  
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Conflicting information is available regarding the effectiveness of physical activity 
counselling as a means of motivating individuals to increase their physical activity level. 
This counselling is supported in literature as a means of improving health by promoting an 
increase in physical activity levels (American College of Sports Medicine, 2014; Williams, 
2013; Hawk, 2010). Bravata et al. (2007), however, found that it did not result in an 
increase in participants’ pedometer steps per day. The authors reported that this could 
have been due to the different counselling methods used in the clinical trials included in the 
systematic review.  Similarly, Eden et al. (2002) reported that there was inconclusive 
evidence regarding the effect of physical activity counselling when provided by a patient’s 
primary care clinician (nurse practitioner, nurse, physician or physician’s assistant). In this 
review studies involving pedometers were not included, and the counselling was done in 
different ways. Counselling sessions differed with regard to time, number of sessions and 
whether education material was provided. Frerichs et al. (2012), on the other hand, 
indicated that counselling patients effectively regarding changing lifestyle behaviour is 
possible. The authors conducted a systematic review, analysing seven clinical trials that 
focused on lifestyle behavioural change in terms of physical activity and/or diet, or both 
aspects combined. The authors noted that the counselling performed by physiotherapists 
had an influence in the short term on outcomes. In addition, Fitzsimons et al. (2012) 
evaluated the effect of two approaches to delivering a pedometer-based activity programme 
on physical activity levels in low-active Scottish men and women over a 12 month period. 
One included physical activity counselling, while the other did not. The authors found that 
the group that received physical activity counselling had higher physical activity levels, and 
more of these participants had achieved their step-count goals at the 12 month period. The 
differences were, however, not statistically significant. In the current study physical activity 
levels, as determined with the pedometer, increased significantly from baseline to six 
months, but a drop in activity was noted in the six- to 12 month period. In that period the 
motivational aspects related to the counselling sessions and SMS prompts were absent. 
The effect on behaviour regarding physical activity level related to these components of the 
intervention cannot, therefore, be dismissed as ineffective.  
 
Despite the decreased pedometer-determined step-count of the intervention participants 
from the six-month interval, they nevertheless logged more steps per day than the control 
group. Considering that they were less active than the control group at baseline, they 
subsequently improved their pedometer physical activity level by 3 809.96 (±2 041.44) 
steps per day from baseline to 12 months. These additional steps would correspond to an 
estimated 38 minutes of additional walking per day at 12 months, assuming that they 
walked at a moderate intensity level of 100 step.min-1 (Marshall et al., 2009). The increased 
step-count was of clinical value, as they were accumulating in excess of 30 minutes of 
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walking per day, as recommended by the public health physical activity guidelines (Haskell 
et al., 2007). The pedometer physical activity category of the intervention group also 
improved over time when considering their increase in step-count. The mean baseline step-
count was 6 888.1 (± 2 925.8) steps per day (“light active”) and, with the additional steps at 
12 months, the intervention group progressed to “active”, with a daily step-count of above 
10 000 steps per day (Tudor-Locke and Bassett, 2004). The inclusion of the pedometer in 
this period and the education received in the earlier part of the intervention, therefore, 
continued to motivate participants to becoming more physically active than they had been 
at baseline.  
 
It is interesting to note that control participants’ pedometer-determined steps per day also 
increased from baseline to six months followed by a small drop in steps per day in the six- 
to 12 month period, despite not having a pedometer or education physical activity diary. At 
six months the control participants accrued an additional 1 123.41 (±422.12) steps per day 
that would correspond to an estimated 11 minutes of additional walking per day. That 
increase could be of clinical value. The control group’s management consisted of phoning 
participants once a month in the baseline to six month assessment period. In these calls 
they were asked about their general health and whether they were still within the Gauteng 
province. They received no advice regarding exercise or how to increase their physical 
activity levels. Merely knowing that they were participating in a clinical trial where physical 
activity was being assessed, besides participating in the assessments and receiving the 
monthly phone calls, could have raised their awareness of their activity level, and motivated 
them to improve. This suggestion regarding how participating in assessment in clinical trials 
could influence control participants to increase their physical activity level is supported by 
Sheedy et al. (2000) and Frerichs et al. (2012). A reduction in the control participants’ steps 
per day occurred between the six to 12 month assessments. This is an important finding in 
that it supports motivational contact, whether face-to-face or by telephone has potential for 
influencing individuals’ physical activity levels as found in the intervention group.   
 
Results for the intervention group from baseline to 12 months show an increase in the 
mean distance walked in the 6MWT. By comparison the control group’s results indicated a 
decrease in the same period. The between-group changes in 6MWT were statistically 
significant (p=0.01) and the programme therefore resulted in an improved physical function 
capacity in the intervention group. Similarly, Serwe et al. (2011) found a significant increase 
in 6MWT distance in an eight-week pedometer walking programme when participants not 
infected with HIV were encouraged to accumulate 30 minutes of walking per day. 
Established minimal clinically important difference for the 6MWT is not available for PLWHA 
but 6MWT findings from another study are available for comparison. Dolan et al. (2006) 
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noted a significant improvement in 6MWT distance (p<0.00) of 34 (±11) meters in their 
intervention group. The authors evaluated the effects of a supervised home-based exercise 
programme in women living with HIV in Boston, USA. The programme involved home visits 
to participants three times per week where strengthening, flexibility and aerobic exercises 
were performed over 16 weeks. It is important to note that the cohort of Dolan et al. (2006) 
had more room for improvement in 6MWT distance than the current study, as their baseline 
findings were: intervention group, 489 (±20) meters and control group, 474 (±14) meters, 
compared to the current study’s 6MWT findings of: intervention group, 540 (±71.6) meters 
and control group, 547.8 (±56.9) meters. The lower 6MWT distance baseline finding in 
Dolan et al.’s study (2006) could be due to their cohort consisting of a slightly older 
population (intervention group, 43 [±2 years] and control group, 40 [±2 years]). In addition, 
study participants also had a higher BMI baseline value (intervention group, 29.3 [±1.4] 
kg/m2 and control group, 28.6 [±1.6] kg/m2) than the current study. The effect of age and 
BMI on predicted 6MWT distance is well-reported in the literature (Troosters, Gosselink and 
Decramer, 1999; Enright and Sherrill, 1998). Even though the mean change in the current 
study was smaller, the improvement in 6MWT distance brought the intervention group 
closer to the predicted normal value for healthy individuals (571 [±90] m) (Casanova et al., 
2011).  
 
In addition, the log-transformed univariate model showed a positive association between 
6MWT distance and the interaction (time and treatment) at six months for both control and 
intervention groups: at group level (GEE), and at six months intervention group at individual 
level (MEM). Therefore the increased pedometer physical activity levels at six months were 
associated with an increase in 6MWT distance. This positive association indicates that the 
potential for an increase in 6MWT distance and improved functional exercise tolerance 
level was possible, especially in the intervention group, as demonstrated by GEE and MEM 
analysis. The education and pedometer walking programme could therefore be a means of 
improving functional exercise tolerance in PLWHA.  
 
In study 1 the moderately high perceived stress levels in participants were of concern. 
Stress was also a reason for study 2 participants perceiving themselves to be at risk of 
developing IHD. A statistically significant association (p=0.03) between Hs-CRP and 
perceived stress was observed at baseline, and, considering the association reported to 
exist between Hs-CRP and IHD, this finding was of concern.  Assessing the effect of the 
education and home-based walking programme on perceived stress levels of participants 
was therefore an important objective, as stress was a recurring theme throughout the 
research project.  
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The within-group analysis indicated that a reduction in perceived stress levels occurred in 
the control (six months: mean change -1.95 [±1.14] and 12 months: -0.98 [±1.00]) and 
intervention (six months: mean change -1.76 [±1.02] and 12 months: -2.12 [±1.01]) groups 
overtime but progressively more so in the intervention group. No significant (p=0.61) 
between-group effect was however noted. However, a statistically significant inverse 
relationship (p<0.00) between perceived stress level and pedometer-determined physical 
activity at the six-month interval was observed in the intervention group at both group 
(GEE) and also individual levels (MEM), compared to the baseline control group in the log-
transformed univariate analysis. This inverse relationship was confirmed in the multivariate 
logistic regression analysis. It shows that, as the physical activity level in the intervention 
group improved, perceived stress declined. This relationship was not observed in the 
control group.  
 
The reduced stress association observed in the intervention programme at this sixth month 
stage could have been due to the combined effects of the exercise programme and the 
physical activity counselling sessions. The counselling most probably provided a supportive 
environment for participants.  Perceived support was also reported in the post-intervention 
questionnaire. The importance of a support structure was highlighted in study 2 as a coping 
mechanism for participants. The physical activity counselling sessions could therefore have 
indirectly improved participants’ coping behaviour, and resulted in additional stress 
reduction.  There is no literature on the effects of a pedometer walking programme on 
perceived stress levels in either the general or HIV population. Two study protocols, 
however, have been published: one in a general population consisting of university staff 
(Ainsworth et al., 2012) and another in PLWHA (Jaggers et al., 2013). Comparison with this 
study’s findings will be possible when findings from those studies become available. 
Likewise, no information with regard to the effect of a structured exercise programme on 
stress reduction in PLWHA has been published. Studies done in PLWHA indicate that 
exercise is beneficial in improving certain parameters, including psychological components. 
These psychological parameters are: an improvement in quality of life (Ogalha et al., 2011; 
Mutimura et al., 2008), improvement in life satisfaction (Gomes et al., 2010), improvement 
in self-efficacy (Fillipas et al., 2006) and reduction in symptoms of depression (Neidig, 
Smith and Brashers, 2003). Neidig, Smith and Brashers (2003) in addition to determining 
the effect of exercise on depressive symptoms, assessed their cohort’s stress levels with 
the PSS-4. The outcome of their intervention was however not assessed according to the 
PSS-4 and changes in PSS-4 between the exercise and control groups also not reported 
on. The current study thus builds on the body of knowledge of the beneficial effects of 
exercise on psychological parameters that present in PLWHA.  
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The effects of the education and home-based walking programme on the clinical risk 
factors for IHD assessed are discussed in section 6b.7.4. 
 
6b.7.4 Effects of the Education and Home-Based Walking Programme on Clinical Risk 
Factors for IHD among PLWHA (on HAART) 
 
The clinical risk factors for IHD assessed in the study were RHR, blood pressure and the 
anthropometric measures (weight, BMI, WC and WHR).  
 
No statistically significant changes in RHR and DBP were observed between the control 
and intervention groups. The within-group changes did however indicate a slight reduction 
in these parameters overtime with more pronounced changes occurring in the intervention 
group. The education and home-based walking programme did not influence these 
parameters significantly. The study’s findings regarding DBP were similar to those of Dolan 
et al. (2006) that evaluated the effects of a structured home-based exercise programme in 
women living with HIV. The authors likewise noted no statistically significant (p=0.21) 
changes in DBP (intervention group: -3 [±2] mmHg and control group: -2 [±2] mmHg) in 
their study participants in the 16 week programme. The RHR findings were in contrast to 
Ogalha et al. (2011) who evaluated the effect of aerobic exercise and counselling on diet 
and physical activity in PLWHA. Authors observed a significant change in their intervention 
group (pre-: 74.09 [±7.09] bpm and post-intervention: 70.30 [±6.44] bpm; p=0.001). In this 
study intervention participants were encouraged to perform one hour of aerobic activity 
such as walking, cycling or running at least three times per week. The greater change in 
RHR in their study could have been due to the higher activity time and possibly greater 
intensity-level than the current study.  
 
In the current study a significant reduction in SBP was noted in the within-group analysis in 
both the control (mean change: -4.24 [±1.58] mmHg; p=0.03) and intervention (mean 
change: -5.07 [±1.26] mmHg; p<0.00) groups at the six month assessment period. These 
mean change results are similar to findings from Tully et al. (2007) in which participants 
performed a walking programme 30 minutes/ three times a week (SBP reduction: 4.51 
[±8.77] mmHg) compared to five times a week (SBP reduction: 6.00 [±9.72] mmHg). It is in 
contrast to findings from Dolan et al. (2006) where authors noted an increase of 1 (±4) 
mmHg in intervention and 3 (±4) mmHg in control groups’ SBP readings. In the current 
study, the changes in SBP at 12 months were not significant in either group but their SBP 
findings at this time point was still lower than baseline and more so in the intervention 
group. The between-group effect was however not significant for SBP (p=0.14). 
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Conflicting findings are given in the literature related to pedometer programmes and the 
effect on cardiovascular parameters. Iwane et al. (2000) indicated that blood pressure of 
hypertensive patients could be lowered from 149 (±2.7)/ 98.5 (±1.4) mmHg to 139.1 (±2.0)/ 
90.1 (±1.9) mmHg if they walked 13 510 (±837) steps per day for 12 weeks. Musto et al. 
(2010) indicated that an incremental 12-week programme conducted in the general 
population with 10 000 steps per day as an aim could have a significant within-group 
reduction in intervention participants’ RHR. The reduction in RHR recorded in that study 
was 2.8 (±3.5) bpm. This was, however, not the case in the between-group comparison of 
the authors. On the other hand, Serwe et al. (2011) found no statistically significant 
changes in SBP or RHR when women performed short (10 minutes three times per day) or 
long (30 minutes) bouts of walking per day. The authors did, however, notice a significant 
decrease in DBP in the group that performed short bouts of walking. In addition, Gray et al. 
(2009) and Baker et al. (2008) noted no significant change in blood pressure in a 12-week 
pedometer-based walking programme where the aim was to accumulate 3 000 steps daily. 
The differences in findings among studies could be due to length of programmes, 
participants’ adherence, and whether participants were evaluating parameters to ensure a 
moderate-intensity walking pattern, such as heart rate or breathlessness during walking 
bouts. 
 
An increased BMI was highlighted in study 1 as a risk factor. It was therefore important to 
evaluate whether the education and home-based walking programme could influence 
weight and BMI.  
 
The mean weight and BMI of the control and intervention groups increased between each 
assessment period with BMI changes being significant. The between-group analysis 
showed no significant effect in either weight (p=0.13) or BMI (p=0.33). This finding is similar 
to Dolan et al. (2006), who found no statistically significant change (p=0.34) in BMI when 
women living with HIV participated in a structured home-based exercise and resistance 
programme. The mean changes observed in the authors’ study were as follows: 
intervention group an increase of 0.4 (±0.2) kg/m2 and control group a reduction of 0.1 
(±0.4) kg/m2. Similarly, Ogalha et al. (2011) noted no significant (p=0.06) change in BMI in 
their PLWHA intervention group when performing one hour of aerobic exercises three times 
per week.  
 
 In the current study the log-transformed physical activity model indicated a significant 
inverse relationship between weight and BMI with the physical activity modification 
programme respectively. The relationship was observed in the intervention group at six and 
12 months at group- (GEE) and individual level (MEM), and also in the control group at six 
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months (GEE). The association between BMI and the interaction (time and treatment effect) 
was confirmed in multivariate analysis. The interaction could possibly lead to weight loss, 
even though this was not observed in either the control or intervention groups. This is in 
keeping with the literature concerning the effect of pedometer-based walking programmes 
on weight loss in the general population. Richardson et al. (2008) demonstrated in a meta-
analysis that the range of weight change in such programmes was +0.30 to -3.70 kg. The 
authors suggested that the average participant in such a programme could expect to lose 
about one kg without implementing dietary change. Musto et al. (2010) also reported a 
modest weight reduction of 0.8 (±1.0) kg and a reduction of 0.3 (±0.4) kg/m2 in BMI, in their 
incremental 12-week pedometer-based walking programme with sedentary, overweight 
women. Serwe et al. (2011), on the other hand, found no change in either weight or BMI of 
their study participants in an eight-week pedometer walking programme. Weight loss in 
pedometer-based walking programmes is therefore expected to be modest.  
 
Encouraging more than 12 000 steps per day might have resulted in actual weight loss, 
thereby influencing BMI. Tudor-Locke et al. (2008) reported that taking more than 12 000 
steps per day is associated with a healthy body-weight category of BMI < 25 kg/m2 in a 
general population. Adding dietary counselling to the current physical activity programme 
might have further enhanced weight loss in PLWHA at primary care level. The current 
format of the education and home-based walking programme might therefore be suggested 
as a means to maintaining PLWHA’s weight and BMI at a stable level, instead of reducing it 
significantly over the longer term.  
 
Central obesity was evaluated by WC and WHR measurements. The within-group analysis 
indicated that WC decreased in the control and intervention groups at the six month 
assessment period compared to baseline. At 12 months, both groups however had an 
increase in WC when compared to their baseline findings. The within-group and between-
group effect on WC were not significant. This was in contrast to findings from Dolan et al. 
(2006) as authors noted a significant between-group effect (p=0.03). The authors noted that 
their intervention group had a reduction of 1 (±0.6) cm and their control group an increase 
of 1.5 (±1.0) cm after their 16 week supervised home-based programme. Similarly, 
Mutimura et al. (2008) found a significant between-group effect in WC (p<0.0001) when 
PLWHA attended a centre-based supervised aerobic and strengthening programme. The 
authors noted that their intervention group reduced their WC by 7.13 (±4.4) cm and their 
control group’s WC increased by 0.03 (±10.7) cm. It therefore seems that programmes that 
include direct supervision and include exercises that strengthen the abdominal wall 
(Mutimura et al., 2008) will have a larger effect on WC in PLWHA. 
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With regards to WHR changes, the intervention group had a reduction in WHR at the six 
month period and this reduction was maintained at the 12 month assessment. In 
comparison, the control group’s WHR had a reduction at six months but then at 12 months 
they had an increase in WHR when compared to their baseline finding. The within-group 
changes were not statistically significant but the differences led to a statistically significant 
between-group effect (p<0.00). Waist: hip ratio changes in the intervention group in the 
current study was less than that noted by Mutimura et al. (2008):  reduction of 0.10 (±0.1). 
This might have been due to the current study not including strengthening exercises that 
could have resulted in greater weight loss at the waist of participants as was done by 
Mutimura et al. (2008).  
 
The current study’s findings are supported by Baker et al. (2008) with regards to effect on 
WC not being significant. They implemented a 12-week pedometer walking programme at 
community level with an accumulation of 3 000 steps as a goal. Central obesity parameters 
recorded in Baker’ study (2008) were as follows: WC in intervention group (pre-: 89.5 
[±12.6] cm to post-intervention: 89.9 [±12.6] cm) and control group (pre-: 90.4 [±14.6] cm to 
post-intervention: 91.1 [±15.6] cm). Additionally the authors findings regarding WHR 
changes were: intervention group (pre-: 0.82 [±0.08] to post-intervention: 0.83 [±0.08]) and 
control group (pre-: 0.82 [±0.09] to post-intervention: 0.82 [±0.09]). Gray et al. (2009), who 
also implemented a 12-week pedometer walking programme with an accumulated 3 000 
steps as a goal, had similar findings to Baker et al. (2008), but contrasting findings to the 
current study. The authors found no significant changes in WHR as reflected by the 
following findings: intervention group (pre-: 0.81 [±0.08] to post-intervention: 0.81 [±0.08]) 
and control group (pre-: 0.82 [±0.10] to post-intervention: 0.82 [±0.09]). In contrast, Tully et 
al. (2007) found significant changes in WC of study participants in a pedometer-based 
walking programme. Participants had to walk briskly for 30 minutes three or five days/week, 
document their steps, time walked and breathlessness in their activity diary. Contact with 
participants was also made every two weeks. The changes in WC that Tully et al. found 
was as follows: three times per week (reduction of 2.63 [±4.05] cm; p<0.001) and five times 
per week (reduction of 2.48 [±4.20] cm; p<0.001). No significant changes in WHR were 
however noted by Tully et al. (2007). The increased contact and self-monitoring of the 
parameters recorded in participants’ diaries could have influenced their findings. 
Additionally, having participants walk 30 minutes from the beginning of the programme 
could have contributed to their results.  
 
In the current study an inverse, statistically significant, association in WC and the 
interaction at the six and 12 month intervals of the intervention group compared to the 
baseline control group findings was found in the log-transformed model. The beneficial 
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effects of supervised structured exercise programmes, consisting of aerobic and resistance 
training, on abdominal obesity in PLWHA have been well documented. Such programmes 
were found to be effective in reducing WC (Mutimura et al., 2008; Dolan et al., 2006) and 
WHR (Mutimura et al., 2008). The current study thus adds to the body of knowledge related 
to the effect of exercise on WC in PLWHA. It also possibly provides an alternative method 
for influencing WC in PLWHA, by implementing an activity programme that requires fewer 
man-hours to implement, as it promotes self-management.  
 
The effects of the education and home-based walking programme on the biochemical risk 
factors for IHD evaluated in the study are discussed in section 6b.7.5 below. 
 
6b.7.5 Effects of the Education and Home-Based Walking Programme on Biochemical Risk 
Factors of IHD among PLHV (on HAART) 
 
The biochemical risk factors for IHD assessed in the study consisted of glucose, lipid profile 
(total cholesterol, HDL, LDL and TG) and Hs-CRP. A statistically significant within-group 
change occurred in total cholesterol (p=0.04) and LDL (p<0.00) in the control group at the 
12 month assessment when compared to their baseline findings. The initiation of Statin 
therapy in two control participants in the course of the investigation period might have 
contributed to the within-group changes noted in these lipid profile markers in the control 
group. Statins are recommended drugs for the management of hypercholesterolaemia, as 
they are known to lower total cholesterol and LDL levels (NCEP ATP-III, 2002). No 
statistically significant changes occurred in biochemical markers assessed in the 
intervention group.  
 
The education and home-based walking programme had no statistically significant 
between-group effect on total cholesterol, LDL, TG and Hs-CRP. A significant between-
group effect was observed in glucose (p<0.00) and HDL (p=0.01) respectively. The log-
transformed physical activity model indicated a statistically significant between-group 
association between the interaction (time and treatment) and total cholesterol, LDL and TG 
respectively at the six month interval for the intervention group compared to baseline 
control group findings. This was, however, shown with the MEM analysis, indicating an 
association between the interaction (time and intervention management) and these 
parameters in individual intervention participants, compared to individual control 
participants. With further multivariate logistic regression analysis a statistically significant 
inverse association between the interaction (time and treatment effect) and LDL and TG 
was still observed in MEM analysis. The physical activity modification programme, 
therefore, is possibly an effective method for addressing these risk factors in PLWHA at 
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individual level. The effect of the education and home-based walking programme on lipid 
profiles might be explained by considering the baseline lipid profile results.  
 
The mean total cholesterol, HDL, LDL and TG results of both the intervention and control 
groups were within normal limits at baseline, according to the Adult Treatment Panel III 
Guidelines of the National Cholesterol Education Programme (2002). Abnormal values in 
total cholesterol, HDL and LDL must have been present in individual control and 
intervention participants when one considers the standard deviations of these results. As a 
result, improvement in these parameters might be reflected in the MEM analysis. Even if 
favourable changes had occurred in individuals with normal lipid profile values, the finding 
is still of benefit, considering the known variable degree of dyslipidaemia that is said to 
develop in PLWHA on HAART (Grinspoon and Carr, 2005). The minimal change in lipid 
profile can also be explained in terms of the energy expenditure elicited by the walking 
programme which may have been suboptimum. 
 
Research indicates that exercise can influence lipid profile favourably, though only when a 
particular exercise threshold is reached. This threshold is the accumulation of 24 to 32 
kilometres of brisk walking or jogging per week, that results in an energy expenditure of 1 
200 to 2 200 kilocalories per week (Durstine et al., 2001). Walking 2 000 steps is said to 
result in an energy expenditure of 100 kilocalories (Thompson et al., 2008). It is thus 
possible that the intervention group did not meet the energy expenditure required to 
facilitate a marked change in the lipid profile. An increased intensity, by walking more than 
the stipulated 3 000 steps per day above their baseline level, might therefore have had a 
more favourable response than the one observed. Combining dietary advice with the 
walking programme might also produce more favourable results in lipid profile. 
 
The current study’s results are supported by pedometer-based walking programme 
literature. Bravata et al. (2007), in a systematic review of effects of pedometer-based 
walking programmes, found no statistically significant changes in glucose level and lipid 
profiles in the trials under review. The authors suggested that this might be due to 
normative values at baseline. Musto et al. (2010) also found no statistically significant 
between-group or within-group changes in TG or HDL values when an incremental 10 000 
steps per day programme was implemented in sedentary overweight women for 12-weeks. 
The authors suggested that their findings might be due to participants not reaching an 
adequate energy expenditure level in the intervention. Bell et al. (2010), however, found a 
statistically significant change in TG and glucose level in an incremental 10 000 steps per 
day programme when they performed the programme for seven days per week over a six 
month period. They found no significant changes in total cholesterol, HDL or LDL. Baker et 
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al. (2008) found no significant changes in total cholesterol or HDL in a 12-week walking 
programme where participants had to incrementally increase their step count with 3 000 
steps. Gray et al. (2009) also found no significant changes in glucose level in a 12-week 
walking programme where participants increased their step count by 3 000 steps. On the 
other hand, Tully et al. (2007) noted a significant change in log-transformed TG in a 12-
week walking programme when participants performed a 30 minute walk three times per 
week. Results therefore vary depending on length of trial, pedometer prescription 
(incremental step increase, or 10 000 steps, or time length of walk), and the number of 
days walking is performed (e.g. daily or three times per week). 
 
This study showed elevated Hs-CRP values in the sample at baseline, and it was therefore 
important to assess whether the education and home-based walking programme could 
influence this parameter. No significant between-group or within-group changes occurred in 
hs-CRP in the investigation period. This might have been due to the close relationship 
observed between anthropometric measures and Hs-CRP. If a significant change in 
anthropometric measures had occurred, it might have resulted in reduced Hs-CRP. In the 
MEM model a significant inverse association between the interaction (time and treatment 
effect) and Hs-CRP and the intervention group at six and 12 months compared to baseline 
control findings was observed. The interaction thus has the potential to decrease Hs-CRP, 
even though no significant change in the Hs-CRP was observed in the current study.  
 
Published findings regarding the effect of a pedometer-based walking programme on hs-
CRP are limited. One such study was found: Gray et al. (2009) conducted a 12-week 
community pedometer-based walking programme in individuals that perceived themselves 
as not meeting public health physical activity recommendations. Participants were 
randomised to control and intervention groups, and control participants were asked to 
continue with their normal activity during the programme. The intervention participants 
received a pedometer and physical activity counselling formulated to assist them in 
increasing their step-count by 3 000 steps per day on at least five days of the week. They 
were asked to perform brisk walking during the programme. The authors found no 
significant between- or within-group changes in weight, BMI, body fat, WHR, blood 
pressure, glucose, insulin, Hs-CRP, IL-6, soluble IL-6 receptor, TNF-α, soluble TNF 
receptor I or II following the programme. Certain secondary outcomes (body fat, blood 
pressure, WHR, glucose and insulin) were within normal ranges, and the programme would 
therefore have had minimal effect on these parameters. The authors did, however, indicate 
that the intervention group increased their pedometer-determined physical activity levels 
significantly (p<0.001), increasing it by 3 300 (± 2 215) steps per day over the 12 week 
period. It could be suggested that their results in the secondary outcomes might have been 
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significant if their intervention period had extended over a longer timeframe or the 
pedometer step-count goal had been higher.  
 
Conflicting findings regarding the effect of exercise on CRP are seen in general exercise 
studies conducted in less-active individuals. Some authors noted no change in CRP values 
in exercise programmes with sedentary overweight men and women (Stewart et al., 2009; 
Campbell et al., 2008). The length of the interventions were six and 12 months respectively.  
Other authors reported a reduction in CRP values in an exercise programme with less-
active individuals (Campbell et al., 2009; Viera et al., 2009). The authors did note that this 
result was related to a significant reduction in trunk fat (Viera et al., 2009) if individuals were 
obese or had an abnormal WC value at baseline (Campbell et al., 2009). In addition, Selvin, 
Paynter and Elinger (2007), in a systematic review, reported weight-loss associated with a 
reduction in CRP value when lifestyle and surgical interventions were evaluated. The 
authors reported that a reduction of one kg of weight produced an estimated reduction of 
0.13 mg/l in CRP results. Findings with regard to Hs-CRP in the current study could thus be 
explained by the study sample not being obese and not having abnormal WC values at 
initiation, as well as no change in weight over time.  
 
The last objective of the study was to monitor and evaluate participants’ adherence to the 
education and home-based walking programme. Discussion of this follows, Section 6b.7.6, 
below.   
 
6b.7.6 Adherence to the Education and Home-Based Walking Programme among PLHV (on 
HAART) 
 
The final objective of the study was to monitor adherence to the intervention in the 
baseline-to-six month interval, and identify the barriers and enablers that influenced 
adherence to the programme. A second interest was to identify whether and how 
participants continued with the intervention in the six- to 12 month interval, being reliant 
solely on what they had learned earlier, and equipped with a pedometer for self-monitoring. 
Adherence is defined as taking one’s medication and other interventions, e.g. exercising 
correctly, as prescribed in the programme (Reda and Biadgilign, 2012). Others, discussing 
exercise programmes in the HIV sector, defined adherence more leniently, as attending 
50% of exercise sessions (O’Brien et al., 2010). Adherence in pedometer literature is 
usually defined as the number of days walked as a percentage of the total number of days 
prescribed (Serwe et al., 2011; Tully et al., 2007). In the current study adherence was 
assessed by attendance of face-to-face sessions and whether participants achieved their 
walking aim each week during the preceding month. 
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The monthly adherence to attendance of face-to-face sessions with the researcher at the 
clinic ranged between 89.5%-97.4%. This high attendance was possible because it was 
only monthly, and efforts were made to schedule the sessions to coincide with regular clinic 
visits. This was done because study 1 highlighted that loss to follow-up was due to difficulty 
in attending sessions because of work obligations and/or financial constraints. It is difficult 
to compare the attendance data with other exercise studies in the HIV sector, as they were 
structured in such a way that individuals had to attend a number of sessions per week, thus 
requiring greater determination. This might explain the slightly lower attendance rate of 
exercise sessions (82.2%) in Mutimura et al.s’ (2008) study, conducting a six-month 
intervention. Petroczi et al. (2010) had a lower attendance of exercise sessions, with only 
12 of a sample of 22 attending more than eight of 20 sessions in a 10-week period. In a 
four-month home-based exercise programme conducted by Dolan et al. (2006), 96% of 
intervention participants completed exercise sessions. It is again difficult to compare 
Mutimura et al. (2008) with Dolan et al. (2006), as participants in the former had to make 
their own way to a fitness centre, whereas in the latter a physical therapist did home visits 
with participants. The higher adherence to attendance of exercise sessions in the latter 
study can be assumed to be the result of participants not having had to make any effort. 
Considering the degree of variation of exercise attendance across the studies, the current 
study’s structure, relying on only a monthly session by encouraging self-management, 
could be an option to consider when planning an exercise programme in PLWHA. 
 
Reasons for non-attendance of monthly sessions were financial, work obligations and 
participants travelling outside Gauteng Province in a particular month. Social difficulties 
such as financial constraints preventing visits to a clinic are reported as one of the reasons 
why individuals in Africa are often unable to adhere to HAART (Reda and Biadgilign, 2012). 
Withdrawal from exercise studies in the HIV sector is often due to inability to attend as a 
result of work obligations and travelling to a different province (O’Brien et al., 2010). The 
reasons reported in the current study are thus known in the literature as obstacles that 
could present when implementing an intervention in PLWHA. 
 
Even though participants attended only monthly sessions in the baseline to six month 
interval, more dedication was required from them to follow their individualised walking 
programme between these sessions. Chao and Foy (2000) report that home-based 
physical activity programmes pose unique challenges compared to structured centre-based 
programmes. Participants have to decide when and where to perform the physical activity, 
and depend on self-motivation to carry it through. Less decision-making is required by 
participants in a structured centre-based programme. The difficulties encountered with the 
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home-based walking programme became apparent when reviewing participants’ 
achievement of the prescribed pedometer step-count.  
 
Participants’ individualised weekly step-count goal was assessed at the face-to-face 
sessions. Adherence to their individualised prescribed walking programme was determined 
in terms of achieving each week’s prescription in the course of a month by reviewing 
participants’ notations in their diaries. Individuals that achieved their pedometer prescription 
ranged between 36.8%-73.7% in the baseline to six month interval. In a study conducted by 
Serwe et al. (2011) adherence to prescribed pedometer walking ranged between 69% and 
80%. In addition, Tully et al. (2007) reported adherence to their pedometer walking 
programmes as ranging between 82.6% and 89.3%. The study conducted by Serwe et al. 
(2011) was eight weeks long, and that of Tully et al. (2007) 12 weeks. Both research 
groups calculated each day achieved as a percentage of the prescribed walking 
programme. This way of calculating adherence was possible in their respective studies as 
participants in Serwe’s study handed in their pedometer log-sheets every week for 
evaluation. In Tully’s study, dairies were collected every second week and a new one 
issued to participants. This was not possible in the current study as participants used their 
diaries throughout the project and only attended monthly sessions with the researcher. 
Therefore the way the authors calculated adherence would account for the higher 
adherence levels than those as calculated in the current study.  
  
During the first month the lowest percentage of individuals achieved their step-count goal, 
and this was attributed to the high number who experienced physical complaints (n=22: 
57.9%) during this time. It was winter at the start of the intervention, and respiratory 
ailments were often reported by intervention as well as control participants in the earlier 
part of the programme. Over time more intervention participants achieved their weekly step-
count goal. In the second and fourth visits 68.4%-73.7% adhered to their step-count 
prescription, well above the suggested 50% reported by O’Brien et al. (2010). It is also well 
above adherence findings reported by Meikle et al. (2009), as evaluated in the Healthy 
Heart programme conducted at a prevention clinic in Vancouver, Canada. They reported 
that only 50% of individuals adhered to exercise suggestions, despite repeated messages 
regarding the importance of regular exercise. This increased adherence to exercise 
prescription in the current study could be explained in part by findings from Escolar-Reina 
et al. (2010). They noted that patients were more likely to adhere to a home-based back 
and neck exercise programme if the healthcare provider provided facts about the disease 
and gave feedback regarding progress and reminders to exercise. Considering that the 
education and home-based walking programme of this study included these components, it 
may explain the increased adherence. A slight drop in achievement of pedometer step-
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count goal was observed in the last month (n=20; 52.6%). At this time the frequency of the 
pedometer step-count goal was increased to five times per week, and this might have 
contributed to the lower level of achievement. Tully et al. (2007) reported that when 
individuals performed walking three times per week their adherence to a pedometer-based 
walking programme was higher (89.3%) than those walking five times per week (82.6%). In 
addition, the fifth contact session in the current study occurred in December, when 
participants were busy preparing for vacation and Christmas. It being summer, deterrents 
such as higher temperatures and thunderstorms were faced. Both these factors could have 
contributed to the lower adherence.  
 
Literature suggests that exercise prescription guidelines do not influence adherence to 
physical activity programmes. In a systematic review evaluating the characteristics of 
physical activity guidelines in randomised trials and their effect on adherence, the authors 
suggested that frequency, intensity, duration or mode of exercise played no role (Rhodes, 
Warburton and Murray, 2009), whereas personality, social and environmental factors 
played a larger role. An environmental barrier that influenced participants’ adherence to 
their pedometer step-count prescription was often reported to be the weather.  
 
Weather was identified by participants as a barrier to achieving their weekly pedometer 
step-count goal. Cold weather was reported early in the programme, and later on hot 
weather with increased rainfall. Weather conditions had an impact, as they walked outdoors 
to increase their step-count. Owing to financial factors they lacked access to an exercise 
facility where they could walk indoors. A large proportion of the intervention group were 
unemployed (n=17; 40.5%) and most (n=19: 45.2%) who were employed earned very little 
(less than R500 per month). The environment, therefore, presented itself as a barrier 
throughout the programme to a varying extent. Adverse weather conditions are reported as 
a barrier to regular exercise in the literature (Chan and Tudor-Locke, 2008; Serour et al., 
2007). The study conducted by Serour et al. (2007) was done in Kuwait where a hot climate 
is a formidable obstacle. In contrast, Chan and Tudor-Locke (2008) noted snowfall as a 
challenge to following a community pedometer-based programme in North America.   
 
Two social environmental barriers highlighted in the study were domestic abuse and crime. 
Street-robbery is said to primarily affect poorer people in SA, and usually occurs when 
individuals are walking to buses, taxi ranks and train stations (Africa Check, 2013). 
Considering that participants used walking to the taxi rank or to work as a means of 
increasing their step-count, this information is of concern. Two intervention participants 
experienced such events in the baseline to six month interval. During the street robbery 
they were also assaulted, which resulted in superficial bruises and muscle tenderness that 
237 
 
were self-managed.  One intervention participant and one control participant were burgled 
at home, and pedometers stolen. In the case of the control group participant, this occurred 
after her seven-day physical activity period at the baseline assessment. In the intervention 
group participant it occurred during the intervention, and an additional pedometer was 
issued to him. Lastly, one intervention group participant suffered domestic abuse from her 
life partner, and prevented a repeat by moving in with her mother. This influence of 
domestic abuse and crime on the home-based physical activity programme was not 
anticipated, but became a factor to be reckoned with when implementing home-based 
physical activity programmes.   
 
Individual barriers, such as physical or psychological, were often reported in the baseline to 
six month interval as factors influencing adherence to their exercise prescription. Physical 
complaints were presented to varying degrees during the programme, and were often 
linked to the weather: respiratory ailments in cold weather, and lower energy levels or skin 
allergies in the hot weather. Psychological barriers such as poor motivation, stress and 
worry about family members were also reported as influencing their adherence. Major life 
events such as loss of family members occurred in the intervention period. These identified 
barriers are mentioned in exercise adherence literature: stress and physical ailments 
(Serour et al., 2007) and major life events (White et al., 2005). Even though participants 
experienced individual and contextual challenges that influenced their adherence, they 
implemented strategies to increase their adherence to the home-based walking 
programme.  
 
 A prominent enabler assisting participants in adhering to their walking programme and 
achieving their step-count prescription was support and encouragement from family 
members and friends. This was reflected by the interest that friends and family members 
showed by occasionally attending monthly sessions with intervention participants. They 
also influenced motivation by actively participating with the participants’ walking sessions in 
the community. The importance of the support of family and friends in physical activity 
programmes is highlighted in literature. Tierney et al. (2011) reported that patients with 
heart failure are more likely to adhere to exercise programmes when there is a measure of 
encouragement to exercise from family, friends and professionals. White et al. (2005) 
reiterated that this social support is especially important for women in the initiation part of a 
programme, as it creates a bonding experience. The wider community health effect of 
participants’ involving friends and family members with their programme should not be 
ignored. It could have indirectly raised their friends and family members’ awareness of their 
own activity levels, thereby prompting them to participate. White et al. (2005) reported that 
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support from family and friends play a smaller role in long-term maintenance of physical 
activity levels.  
 
The secondary adherence objective of the study was to evaluate whether participants 
continued with the physical activity programme in the six to 12 month interval. Dropout 
rates in pedometer walking programmes vary in the literature: in an eight-week programme, 
12% (Serwe et al., 2011); in twelve-week programmes,  8% (Musto et al., 2010); 27% (Gray 
et al., 2009); 19% (Baker et al., 2008); 12% (Tully et al., 2007); in a six-month programme, 
20% (Zoelliner et al., 2010), and in 12-month programmes, 39% (Fitzsimons et al., 2012) 
and 77% (Chan and Tudor-Locke, 2008). The dropout rates in these studies referred to 
individuals not attending final assessment. In the current study 36 intervention and 33 
control participants participated in the six month assessment, indicating a dropout rate of 
18% (n=15) of the study sample as a whole at six months. At the twelve month assessment 
29 intervention and 23 control participants completed the 12 month assessment. The 
dropout rate of the original 84 study participants was, therefore, 38% (n=32). The six month 
dropout rate was lower than Zoelliner et al. (2010) in their study of a cohort of 
disadvantaged African-American adults in the USA. The 12 month dropout rate was also 
lower than Chan and Tudor-Locke (2008) and Fitzsimons et al. (2012). Findings from the 
29 intervention participants at the 12 month assessment provide information regarding their 
adherence to the programme between the six and 12 month interval.    
 
A decline in pedometer-determined physical activity occurred in the six to 12 month interval, 
but the intervention group’s activity level was still greater than at baseline. The reduction in 
pedometer step-count from the six to 12 month assessments in the current study could be 
explained by the way in which participants performed the home-based walking programme 
in this period. A variation in the number of times per week that participants wore the 
pedometer to enable them to self-monitor their step-count was identified. Chan and Tudor-
Locke (2008) provide similar findings regarding adherence to a 12 month pedometer 
community programme.  The programme initiated by the authors was called the First Step 
Programme, and aimed to promote walking in individuals living with type two diabetes. The 
authors reported that 68% of those that completed the 12-month programme reported 
wearing their pedometers (either sometimes or always). Despite this infrequent use of 
pedometers, pedometer steps per day were still higher at the 12 month assessment 
compared to baseline. The authors reported that other parameters, assessed earlier in their 
study, had returned to baseline values at the 12 month assessment, e.g. general health, as 
assessed with the SF-20. Similarly, Fitzsimons et al. (2012) examined the effects of two 
approaches to delivering a pedometer-based programme, one including physical activity 
consultations and the other without, on physical activity levels in low-active Scottish men 
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and women over a 12 month period. The authors reported an increase in pedometer step-
count from baseline in both groups, and maintained over the intervention period. In 
addition, they indicated that the quality of life of study participants improved in the 12 month 
period, but that no significant changes were noted in weight, BMI, waist and hip 
circumference or WHR respectively. The pedometer in the current study and in those of 
Chan and Tudor-Locke (2008) and Fitzsimons et al. (2012) was thus a tool that assisted 
with raising the awareness of physical activity levels in study participants. 
 
A further reason for lower adherence to the walking programme might have been the 
absence of motivational support compared to that received in the baseline and six month 
period. Participants reported they found the face-to-face sessions and SMS prompts 
beneficial to their motivation to exercise. The absence of these components in the six to 12 
month period could thus have explained why participants wore the pedometer less 
frequently in the latter period.  
 
Nineteen of the 29 intervention participants that completed the 12 month assessment 
(65.5%) in the current study continued documenting their pedometer step-count in their 
education diary as means to continue with self-monitoring. Reasons why some did not do 
so were that they no longer had pages left to use in their diaries. It can therefore be 
recommended that ample space for documentation be included in physical activity diaries in 
future. The stretches and range of motion exercises taught to participants were continued 
by more participants (n=23; 79.3%) in this period in comparison to the walking. It might be 
simply that they required less time and effort to perform.  
 
Even though participants used the pedometer to varying degrees, 21 of the 29 intervention 
participants that completed the 12 month assessment continued being mindful of their 
physical activity level throughout the intervention. Thus, 50% of the original intervention 
group continued with self-monitoring their physical activity level as a means of improving 
their health 12 months following initiation of the programme.  
 
The conclusion of the study is presented in section 6b.8. 
 
6b.8  CONCLUSION  
Study 4 was successful in raising awareness of physical activity levels in both the control 
and intervention groups, as participants’ pedometer-determined step-count increased from 
baseline. It was however of clinical value in the intervention group, due to the group 
exceeding the step count aim of the programme, that being 3 000 steps above baseline at 
each assessment point. Translating the step count into time, would amount to 
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approximately 30 minutes of added walking per day. The group therefore reached the 
Public Health recommendations for physical activity. The guidelines also state that persons, 
who wish to further improve their personal fitness, reduce risk for chronic diseases and 
disabilities, will likely benefit by exceeding the minimum recommended amount of physical 
activity. This added benefit was seen in the secondary outcomes assessed. 
 
The education and home-based walking programme was effective in reducing risk factors 
for IHD, in particular, improving physical function capacity (6MWT distance), reducing waist: 
hip ratio, decreasing glucose and increasing HDL level as evaluated in between-group 
analysis. In addition, the programme lowered SBP in both groups, but more so in the 
intervention group. The largest effect was noted at the six month assessment period as this 
with-in group change was statistically significant. Multivariate analysis indicated an inverse 
association between the interaction (time and treatment effect) and perceived stress levels 
and BMI in the control and intervention groups at six months at group level (GEE). 
Similarly, the associations were noted between the interaction (time and treatment effect) 
and perceived stress levels, BMI, LDL and TG in the intervention group at six months at 
individual level (MEM). The interaction, consisting of an education and home-based walking 
programme performed over time, therefore has the potential to reduce these risk factors for 
IHD in PLWHA.  
 
Intervention participants’ attendance of physical activity counselling sessions was good, at 
greater than 75%, and adherence to their pedometer step-count prescription in the baseline 
to six month interval was average, at more than 50%. Individual and contextual barriers, 
however, influenced adherence to the physical activity programme. The influence of crime 
and domestic abuse were highlighted as factors to consider when introducing future such 
programmes in Johannesburg, SA. Social support in the form of encouragement, motivation 
and participation of friends and family was noted as an important enabler that assisted 
intervention participants to adhere to their programme. 
 
When reviewing the feedback given by intervention participants (Appendix 50) regarding 
what they found most helpful in the programme, it contains positive feedback regarding all 
aspects of the programme. Participants viewed the programme as an exercise programme 
as noted by their responses on the post-intervention questionnaire. They reported that the 
knowledge that they gained by doing the progamme was of benefit e.g. importance of 
exercise. In addition, performing the walking programme was of social benefit as they made 
new friends in the community while walking and enjoyed walking with friends and family. It 
had physical benefits as some reported losing weight, becoming more flexible, having less 
respiratory symptoms and being less tired. It also had psychological benefits as it helped 
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individual participants to manage their stress levels. Having the contact sessions provided 
motivation and receiving the SMS prompts made them feel someone cared about how they 
were fairing. Lastly, having access to a pedometer and being able to self-monitor their 
steps was noted as a beneficial aspect of the programme.    
 
Although a decline in physical activity levels was observed in both the control and 
intervention groups in the six to 12 month period, their respective activity levels were 
nonetheless higher than at baseline. The drop suggests that the motivational components 
in the management of the groups influenced physical activity levels in the baseline to six 
month interval, and hence the lower levels at 12 months. A second factor influencing the 
intervention group’s activity level at the 12 month assessment was the variation in how 
participants adhered to the pedometer-based walking programme.  
 
The MEM analysis included in the study was beneficial in highlighting associations between 
the interaction (time and treatment) and secondary outcomes not apparent when reviewing 
mean group changes as reflected by the GEE analysis. Individuals often perceive/ 
experience symptoms differently e.g. perceived stress. It thus allowed for assessment of 
the effect of the interaction within individuals.  Including both MEM and GEE analysis when 
evaluating the effect of a behavioural intervention is therefore recommended to improve 
interpretation of findings.  
 
The IHD risk according to the FRS was low, as the equation does not include pertinent risk 
factors present in the study population, e.g. Hs-CRP. The study highlighted that elevated 
hs-CRP values were present in the study cohort, indicating inflammation: a cause for 
concern, considering the link between IHD and chronic inflammation over time. The need 
for a validated IHD prediction equation that includes this inflammatory component, and 
which could be used in a younger population (less than 45 years), is therefore apparent. 
This inflammatory marker was positively associated with perceived stress levels and 
anthropometric parameters (weight, BMI, waist and hip circumference and WHR). An 
inverse association between Hs-CRP and the interaction (time and treatment) was 
observed in univariate analysis in the GEE and MEM models. This association highlights 
that the education and home-based walking programme could potentially be an effective 
method for reducing this inflammatory risk factor for IHD.  
 
Chapter 7 consists of the conclusion to the study as a whole, including limitations and 
recommendations identified in the course of the research project. 
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CHAPTER 7 
7.  CONCLUSION, LIMITATIONS AND RECOMMENDATIONS 
 
7.1  CONCLUSION 
The research project was beneficial in highlighting the presence of risk factors for IHD in 
PLWHA (on HAART) attending an outpatient HIV clinic in Johannesburg, SA. It also 
contributes to the known literature related to the socio-demographic profile of those 
individuals. In addition, the project provided information regarding the effects of an 
education and home-based pedometer walking programme on physical activity levels and 
additional risk factors for IHD.  
 
The project highlighted that socio-demographic factors of PLWHA in SA, such as 
unemployment or low-income employment (less than R500 per month: ± 50 US dollars) are 
impediments. Exacerbating factors were that participants were often supporting 
dependants, and were single. This situation contributed to increased perceived stress 
levels, as well as influencing their dietary choices. Most participants reported eating fruit 
and vegetables weekly, though few were able to consume three to five vegetables and fruit 
combined daily. In addition, most participants reported that they were unable to eat fish 
every week. Diet therefore increased their risk of IHD. A number of participants also 
perceived themselves at risk of IHD due to their perceived stress levels, and knew that they 
were following an unhealthy diet and not doing enough exercise. Education strategies 
regarding a healthy diet on its own would therefore not solve the problem of participants’ 
dietary choices, as financial constraints play a significant role.  
 
International literature suggests that PLWHA are at increased risk of IHD due to the higher 
prevalence of smoking (Saves et al., 2003). The current study highlighted that smoking in 
the evaluated study cohort was not as prevalent. This might have been due to the group 
consisting mostly of women, as fewer women in the study reported smoking than the men. 
In the general population of SA smoking is also less common among women than men 
(Peer et al., 2009). Physical inactivity, perceived stress levels and participants being 
overweight were more prevalent risk factors in this study cohort.  
 
Most participants in study 1 took fewer than 10 000 steps per day, and were thus not active 
(Tudor-Locke and Bassett, 2004). Participants tried to include some form of exercise in 
their lives, and the preferred mode of activity reported was walking and running. In the 
study wheeled transportation was used more frequently than walking as a means of getting 
around, and the homes of the majority of study participants also constituted a smaller living 
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environment. Both these factors are social components that would influence physical 
activity level in an urban environment, as they tend to reduce the amount of normal walking.  
 
The beneficial effect of the education and home-based pedometer walking programme on 
physical activity level was a positive outcome of the research project. Prominent factors 
enhancing adherence to the physical activity programme were support and encouragement 
from friends and family. Barriers to adherence to the physical activity modification often 
included physical and psychological complaints. In the South African context HIV 
prevalence is high (±5.26 million in 2013 [Stats SA, 2013]) and the number of practising 
physiotherapists are low (practising physiotherapist estimated at n=6 328 [World 
Confederation of Physical Therapist News, 2014]). This physical activity modification 
programme could therefore be an effective means of implementing a self-management 
programme to enhance physical activity levels. Participants enjoyed using the pedometer, 
and found it useful in tracking their walking throughout the project. Issuing a pedometer to 
individuals attending an HIV clinic and education regarding a healthy step-count could be a 
simple and effective means to promote activity and enhance health in ambulatory PLWHA.   
 
Stress was a theme that permeated the entire research project. Participants perceived 
themselves to be at risk of IHD due to stress and ‘thinking too much’, e.g., worrying. Stress 
was also reported to be a barrier to adhering to the physical activity modification 
programme. High-sensitivity CRP was found to correlate with perceived stress levels. The 
positive effect that the education and home-based pedometer walking programme had on 
the perceived stress levels of participants was therefore significant in managing this risk 
factor. 
 
In the physical activity modification programme the mean weight and BMI of participants 
increased very slightly between assessments periods. The programme thus did not bring 
about significant change in these parameters. The log-transformed analysis did, however, 
indicate a significant inverse association between the interaction at the different stages and 
these parameters. The programme as it was conducted can therefore be recommended as 
a means to enhance physical activity in PLWHA while maintaining these parameters 
constant, with the potential for weight reduction. Since weight gain can develop over time 
due to HAART (Hurley et al., 2011), a higher step-count goal might be required to achieve a 
further weight-loss effect with the addition of dietary counselling and combined resisted 
exercise.  
 
Study 2 highlighted that participants had an optimistic bias concerning their risk of IHD 
when self-perception of the risk was evaluated. Participants presented with knowledge and 
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understanding regarding IHD, but often did not apply it to evaluate their own risk. A 
discrepancy between self-perception of IHD risk and status of risk factors assessed in 
participants was apparent. The study highlighted that participants were unaware of the link 
between risk of IHD and being HIV+, or HAART exposure and risk of IHD. A positive finding 
of study 2 was the participants’ understanding of their HIV status and their role involved in 
managing the disease. This characteristic of responsibility might have influenced 
intervention participants’ adherence to the physical activity modification programme.  
 
An elevated level of chronic inflammation (Hs-CRP) was identified in the study cohort as a 
risk factor for IHD. The relationship between Hs-CRP and assessed IHD risk factors 
included anthropometric measures and perceived stress levels. Due to the high Hs-CRP 
results, the study cohort could be considered at a high risk of IHD. By contrast, the FRS put 
the study cohort at a low risk. This conflicting finding indicates that a prediction equation 
applicable to PLWHA of all ages that includes an inflammatory component is required. The 
programme did not produce a significant change in Hs-CRP, and this might be due to the 
absence of significant change in weight and BMI. The log-transformed univariate model did, 
however, indicate an inverse association between the interaction and Hs-CRP at the 
different stages when compared to baseline control findings. There is, therefore, the 
potential to influence this parameter by physical activity if an increased change in 
anthropometric measures can be achieved. 
 
The physical activity modification programme resulted in significant reduction in SBP in 
both groups in the within-group analysis with higher reductions noted in the intervention 
group. Hypertension was a risk factor highlighted in the INTERHEART Africa study as more 
prominent in the black African group (Steyn et al., 2005). Additional literature suggests that 
prevalence of HTN in women is twice that of men for Black Africans, Coloured and 
Indian/Asian individuals in SA, as assessed in a nationwide survey (Hasumi and Jacobsen, 
2012). Considering that HIV is more prevalent among women (Stats SA, 2013) and black 
Africans (Shisana et al., 2014) in SA, this effect on SBP is important. The education and 
home-based pedometer walking programme is an effective method to influence this 
prominent risk factor, and thus significant in the South African context.  
 
The study highlighted that contact between the healthcare practitioner and participant is 
important to bring about the greatest change in physical activity. When this contact is no 
longer present a decline in activity level occurs. To prevent this decline from occurring 
when programmes end, innovative methods are required to still encourage and motivate 
individuals to keep being active. Such strategies could be telephone calls and SMS 
prompts to encourage and motivate individuals. Adherence group classes every three 
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months could be an alternative to discuss individuals’ challenges and implement additional 
forms of exercise that individuals can continue with at home. Participants in the current 
study emphasized that receiving support is an important enabler to activity. Support 
structures in the community but also in healthcare would be required to enhance and 
promote being active and more so staying active.   
 
In 2010 O’Brien et al. presented key research priorities requiring attention in HIV. The 
authors created The Framework of HIV and Rehabilitation Research, and included the 
research priorities presented in Figure 7.1:  
 
 
Figure 7.1: Key Research Priorities in HIV and Rehabilitation 
 
The current research project contributes to knowledge related to “Living with HIV across the 
lifespan”, as it provides information regarding the risk factors for IHD in PLWHA in the 
South African context as a means of highlighting concurrent health conditions. In addition it 
includes information regarding PLWHA self-perception for the risk of IHD. It also contributes 
to the body of knowledge related to “Rehabilitation”, as it provides information regarding the 
effects of an education and home-based pedometer walking programme in PLWHA as a 
prevention and management strategy for IHD. Lastly, it highlights environmental and 
personal factors present in PLWHA in SA that could influence all three research priorities.  
 
Section 7.2 contains information regarding the limitations identified in the research project. 
 
Living with HIV 
across the lifespan
RehabilitationDisability
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7.2  LIMITATIONS 
The research project was structured in such a way as to focus on assessing risk factors for 
IHD and implement a physical activity modification programme to manage that risk. 
Therefore the focus when reviewing diet was limited to fruit, vegetable and fish 
consumption. The content of the general diet, and diet on a larger scale were not 
investigated. Moreover, the focus on physical activity was related specifically to walking, as 
walking is often given as an example for increasing activity level. Other aspects of activity, 
e.g. upper limb function when performing tasks, cannot be monitored by a pedometer. 
These additional aspects of activity contribute to general activity on a larger scale. Thus it 
needs to be noted that the findings in the current research project provide information only 
on walking, and not overall physical activity levels, as would be assessed by a more 
comprehensive review of activities of daily living.  
 
Gathering data on pedometer step-count was dependent on participants wearing the 
instrument as instructed, and documenting the daily step-count in their physical activity log 
sheet. In addition, collecting data on smoking status, alcohol consumption and whether 
participants performed exercise (study 1) were also dependent on participants’ truthfulness. 
A margin of error in self-reporting could have occurred. 
 
The physical activity modification period of study 4 was a year, and a progressive increase 
in dropout rate occurred over that time. Attempts were made to follow up all participants, 
but this was not possible due to individual participants’ financial constraints, work 
obligations, moving out of Gauteng province and not being able to contact individuals. 
 
During study 4 all participants continued with standard clinic management that included 
visiting medical doctors, having vital signs assessed by nursing staff and collecting HAART 
from the pharmacy. Participants could thus possibly have received information regarding 
diet and exercise from other medical practitioners or from the general media, and this might 
have influenced their activity level.  
 
Lastly, study 4 indicated that participants’ Hs-CRP results were above 3 mg/l, indicating an 
increased risk of IHD. Unknown to the researcher at the start of the study, CRP levels are 
reported to fluctuate in women of child-bearing age, dependent on the phase of their 
menstrual cycle. Gaskins et al. (2012) reported that more women were classified as being 
at high risk of IHD (Hs-CRP > 3 mg/l) in menses than other phases of the cycle. Both 
control and intervention groups consisted mostly of women, and the mean age 
corresponded to the child-bearing age. Particulars regarding whether participants were 
having their menses at the time of Hs-CRP blood sampling were not collected in the study. 
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Information regarding irregular menses or possible change in menses was also not 
collected during the study. Attempting to schedule appointments according to phase of 
menstrual cycle would have been problematic, as assessments were dependent on 
availability of research assistants. This confounding variable might therefore have 
influenced participants’ Hs-CRP findings.  
 
Section 7.3 contains recommendations for future projects.  
 
7.3  RECOMMENDATIONS 
The research project highlighted several areas where research is still needed: 
 
 Evaluate physical activity levels in PLWHA longitudinally at different time points when 
on HAART. At each time point additional parameters could be evaluated to investigate 
what might be influencing individuals’ activity level. Such outcome parameters could be 
socio-demographic, biomedical, therapeutic or person-specific factors. In the South 
African context pulmonary TB co-infection in PLWHA is high (Van Dyk, 2008). A project 
investigating activity parameters in PLWHA with TB co-infection would be valuable. In 
addition, PLWHA are prone to COPD (Morris et al., 2011) and another project could 
investigate COPD-like changes and their influence on activity parameters. 
Rehabilitation intervention studies could link into these studies. 
 
 The cost implications of rolling out the pedometer physical activity modification 
programme in SA needs to be determined to inform translation of such a programme 
into the community. 
 
 The current research project cohort could be followed up longitudinally for a longer 
period to determine whether participants continue to implement their new knowledge 
regarding trying to be active. Individuals implementing this knowledge could be 
compared to those who do not, and could highlight additional adherence factors. In 
addition, one could evaluate retention of this knowledge.  
 
 In the research project a number of participants were lost to follow-up. Data collected 
from these participants could be compared to those who completed the project, and 
findings could highlight possible adherence impediments.  
 
 The study highlighted that participants found the pedometer beneficial in self-monitoring 
their activity level, and that it assisted in improving their walking activity level. Including 
this device in current HAART initiation group education management on its own, and 
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assessing the effect on activity level without the additional monthly sessions, could be 
beneficial.  
 
 The project focused on assessing the physical activity levels of PLWHA on HAART at 
an outpatient clinic. Additional rehabilitative research is needed specific to PLWHA in 
an acute-care setting.   
 
 PLWHA are at an increased risk of IHD, and secondary management of IHD includes 
angioplasty or coronary artery bypass graft surgery. Research is needed to investigate 
the rehabilitative outcomes in acute care and post-hospital discharge following 
angioplasty or coronary artery bypass graft surgery.  
 
 The research project focused on walking activity, as this is recommended as a means 
of increasing physical activity as a prevention strategy for IHD. Further research could 
investigate a wider scope of physical activity.  
 
 Study 1 provided information regarding participants’ mode of preferences when 
performing physical activity. Additional research could provide information on format, 
location and social setting. 
 
 Important avenues to be investigated in PLWHA in the South African context are 
individuals’ perceptions regarding exercise, obesity and stress.  
 
 Study 1 highlighted that participants were at an increased risk of IHD due to low daily 
intake of vegetables and fruit. Additional research is needed with regard to general diet, 
specifically its content, to identify whether individuals are consuming enough macro- 
and micronutrients. In addition, the research needs to focus on factors influencing diet, 
so that appropriate management strategies can be formulated and implemented.  
 
 The project highlighted that increased perceived stress levels, physical inactivity and 
overweight/obesity presented as risk factors for IHD, requiring management in PLWHA. 
It would be beneficial to conduct a comparative study in individuals not infected with 
HIV to determine whether these factors apply more to PLWHA or are of more general 
concern in SA.   
249 
 
REFERENCES 
 
Abbara LJ, Shturman L, Soni A, Wei J, Rocha-Filho JA, Nasir K, Grinspoon SK 2010 Increased 
prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography 
angiography in HIV-infected men. Aids 24 (2): 243 – 253. 
 
Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K 2007 The burden and cost of chronic 
diseases in low-income and middle-income countries. Lancet 370: 1929 – 1938. 
 
Africa Check 2013 Factsheet South Africa: Official crime statistics for 2012/2013 [Online]. 
Available: http://www.africacheck.org/factsheets/factsheet-south-africas-official-crime-statistics-for-
201213/ - [Accessed: 19 December 2013]. 
 
Ainsworth BE, Der Ananian C, Soroush A, Walker S, Swan P, Poortvliet E, Yngve A 2012 “AUKI 
Step” pedometer intervention in university staff: rationale and design. BMC Public Health 12 (657): 
1 – 10. 
 
Airhihenbuwa CO, Kumanyika S, Agurs TD, Lowe A 1995 Perceptions and beliefs about exercise, 
rest and health among African Americans. American Journal of Health Promotion 9 (6): 426 – 429. 
 
Albert T, Chadwick S 1992 How readable are practice leaflets? British Medical Journal 305 
(November 21): 1266 – 1268. 
 
Albert JS 2011 Nutritional advice for the patient with heart disease. Circulation 124: e258 – e260. 
 
Allen K, Morey MC 2010 Physical activity and adherence. In: Improving Patient Treatment 
Adherence: A clinician’s guide, pp. 9 – 38, Springer, New York, New York. 
 
Ambrose JA, Barua RS 2004 The pathophysiology of cigarette smoking and cardiovascular 
disease: an update. Journal of the American College of Cardiology 43 (10): 1731 – 1737. 
 
American College of Sports Medicine 2010 ACSM’s Benefits and Risks associated with Physical 
activity. In: ACSM’s Guidelines for Exercise Testing and Prescription 8th edition, pp. 2 – 15, 
Lippincott Williams and Wilkins, Philadelphia, Pennsylvania.  
 
American College of Sports Medicine 2010 ACSM’s Health-related physical fitness testing and 
interpretation. In: ACSM’s Guidelines for Exercise Testing and Prescription 8th edition, pp. 66 – 
104, Lippincott Williams and Wilkins, Philadelphia, Pennsylvania. 
 
American College of Sports Medicine 2010 ACSM’s Exercise prescription for other clinical 
populations. In: ACSM’s Guidelines for exercise testing and prescription 8th edition, pp. 225 – 265, 
Lippincott Williams and Wilkins, Philadelphia, Pennsylvania.   
 
American College of Sports Medicine 2014 Behavioral Theories and strategies for promoting 
exercise. In: ACSM’s guidelines for exercise testing and prescription, 9th ed., pp. 355 – 382, 
Lippincott Williams and Wilkins, Philadelphia, Pennsylvania.  
 
American Heart Association 2013 HIV and Your Heart [Online]. Available: 
http://www.heart.org/HEARTORG/Conditions/More/HIVandYourHeart/HIV-and-Your-Heart_UCM_ 
313033_SubHomePage.jsp# [Accessed 1 September 2013] 
 
American Thoracic Society 2002 ATS Statement: Guidelines for the six-minute walk test. American 
Journal of Respiratory and Critical Care Medicine 166: 111 – 117. 
 
250 
 
Angus J, Rukholm E, St Onge R, Michel IM, Nolan RP, Lapum J, Evans S 2007 Habitus, Stress 
and the body: The everyday production of health and cardiovascular risk. Qualitative Health 
Research 17 (8): 1088 – 1102.  
 
Angus JE, Rukholm E, Michel I, Larocque S, Seto L, Lapum J, Timmermans K, Chevrier-
Lamoureux R, Nolan RP 2009 Context and cardiovascular risk modification in two regions of 
Ontario, Canada: A photo elicitation study. International Journal of Environmental Research and 
Public Health 6: 2481 – 2499.   
  
Ansa VO, Oyo-Ita A, Essien OE 2007 Perception of ischaemic heart disease, knowledge of and 
attitude to reduction of its risk factors. East African Medical Journal 84 (7): 318 – 323. 
 
Artalejo FR, Banegas JR, Colmenero CG, Calero JDR 1996 Lower consumption of wine and fish 
as possible explanation for higher ischaemic heart disease mortality in Spain’s Mediterranean 
region. International Journal of Epidemiology 25 (6): 1196 – 1201. 
 
Ashworth NL, Chad KE, Harrison EL, Reeder BA, Marshall SC 2005 Home versus center based 
physical activity programs in older adults. Cochrane Database of Systematic Reviews, Issue 1. 
Art.No.: CD004017.D01:10.1002/14561858.CD004017.pub2. 
 
Avis NE, Smith KW, McKinlay JB 1989 Accuracy of perceptions of heart attack risk: what 
influences perceptions and can they be changed? American Journal of Public Health 79 (12): 1608 
– 1612. 
 
Baker G, Gray SR, Wright A, Fitzsimons C, Nimmo M, Lowry R, Mutrie N for Scottish Physical 
Activity Research Collaboration (SPARColl) 2008 The effect of a pedometer-based community 
walking intervention “Walking for Wellbeing in the West” on physical activity levels and health 
outcomes: a 12 week randomised controlled trial. International Journal of Behavioral Nutrition and 
Physical Activity 5 (44): 1 – 15. 
 
Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JA, Franklin B, Sanderson B, 
Southard D; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention 
Committee; Council on Clinical Cardiology; Councils on Cardiovascular Nursing, Epidemiology and 
Prevention, and Nutrition, Physical Activity, and Metabolism; American Association of 
Cardiovascular and Pulmonary Rehabilitation 2007 Core components of cardiac 
rehabilitation/secondary prevention programs: 2007 update. Journal of Cardiopulmonary 
Rehabilitation and Prevention 27: 121 – 129. 
 
Ballington M, Stewart A, Richards C, Becker P 2012 To establish the effect of task orientated 
group circuit training for people affected by stroke in the public Healthcare sector in RSA [Online]. 
Available: 
http://wiredspace.wits.ac.za/bitstream/handle/10539/12559/Ballington%20PHD.pdf?sequence=1 
[Accessed: 2 February 2014]. 
 
Bärnighausen T, Welz T, Hosegood V, Bätzing-Feigenbaum J, Tanser F, Herbst K, Hill C, Newell 
ML 2008 Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population 
with very high HIV prevalence in South Africa. Journal of Human Hypertension 22: 236 – 239. 
 
Bauman A, Reis RS, Sallis JF, Wells JC, Loos RJF, Martin BW, for the Lancet Physical Activity 
Series Working Group 2012 Correlates of physical activity: why are some people physically active 
and others not? Lancet 380: 258 – 271. 
 
BBC News 2006 AIDS experts condemn SA minister. Story from BBC News [Online]. Available: 
http://news.bbc.co.uk/go/pr/fr/-/2/hl/africa/5319680.stm Published: 2006/09/06 10:58:03 GMT 
[Accessed on 2013-12-03]. 
 
251 
 
Bell GJ, Harber V, Murray T, Courneya KS, Rodgers W 2010 A comparison of fitness training to a 
pedometer-based walking program matched for total energy cost. Journal of Physical Activity and 
Health 7: 203 – 213. 
 
Bellet RN, Adams L, Morris NR 2012 The 6-minute walk test in outpatient cardiac rehabilition: 
validity, reliability and responsiveness – a systematic review. Physiotherapy 98: 227 – 286. 
 
Belue R, Schneider AS, Taylor-Richardson K, Murray-Kolb LE, Beard JL 2008 What matters most: 
an investigation of predictors of perceived stress among young mothers in Khayelitsha. Health 
Care Women International 29 (6): 638 – 648. 
 
Belue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, Ogedegbe G 2009 An 
overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural 
perspective. Globalization and Health 5 (10): 1 – 12. 
 
Berlin JE, Storti KL, Brach JS 2006 Using activity monitors to measure physical activity in free-
living conditions. Physical Therapy 86 (8): 1137 – 1145. 
 
Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K 2008 
Changes in the risk of death after HIV seroconversion compared with mortality in the general 
population. Journal of the American Medical Association 300 (1): 51 – 59. 
 
Bogart LM, Chetty S, Giddy J, Sypek A, Sticklor L, Walensky RP, Losina E, Katz JN, Bassett IV 
2013 Barriers to care among people living with HIV in South Africa: contrasts between patients and 
healthcare provider perspectives. Aids Care 25 (7): 843 – 853. 
 
Bland JM and Altman DG 1999 Measuring agreement in method comparison studies. Statistical 
Methods in Medical Research 8: 135-160. 
 
Blom DJ 2011 Cardiovascular risk assessment. South Africa Family Practice 53 (2): 121 – 128.  
 
Booth ML, Bauman A, Owen N, Gore CJ 1997 Physical activity preferences, preferred sources of 
assistance, and perceived barriers to increased activity among physically inactive Australians. 
Preventive Medicine 26: 131 – 137. 
 
Bopp CM, Phillips KD, Fulk LJ, Dudgeon WD, Sowell R, Hand GA 2004 Physical activity and 
immunity in HIV-infected individuals. Aids Care 16 (3): 387 – 393. 
 
Borato DCK, Parabocz GC, Ribas SRW, Kalva-Filho CA, Borba LM, Ito CAS, Bail L, dos Santos 
FA, Vellosa JCR 2012 Changes of metabolic and inflammatory markers in HIV infection: glucose, 
lipids, serum hs-CRP and myeloperoxidase. Metabolism Clinical and Experimental 61: 1353 – 
1360.  
 
Boutain DM 2001 Discourses of stress, worry and high blood pressure in rural south Louisiana. 
Journal of Nursing Scholarship 33 (3): 225 – 230. 
 
Bradshaw D, Norman R, Lewis S, Joubert J, Schneider M, Nannan N, Groenewaldt P, Laubscher 
R, Matzopoulos R, Nojilana B, Pieterse D, Steyn K, Vos T and the South African Comparative Risk 
Assessment Collaborating Study 2007 Strengthening public health in South Africa: Building a 
stronger evidence base for improving the health of the nation. South African Medical Journal 97 
(8): 643 – 649. 
 
Bradshaw D, Pillay-Van Wyk V, Laubscher R, Nojilana B, Groenewald P, Nannan N, Metcalf C 
2010 Cause of death statistics for South Africa: challenges and possibilities for improvement 
[Online]. Available: www.mrc.ac.za/bod/cause_death_statsSA.pdf [Accessed 10 September 2012]. 
 
252 
 
Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz 
E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N; Antiretroviral Therapy in 
Lower Income Countries (ART-LINC) study group 2008 Gender and the use of antiretroviral 
treatment in resource-constraint settings: findings from a multicentre collaboration. Journal of 
Women’s Health 17 (1): 47 – 55.  
 
Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, 
Sirard JR 2007 Using pedometers to increase physical activity and improve health: A systematic 
review. Journal of American Medical Association 298 (19): 2296 – 2304. 
 
Britton A, Gaziano T 2010 The Framingham Heart Study’s Impact on global risk assessment. 
Progress in Cardiovascular Diseases 53 (1): 68 – 78.  
 
Brown T, Wang Z, Chu H, Palella FJ, Kingsley L, Witt MD, Dobs AS 2006 Longitudinal 
anthropometric changes in HIV-infected and HIV-uninfected men. Journal of Acquired Immune 
Deficiency 43 (3): 356 – 362. 
 
Buckley DI, Fu R, Freeman M, Rogers K, Helfand M 2009 C-Reactive protein as a risk factor for 
coronary heart disease: a systematic review and meta-analysis for the US Preventive Services 
Task Force. Annals of Internal Medicine 151: 483 – 495. 
 
Burr JF, Bredin SSD, Faktor MD, Warburton DER 2011 The six-minute walk test as a predictor of 
objectively measured aerobic fitness in healthy working-aged adults. The Physician and 
Sportsmedicine 39 (2): 1 – 7. 
 
Burton NW, Khan A, Brown WJ 2012 How, where and with whom? Physical activity context 
preferences of three adult groups at risk of inactivity. British Journal of Sports Medicine 46: 1125-
1131. 
 
Butler L, Furber S, Phongsavan P, Mark A, Bauman A 2009 Effects of a pedometer-based 
intervention on physical activity levels after cardiac rehabilitation: a randomised controlled trial. 
Journal of Cardiopulmonary Rehabilitation and Prevention 29: 105 – 114. 
 
Campbell KL, Campbell PT, Ulrich CM, Wener M, Alfano CM, Foster-Schubert K, Rudolph RE, 
Potter JD, McTiernan A 2008 No reduction in C-reactive protein following a 12 month randomized 
controlled trial of exercise in men and women. Cancer Epidemiology Biomarkers and Prevention 
17 (7): 1714 – 1718. 
 
Campbell PT, Campbell KL, Wener MH, Wood BL, Potter JD, Mctiernan A, Ulrich CM 2009 A 
yearlong exercise intervention decreases CRP among obese postmenopausal women. Medicine 
and Science in Sport and Exercise 41 (8): 1533 – 1539. 
 
Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I, Day N, Khaw KT 
2007 Body fat distribution and risk of coronary heart disease in men and women in the European 
Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort: A population-based 
prospective study. Circulation 116: 2933 – 2943. 
 
Cappuccio FP, Kerry SM, Adeyemo A, Luke A, Amoah AGB, Bovet P, Connor MD, Forrester T, 
Gervasoni JP, Kaki GK, Plange-Rhule J, Thorogood M, Cooper RS 2008 Body size and blood 
pressure: an analysis of Africans and the African Diaspora. Epidemiology 19 (1): 38 – 46.  
 
Caro CG 2009 Discovery of the role of wall shear in atherosclerosis. Arteriosclerosis, Thrombosis, 
and Vascular Biology 29: 158 – 161. 
 
Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B 2003 6-Minute walk work for 
assessment of functional capacity in patients with COPD. Chest 123: 1408 – 1415. 
 
253 
 
Casanova C, Celli BR, Barria P, Cassas A, Cote C, de Torres JP, Jardim J, Lopez MV, Marim JM, 
Montes de Oca M, Pinto-Plata V, Aguirre-Jaime A on behalf of the Six-Minute Walk Distance 
Project (ALAT) 2011 The 6-minute walk distance in healthy subjects: reference standards from 
seven countries. European Respiratory Journal 37: 150-156. 
 
Center for Devices and Radiological Health 2005 Review criteria for assessment of C-reactive 
(CRP), high sensitivity C-reactive protein (hsCRP) and cardiac c-reactive protein (cCRP) assays 
[Online]. Available: www.fda.gov/cdrh/oivd/guidance/1246.pdf [Accessed: 18 June 2013].  
 
Chan CB, Tudor-Locke C 2008 Real-world evaluation of a community-based pedometer 
intervention. Journal of Physical Activity and Health 5: 648 – 664.  
 
Chan CB, Spangler E, Valcour J, Tudor-Locke C 2003 Cross-sectional relationship of pedometer-
determined ambulatory activity to indicators of health. Obesity Research 11 (12): 1563 – 1570.  
 
Chang A 2006 Six minute walking test: description. Australian Journal of Physiotherapy 52: 228 - 
229.  
 
Chao D, Foy CG 2000 Exercise adherence among older adults: challenges and strategies. 
Controlled Clinical Trials 21: 212S – 217S. 
 
Charlson ME, Boutin-Foster C, Mancuso CA, Peterson JC, Ogedegbe G, Briggs WM, Robbins L, 
Isen AM, Allegrante JP 2007 Randomized controlled trials of positive affect and self-affirmation to 
facilitate healthy behaviors in patients with cardiopulmonary diseases: Rationale, trial design, and 
methods. Contemporary Clinical Trials 28: 748 – 762. 
 
Chaudhary M, Kashyap B, Gautam H, Saini S, Bhalla P 2008 Role of C-reactive protein in HIV 
infection: a pilot study. Viral Immunology 21 (2): 263 – 266. 
 
Chuang ML, Lin IF, Wasserman K 2001 The body weight-walking distance product as related to 
lung function, anaerobic threshold and peak VO2 in COPD patients. Respiratory Medicine 95: 618 
– 626.  
 
Cioe PA, Crawford SL, Stein MD 2013 Cardiovascular risk-factor knowledge and risk perception 
among HIV-infected adults. Journal of the Association of Nurses in AIDS Care 25 (1): 60 – 69. 
 
Clemes SA, Griffiths PL 2008 How many days of pedometer monitoring predict monthly ambulatory 
activity in adults? Medicine and Science in Sports and Exercise 40 (9): 1589 – 1595. 
 
Clemes SA, Matchett N, Wane SL 2008 Reactivity: an issue for short-term pedometer studies? 
British Journal of Sports Medicine 42: 68 – 70.  
 
Clemes SA, Parker RAA 2009 Increasing our understanding of reactivity to pedometers in adults. 
Medicine and Sports in Sports and Exercise 41 (3): 674 – 680. 
 
Cohen S, Kamarck T, Mermelstein R 1983 A global measure of perceived stress. Journal of Health 
and Social Behavior 24 (4): 385 – 396. 
 
Cohen S, Williamson GM 1988 Perceived stress in a probability sample of the United States. In: 
The Social Psychology of Health, pp. 31 – 67, Sage, Newbury Park, California. 
 
Cohen S, Janicki-Deverts D 2012 Who’s stressed? Distributions of psychological stress in the 
United States in probability samples from 1983, 2006 and 2009. Journal of Applied Social 
Psychology 42 (6): 1320 – 1334. 
 
Collins SM, Dias KJ 2009 Cardiac System. In: Acute Care Handbook for Physical Therapists, 3rd 
ed., pp. 1-46, Saunders Elsevier, St. Louis, Missouri. 
254 
 
Cook I, Alberts M, Lambert EV 2008 Relationship between adiposity and pedometer-assessed 
ambulatory activity in adult, rural African women. International Journal of Obesity 32: 1327 – 1330.  
 
Cook I, Alberts M, Brits JS, Choma SR, Mkhonto SS 2010 Descriptive epidemiology of ambulatory 
activity in rural, black South Africans. Medicine and Science in Sports and Exercise 42 (7): 1261 – 
1268.  
 
Cook NR, Paynter NP, Eaton CB, Manson JE, Martin LW, Robinson JG, Rossouw JE, Wassertheil-
Smoller S, Ridker PM 2012 Comparison of the Framingham and Reynolds Risk Scores for global 
cardiovascular risk prediction in the Multi-Ethnic Women’s Health Initiative. Circulation 125: 1748 – 
1756. 
 
Corbin JM 2003 The body in health and illness. Qualitative Health Research 13 (2): 256 – 267. 
 
Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, Maskew M, Prozesky H, 
Wood R, Johnson LF, Egger M, Boulle A, Myer L for the International Epidemiologic Database to 
Evaluate AIDS Southern Africa (leDEA-SA) Collaboration 2012 Gender differences in survival 
among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. 
PLOS Medicine 9 (9): e1001304.  
 
Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, Weintrob A, Barthel 
RV, Fraser S, Agan BK, the Infectious Disease Clinical Research Program HIV Working Group 
2010 Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLOS ONE 
5 (4): e10106. 
 
Crum-Cianflone N, Dilay A, Collins G, Asher D, Campin R, Medina S, Goodman Z, Parker R, 
Lifson A, Capozza T, Bavaro M, Hale B, Hames C 2009 Nonalcoholic fatty liver disease among 
HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes 50: 464 – 473. 
 
Cuckson AC, Reinders A, Shabeeh H, Shennan AH; British Hypertesion Society 2002 Validation of 
the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified 
British Hypertension Society protocol. Blood Pressure Monitoring 7 (6): 319 – 324. 
 
Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S 2003 Coronary 
heart disease in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndrome 33 (4): 
506 – 512. 
 
D’Agostino RB, Grundy S, Sullivan LM, Wilson P for the CHD Risk Prediction Group 2001 
Validation of the Framingham Coronary Heart Disease Prediction Scores. Journal of the American 
Medical Association 286 (2): 180 – 187.  
 
D’Agostino RB 2012 Cardiovascular risk estimation in 2012: Lessons learned and applicability to 
the HIV population. The Journal of Infectious Diseases 205: S362 – S367. 
 
Dalmida SG, McDonnell Holstad M, Dilorio C, Laderman G 2012 The meaning and use of 
spirituality among African American women living with HIV/Aids. Western Journal of Nursing 
Research 34 (6): 736 – 765. 
 
Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA on behalf of the 
AUSDIAB Steering Committee 2003 Waist circumference, waist-hip ratio and body mass index and 
their correlation with cardiovascular disease risk factors in Australian adults. Journal of Internal 
Medicine 254: 555 – 563. 
 
  
255 
 
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, 
Lim SS, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases 
Collaborating Group (Blood Pressure) 2011 National, regional, and global trends in systolic blood 
pressure since 1980: systematic analysis of health examination surveys and epidemiological 
studies with 786 country-years and 5.4 million participants. Lancet 377: 568 – 577.  
 
Das S, O’Keefe JH 2008 Behavioural cardiology: recognizing and addressing the profound impact 
of psychosocial stress on cardiovascular health. Current Hypertension Reports 10 (5): 374 – 381. 
 
De Cocker KA, De Bourdeaudhuij IM, Cardon GM 2008 What do pedometers counts represent? A 
comparison between pedometer data and data from four different questionnaires. Public Health 
Nutrition 12 (1): 74 – 81. 
 
Dean E 2009 Physical therapy in the 21st century (Part 1): Toward practice informed by 
epidemiology and the crisis of lifestyle conditions. Physiotherapy Theory and Practice 25 (5 – 6): 
330 – 353. 
 
De Luca A, de Gaetano Donati K, Colafigli M, Cozzi-Lepri A, De Curtis A, Gori A, Sighinolfi L, 
Giacometti A, Capobianchi MR, D’Avino A, Lacoviello L, Cauda R, D’Arminio Monforte A 2013 The 
association of high-sensitivity C-reactive protein and other biomarkers with cardiovascular disease 
in patients treated for HIV: a nested case-control study. BMC Infectious Diseases 13 (414): 1 – 12.   
 
Department of Health 2013 The South African Antiretroviral Treatment Guidelines 2013 [Online]. 
Available: www.aurumininstitute.org/phocadownload/guidelines-short.pdf - [Accessed 9 July 2013].  
 
De Socio GV, Martinelli L, Morosi S, Fiorio M, Roscini AR, Stagni G, Schillaci G 2007 Is estimated 
cardiovascular heart disease higher in HIV-infected patients than in the general population? 
Scandinavian Journal of Infectious Diseases 39 (9): 805 – 809. 
 
De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazane C, El-Sadr W, Monforte AA, Fontas E, 
Law MG, Friis-Møller N, Phillips A 2008 Incidence and risk factors for new-onset diabetes in HIV-
infected patients: The DATA Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. 
Cardiovascular and Metabolic Risk 31: 1224 – 1229. 
 
Dicicco-Bloom B, Crabtree BF 2006 The qualitative research interview. Medical Education 40: 314 
– 321. 
 
Dolan SE, Hadigan C, Killilea KM, Sullivan MP, Hemphill L, Lees RS, Schoenfeld D, Grinspoon S 
2005 Increased cardiovascular disease risk indices in HIV-infected women. Journal of Acquired 
Immune Deficiency Syndrome 39 (1): 44 – 54.  
 
Dolan SE, Frontera W, Librizzi J, Ljungquisi K, Juan S, Dorman R, Cole ME, Kanter JR, Grinspoon 
S 2006 Effects of a supervised home-based aerobic and progressive resistance training regimen in 
women infected with human immonudeficiency virus; a randomized control trail. Archives of 
Internal Medicine 166:1225 – 1231. 
 
Dourado VZ 2010 Reference equations for the 6-minute walk test in healthy individuals. Arquivos 
Brasilieros de Cardiologia 
 
Dudgeon WD, Jaggers JR, Phillips KD, Durstine JL, Burgess SE, Lyerly GW, Davis JM, Hand GA 
2012 Moderate-intensity exercise improves body composition and improves physiological markers 
of stress in HIV-infected men. International Scholarly Research Networks Dec 11; 2012: 
145127.doi: 10.5402/2012/145127. 
 
Duran ACFL, Almeida LB, Segurado AAC, Jaime PC 2008 Diet quality of persons living with 
HIV/AIDS on highly active antiretroviral therapy. Journal of Human Nutrition and Dietetics 21: 346 – 
350. 
256 
 
Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD 2001 Blood lipid 
and lipoprotein adaption to exercise: a quantitative analysis. Sports Medicine 31 (15): 1033 – 1062. 
 
Earnest JM 2011 Using Q methodology as a mixed methods approach to study beliefs about early 
childhood education. International Journal of Multiple Research Approaches 5 (2): 223 – 237.  
 
Eastep E, Beveridge S, Eisenman P, Ransdell L, Shultz B 2004 Does augmented feedback from 
pedometers increase adults’ walking behaviour? Perceptual and Motor Skills 99 (2): 392 – 402. 
 
Eden KB, Orleans CT, Mulrow CD, Pender NJ, Teutsch SM 2002 Does counseling by clinicians 
improve physical activity? A summary of the evidence for the US Preventive Service Task Force. 
Annals of Internal Medicine 137 (3): 208 – 215. 
 
Ebrahim S, Smith GD 1998 Lowering blood pressure: a systematic review of sustained effects of 
non-pharmacological interventions. Journal of Public Health Medicine 20 (4): 441-448. 
 
Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, 
Thompson SG, Collins R, Danesh J 2010 Lancet 375 (9709): 132 – 140. 
 
Enright PL, Sherrill DL 1998 Reference equations for the six-minute walk in healthy adults. 
American Journal of Respiratory Critical Care Medicine 158: 1384 – 1387. 
 
Escolar-Reina P, Medina-Mirapeix F, Gascon-Canovas JJ, Montilla-Herrador J, Jimeno-Serrano 
FJ, De Oliviera Sousa SL, Del Bano-Aledo ME, Lomas-Vega R 2010 Hoe do card-provider and 
home exercise program characteristics affect patient adherence in chronic neck and back pain: a 
qualitative study. BMC Health Services Research 10 (60): 1 – 18. 
 
European Medicines Agency 2010 Guideline on missing data in confirmatory clinical trials [Online]. 
Available: 
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/09/WC500096
793.pdf - [Accessed 20 June 2013]. 
 
Evans W 2013 Understanding health behavior. In: Health Promotion and Wellness: an evidence-
based guide to clinical preventive services, pp 4 – 14. Lippincott Williams and Wilkins, 
Philadelphia, Pennsylvania. 
 
Faber M, Laubscher R, Laurie S 2013 Availability of, access to and consumption of fruits and 
vegetables in a peri-urban area in KwaZulu Natal. Maternal and Child Nutrition 9: 409 – 424. 
 
Fernald LCH, Hamad R, Karlan D, Ozer EJ, Zinman J 2008 Small individual loans and mental 
health: a randomised controlled trial among South African adults. BMC Public Health 8 (409): 1 – 
14. 
 
Fillipas S, Oldmeadow LB, Bailey MJ, Cherry CL 2006 A six-months supervised aerobic and 
resistance exercise program improves self-efficacy in people with human immunodeficiency virus: 
a randomised controlled trial. Australian Journal of Physiotherapy 52: 185 – 190. 
 
Fillipas S, Bowell-Harris CA, Old meadow LB, Cicuttini F, Holland AE, Cherry CL 2008 Physical 
activity uptake in patients with HIV: who does how much? International Journal of STG and AIDS 
19: 514-518. 
 
Fillipas S, Cicuttini F, Holland AE, Cherry CL 2010 The International Physical Activity 
Questionnaire overestimates moderate and vigorous physical activity in HIV-infected individuals 
compared to accelerometry. Journal of Association of Nurses in AIDS Care 21 (2): 173 – 182. 
 
257 
 
Fillipas S, Cicuttini FM, Holland AE, Cherry CL 2012 Physical activity participation and 
cardiovascular fitness in people living with HIV. A one-year longitudinal study. Retrovirology 9 
(Suppl. 1): P63. 
 
Fincher S, Tenenberg J 2005 Making sense of card sorting data. Expert Systems 22 (3): 89 – 93. 
 
Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, 
Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, on behalf of the Global Burden of Metabolic 
Risk Factors Chronic Diseases Collaborating Group (Body Mass Index) 2011 National, regional, 
and global trends in body-mass index since 1980: systematic analysis of health examination 
surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 
377: 557 – 567. 
 
Fitzsimons CF, Baker G, Gray SR, Nimmo MA, Mutrie N, The Scottish Physical Activity Research 
Collaboration (SPARColl) 2012 Does physical activity counselling enhance the effects of a 
pedometer-based intervention over the long-term: 12-month findings from the Walking for 
Wellbeing in the west study. BMC Public Health 12: 206. Doi: 10.1186/1471-2458-12-206. 
 
Forbes CC, Plotnikoff RC, Courneya KS, Boule NG 2010 Physical activity preferences and type 
two diabetes: exploring demographic, cognitive and behavioural differences. The Diabetes 
Educator 36 (5): 801 – 815. 
 
Foster C, Hillsdon M, Thorogood M 2009 Interventions for promoting physical activity (Review). 
Cochrane Database on Systematic Reviews Issue 1. Art. No.: CD003180. DOI: 
10.1002/14651858.CD003180.pub2.  
 
Frerichs W, Kaltenbacher E, Van de Leur JP, Dean E 2012 Can physical therapists counsel 
patients with lifestyle-related health conditions effectively? A systematic review and implications. 
Physiotherapy Theory and Practice 28 (8): 571 – 587.   
 
French AL, Gawei SH, Hershow R, Benning L, Hessol NA, Levine AM, Anastos K, Augenbraun M, 
Cohen MH 2009 Trends in mortality and causes of death among women with HIV in the US: a ten-
year study. Journal of Acquired Deficiency Syndrome 51 (4): 399 – 406. 
 
Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, Monforte AA, Pradier C, Morfeldt L, Mateu S, 
Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD for the DAD study group 2003 
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results 
from the DAD study. AIDS 17 (8): 1179 – 1193. 
 
Gallagher KM, Updegraff JA 2012 Health message framing effects on attitudes, intentions, and 
behaviour: a meta-analytic review. Annals of Behavioral Medicine 43: 101 – 116. 
 
Garcia J, Hromi-Fiedler A, Mazur RE, Marquis G, Sellen D, Lartey A, Perez-Escamilla R 2013 
Persistent household food insecurity, HIV, and maternal stress in peri-urban Ghana. BMC Public 
Health 13 (215): 1 – 9. 
 
Gaskins AJ, Wilchesky M, Mumford SL, Whitcomb BW, Browne RW, Wacktawski-Wende J, 
Perkins NJ, Schisterman EF 2012 Endogenous reproductive hormones and C-reactive protein 
across the menstrual cycle: The BioCycle Study. American Journal of Epidemiology 175 (5): 423 – 
431. 
 
Gaziano TA 2005 Cardiovascular disease in the developing world and its cost-effective 
management. Circulation 112 (23): 3547 – 3553. 
 
Gellish RL, Goslin BR, Olson RE, McDonald A, Russi GD, Moudgil VK 2007 Longitudinal modelling 
of the relationship between age and maximal heart rate. Medicine and Science in Sports and 
Exercise 39 (5): 822 – 829. 
258 
 
George JA, Venter WDF, Van Deventer HE, Crowther NJ 2009 A longitudinal study of the changes 
in body fat and metabolic parameters in a South African population of HIV-Positive patients 
receiving an antiretroviral therapeutic regimen containing Stavudine. AIDS Research and Human 
Retroviruses 25 (8): 771 – 781.  
 
Ghisletta P, Spini D 2004 An introduction to generalized estimation equations and an application to 
assess selectivity effects in a longitudinal study on very old individuals. Journal of Educational and 
Behavioral Statistics 29 (4): 421 – 437.  
 
Giannuzzi P, Mezzani A, Saner H, Björnstad H, Fioretti P, Mendes M, Cohen-Solal A, Dugmore L, 
Hambrecht R, Hellemans I, McGee H, Perk J, Vanhees L, Veress G; Working Group on Cardiac 
Rehabilitation and Exercise Physiology. European Society of Cardiology 2003 Physical activity for 
primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation 
and Exercise Physiology of the European Society of Cardiology. European Journal of 
Cardiovascular Prevention and Rehabilitation 10: 319 – 327.  
 
Gibbins WJ, Fruchter N, Sloan S, Levy RD 2001 Reference values for a multiple repetition 6-
minute walk test in healthy adults older than 20 years. Journal of Cardiopulmonary Rehabilitation 
21 (2): 87 – 93. 
 
Gomes RD, Borges JP, Lima DB, Farinatti PTV 2010 Effects of physical exercise in the perception 
of life satisfaction and immunological function in HIV-infected patients: non-randomized clinical 
trial. Revista Brasileira de Fisioterapia 14 (5): 390 – 395.  
 
Graig WY, Palomaki GE, Haddow JE 1989 Cigarette smoking and serum lipid and lipoprotein 
concentrations: an analysis of published data. British Medical Journal 298 (6676): 784 – 788. 
 
Gray SR, Baker G, Wright A, Fitzsimons CF, Mutrie N, Nimmo MA, Scottish Physical Activity 
Research Collaboration 2009 The effect of a 12 week walking intervention on markers of insulin 
resistance and systematic inflammation. Preventive Medicine 48: 39 – 44. 
 
Greenland P, Daviglus ML, Dyer AR, Liu Kiang, Huang CF, Goldberger JJ, Stamier J 1999 Resting 
heart rate is a risk factor for cardiovascular and noncardiovascular mortality: The Chicago Heart 
Association Detection Project in Industry. American Journal of Epidemiology 149 (9): 853 – 862. 
 
Gremeaux V, Troisgros O, Benaïm S, Hannequin A, Laurent Y, Casillas JM, Benaïm C 2011 
Determining the minimal clinically important difference for the six-minute walk test and the 200-
meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after 
acute coronary syndrome. Archives of Physical Medicine and Rehabilitation 29 (4): 611 – 619. 
 
Grinspoon S, Carr A 2005 Medical Progress: cardiovascular risk and body-fat abnormalities in HIV-
Infected Adults. The New England Journal of Medicine 352 (1): 448-62. 
 
Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dube MP, Lipshultz SE, Hsue PY, 
Squires K, Schambelan M, Wilson PWF, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH 2008 
State of the Science Conference: Initiative to decrease cardiovascular risk and increase quality of 
care for patients living with HIV/AIDS; Executive Summary. Circulation 118: 198-210. 
 
Grinsztejn B, Luz PM, Pacheco AG, Santos DVG, Velasque L, Moreira RI, Guimaraes MRC, 
Nunes EP, Lemos AS, Ribeiro SR, Campos DP, Vitoria MAA, Veloso VG 2013 Changing mortality 
profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS 
related conditions in the HAART era. PLOS ONE 8 (4): e59768. 
 
Gowda S, Desai PB, Hull VV, Math AAK, Vernekar SN, Kulkarni SS 2009 A review on laboratory 
liver function tests. Pan African Medical Journal 3 (7): 1 – 15. 
 
259 
 
Guimaraes MMM, Greco DB, De Figueiredo SM, Foscolo RB, De Oiveira AR, De Campos 
Machado LJ 2008 High-sensitivity C-reactive protein levels in HIV- infected patients treated or not 
with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV 
infection. Artherosclerosis 201: 434 – 439. 
 
Gupta SK 2011 Intention-to-treat concept: a review. Perspectives in Clinical Research 2 (3): 109 – 
112.  
 
Guthold R, Ono T, Strong KL, Chatterji S, Morabia A 2008 Worldwide variability in physical 
inactivity: a 51-Country survey. American Journal of Preventative Medicine 34 (6): 486-494. 
 
Hadigan C, Meigs JB, Wilson PWF, D’Agostino RB, Davis B, Basgoz N, Sax PE, Grinspoon S 
2003 Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. 
HIV/AIDS 36: 909- 916. 
 
Hall J 2006 Height and length. In: Handbook of Physical Measurements, 2nd ed., pp. 15 – 48, 
Oxford University Press, New York, New York.  
 
Hamad R, Fernald LCH, Karlan DS, Zinman J 2008 Social and economic correlates of depressive 
symptoms and perceived stress in South African adults. Journal of Epidemiology Community 
Health 62: 538 – 544. 
 
Hamarneh YN, Agus A, Campbell D, Crealey GE, McElnay JC 2012 Public perceptions of coronary 
events risk factors: a discrete choice experiment. BMJ Open 2: e001560. doi: 10.1136/bmjopen-
2012-001560. 
 
Hammer SM, Eron JJ, Reiss P 2008 Antiretroviral treatment of adult HIV infection: 2008 
recommendations of the International AIDS Society of USA Panel. Journal of the American Medical 
Association 300 (5): 555 – 570. 
 
Hand GA, Phillips KD, Dudgeon WD, Lyerly GW, Dursine JL, Burgess SE 2008 Moderate intensity 
exercise training reverses functional aerobic impairment in HIV-infected individuals. AIDS Care 20 
(9): 1066 – 1074.  
 
Hart PL 2005 Women’s perceptions of coronary heart disease: an integrative review. Journal of 
Cardiovascular Nursing 20 (3): 170 – 176. 
 
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, 
Thompson PD, Bauman A 2007 ACSM/AHA Recommendations. Physical activity and Public 
Health. Updated recommendations for adults from the American College of Sports Medicine and 
the American Heart Association. Circulation 116: 1081 – 1093. 
 
Hasumi T, Jacobsen KH 2012 Hypertension in South African adults: results of a nationwide survey. 
Journal of Hypertension 30 (11): 2098 – 2104. 
 
Hawk C 2010 Integration of wellness principles into chiropractic practice in the United States. In: 
Patient Education and Wellness: A Handbook for Manual Therapists, pp. 27 – 44. Churchill 
Livingstone Elsevier, Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, 
Toronto. 
 
Hendricks KM, Willis K, Houser R, Jones CY 2006 Obesity in HIV-infection: Dietary correlates. 
Journal of the American College of Nutrition 25 (4): 321 – 331. 
 
Hertzog MA 2008 Considerations in determining sample size for pilot studies. Research in Nursing 
and Health 31: 180 – 191. 
 
260 
 
Hill J, Bird H 2003 The development and evaluation of a drug information leaflet for patients with 
rheumatoid arthritis. Rheumatology 42: 66 – 70.   
 
Hillsdon M, Thorogood M, Anstiss T, Morris J 1995 Randomised controlled trials of physical activity 
promotion in free living populations: a review. Journal of Epidemiology and Community Health 49: 
448 – 453. 
 
Hodge DR, Roby JL 2010 Sub-Saharan African women living with HIV/Aids: an exploration of 
general and spiritual coping strategies. Journal of Social Work 55 (1): 27 – 37. 
 
Hsia J, Larson CJ, Ockene JK, Sarto GE, Allison MA, Hendrix SL, Robinson JG, LaCroix AZ, 
Manson JE, for the Women’s Health Initiative Research Group 2009 Resting heart rate as a low 
tech predictor of coronary events in women: prospective cohort study. British Medical Journal 338 
(b219): 1 – 6. 
 
Hsieh HF, Shannon SE 2005 Three approaches to qualitative content analysis. Qualitative Health 
Research 15 (9): 1277 – 1288.  
 
Hsue PY, Squires K, Bolger AF, Capili B, Mensah GA, Temesgen Z, Wanke CA, Wohl DA; 
Working Group 4 2008 Screening and assessment of coronary heart disease in HIV-infected 
patients. Circulation 118 (2): e41-e47. 
 
Hurley E, Coutsoudis A, Giddy J, Knight SE, Loots E, Esterhuizen TM 2011 Weight evolution and 
perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African 
urban setting. South African Medical Journal 101 (9): 645 – 650. 
 
IBM Corp. 2012 IBM SPSS Statistics for Windows, Version 21.0: Released 2012. Armonk, NY: IBM 
Corp. 
 
IBM Corp. 2013 IBM SPSS Statistics for Windows, Version 22.0: Released 2013. Armonk, NY: IBM 
Corp. 
 
Ibrahim MM, Damasceno A 2012 Hypertension in developing countries. Lancet 380: 611 – 619. 
 
Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, 
Yusuf S 2008 Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of 
the INTERHEART study. Circulation 118: 1929 – 1937. 
 
International Classification of Diseases 2013 Ischaemic Heart Disease [Online]. Available: 
www.bioportal.bioontology.org/ontologies/35686?p=termsandcoceptid=410-414.99 [Accessed: 20 
May 2013].  
 
Iwane M, Arita M, Tomimoto S, Satani O, Matsumoto M, Miyashita K, Nishio I 2000 Walking 10 000 
steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential 
hypertension. Hypertension Research 23 (6): 573 – 580. 
 
Jaggers JR, Dudgeon W, Blair SN, Sui X, Burgess S, Wilcox S, Hand GA 2013 A home-based 
exercise intervention to increase physical activity among people living with HIV: study design of a 
randomised clinical trial. BMC Public Health 13 (502): 1 – 12. 
 
Jamison JR 2010 Strategies for promoting self-care. In: Patient Education and Wellness: A 
Handbook for Manual Therapists, pp. 91 – 106. Churchill Livingstone Elsevier, Philadelphia, 
Pennsylvania. 
 
Janz NK, Becker MH 1984 The Health Belief Model: A decade later. Health Education and 
Behavior 11 (1): 1 – 47. 
 
261 
 
Jensen LA, Onyskiw JE, Prasad NG 1998 Meta-analysis of arterial oxygenation saturation 
monitoring by pulse oximetry in adults. Heart and Lung 27 (6): 387 – 408. 
 
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F 1997 Relation of high TG-low HDL cholesterol 
and LDL cholesterol to the incidence of Ischemic Heart Disease. Arteriosclerosis, Thrombosis, and 
Vascular Biology 17: 1114 – 1120. 
 
Jerico C, Knobel H, Sorli ML, Montero M, Guelar A, Pedro-Botet J 2006 Prevalence of 
cardiovascular risk factors in HIV-infected patients. Revista Clinical Espanola 206 (11): 556 – 559. 
 
Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, 
Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A, for the International 
Epidemiological Databases to Evaluate AIDS Southern Africa (leDEA-SA) Collaboration. Plos 
Medicine 10 (4): e1001418. 
 
Joubert J, Norman R, Lambert EV, Groenewald P, Schneider M, Bull F, Bradshaw D 2007 
Estimating the burden of disease attributable to physical inactivity in South Africa in 2000. South 
African Medical Journal 97: 725-731. 
 
Joyner MJ, Green DJ 2009 Exercise protects the cardiovascular system: effects beyond traditional 
risk factors. The Journal of Physiology 587 (23): 5551 – 5558. 
 
Justman JE, Hoover DR, Shi Q, Tan T, Anastos K, Tien P, Cole SR, Hyman C, Karim R, Weber K, 
Grinspoon S 2008 Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected 
women. Journal of Acquired Immune Deficiency Syndromes: 47 (3): 312 – 319. 
 
Katsoulidou A, Rokka C, Issaris C, Haida C, Tzannis K, Sypsa V, Detsika M, Paraskevis D, 
Hatzakis A 2011 Comparative evaluation of the performance of the Abbott Real Time HIV-1 assay 
for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virology 
Journal 8: 10. doi: 10.1186/1743-422X-8-10  
 
Katzmarzyk PT, Heymsfield SB, Bouchard C 2013 Clinical utility of visceral adipose tissue for the 
identification of cardiometabolic risk in white and African American adults. American Journal of 
Clinical Nutrition 97 (3): 480 – 486. 
 
Kerr J, Hilari K, Litosseliti L 2010 Information needs after stroke: What to include and how to 
structure it on a website. A quality study using focus groups and card sorting. Aphasiology 24 (1): 
1170 – 1196. 
 
Killam LA, Montgomery P, Raymond JM, Mossey S, Timmermans KE, Binette J 2012 Unsafe 
clinical practices as perceived by final year baccalaureate nursing students: Q methodology. BMC 
Nursing 11 (26): 1 – 13. 
 
Kim AS, Johnston SC 2011 Global variation in the relative burden of stroke and ischemic heart 
disease. Circulation 124: 314 – 323. 
 
Kinsey K, McVeigh J, Chantler I 2008 Habitual physical activity levels are positively correlated with 
CD4 count in an HIV-positive South African population. African Journal of AIDS Research 7 (2): 
237 – 242. 
 
Klug EQ, Raal FJ, Marais AD, Taskinen MR, Dalby AJ, Schamroth C, Rapeport N, Jankelow D, 
Blom DJ 2012 South African Dyslipidaemia Guideline Consensus Statement. South African 
Medical Journal 102 (3): 177-188. 
 
Koopman C, Gore-Felton C, Marouf F, Butler LD, Field N, Gill M, Chen XH, Israelski D, Spiegel D 
2000 Relationships of perceived stress to coping, attachment and social support among HIV-
positive persons. AIDS Care 12 (5): 663 – 672. 
262 
 
Kruger A, Wissing MP, Towers GW, Doak CM 2012 Sex differences independent of other psycho-
sociodemographic factors as a predictor for body mass index in black South African adults. Journal 
of Health, Population, Nutrition 30 (1): 56 – 65.  
 
Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT 1994 Relation of 
leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction 
in men. The New England Journal of Medicine 330: 1549 – 1554. 
 
Latimer AE, Brawley LR, Bassett RL 2010 A systematic review of three approaches for 
constructing physical activity messages: what messages work and what improvements are 
needed? International Journal of Behavioral Nutrition and Physical Activity 7 (36): 1 – 48. 
 
Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ 2006 C-Reactive 
protein is a marker for human immunodeficiency virus disease progression. Archives of Internal 
Medicine 166 (1): 64 – 70. 
 
Lawlor DA, Bedford D, Taylor M, Ebrahim S 2002 Agreement between measured and self-reported 
weight in older women. Results from the British Women’s Heart and Health Study. Age and Ageing 
31: 169 – 174. 
 
Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R 2006 Determinants of mortality and 
nondeath losses from antiretroviral treatment service in South Africa: Implications for Program 
evaluation. HIV/AIDS 43: 770 – 776.  
 
Lawn SD, Harries AD, Anglaret X, Myer L, Wood R 2008 Early mortality among adults assessing 
antiretroviral treatment programmes in Sub-Saharan Africa. AIDS 22: 1897 – 1908. 
 
Lebech AM, Kristoffersen US, Mehlsen J, Wiinberg N, Petersen CL, Hesse B, Gerstoft J, Kjaer A 
2007 Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate 
variability. Clinical Physiology and Functional Imaging 27 (6): 363 – 367. 
 
Lee IM, Sesso HD, Paffenbarger Jr RS 2000 Physical activity and coronary heart disease in men. 
Does the duration of exercise episodes predict risk? Circulation 102: 981 – 986. 
 
Lee IM, Skerrett PJ 2001 Physical activity and all-cause mortality: what is the dose-response 
relation? Medicine and Science in Sports and Exercise 33 (6 Suppl): S459 – S471. 
 
Lee IM, Shiroma EJ, Lobelo E, Puska P, Blair SN, Katzmarzyk PT 2012 Effects of physical 
inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and 
life expectancy. Lancet 380: 219-229. 
 
Legato MJ, Padus EP, Slaughter E 1997 Women’s perceptions of their general health, with special 
reference to their risk of coronary artery disease: results of a national telephone survey. Journal of 
Women’s Health 6 (2): 189 – 198. 
 
Linetzky B, De Maio F, Ferrante D, Konfino J, Boissonnet C 2013 Sex-stratified socio-economic 
gradients in physical inactivity, obesity and diabetes: evidence of short-term changes in Argentina. 
International Journal of Public Health 58 (2): 277 – 284. 
 
Lisk CJ, Grau L 1999 Perceptions of women living with coronary heart disease: a pilot 
investigation. Women and Health 19 (1): 31 – 46. 
 
Liu J, Hong Y, D’Agostino RB, Wu Z, Wang W, Sun J, Wilson PWF, Kannel WB, Zhao D 2004 
Predictive value for the Chinese population of the Framingham CHD risk assessment tool 
compared with the Chinese Multi-provincial Cohort Study. The Journal of the American Medical 
Association 291 (21): 2591 – 2599.  
 
263 
 
Lundgren JD, Battegay M, Behrens G, De Witt S, Guaraldi G, Katlama C, Martinez E, Nair D, 
Powderly WG, Reiss P, Sutinen J, Vigano A and the EACS Executive Committee 2008 European 
AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases 
in HIV. HIV Medicine 9: 72 – 81. 
 
Lugina HI, Nyström L, Christensson K, Lindmark G 2004 Assessing mothers’ concerns in the 
postpartum period:  methodological issues. Methodological Issues in Nursing Research 48 (3): 279 
– 290. 
 
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal 
R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, 
Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, 
Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, 
Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, 
Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, 
Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais 
DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, 
Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel 
SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, 
Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, 
Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, 
Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, 
MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi 
BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, 
Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan 
KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, 
Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, 
Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, 
Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman 
E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, 
Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, 
Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, 
Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, 
AlMazroa MA, Memish ZA Global and regional mortality from 235 causes of death for 20 age 
groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. 
Lancet 380: 2095 – 2128. 
 
Ma Y, Mazumdar M, Memtsoudis SG 2012 Beyond repeated measures ANOVA: advanced 
statistical methods for the analysis of longitudinal data in anesthesia research. Regional 
Anesthesia and Pain Medicine 37 (1): 99 – 105. 
 
Maartens G, Cotton M, Wilson D, Venter F, Meyers T, Bekker LG 2012 Approach to HIV infection 
in adults. In: Handbook of HIV medicine, 3rd ed., pp. 224 – 231, Oxford University Press, Cape 
Town.  
 
Mackay J, Menash GA 2004 The Atlas of Heart Disease and Stroke [Online]. Available: 
http://www.who.int/cardiovascular_diseases/resources/atlas/en/index.html [Accessed 1 July 2009]. 
 
Majewski M, Rozek K, Alawale O 2010 Ambulatory pulmonary rehabilitation programme in patients 
suffering from chronic obstructive pulmonary disease (COPD): a preliminary study. Fizjoterapia 18 
(4): 11 – 20.  
 
Marshall SJ, Levy SS, Tudor-Locke CE, Kolkhorst FW, Wooten KM, Ji M, Macera CA, Ainsworth 
BE 2009 Translating physical activity recommendations into a pedometer-based step goal 3000 
steps in 30 minutes. American Journal of Preventive Medicine 36 (5): 410 – 415. 
 
264 
 
Martin SA, Pence BD, Woods JA 2009 Exercise and respiratory tract viral infections. Exercise 
Sports Science Review 37 (4): 157 – 164. 
 
Mascolini M 2010 What speeds aging with HIV – and what can be done about it? Research 
Initiative/ Treatment Action! 15 (2): 29 – 50.  
 
Masia M, Bernal E, Padilla S, Graells ML, Jarrin I, Almenar MV, Molina J, Hernandez I, Gutierrez F 
2007 The role of C-reactive protein as a marker for cardiovascular risk associated with 
antiretroviral therapy in HIV-infected patients. Atherosclerosis 195: 167 – 171.  
 
Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D 2009 The burden of non-
communicable diseases in South Africa. Lancet 374: 934-947. 
 
Mayosi BM, Lawn JE, Van Niekerk A, Bradshaw D, Karim SS, Coovadia HM 2012 Health in South 
Africa: changes since 2009. Lancet 380: 2029 – 2043. 
 
Mbada CE, Onayemi O, Ogunmoyole Y, Johnson OE, Akosile CO 2013 Health-related quality of 
life and physical functioning in people living with HIV/AIDS: a case-control design. Health and 
Quality of Life Outcomes 11 (106): 1 – 8.  
 
Medina-Torne S, Ganesan A, Barahona I, Crum-Cianflone NF 2012 Hypertension is common 
among HIV-infected persons, but not associated with HAART. Journal of the International 
Association of Physicians in AIDS Care (JIAPAC) 11: 20 -25.  
 
Meikle J, Al-Sarraf A, Li M, Grierson K, Frohlich J 2013 Exercise in a Healthy Heart Program: A 
cohort study. Clinical Medicine Insights: Cardiology 7: 145 – 151. 
 
Meischke H, Sellers DE, Goff DC, Daya MR, Meshack A, Taylor J, Zapka J, Hand MM 2000 
Factors that influence personal perceptions of the risk of an acute myocardial infarction. Behavioral 
Medicine 26 (1): 4 – 13.  
 
Mensah GA 2008 Ischaemic heart disease in Africa. Heart 94: 836-843. 
 
Mehra VC, Ramgolam VS, Bender JR 2005 Cytokines and cardiovascular disease. Journal of 
Leukocyte Biology 78: 805 – 818. 
 
Mfenyana K, Griffin M, Yoqeswaran P, Modell B, Modell M, Chandia J, Nazareth I 2006 Socio-
economic inequalities as a predictor of Health in South Africa – the Yenza cross-sectional study. 
South Africa Medical Journal 96 (4): 323 – 330.  
 
Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, Flores M, Shor-
Posner G 2005 Increased risk of pneumocystis carinii and community-acquired pneumonia with 
tobacco use in HIV disease. International Journal of Infectious Diseases 9: 208 – 217.  
 
Milner QJW, Mathews GR 2012 An assessment of the accuracy of pulse oximeters. Anaesthesia 
67: 396 – 401. 
 
Mkhonto SS, Labadarios D, Mabaso ML 2012 Association of body weight and physical activity with 
blood pressure in a rural population in the Dikgale village of Limpopo Province in South Africa. 
BMC Research Notes 23 (5): 118. doi: 10.1186/1756-0500-5-118. 
 
Mkandawire-Valhmu L, Kako P, Kibicho J, Stevens PE 2013 The innovative and collective capacity 
of low-income East African women in the era of HIV/AIDS: contesting western notions of African 
women. Health Care for Women International 34 (3): 332 – 350. 
 
265 
 
Moore R, Berlowitz D, Denehy L, Jackson B, McDonald CF 2009 Comparison of pedometer and 
activity diary for measurement of physical activity in chronic obstructive pulmonary disease. 
Journal of Cardiopulmonary Rehabilitation and Prevention 29: 57 – 61. 
 
Mora S, Cook N, Buring JE, Ridker PM, Lee IM 2007 Physical activity and reduced risk of 
cardiovascular events: potential mediating mechanisms. Circulation 116: 2110 – 2118. 
 
Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, Kleerup EC on behalf of the 
Lung HIV Study 2011 HIV and chronic obstructive pulmonary disease: is it worse and why? 
Proceedings of the American Thoracic Society 8: 320 – 325. 
 
Mosca L, Edelman D, Mochari H, Christian AH, Paultre F, Pollin I 2006 Waist circumference 
predicts cardiometabolic and global Framingham Risk among women screened during National 
Woman’s Heart Day. Journal of Women’s Health 15 (1): 24 – 34. 
 
Murtagh EM, Boreham CA, Murphy MH 2002 Speed and exercise intensity of recreational walkers. 
Prevention Medicine 35 (4): 397 – 400. 
 
Murtagh EM, Murphy MH, Boone-Heinonen J 2010 Walking: the first step in cardiovascular 
disease prevention. Current Opinion in Cardiology 25 (5): 490 – 496. 
 
Musto A, Jacobs K, Nash M, DelRossi G, Perry A 2010 The effects of an incremental approach to 
10000 steps/day on metabolic syndrome components in sedentary overweight women. Journal of 
Physical Activity and Health 7: 737 – 745. 
 
Mutimura E, Stewart A, Rheeder P, Crowther NJ 2007 Metabolic function and the prevalence of 
lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral 
therapy. Journal of Acquired Immune Deficiency 46 (4): 451 – 455.  
 
Mutimura E, Stewart A, Crowther NJ, Yarasheski KE, Cade WT 2008 The effects of exercise 
training on quality of life in HAART-treated HIV-positive Rwandan subjects with body fat 
redistribution. Quality of Life Research 17: 377 – 385. 
 
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant CF, Kaczorowski J 2011 Conventional 
versus automated measurement of blood pressure in primary care patients with systolic 
hypertension: randomised parallel design controlled trial. British Medical Journal 342 (d286): 1 – 9. 
 
Myles PS 2007 Using the Bland-Altman method to measure agreement with repeated measures. 
British Journal of Anaesthesia 99 (3): 309 – 311. 
 
Myezwa H, Stewart A, Musenge E, Nesara P 2009 Assessment of HIV-positive in-patients using 
the International Classification of Functioning, Disability and Health (ICF) at Chris Hani 
Baragwaneth Hospital, Johannesburg. African Journal of Aids Care 8: 93 – 105. 
 
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002 Third Report of the 
National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, Treatment 
of High Blood Cholesterol in Adults (Adults Treatment Panel III) final report. Circulation 106: 3143 – 
3421. 
 
Noursadeghi M, Miller RF 2005 Clinical value of C-reactive protein measurements in HIV-positive 
patients. International Journal of STD and AIDS 16 (6): 438 – 441. 
 
Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F, Neuhaus K, 
Kondratieva J, Buck T, Müller-Tasch T, Wachter R, Prettin C, Gelbrich G, Herzog W, Pieske B, 
Rauchhaus M, Löffler M, Maisch B, Mügge A, Wasem J, Gerken G, Brockmeyer NH, Erbel R; HIV-
HEART Study Investigative Group 2007 Prevalence and natural history of heart failure in outpatient 
266 
 
HIV-infected subjects: rationale and design of the HIV-Heart study. European Journal of Medical 
Research 12: 243 – 248. 
 
Neidig JL, Smith BA, Brashers DE 2003 Aerobic exercise training for depressive symptom 
management in adults living with HIV infection. The Journal of the Association of Nurses in AIDS 
Care 14 (2): 30 – 40.  
 
Nixon S, O’Brien K, Glazier R, Tynan AM 2005 Aerobic exercise interventions for adults living with 
HIV/AIDS. Cochrane Database of Systematic Reviews Issue 2, Art. No.: CD001796. DOI: 
10.1002/14651858.CD001796.pub2. 
 
Noonan V, Dean E 2000 Submaximal exercise testing: clinical application and interpretation. 
Physical Therapy 80: 782 – 807. 
 
Ntusi N 2011 Dismal management of hypertension at primary level: does it reflect a failure of 
patients, a failure of the system or a failure of doctors? Cardiovascular Journal of Africa 22 (4): 172 
– 174. 
 
Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sorensen HT, Gerstoft J 2007 
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort 
study. Clinical Infectious Diseases 44 (12): 1625 – 1631. 
 
O’Brien K, Nixon S, Tynann AM, Glazier R 2010 Aerobic exercise intervention for adults living with 
HIV/AIDS. Cochrane Database of Systematic Reviews, Issue 8. Art No: CD001796. DOI: 
10.1002/14651858.CD001796.pub3. 
 
O’Brien K, Wilkins A, Zack E, Solomon P 2010 Scoping the field: Identifying key research priorities 
in HIV and Rehabilitation. AIDS Behavior 14: 448 – 458.  
 
Ockene JK, Schneider KL, Lemon SC, Ockene IS 2011 Can we improve adherence to preventive 
therapies for cardiovascular health? Circulation 124: 1276 – 1282. 
 
O’Donovan G, Blazevich AJ, Boreham C, Cooper AR, Crank H, Ekelund U, Fox KR, Gately P, 
Giles-Corti B, Gill JMR, Hamer M, McDermott I, Murphy M, Mutrie N, Reilly JJ, Saxton JM, 
Stamatakis E 2010 The ABC of physical activity for health: a consensus statement from the British 
Association of Sport and Exercise Sciences. Journal of Sports Sciences 28 (6): 573 – 591. 
 
Ogalha C, Luz E, Sampaio E, Souza R, Zarife A, Neto MG, Netto E, Brites C 2011 A randomized 
clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology 
and metabolic parameters of patients with AIDS in Salvador, Brazil. Journal of Acquired Immune 
Deficiency Syndrome 57 (Suppl. 3): S179 – S185. 
 
Ogilvie D, Foster CE, Rothnie H, Cavill N, Hamilton V, Fitzsimons CF, Mutrie N, on behalf of the 
Scottish Physical Activity Research Collaboration (SPARColl) 2007 Interventions to promote 
walking: systematic review. British Medical Journal 334 (7605): 1 – 10. 
 
Onen CL 2013 Epidemiology of ischaemic heart disease in sub-Saharan Africa. Cardiovascular 
Journal of Africa 24 (2): 34 – 42. 
 
Oursler KK, Katzel LI, Smith BA, Scott WB, Russ DW, Sorkin JD 2009 Prediction of 
cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical 
factors and value of the six-minute walk distance. Journal of the American Geriatrics Society 57 
(11): 2055 – 2061. 
  
Pace R, Dawkins N, Wang B, Person S, Shikany JM 2008 Rural African Americans’ dietary 
knowledge, perceptions, and behaviour in relation to cardiovascular disease. Ethnicity and Disease 
18: 6 - 12. 
267 
 
Paddison J, Fricchione G, Gandhi RT, Freudenreich O 2009 Fatigue in psychiatric HIV patients: a 
pilot study of psychological correlates. Psychosomatics 50 (5): 455 – 460. 
   
Palatini P 2007 Heart rate as an independent risk factor for cardiovascular disease: Current 
evidence and basic mechanisms. Drugs 67 (Supplement 2): 3 – 13.  
 
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg 
S and the HIV Outpatient Study Investigators 1998 Declining morbidity and mortality among 
patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 
338: 853-860. 
 
Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD and HIV 
Outpatient Study Investigators 2006 Mortality in the highly active antiretroviral therapy era: 
changing causes if death and disease in the HIV Outpatient Study. Journal of Acquired Immune 
Deficiency Syndrome 43 (1): 27 – 34. 
 
Palermo B, Bosch RJ, Bennett K, Jacobson JM 2011 Body mass index and CD4+ T-Lymphocyte 
recovery in HIV-infected men with viral suppression on antiretroviral therapy. HIV Clinical Trials 12 
(4): 222 – 227. 
 
Parker A, Nagar B, Thomas G, Badri M, Ntusi NBA 2011 Health practitioners’ state of knowledge 
and challenges to effective management of hypertension at primary level. Cardiovascular Journal 
of Africa 22 (4): 186 – 190.  
 
Paterson BL 2001 The Shifting Perspectives Model of chronic illness. Journal of Nursing 
Scholarship 33 (1): 21 – 26. 
 
Patton MQ 1999 Enhancing the quality and credibility of qualitative analysis. HSR: Health Services 
Research 34 (5): 1189 – 1208. 
 
Pavan MV, Saura GE, Korkes HA, Nascimento KM, Domingues N, Neto M, Davila R, Rodrigues 
CIS, Almeida FA 2012 Similarity between blood pressure values assessed by auscultatory method 
with mercury sphygmomanometer and automated oscillometric digital device. Jornal Brasileiro de 
Nefrologia 34 (1): 43 – 49.  
 
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann 
SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F 2003 AHA/CDC 
Scientific Statement: Markers of inflammation and cardiovascular disease. Circulation 107 (3): 499 
– 511. 
 
Peer N, Bradshaw D, Laubscher R, Steyn K 2009 Trends in adult tobacco use from two South 
African demographic and health surveys conducted in 1998 to 2003. South African Medical Journal 
99 (10): 744 – 749. 
 
Peltzer K, Promtussananon S 2004 Knowledge, barriers, and benefits of fruit and vegetable 
consumption and lay conceptions of nutrition among rural and semi-urban Black South Africans. 
Psychological Reports 94 (3): 976 – 982.  
 
Peltzer K, Ramlagan S, Khan MS, Gaede B 2011 The social and clinical characteristics of patients 
on antiretroviral therapy who are ‘lost to follow-up’ in KwaZulu Natal, South Africa: a prospective 
study. Journal of Social Aspects of HIV/AIDS: An Open Access Journal 8 (4): 179 – 186. 
 
Peltzer K, Phaswana-Mafuya N 2012 Fruit and vegetable intake and associated factors in older 
adults in South Africa. Global Health Action 5 (18668): 1 – 8. 
 
Petroczi A, Hawkins K, Jones G, Naughton DP 2010 HIV patient characteristics that affect 
adherence to exercise programmes: an observational study. The Open AIDS Journal 4: 148 – 155. 
268 
 
Portney LG, Watkins MP 2009 Validity of Measurements. In: Foundations of Clinical Research: 
Applications to Practice, 3rd ed., pp 97 – 118. Pearson Education, Inc., Upper Saddle River, New 
Jersey. 
 
Portney LG, Watkins MP 2009 Qualitative Research. In: Foundations of Clinical Research; 
Applications to Practice, 3rd ed., pp 306 – 313. Pearson Education, Inc., Upper Saddle River, New 
Jersey.  
 
Portney LG, Watkins MP 2009 Correlation. In: Foundations of Clinical Research; Applications to 
Practice, 3rd ed., pp 523 - 538. Pearson Education, Inc., Upper Saddle River, New Jersey.  
 
Potvin L, Richard L, Edwards AC 2000 Knowledge of cardiovascular disease risk factors among 
the Canadian population: relationships with indicators of socioeconomic status. Canadian Medical 
Association Journal 162 (9 Suppl): S5 – S11.  
 
Program for Appropriate Technology in Health (PATH) 2005 RBP – EIA: Collecting, Processing 
and Handling Venous, Capillary, and Blood Spot Samples [Online]. Available:  
http://www.path.org/publications/files/TS_rbp-eia_blood_collct.pdf - [Accessed 6 November 2013]. 
  
Pujari SN, Dravid A, Naik E, Bhagat S, Tash K, Nadler JP, Sinnott JT 2005 Lipodystrophy and 
dyslipidemia among patients taking first-line, World Health Organisation-recommended highly 
active antiretroviral therapy regimens in Western India. Journal of Acquired Immune Deficiency 
Syndrome 39 (2): 199 – 202.  
 
Ramirez-Marrero FA, Rivera-Brown AM, Nazario CM, Rodriquez-Orengo JF, Smit E, Smith BA 
2008 Self-reported physical activity in Hispanic Adults living with HIV: Comparison with 
accelerometer and pedometer. Journal of the Association of Nurses in AIDS Care 19 (4): 283-294. 
 
Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE 2009 The six-minute walk test: a 
useful metric for the cardiopulmonary patient. Internal Medicine Journal 39: 495 – 501.  
 
Rayner B, Blockman M, Baines D, Trinder Y 2007 A survey of hypertensive practices at two 
community health centres in Cape Town. South African Medical Journal 97 (4): 280 – 284.  
 
Reda AA, Biadgilign S 2012 Determinants of adherence to antiretroviral therapy among HIV-
infected patients in Africa. AIDS Research and Treatment 2012: 574656. doi: 
10.1155/2012/574656.  
 
Reddigan JI, Ardern CI, Riddell MC, Kuk JL 2011 Relation of physical activity to cardiovascular 
disease mortality and the influence of cardiometabolic risk factors. American Journal of Cardiology 
108: 1426 – 1431. 
 
Redfern J, Ellis E, Briffa T, Freedman SB 2006 Development and testing of innovative patient 
resources for the management of coronary heart disease (CHD): a descriptive study. BMC Health 
Services Research 6 (95): 1 – 9.  
 
Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, Jooste S 2010 A decline 
in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 
2002, 2005 and 2008. PLOS One 5 (6): 1 - 8. 
 
Remor E, Penedo FJ, Shen BJ, Schneiderman N 2007 Perceived stress is associated with CD4+ 
cell decline in men and women living with HIV/AIDS in Spain. AIDS Care 19 (2): 215 – 219.  
 
Reynolds NR, Neidig JL, Wu AW, Gifford AL, Holmes WC 2006 Balancing disfigurement and fear 
of disease progression: Patient perceptions of HIV body fat redistribution. AIDS Care 18 (7): 663 – 
673. 
 
269 
 
Reynolds NR 2009 Cigarette smoking and HIV: more evidence for action. AIDS Education and 
Prevention 21 (3 Suppl): 1 – 17.  
 
Rhodes RE, Warburton DE, Murray H 2009 Characteristics of physical activity guidelines and their 
effect on adherence: a review of randomised trials. Sports Medicine 39 (5): 355 – 375. 
 
Richardson CR, Newton TL, Abraham JJ, Sen A, Jimbo M, Swartz AM 2008 A meta-analysis of 
pedometer-based walking interventions and weight loss. Annals of Family Medicine 6 (1): 69 – 77. 
 
Richardson G, Van Woerden HC, Morgan L, Edwards R, Harries M, Hancock E, Sroczynsk S, 
Bowley M 2008 Healthy Hearts – A community-based primary prevention programme to reduce 
coronary heart disease. BMC Cardiovascular Disorder 8 (18): 1 – 8. 
 
Ridker PM, Buring JE, Rafai N, Cook NR 2007 Development and validation of improved algorithms 
for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. Journal of 
the American Medical Association 297 (6): 611 – 619. 
 
Right-to-Care 2010 Themba Lethu Clinic [Online]. Available: 
http://www.righttocare.org/index.php?option=com_contentandview=articleandid=69andItemid=108
? [Accessed: 1 March 2011]. 
 
Rod NH, Grønbaek M, Schnohr P, Prescott E, Kristensen TS 2009 Perceived stress as a risk 
factor for changes in health behaviour and cardiac risk profile: a longitudinal study. Journal of 
Internal Medicine 266 (5): 467 – 75. 
 
Rosa Neto JC, Lira FS, de Mello MT, Santos RVT 2011 Importance of exercise immunology in 
health promotion. Amino Acids 41: 1165 – 1172. 
 
Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-
Amon C, Sato H, Yusuf S; INTERHEART investigators 2004 Association of psychosocial risk 
factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 
countries (the INTERHEART study): case-control study. Lancet 364 (9438): 953 – 962. 
 
Rugg G, McGeorge P 1997 The sorting techniques: a tutorial paper on card sorts, picture sorts and 
item sorts. Expert Systems 14 (2): 80 – 93. 
 
Saladini F, Benetti E, Masiero S, Palatini P 2011 Accuracy of Microlife WatchBP Office ABI monitor 
assessed according to the 2002 European Society of Hypertension protocol and British 
Hypertension Society protocol. Blood Pressure Monitoring 16 (5): 258 – 261. 
 
South African National AIDS Council 2011 National Strategic Plan on HIV, STIs and TB 2012 – 
2016 Summary [Online]. Available: www.SANAC.org.za [Accessed: 29 April 2013]. 
 
Santos-Lozano A, Garatachea N 2011 Physical activity measurements using accelerometers and 
pedometers in HIV-infected people. Journal of AIDS and Clinical Research 2 (5): 1 – 4.  
 
Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouei P, Arveiler D, Ruidavets JB, 
Reynes J, Bingham A, Raffi F 2003 Risk factors for coronary heart disease in patients treated for 
human immunodeficiency virus infection compared with the general population. HIV/AIDS 37: 292- 
298. 
 
Saves PD, Philip AA 2008 Pedometer step counts predict cardiac risk factors at entry to cardiac 
rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 28: 370 – 377.  
 
Saunders MNK, Thornhill A 2011 Researching sensitively without sensitizing: using a card sort in a 
concurrent mixed methods design to research trust and distrust. International Journal of Multiple 
Research Approaches 5 (3): 334 – 350. 
270 
 
Saunders TJ, Tremblay MS, Despres JP, Bouchard C, Tremblay A, Chaput JP 2013 Sedentary 
behaviour, visceral fat accumulation and cardiometabolic risk in adults: a 6-year longitudinal study 
from the Quebec Family Study. PLOS One 8 (1): e54225.  
 
Schambelan M, Wilson PWF, Yarasheski KE, Cade WT, Davila-Roman VG, D’Agostino RB, Helmy 
TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; for Working Group 5 2008 
Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. 
Circulation 118: e48 – e53. 
 
Scherman T, Leenders J, Veen H, van den Bosch W, Wissink A, Smeele I, Chavannes N 2009 
Pulse oximetry in family practice: indications and clinical observations in patients with COPD. 
Family Practice 26 (6): 524 – 531. 
 
Schmidt MI, Duncan BB, Tavares M, Polanczyk CA, Pellanda L, Zimmer PM 1993 Validity of self-
reported weight – a study of urban Brazilian adults. Revista de Saude Publica 27 (4): 271 – 276. 
 
Schneider PL, Crouter SE, Bassett DR 2004 Pedometer measures of free-living physical activity: 
comparison of 13 models. Medicine and Science in Sports and Exercise 36 (2): 331 – 335.  
 
Schneider M, Norman R, Steyn N, Bradshaw D and the South African Comparative Risk 
Assessment Collaborating Group 2007 Estimating the burden of disease attributable to low fruit 
and vegetable intake in South Africa in 2000. South African Medical Journal 97 (8): 717 – 723. 
 
Schneider M, Bradshaw D, Steyn K, Norman R, Laubscher R 2009 Poverty and non-
communicable diseases in South Africa. Scandinavian Journal of Public Health 37: 176 – 186.  
 
Schulz KF, Grimes DA 2002 Generation of allocation sequences in randomised trials: chance, not 
choice. Lancet 359 (February 9): 515 – 519. 
 
Schulz KF, Grimes DA 2002 Allocation concealment in randomised trials: defending against 
deciphering. Lancet 359 (February 16): 614 – 618 
 
Seale H 2006 Six minute walk test: commentary. Australian Journal of Physiotherapy 52: 228 – 
229. 
 
Seedat YK, Croasdale MA, Milne FJ, Opie LH, Pinkney-Atkinson VJ, Rayner BL, Veriava Y 2006 
South African Hypertension Guidelines 2006 South African Medical Journal 96: 337 – 362. 
 
Selvin E, Paynter NP, Elinger TP 2007 The effect of weight loss on C-reactive protein: a systematic 
review. Archives of Internal Medicine 167 (1): 31 – 39. 
 
Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A 2007 Cultural factors and patients’ 
adherence to lifestyle measures. British Journal of General Practice 57 (537): 291 – 295. 
 
Serwe KM, Swartz AM, Hart TL, Strath SJ 2011 Effectiveness of long and short bout walking on 
increasing physical activity in women. Journal of Women’s Health 20 (2): 247 – 253. 
 
Shaw JE, Sicree RA, Zimmet PZ 2010 Global estimates of the prevalence of diabetes for 2010 and 
2030. Diabetes Research and Clinical Practice 87: 4 – 14. 
 
Sheedy J, Smith B, Bauman A, Barnett A, Calderan A, Culbert J, Jacka J 2000 A controlled trial of 
behavioural education to promote exercise among physiotherapy outpatients. Australian Journal of 
Physiotherapy 46: 281 – 289. 
 
Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya D 2014 South 
African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town, HSRC 
Press. 
271 
 
Shoemaker MJ, Curtis AB, Vangsnes E, Dickinson MG 2013 Clinically meaningful change 
estimates for the six-minute walk test and daily activity in individuals with chronic heart failure. 
Cardiopulmonary Physical Therapy Journal 24 (3): 21 – 29.  
  
Silagy C, Muir J, Coulter A, Thorogood M, Roe L 1993 Cardiovascular risk and attitudes to lifestyle: 
what do patients think? British Medical Journal 306: 1657 – 1660. 
 
Sitas F, Egger S, Bradshaw D, Groenewald P, Laubscher R, Kielkowski D, Peto R 2013 
Differences among coloured, white, black and other South African populations in smoking-
attributed mortality at ages 35 – 74 years: a case-control study of 481640 deaths. Lancet 382 
(9893): 685 – 693.  
 
Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S 2012 Contribution of the 
human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo 
presentations of heart disease in the Heart of Soweto Study cohort. European Heart Journal 33: 
866 – 874. 
 
Smith CP 2000 Content analysis and narrative analysis. In: Handbook of Research Methods in 
Social and Personality Psychology, pp 313 – 326. Cambridge University Press, New York. 
 
Smith JD, Borel AL, Nazare JA, Haffner SM, Balkau B, Ross R, Massien C, Almeras N, Despres 
JP 2012 Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and 
without type 2 Diabetes: Results from the INSPIRE ME IAA Study. Journal of Clinical 
Endocrinology and Metabolism 97 (5): 1517 – 1525. 
 
Schneider PL, Crouter SE, Bassett DR 2004 Pedometer measures of free-living physical activity: 
comparison of 13 models. Medicine and Science in Sports and Exercise October: 331-335. 
 
Spranger J, Kroke A, Möhlig M, Hoffman K, Bergman MM, Ristow M, Boeing H, Pfeiffer AFH 2003 
Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the Prospective 
Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam 
Study. Diabetes 52: 812 – 817. 
 
StataCorp. 2011 Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.  
 
Statistics South Africa 2011 The languages of South Africa [Online]. Available: 
http://www.southafrica.info/about/people/language.htm#.Uu8tqD2Swxk [Accessed: 3 February 
2014].   
 
Statistics South Africa 2013 Mid-year population release, 2013 [Online]. Available: 
http://www.statssa.gov.za/publications/p0302/p03022013.pdf [Accessed: 1 August 2013].  
 
Statistics South Africa 2013 Mortality and causes of death in South Africa, 2010 [Online].  
Available: http://www.statssa.gov.za/publications/p03093/p030932010.pdf [Accessed: 29 April 
2013].  
 
Stergiou GS, Lin CW, Lin CM, Chang SL, Protogerou AD, Tzamouranis D, Nasothimiou E, Tan TM 
2008 Automated device that complies with current guidelines for office blood pressure 
measurement: design and pilot application study of the Microlife WatchBP office device. Blood 
Pressure Monitoring 13 (4): 231 – 235. 
 
Stewart LK, Earnest CP, Blair SN, Church TS 2009 Effects of different doses of physical activity on 
C-reactive protein among women. Medicine and Science in Sports and Exercise 42 (4):701 – 707. 
 
Steyn K, Levitt N, Fourie J, Rossouw K, Martell R, Stander I 1999 Treatment status and 
experiences of hypertension patients at a large health center in Cape Town. Ethnicity and Disease 
9: 441 – 450.  
272 
 
Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounput S, Yusuf S 2005 
Risk factors associated with myocardial infarction in Africa. Circulation 112 (23): 3554-3561. 
 
Steyn K 2008 Hypertension in South Africa. In: Chronic diseases of Lifestyle in South Africa since 
1995-2005, pp. 1 - 17. Available: http://www.mrc.ac.za/chronic [Accessed: 10 October 2009]. 
 
Swartz AM, Bassett DR Jr, Moore JB, Thompson DL, Strath SJ 2003 Effects of body mass index 
on the accuracy of an electronic pedometer. International Journal of Sports Medicine 24 (8): 588 – 
592. 
 
Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB (2002) Exercise type 
and intensity in relation to coronary heart disease in men. Journal of the American Medical 
Association 288 (16): 1994 – 2000. 
 
The DATA Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group 2010 Factors 
associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS 
24: 1537 – 1548. 
 
Thoits PA 2011 Mechanisms linking social ties and support to physical and mental health. Journal 
of Health and Social Behavior 52 (2): 145 – 161.  
 
Thomas DR 2006 A general inductive approach for analysing qualitative evaluation data. American 
Journal of Evaluation. 27 (2): 237 – 246.  
 
Thompson WG, Foster RC, Eide DS, Levine JA 2008 Feasibility of a walking workstation to 
increase daily walking. British Journal of Sports Medicine 42 (3): 225 – 228. 
 
Tremblay MS, Warburton DER, Janssen I, Paterson DH, Latimer AE, Rhodes RE, Kho ME, Hicks 
A, LeBlanc AG, Zehr L, Murumets K, Duggan M 2011 New Canadian Physical Activity Guidelines. 
Applied Physiology, Nutrition, and Metabolism 36: 36 – 46. 
 
Triant VA, Lee H, Hadigan C, Grinspoon SK 2007 Increased acute myocardial infarction rates and 
cardiovascular risk factors among patients with human immunodeficiency virus disease. The 
Journal of Clinical Endocrinology and Metabolism 92 (7): 2506 – 2512. 
 
Triant VA, Meigs JB, Grinspoon SK 2009 Association of C-Reactive protein and HIV infection with 
acute myocardial infarction. Journal of Acquired Immune Deficiency Syndrome 51 (3): 268 – 273. 
 
Tierney S, Mamas M, Skelton D, Woods S, Rutter MK, Gibson M, Neyses L, Deaton C 2011 What 
can we learn from patients with heart failure about exercise adherence? A systematic review of 
qualitative papers. Health Psychology 30 (4): 401 – 410. 
 
Trooster T, Gosselink R, Decramer M 1999 Six minute walking distance in healthy elderly subjects. 
European Respiratory Journal 14: 270 – 274. 
 
Tudor-Locke C, Ainsworth BE, Thompson RW, Matthews CE 2002 Comparison of pedometer and 
accelerometer measures of free-living physical activity. Medicine and Science in Sports and 
Exercise 34 (12): 2045 – 2051.  
 
Tudor-Locke CE, Myers AM, Bell RC, Harris SB, Rodger NW 2002 Prelimary outcome evaluation 
of the First Step Program: a daily physical activity intervention for individuals with type 2 diabetes. 
Patient Education and Counselling 47: 23 – 28. 
 
Tudor-Locke C, Williams JE, Reis JP, Pluto D 2002 Utility of pedometers for assessing physical 
activity. Convergent validity. Sports Medicine 32 (12): 795 – 808.  
 
Tudor-Locke C, Basset DR Jr 2004 How many steps/day are enough? Sports Medicine 34 (1): 1-8. 
273 
 
Tudor-Locke C, Burkett L, Reis JP, Ainsworth BE, Macera CA, Wilson DK 2005 How many days of 
pedometer monitoring predict weekly physical activity in adults? Preventive Medicine 40: 293 – 
298. 
 
Tudor-Locke C, Sisson SB, Collova T, Lee SM, Swan PD 2005 Pedometer-determined step count 
guidelines for classifying walking intensity in a young ostensibly healthy population. Canadian 
Journal of Applied Physiology 30(6): 666 – 676. 
 
Tudor-Locke C, Bassett DR Jr, Rutherford WJ, Ainsworth BE, Chan CB, Croteau K, Giles-Corti B, 
Le Masurier G, Moreau K, Mrozek J, Oppert JM, Raustorp A, Strath SJ, Thompson D, Whitt-Glover 
MC, Wilde B, Wojcik JR 2008 BMI-referenced cut points for pedometer-determined steps per day 
in adults. Journal of Physical Activity and Health 5 (Suppl 1): S126 – S139.  
 
Tudor-Locke C, Lutes L 2009 Why do pedometers work? A reflection upon the factors related to 
successfully increasing physical activity. Sports Medicine 39 (12): 981 – 993. 
 
Tudor-Locke C 2012 Walk more (frequently, farther, faster): the perfect preventive medicine. 
Preventive Medicine 55 (6): 540 – 541. 
 
Tully MA, Cupples ME, Chan WS, McGlade K, Young IS 2005 Brisk walking, fitness, and 
cardiovascular risk: a randomised controlled trial in primary care. Preventive Medicine 41: 622 – 
628. 
 
Tully MA, Cupples ME, Hart ND, McEneny J, McGlade KJ, Chan WS, Young IS 2007 Randomised 
controlled trial of home-based walking programmes at and below current recommended levels of 
exercise in sedentary adults. Journal of Epidemiology and Community Health 61(9): 778-783.  
 
UNAIDS 2012 World AIDS Day Report, 2012 [Online]. Available: 
www.unaids.org/en/resources/publications/2012 [Accessed 1 March 2012]. 
 
UNAIDS 2013 UNAIDS Report on the Global AIDS Epidemic, 2013 [Online]. Available: 
http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAI
DS_Global_Report_2013_en.pdf [Accessed 24 October 2014]  
 
Vallance JKH, Courneya KS, Plotnikoff RC, Yassui Y, Mackey JR 2007 Randomized controlled trial 
of the effects of print material and step pedometers on physical activity and quality of life in breast 
cancer survivors. Journal of Clinical Oncology 25 (17): 2352 – 2359. 
 
Van As M, Myezwa H, Stewart A, Maleka D, Musenge E 2009 The International Classification of 
Function Disability and Health (ICF) in adults visiting the HIV outpatient clinic at a regional hospital 
in Johannesburg South Africa. AIDS Care 21: 50 – 58. 
 
Van Dyk A 2008 Symptoms and diseases associated with HIV/AIDS. In: HIV/AIDS Care and 
Counselling: a multidisciplinary approach, 4th ed., pp.49 - 81, Pearson Education South Africa (Pty) 
Ltd., Cape Town. 
 
Van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP 2008 Systematic 
inflammation as a risk factor for atherothrombosis. Rheumatology 47: 3 – 7. 
 
Van Rooijen AJ, Viviers CM, Becker PJ 2010 A daily physical activity and diet intervention for 
individuals with type 2 diabetes mellitus: a randomised controlled trial. The South African Journal of 
Physiotherapy 66 (2): 9 – 16. 
 
Viera AJ, Bangdiwala SI 2007 Eliminating bias in randomised controlled trials: importance of 
allocation concealment and masking. Family Medicine 39 (2): 132 – 137. 
 
274 
 
Viera VJ, Hu L, Valentine RJ, McAuley E, Evans EM, Baynard T, Woods JA 2009 Reduction in 
trunk fat predicts cardiovascular exercise training related reductions in C-reactive protein. Brain, 
Behavior, and Immunity 23: 485 – 491. 
 
Voster HH, Kruger A, Margetts BM, Venter CS, Kruger HS, Veldman FJ, MacIntyre UE 2004 The 
nutritional status of asymptomatic HIV-infected Africans: directions for dietary interventions? Public 
Health Nutrition 7 (8): 1055 – 1064. 
 
Voster HH, Kruger A, Venter CS, Margetts BM, Macintyre UE 2007 Cardiovascular disease risk 
factors and socio-economic position in Africans in transition: the THUSA study. Cardiovascular 
Journal of Africa 18 (5): 282 – 289.  
 
Warwick GR, Knopp RH, Fitzpatrick V, Branson L 1990 Estimating low-density lipoprotein 
cholesterol by the Friedewald Equation is adequate for classifying patients on the basis of 
nationally recommended cutpoints. Clinical Chemistry 36 (1): 15 – 19. 
 
Waweru P, Anderson R, Steel H, Venter WD, Murdoch D, Feldman C 2013 The prevalence of 
smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV-
positive patients in Johannesburg, South Africa. South African Medical Journal 103 (11): 858-860. 
 
West MP 2009 Noninvasive medical monitoring. In: Acute Care Handbook for Physical Therapists, 
3rd ed.,   p. 449, Saunders Elsevier, St. Louis, Missouri.  
  
Whaley AL, Longoria RA 2009 Preparing card sort data for multidimensional scaling analysis in 
social psychological research: a methodological approach. The Journal of Social Psychology 149 
(1): 105 – 115. 
 
When To Start Consortium 2009 Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-
infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352 – 1363. 
 
White JL, Randsdell LB, Vener J, Flohr JA 2005 Factors related to physical activity adherence in 
women: review and suggestions for future research. Women and Health 41 (4): 123 – 148. 
 
White IR, Horton NJ, Carpenter N, Pocock SJ 2011 Strategy for intention to treat analysis in 
randomised trials with missing outcome data. British Medical Journal Feb 7; 342:d40. doi: 
10.1136/bmj.d40. 
 
Whitlock EP, Orleans T, Pender N, Allan J 2002 Evaluating primary care behavioural counselling 
interventions: an evidence-based approach. American Journal of Preventative Medicine 22 (4): 267 
– 284.  
 
Williams RD 2013 Counselling and coaching on physical activity. In: Health Promotion and 
Wellness: An Evidence-Based Guide to Clinical Preventive Services, pp. 68 – 82. Lippincott 
Williams and Wilkins, Philadelphia, Pennsylvania. 
 
Wood WA, Stewart A, Becker P 2010 A report to inform the development of a clinical practice 
guideline for rehabilitation post total knee arthroplasty in a South African public hospital. Available: 
http://wiredspace.wits.ac.za/bitstream/handle/10539/10635/All_Pages_Final%5B1%5D.pdf?seque
nce=1  [Accessed: 2 February 2014].  
 
World Confederation of Physical Therapy News 2014 Global Data Collection Shows Dramatic 
Global Variations in Availability of Physical Therapy [Online]. Available: 
http://www.wcpt.org/node/105194  [Accessed 16 May 2014]. 
 
World Health Organisation 2004 BMI Classification [Online]. Available: 
www.who.int/bmi/index.jsp?introPage=intro_3.html [Accessed 10 January 2014]. 
 
275 
 
World Health Organisation 2005 Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case 
Definitions for Surveillance: Africa Region [Online]. Available: 
www.who.int/hiv/pub/guidelines/clinicalstaging.pdf [Accessed 23 September 2013].  
 
World Health Organisation 2008 STEPS Surveillance system [Online]. Available: 
www.who.int/chp/steps/en/ [Accessed 1 May 2009].  
 
World Health Organisation 2009 Mortality and Burden of Diseases Estimates for WHO Member 
States in 2004 [Online]. Available: 
www.who.int/healthinfo/global_burden_disease/estimates_country/en/  [Accessed 5 July 2013].  
 
World Health Organisation 2010 South Africa Factsheets of Health Statistics 2010 [Online]. 
Available: www.aho.afro.who.int/profiles_information/images/c/c7/South_Africa-
Statistical_Factsheet.pdf [Accessed 5 July 2013].  
 
World Health Organisation 2013 MDG6: Combat HIV/AIDS, Malaria and Other Diseases [Online].  
Available: www.who.int/topics/millenium_development_goals/disease/en/index.html [Accessed 29 
April 2013].  
 
World Health Organisation 2013 Draft comprehensive Global Monitoring Framework and Targets 
for the Prevention and Control of Noncommunicable Disease [Online]. 
www.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf - [Accessed: 1 August 2013]. 
 
Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Witt S, Law M, Monforte AD, Friis-
Moller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J 2010 Risk of myocardial infarction in 
patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug 
classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Journal of 
Infectious Diseases 201 (3): 318 – 330.  
 
Yamax 2011 Yamax Digi-walker SW-200 System Walking Program [Online]. Available: 
http://www.yamaxx.com/digi.SW-200.pdf - [Accessed: 07/12/2010] 
 
Yamax 2011 Yamax digi-walker CW-Series Instruction Manual [Online]. Available: 
http://www.yamaxx.com/digi/CWS_manual.pdf - [Accessed: 07/12/2010] 
 
Yudkin JS, Stehouwer JJ, Emeis S, Coppack SW 1999 C-reactive protein in healthy subjects: 
associations with obesity, insulin resistance and endothelial dysfunction: a potential role for 
cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 19: 
972 – 978. 
 
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, 
Varigos J, Lisheng L 2004 Effect of potentially modifiable risk factors associated with myocardial 
infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (9438): 937 - 
952. 
 
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MS, Commerford P, Lang CC, Rumboldt Z, 
Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak S, Sharma AM, Anand SS; INTERHEART 
study investigators 2005 Lancet 366 (9497): 1640 – 1649. 
 
Zanni MV, Grinspoon SK 2012 HIV-specific immune dysregulation and atherosclerosis. Current 
HIV/AIDS Reports 9: 200 – 205. 
 
Zanni MV, Abbara S, Lo J, Wai B, Hark D, Marmarelis E, Grinspoon SK 2013 Increased coronary 
atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected 
men. AIDS 27: 1263 – 1272.   
 
276 
 
Zoelliner J, Connell C, Powers A, Avis-Williams A, Yadrick K, Bogle ML 2010 Does a six-month 
pedometer intervention improve physical activity and health among vulnerable African Americans? 
A feasibility study. Journal of Physical Activity and Health 7: 224 – 231.  
277 
 
APPENDIX 1 
ETHICAL CLEARANCE CERTIFICATE OF THE RESEARCH PROJECT 
 
 
278 
 
APPENDIX 2  
TITLE APPROVAL LETTER OF THE RESEARCH PROJECT 
 
279 
 
APPENDIX 3 
CLINICAL SITE APPROVAL LETTER 
 
  
280 
 
APPENDIX 4 
INFORMATION DOCUMENT (ENGLISH) 
 
Study Title: Risk factors and the effect of physical activity modification for ischemic heart disease 
in individuals living with HIV. 
 
Good Day, 
 
My name is Ronel Roos. I am a physiotherapy lecturer at the University of the Witwatersrand.  I am 
doing research on heart disease in individuals with an HIV positive status. Research is just a way 
to learn the answer to specific questions. In this specific study we want to see if there is a risk of 
heart disease in individuals with an HIV positive status and if an education and exercise program 
will help to lessen this risk. I am therefore asking/ inviting you to participate in this research study. 
 
What does the study involve? 
Individuals with an HIV positive status attending the Themba Lethu Clinic at Helen Joseph Hospital 
are invited to participate in this research study. The study will consist of two parts.  
 
Part One 
 
In part one, I will evaluate your risk of heart disease by evaluating your heart rate, blood pressure, 
weight, waist circumference and waist: hip ratio. You will also be asked to complete two 
questionnaires. The first questionnaire will ask you about general information such as age, date of 
birth, smoking history, HIV history and general symptoms that you experience etc. The second 
questionnaire will ask information about the amount of stress you experience in your life. We will 
also evaluate your physical activity level with a pedometer (small calculator) that counts the 
number of steps you take per day. You will be asked to wear this small calculator during the day for 
a week. During this part of the study I will also conduct an interview with you to see what you 
understand about living a healthy lifestyle and risk factors of heart disease. I will also ask you to 
look at specific cards and select important cards that you think explains the concept of living a 
healthy lifestyle during this interview. This interview will also be tape recorded so that I will be able 
to interpret it at a later stage. These tape recordings will be kept for a period of five years in a safe 
place and after five years it will be destroyed. Part one will consist of two consultation sessions of 
approximately an hour in duration. 
Part Two 
 
People from part one of the study who have an increased risk of heart disease and on a specific 
antiretroviral regime will be invited to participate in the second part of the study. The second part of 
the study will again consist of two consultation sessions: an evaluation session and an education 
session. During the evaluation session a research assistant will reassess your heart rate, blood 
pressure, weight, waist circumference and waist: hip ratio as well as your level of stress. The 
amount of steps you take per day will again be measured by the pedometer. This is necessary 
because the values might be different since part one. A blood test will also be needed at this time 
to evaluate your glucose, cholesterol and inflammatory heart marker levels.  The blood sampling 
procedure will be done by a laboratory nurse and approximately four teaspoons of blood will be 
drawn. There might be some physical discomfort during the blood sampling procedure.  
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People participating in part two will then be assigned to either a control or intervention group. This 
means that some people will receive an education-exercise program from me and some will not. 
The participants who do not receive a program will continue with the standard clinical 
management. When the study is completed and if the intervention worked, the control participants 
will be educated regarding the intervention if they are interested. Every month I will phone these 
participants to find out how they are doing. The people that do receive the education-exercise 
program from me will be asked to try and do this for twelve months at their own pace. Every month 
we will meet at Helen Joseph hospital to monitor your progress and I will send a reminder SMS to 
you every two weeks to encourage you to exercise. After six months a consultation session at 
Helen Joseph will take place with all participants of the study to establish how you are coping and 
to evaluate all the parameters tested at the initiation of the study. The following six months will 
require you to exercise on your own without any contact from the researcher or research assistant. 
After a year we will need to do the whole evaluation procedure again to see how your body 
responded over time.  All consultation sessions will be done at Helen Joseph Hospital and you will 
be reimbursed for your travel expenses at R50 a session. 
 
What are the benefits to the participants? 
 
If you participate in the research study you will be able to find out if you are at risk of heart disease 
and could be educated on how you can lessen the risk. If you are selected as one of the education-
exercise participants the year exercise program could lessen your risk for heart disease. The 
participants will be given information on the study while involved in the project and when results 
are available. Participation in this research study is voluntary, refusal to participate will involve no 
penalty or loss of benefits to which you are otherwise entitled, and you may discontinue 
participation in this research study at any time.  
 
Are there any risks involved in participation in the study? 
There are no risks involved to you while participating in the intervention. Taking medication such as 
anti-retroviral therapy, could involve some risks but if the researcher or research assistant notice 
any deterioration in health status while you are participating in the study she will refer you to a 
medical practitioner at Themba Lethu clinic.   
 
Will information be handled as confidential? 
Efforts will be made to keep personal information confidential. If you have any further questions 
regarding the research study you can contact me, Ronel Roos at the following contact number: 011 
7173723 during office hours.  
 
If you wish to report any complaints/problems regarding the research study you can contact Anisa 
Keshav at The Human Research Ethics Committee of the University of Witwatersrand on 
telephone number 011 7171234. 
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APPENDIX 5 
CONSENT FORM 1 (ENGLISH) 
 
Title of Study: Risk factors and the effect of physical activity modification for ischemic heart 
disease in individuals living with HIV. 
 
Informed Consent 
 
 I hereby confirm that I have been informed by the researcher, Ronel Roos or her research 
assistant about the nature, conduct, benefits and risks of this study 
 I have also received, read and understood the above written information document regarding 
the research study. 
 I am aware that the results of the study, including personal details regarding my sex, age, date 
of birth, initials and diagnosis will be anonymously processed into a study report. 
 In view of the requirements of research, I agree that the data collected during this study can be 
processed in a computerised system by Ronel Roos or on her behalf.  
 I may, at any stage, without prejudice, withdraw my consent and participation in the study. 
 I have had sufficient opportunity to ask questions and (of my own free will) declare myself 
prepared to participate in the study.  
 
PARTICIPANT: 
 
 
Printed Name   Signature / Mark or Thumbprint  Date and Time 
 
I, Ronel Roos or research assistant, herewith confirm that the above participant has been fully 
informed about the nature, conduct and risks of the above study. 
 
RESEARCHER/ RESEARCH ASSISTANT: 
 
 
Printed Name     Signature     Date and Time 
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APPENDIX 6 
CONSENT FORM 2 (ENGLISH) 
 
Title of the study: Risk factors and the effect of physical activity modification for ischemic heart 
disease in individuals living with HIV. 
 
Informed Consent form: Semi-structured interview 
 
 I hereby confirm that I was informed by the researcher, Ronel Roos or her research assistant 
that the semi-structured interview of phase one of this study will be tape recorded to enable 
transcription following the interview. 
 I hereby confirm that I was informed by the researcher, Ronel Roos or her research assistant 
that these tape recordings will be kept in a safe place and locked away for five years following 
the completion of the study. After a period of five years these tapes will be destroyed. 
 
PARTICIPANT: 
 
 
 
Printed Name  Signature/ Mark or Thumbprint  Date and Time 
 
I, Ronel Roos or research assistant, herewith confirms that the above participant has been fully 
informed about the nature of the semi-structured interview. 
 
RESEARCHER/ RESEARCH ASSISTANT 
 
 
 
Printed Name  Signature     Date and Time 
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APPENDIX 7 
CODING FORM 
 
Participant’s Code: 
 
Title of study: Risk factors and the effect of physical activity modification for ischemic heart 
disease in individuals living with HIV. 
 
Name   : ………………………………………………………………......................……… 
Physical address:  
………………………………………………………………………………………………………………….. 
………………………………………………………………………………………………………………….. 
………………………………………………………………………………………………………………….. 
 
Postal address: 
………………………………………………………………………………………………………………….. 
………………………………………………………………………………………………………………….. 
………………………………………………………………………………………………………………….. 
 
 
Home telephone number : ………………………………………………………………................... 
Work telephone number : ………………………………………………………………................... 
Cell phone number  : ………………………………………………………………................... 
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APPENDIX 8 
DEPARTMENT OF HEALTH CLINICAL TRIAL REGISTRATION INFORMATION 
 
From:  confirmation@sanrr.co.za 
Sent:  04 May 2012 08:23 AM 
To:  Ronel Roos 
Subject:National Ethics Application #: 2982 
 
Dear Ronel Roos 
 
Your Application, "Risk factors and the effect of physical activity modification for ischemic heart disease in 
individuals  living  with  HIV.",  Protocal  #  "M10238"  has  been  assigned  the  following  unique  DOH  Trial 
Number: "DOH‐27‐0512‐3982". 
 
Kind regards, 
Department of Health   
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APPENDIX 9 
COHEN’S PERCEIVED STRESS SCALE – 10 (PERMISSION LETTER) 
 
From: Sheldon Cohen [mailto:scohen@andrew.cmu.edu]  
Sent: 01 December 2009 02:38 PM 
To: Ronel Roos 
Subject: RE: Perceived Stress Scale: PhD  
 
Ronel, You have my permission to use the PSS in your study.  You can find information on the PSS on our 
website: www.psy.cmu.edu/~scohen  click on scales on the front page.  Best of luck with your work.  Sheldon 
Cohen 
 
From: Ronel Roos [mailto:Ronel.Roos@wits.ac.za]  
Sent: Tuesday, December 01, 2009 4:49 AM 
To: scohen@cmu.edu 
Subject: Perceived Stress Scale: PhD  
 
Dear Dr. Cohen, 
 
My name is Ronel Roos and I am a physiotherapy lecturer and potential PhD candidate at the University of 
the Witwatersrand in Johannesburg, South Africa.  
 
I am planning to do my PhD in the HIV research arena.  
 
As part of my study I would like to use your “Cohen’s Perceived Stress Scale” to evaluate the participants’ 
perceived stress levels. 
 
I  am  thus writing  to  you  in order  to obtain permission  to use  your  “Cohen’s Perceived  Stress  Scale”  as 
assessment tool in my study. 
 
It would be highly appreciated if this could be made possible. 
 
Sincerely, 
Ronel Roos 
(Physiotherapy Lecturer) 
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APPENDIX 10 
COHEN’S PERCEIVED STRESS SCALE – 10 
 
Participant’s Code:    Date: 
 
Items and instructions for Perceived Stress Scale 
The questions in this scale ask you about your feelings and thoughts during the last month. In each case, 
you will be asked to indicate how often you felt or thought a certain way. Although some of the questions are 
similar, there are differences between them and you should treat each one as a separate question. The best 
approach is to answer each question fairly quickly. For each question choose from the following alternatives 
and then tick the appropriate box 
 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
 
1. In the last month, how often have you been upset because of something that happened unexpectedly? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
2. In the last month, how often have you felt that you were unable to control the important things in your 
life? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
3. In the last month, how often have you felt nervous and “stressed”? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
4. In the last month, how often have you felt confident about your ability to handle your personal problems? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
5. In the last month, how often have you felt that things were going your way? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
6. In the last month, how often have you found that you could not cope with all things that you had to do? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
7. In the last month, how often have you been able to control irritations in your life? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
8. In the last month, how often have you felt that you were on top of things? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
9. In the last month, how often have you been angered because of things that were outside of your control? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
 
10. In the last month, how often have you felt difficulties were piling up so high you could not overcome 
them? 
0. Never 1. Almost Never 2. Sometimes 3. Fairly often 4. Very often 
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APPENDIX 11 
CONTRACT LABORATORY SERVICES ACCREDITATION WITH THE SOUTH AFRICAN 
NATIONAL ACCREDITATION BOARD 
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APPENDIX 12  
DEMOGRAPHIC QUESTIONNAIRE (1) 
 
Demographic Questionnaire (1)     Participant’s Code: 
 
 
10. Recreational activities 
10.1. Do you participate in any formal sport activity? (tick the relevant box) 
Yes    No 
If you do, what sport do you play?  
 
10.2. Do you do any exercises on your own?   
Yes No 
 
If you do, what type of exercise do you do?  
 
11.   Smoking History (tick the relevant box) 
11.1  Do you smoke? 
Yes No 
 
1. Date of Birth: 2. Gender: 
Male  □   Female  □ 
 
3. Dependents:   Yes  □      No  □ 
            
Age of dependents: 
4. Education level: 
No education                 □ 
Primary School               □ 
Secondary School          □ 
Post Secondary School  □ 
 
5. Occupation:  
6. Past Medical History: 
 
 
 
 
 
7. Past Surgical History: 
 
 
8. Current medications (Participant) 
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________ 
9. Drug History (Participants File) 
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________ 
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11.2  If no, have you ever smoked? 
Yes No 
 
11.3  If yes, did you smoke in the last 12 months? 
Yes No 
 
11.4  How many cigarettes do you smoke per day? 
0-5  5-10 10-20 More than 20 
 
11.5  How many years have you smoked? 
0-5 5-10 10-20 More than 20 
 
11.6  If you stopped smoking, why did you stop?  
 
12.       HIV History  
12.1  When were you diagnosed as being HIV positive?  
       
12.2  How long have you been taking antiretroviral therapy?  
 
12.3  How would you rate your current health status? (Tick the relevant box) 
Excellent Good Average Poor 
        
12.4  Do you feel that your body shape has changed in the last six months? 
Yes No 
            
 If it did change, how did your body shape change?  
       
12.5  Do you feel that you have gained weight in the last six months? 
Yes No 
 
 12.6  Do you feel that you have lost weight in the last six months? 
Yes No 
 
13.       General Symptoms (tick the relevant box) 
13.1  Is there a history of heart disease in your family? 
Yes No 
 
If there is a history of heart disease in your family, did it involve your parents or    
grandparents? 
Yes No 
 
13.2  Do you often feel short of breath? 
Yes No 
    
If you do, when do you often feel short of breath?  
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13.3  Do you often feel tired or fatigued? 
Yes No 
        
If you do, when do you often feel tired or fatigued?     
 
13.4  Have you ever experienced chest pain? 
Yes No 
        
If you have, where on your chest did you have chest pain? 
      
What were you doing when you experienced chest pain? 
  
How many minutes did the chest pain remain? 
        
What did you do for the chest pain to subside? 
             
14.        Dietary evaluation (tick the relevant box) 
14.1  How often do you drink alcoholic beverages? 
Daily weekly monthly I do not drink  
 
14.2  How many alcoholic beverages do you drink per day? 
 None 0-2 More than 5 More than 10 
 
14.3  How often do you eat fish in a week? 
 I do not eat fish I do not eat fish every week Once a week 
More than two 
times a week 
 
14.4  Do you eat vegetables and/or fruit? 
Yes No 
 
14.5  How often do you eat vegetables and/or fruit? 
 Daily Weekly 
I do not eat 
vegetables or fruit
 
14.6  Do you eat 3-5 vegetables and/or fruit per day? 
 Yes No I do not eat vegetables or fruit 
 
 
Thank you for completing this information! 
 
Have a good day! 
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APPENDIX 13 
PHASE 1 EVALUATION FORM 
 
Participant Code:     Date: 
MEASUREMENTS  
Vital Signs: 
Heart rate: 
HR 1:                         HR 2: 
Average HR: 
 
Blood pressure: 
Right SBP: 
Right DBP: 
 
Left SBP: 
Left DBP: 
 
Average SBP: 
Average DBP: 
 
Respiratory rate: 
Anthropometric measure: 
Height: 
 
Weight: 
 
Waist circumference: 
 
Hip circumference: 
 
Placement during hip circumference 
Waist: Hip ratio Body Mass Index: 
(kg/m²) 
Pedometer results 
Steps per day: 
Steps per seven days: 
 
EXISTING DATA FROM   
PARTICIPANT’S CLINIC FILE 
 
Liver Function Data 
(Participants clinical captured data) 
 Date of latest full LFD data 
 Date of latest AST/ALT data 
 
 
______________________________ 
______________________________ 
Latest full LFD results 
AST: 
 
ALT: 
 
GGT: 
Latest AST/ALT results 
AST: 
 
ALT: 
Viral load 
 Date of latest results. 
________________________ 
 Results: 
________________________ 
CD4 count 
 Date of latest results. 
_________________________ 
 Results: 
_________________________ 
 
Latest HIV testing date:  
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APPENDIX 14 
PEDOMETER ACTIVITY WALKING LOG (ENGLISH) 
 
Participant Code:    Date: 
Dear Participant, 
 
Remember at this phase of the study we want to evaluate the number of steps you take during the 
day. We are able to evaluate this by using the pedometer (step counter) supplied to you. There are 
a few things to remember during this process and they are as follows: 
 
 The time period for assessment is seven days. At the end of each day when going to bed, 
document the pedometer readings on the table provided. The seven days should be 
consecutive days.  
 
 The pedometer should be worn during the day, from getting up in the morning until going to 
bed at night. The pedometer should not be worn when sleeping, showering, bathing or washing 
one self. 
 
 The pedometer should be placed at the waist at mid-thigh level e.g. clipped to a belt or 
waistband of skirt or pants. Wear it on the same side of your body every day. 
 
 The pedometer is an electronic devise. Please do not let the pedometer get wet, don’t throw or 
drop the pedometer and keep the pedometer away from young children. 
 
Day Date Pedometer Count Activity Time 
Saturday    
Sunday    
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
Saturday    
Sunday    
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
 
Please bring this paper filled in as requested to your next appointment. Thank you! 
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APPENDIX 15 
PEDOMETER ACCURACY SHEET 
 
QUICK PEDOMETER VALIDATION TEST 
Participant’s Code:  
Pedometer type:  
Pedometer number:  
Date:  
Distance measured: 10 meters 
Number of steps counted in distance:  
Pedometer step count in distance:  
Stride length: 
Distance divided by number of steps counted.   
 
Instruction for measuring stride: 
1. Measure a distance of 10 meters using a tape measure. 
2. By starting with both feet behind the starting point count how many steps it takes you to walk 
10 meters (try and walk at a normal fast pace). 
 
Position of pedometer: 
1. Position on belt or waistband, in the midline of the thigh. 
2. Pedometer’s writing should be level (horizontal) with no tilting of pedometer. 
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APPENDIX 16 
INFORMATION DOCUMENT (ISIZULU) 
 
Idokumende Lemfomesheni 
Isihloko Salolu Cubungulo: Amaphuzu amathuba engozi (risk factors) kanye nomthelela 
wokushintshwa komnyakazo womzimba mayelana nesifo senhliziyo se-ischemia (ukushoda 
kwezinhlayiya zegazi ezibomvu endaweni ethile emzimbeni) kubantu abaphila ne-HIV. 
 
Sawubona, 
 
Igama lami wuRonel Roos. Ngiwumfundisi we-physiotherapy (ukwelashwa ngokunyakazisa 
umzimba) eNyuvesi yaseWitwatersrand. Ngenza ucwaningo ngesifo senhliziyo kubantu abane-
HIV. Ucwaningo lumane luyindlela yokuthola impendulo emibuzweni ethile ekhethekile. Kulolu 
cubungulo ngokukhethelile sifuna ukubona ukuthi likhona yini ithuba lengozi yokuphathwa yisifo 
senhliziyo kubantu abane-HIV nanokuthi uhlelo lokufundiswa nokuvocavoca umzimba lungasiza 
yini ekwehliseni leli thuba lengozi. Ngakho-ke ngiyakucela/ngiyakumema ukuba ubambe iqhaza 
kulolu cubungulo locwaningo.  
 
Lolu cubungulo lubizelani? 
 
Abantu abane-HIV abahamba uMtholampilo iThemba Lethu eSibhedlela iHelen Joseph bamenywa 
ukuba babambe iqhaza kulolu cubungulo locwaningo. 
 
Ingxenye Yokuqala 
 
Kungxenye yokuqala, ngizokala ithuba lakho lokubanjwa yisifo senhliziyo ngokukala ukushaya 
kwenhliziyo, umfutho wegazi, isisindo, umjikelezo wokhalo kanye nesilinganiso sokhalo: inqulu 
(waist: hip ratio). Uzocelwa futhi ukuba ugcwalise izinhla zemibuzo ezimbili (questionnaires). Uhla 
lwemibuzo lokuqala luzokubuza ngemfomesheni ejwayelekile njengobudala, usuku lokuzalwa, 
umlando wokubhema, umlando we-HIV kanye nezimpawu ezivamile ozilindele, njl. Olwesibili 
uhlaka lwemibuzo luzobuza imfomesheni ngobungako bokucindezeleka (stress) obhekana nabo 
ekuphileni kwakho. Sizokala futhi iqophelo lomnyakazo wakho womzimba nge-pedometer (umshini 
wokubala omncanyana) obala izinyathelo ozithathayo ngosuku. Uzocelwa ukuba ulokhu unalo 
mshini wokubala kuwe phakathi nosuku isikhathi esiyiviki. Kule ngxenye yocubungulo ngizobuye 
ngibe nengxoxiswano nawe ukuze ngibone ukuthi ukuqonda kanjani ukuphila ngendlela enempilo 
kanye namaphuzu ethuba lokubanjwa yisifo senhliziyo. Futhi kule ngxoxiswano ngizokucela ukuba 
ubheke amakhadi akhethekile bese ukhetha lawo makhadi ocabanga ukuthi achaza umqondo 
wokuphila ngendlela enempilo. Futhi le ngxoxiswano izoqoshwa ngetheyiphu ukuze ngikwazi 
ukuyihlaziya kamuva. Le miqopho yetheyiphu izogcinwa inkathi eyiminyaka emihlanu endaweni 
ephephile bese kuthi emva kweminyaka emihlanu ibhujiswe. Ingxenye yokuqala izohlanganisa 
iziwombe ze-consultation ezimbili ezicishe zibe yihora sisinye. 
 
Ingxenye Yesibili 
 
Labo bantu abakungxenye yokuqala yalolu cubungulo abanethuba elithe xaxa lokubanjwa yisifo 
senhliziyo futhi abasonyangweni lwe-antiretroviral bazomenyelwa kungxenye yesibili yalolu 
cubungulo. Ingxenye yesibili yocubungulo nayo izoba neziwombe ezimbili ze-consultation: 
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isiwombe sokukala kanye nesiwombe sokufundisa. Ngenkathi siqhubeka isiwombe umsizi 
wocwaningo uzophinda akale busha ukushaya kwenhliziyo yakho, umfutho wegazi, isisindo 
somzimba, isilinganiso sokhalo: inqulu kanye neqophelo lakho lokucindezeleka. Inani lezinyathelo 
ozithatha ngosuku lizophinda likalwe yi-pedometer. Loku kubalulekile ngoba amanani kungenzeka 
asehlukile ukusuka kungxenye yokuqala. Futhi ngalesi sikhathi kuzodingeka ukuhlolwa kwegazi 
ukuze kukalwe iglukhosi, ikholesteroli kanye namaqophelo okuphawula inhliziyo enezilonda 
zokugula. Inqubo yesampula legazi izokwenziwa wunesi waselebhu futhi kuzothathwa cishe 
amathesipuni amane egazi. Kungase kube khonyana ukungaphatheki kahle ngenkathi kwenziwa 
inqubo yesampula legazi. 
 
Abantu ababamba iqhaza kungxenye yesibili bazobe sebabelwa eqenjini eligcinwa linjalo noma 
okwenziwa kulo ushintsho. Loku kusho ukuthi abantu abathile bazothola kimi uhlelo lokufundiswa 
kuthi abanye bangalutholi. Labo abangatholi hlelo bazoqhubeka benakekelwa ngendlela 
ejwayelekile yezokwelapha (clinical management). Lapho lolu cubungulo seluphothuliwe futhi 
noshintsho olwenziwe eqenjini lusebenzile, ababambi-qhaza beqembu eligcinwe linjalo nabo 
bazofundiswa ngoshintsho oluye lwenziwa uma bethanda. Njalo ngenyanga ngizobafonela laba 
bambi-qhaza ukubabuza ukuthi kuhamba kanjani. Labo bantu abathola kimi uhlelo lokufundiswa 
bazocelwa ukuba bazame ukukwenza loku izinyanga eziyi-12 ngesivinini sabo. Njalo ngenyanga 
sizohlangana esibhedlela iHelen Joseph ukuze ngiqaphe intuthuko yenu futhi ngizokuthumelela i-
SMS njalo emavikini amabili yokukukhumbuza ukuba unyakazise umzimba. Emva kwezinyanga 
eziyi-6 kuzoba khona isiwombe se-consultation eHelen Joseph nabo bonke ababambi-qhaza 
balolu cubungulo ukuze kutholwe ukuthi niqhuba kanjani nanokukala imininingwane eye yahlolwa 
lapho kuqaliswa lolu cubungulo. Izinyanga eziyi-6 ezilandelayo zizobizela ukuba wena 
uzinyakazisele umzimba ngaphandle kokuthintwa wumcwaningi noma umsizi wocwaningo. Emva 
konyaka kuzodingeka siyiphinde yonke le nqubo yokukala futhi ukuze sibone ukuthi umzimba 
wakho uye wasabela kanjani. Zonke iziwombe ze-consultation zizokwenzelwa eSibhedlela iHelen 
Joseph futhi uzobuyiselwa izindleko zakho zokugibela kube yi-R50 isiwombe ngasinye. 
 
Ziyini izinzuzo kubabambi-qhaza? 
 
Uma ubamba iqhaza kulolu cubungulo locwaningo uzokwazi ukuthola ukuthi usethubeni yini 
lokubanjwa yisifo senhliziyo futhi ungase ufundiswe ngokuthi ungalinciphisa kanjani ithuba lale 
ngozi. Uma ukhethwa njengomunye wababambi-qhaza bohlelo lokufundiswa lolu hlelo lonyaka 
lungase lunciphisa ithuba lakho lokubanjwa yisifo senhliziyo. Ababambi-qhaza bazonikwa 
imfomesheni ngalolu cubungulo ngenkathi bekuleli projeke lapho imiphumela isitholakala. 
Ukubamba iqhaza kulolu pahando locwaningo kungokokuzithandela, ukwala ukubamba iqhaza 
akuzukuhambisanba nasijeziso noma ukulahlekelwa yizinzuzo ovele unelungelo lazo, futhi ungase 
uyeke ukuqhubeka nalolu cubungulo nokubamba iqhaza kulolu cubungulo noma nini. 
 
Ingabe akhona amathuba engozi ekubambeni iqhaza kulolu cubungulo? 
 
Akukho mathuba engozi kuwe ngenkathi ubambe iqhaza kulolu nyango lokuhlola. Ukuthatha 
imishanguzo enjengonyango lwe-antiretroviral, kungase kuhilele amathuba athile engozi kodwa 
uma umcwaningi noma umsizi wocwaningo eqaphela ukwehla kwesimo sempilo ngenkathi 
ubambe iqhaza uzokukhomba kudokotela wokwelapha emtholampilo iThemba Lethu. 
 
  
297 
 
Ingabe imfomesheni izophathwa njengeyisifuba? 
 
Kuzokwenziwa imizamo yokugcina imfomesheni yomuntu siqu iyisifuba. Uma useneminye imibuzo 
mayelana nalolu cubungulo locwaningo, ungangithinta mina, Ronel Roos, kule namba 
yokuxhumana elandelayo: 011 7173723 ngesikhathi somsebenzi. 
 
Uma ufisa ukubika noma yiziphi izikhalo/ izinkinga ngokuphathelene nalolu cubungulo locwaningo 
ungathinta u-Anisa Keshav e-Human Research Ethics Committee yeNyuvesi yaseWitwatersrand 
kunamba yocingo u-011 7171234.  
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APPENDIX 17 
CONSENT FORM 1 (ISIZULU) 
 
Isihloko Salolu Cubungulo: Amaphuzu amathuba engozi (risk factors) kanye nomthelela 
wokushintshwa komnyakazo womzimba mayelana nesifo senhliziyo se-ischemia (ukushoda 
kwezinhlayiya zegazi ezibomvu endaweni ethile emzimbeni) kubantu abaphila ne-HIV. 
 
Imvume Emva Kokuchazelwa 
 
 Ngaloku ngiyaqinisekisa ukuthi ngazisiwe wumcubunguli, uRonel Roos noma umsizi wakhe 
wocwaningo, ngobunjalo, indlela yokuziphatha, izinzuzo kanye namathuba engozi kwalolu 
cubungulo (study). 
 Futhi ngilitholile, ngalifunda ngaliqonda iphepha lemfomesheni ebhalwe ngenhla mayelana 
nalolu cubungulo locwaningo. 
 Ngiyaqaphela ukuthi imiphumela yalolu cubungulo, kuhlanganise imininingwane yomuntu siqu 
ngobulili bami, ubudala, usuku lokuzalwa, amanishiyeli kanye nopopolo (diagnosis) 
kuzoproseswa ngaphandle kokudalula igama lami kufakwe embikweni wocubungulo. 
 Ngokwezindingeko zalolu cwaningo, ngiyakuvuma ukuthi imininingwane (data) eqoqwe 
ngesikhathi salolu cubungulo iproseswe kusistimu yekhompuyutha wuRonel Roos noma 
egameni lakhe. 
 Nginakho, kunoma yiliphi iqophelo, futhi ngaphandle kokulimala ngandlela thize, ukuhoxisa 
imvume yami kanye nokubamba iqhaza kulolu cubungulo. 
 Ngibé nalo ithuba elanele lokubuza imibuzo futhi (ngokuzithandela) ngazisa obala ukuthi 
ngizimisele ukuhlanganyela kulolu cubungulo. 
 
UMBAMBI-QHAZA: 
 
Igama Eliprintiwe  Isiginesha / Uphawu noma Isithupha   Usuku Nesikhathi 
 
Mina, Ronel Roos noma umsizi wocwaningo, ngaloku ngiqinisekisa ukuthi lo mbambi-qhaza 
ongenhla uye waziswa ngokugcwele ngobunjalo, indlela yokuziphatha kanye namathuba engozi 
alolu cubungulo olungenhla. 
UMCWANINGI / UMSIZI WOCWANINGO: 
 
Igama Eliprintiwe     Isiginesha    Usuku Nesikhathi 
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APPENDIX 18 
DEMOGRAPHIC QUESTIONNAIRE (1) (ISIZULU) 
 
Uhla Lwemibuzo Lwedemografi    Ikhodi Lombambi-qhaza: 
 
10.   Izenzo zokuzilibazisa 
 
10.1. Ingabe imidlalo ehleliwe (formal) ohlanganyela kuyo? (Qhwisha ibhokisi okuyilonalona) 
Yebo Cha  
 
Uma udlala, mdlalo muni owudlalayo?  
 
10.2. Ingabe uyazijimela ngokwakho? 
Yebo Cha  
 
Uma ujima, wenza nhloboni yokuzivocavoca?  
 
11.        Umlando Wokubhema (Qhwisha ibhokisi okuyilonalona) 
 
11.1  Ingabe uyabhema? 
Yebo Cha  
 
  
1. Usuku Lokuzalwa: 2. Ubulili: 
Isilisa  □   Isifazane  □ 
3. Abondliwayo:   Yebo  □      Cha  □ 
            
Ubudala babondliwayo: 
4. Iqophelo lemfundo: 
Akukho mfundo                                    □ 
Isikole Sabaqalayo                               □ 
Isikole semfundo yesibili                       □ 
Ngaphezu kwesikole semfundo yesibili □ 
 
5. Umsebenzi owenzayo:  
6. Umlando Wokwelashwa: 
 
 
 
 
 
7. Umlando Wokuhlinzwa: 
 
 
8. Imishanguzo yanjengamanje (Umbambi-
qhaza) 
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________ 
9. Umlando wezidakamizwa (Ifayela Lombambi-
qhaza) 
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________ 
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11.2  Uma ungabhemi, ingabe wake wabhema? 
Yebo Cha  
 
11.3  Uma ubhema, ingabe uke wabhema kulezi zinyanga eziyi-12 ezidlule? 
Yebo Cha  
 
11.4  Ubhema osikilidi abangaki ngosuku? 
0-5  5-10 10-20 Ngaphezu kuka-20 
 
11.5  Usebheme iminyaka emingaki? 
0-5 5-10 10-20 Ngaphezu kuka-20 
 
11.6  Uma ngabe uyekile ukubhema, wayekelani?  
 
12.       Umlando we-HIV 
 
12.1  Wapotsholwa watholakala nini ukuthi une-HIV?  
       
12.2  Side kangakanani isikhathi uthola unyango lwe-antiretroviral?  
 
12.3  Ungasibeka kuphi isimo sakho sempilo? (Qhwisha ibhokisi okuyilonalona) 
Sihle kakhulu Sihle Silingene nje Sibi 
        
12.4  Ingabe unomuzwa wokuthi isakheko somzimba wakho sishintshile kulezi zinyanga ezi-6 
ezidlule? 
Yebo Cha  
            
Uma sishintshile, sishintshe kanjani isakheko sakho somzimba? 
       
12.5  Ingabe unomuzwa wokuthi uye wakhuluphala kulezi zinyanga ezi-6 ezidlule?  
Yebo Cha  
 
12.6  Ingabe unomuzwa wokuthi uye wehla ngesisindo kulezi zinyanga ezi-6 ezidlule? 
Yebo Cha  
 
13.       Izimpawu Ezijwayelekile (Qhwisha ibhokisi okuyilonalona) 
 
13.1  Ingabe bakhona abake baba nesifo senhliziyo emndenini wakini? 
Yebo Cha  
 
Uma bekhona abake baba nesifo senhliziyo emndenini wakini, ingabe kwakukubazali 
bakho noma komkhulu nogogo? 
Yebo Cha  
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13.2  Ingabe uvamile ukuphelelwa wumoya? 
Yebo Cha  
    
Uma kunjalo, uvame ukuphelelwa nini wumoya?  
 
13.3  Ingabe uvamile ukuzizwa ukhathele noma ucobekile? 
Yebo Cha  
        
Uma kunjalo, uvame ukuzizwa nini ukhathele noma ucobekile?  
    
13.5  Ingabe wake wezwa ubuhlungu esifubeni? 
Yebo Cha  
        
Uma kunjalo, kumaphi esifubeni lapho wezwa khona ubuhlungu? 
             
Wawenzani ngesikhathi uzwa ubuhlungu esifubeni? 
        
Lobu buhlungu esifubeni bathatha imizuzu emingaki? 
 
Yini owayenza ukuze budambe lobu buhlungu esifubeni? 
                        
14.       Ukuhlolwa kwesimo sokudla (Qhwisha ibhokisi okuyilonalona) 
 
14.1  Uvame kangakanani ukuphuza uphuzo oludakayo? 
Njalo ngosuku Njalo ngeviki Njalo ngenyanga Angiphuzi 
 
14.2  Uphuza iziphuzo ezidakayo ezingaki ngosuku? 
 Azikho 0-2 Ngaphezu kuka-5 Ngaphezu kuka-10 
 
14.3  Uvame ukuwudla kangaki ufishi ngeviki? 
Angiwudli ufishi  Angidli ufishi onke 
amaviki. 
Kanye ngeviki Ngaphezu kwakabili ngeviki 
 
14.4  Ingabe uyawadla amaveji noma izithelo? 
Yebo Cha  
 
14.5  Uvame kangakanani ukudla amaveji noma izithelo? 
 Njalo ngosuku Njalo ngeviki Angiwadli amaveji noma izithelo 
 
14.6  ingabe udla amaveji ayi-3-5 noma izithelo ngosuku? 
 Yebo Cha  Angiwadli amaveji noma izithelo 
 
 
Siyabonga ngokugcwalisa kwakho le mfomesheni! 
 
Ube nosuku oluhle! 
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APPENDIX 19 
PEDOMETER ACTIVITY WALKING LOG (ISIZULU) 
 
Ikhodi Lombambi-qhaza:    Usuku: 
 
Mbambi-qhaza othandekayo 
 
Khumbula ukuthi kulesi sigaba socubungulo sifuna ukukala inani lezinyathelo ozithathayo phakathi 
nosuku. Loku sikwazi ukukukala ngokusebenzisa i-pedometer (isibali-zinyathelo) esiyinikwa 
nguwe. Kunezinto ezimbalwa zokukhunjulwa phakathi nale nqubo futhi yilezi ezilandelayo: 
 
 Ubude benkathi yokukala yizinsuku eziyi-7. Ekupheleni kosuku ngalunye lapho usuyolala, 
bhala phansi ama-reading e-pedometer kuthebula elihlinzekiwe. Lezi zinsuku eziyi-7 kufanele 
kube ngezilandelanalayo. 
 
 I-pedometer kufanele ibe semzimbeni, ukusuka ekuvukeni ekuseni kuze kube yisikhathi 
sokuyolala ebusuku. I-pedometer akufanele ibe semzimbeni lapho umuntu elele, eseshaweni, 
esebhavini noma egeza. 
 
 I-pedometer kufanele ibekwe okhalweni iqondane nemaphakathi lethanga, okuwukuthi 
ipaqekwe ebhandeni noma endaweni yebhande lasokhalweni yesiketi noma ibhulukwe. Ifake 
ohlangothini olufanayo lomzimba nsuku zonke. 
 
 I-pedometer iyithuluzi lelektroniki. Siza ugweme ukuba i-pedometer ibe manzi, ungayiphonsi 
noma uyiwise i-pedometer futhi gcina i-pedometer ikude nezingane ezincane. 
 
Usuku lweviki Usuku Isibalo se-Pedometer  Isikhathi Somnyakazo 
Mgqibelo    
Sonto    
Msombuluko    
Lwesibili    
Lwesithathu    
Lwesine    
Lwesihlanu    
Mgqibelo    
Sonto    
Msombuluko    
Lwesibili    
Lwesithathu    
Lwesine    
Lwesihlanu    
 
Ucelwa ukuba uze naleli phepha ligcwalisiwe lapho uza ku-appointment yakho elandelayo. 
 
Siyabonga!  
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APPENDIX 20 
PILOT STUDY 1 
 
Procedure 
Participants were educated regarding the two pedometers and how to keep a physical activity log. 
An accuracy test of the pedometers used in the study was done with each participant. Accuracy 
was determined by demarcating a 10 meter distance in a corridor of the physiotherapy department 
and participants were instructed to wear each of the pedometers respectively on the right side of 
the body. The participants walked at a comfortable normal pace over the 10 meters, starting with 
the right leg and counting the number of steps taken. The researcher also counted the steps taken 
and was positioned at a distance behind the participant so that the walking speed would not be 
influenced. The counted steps were evaluated against the pedometer reading and recorded on a 
pedometer accuracy sheet (Appendix 15). During the course of the pilot study 1 four of each 
pedometer model was used to provide a representative pedometer sample. This procedure of 
including more than one pedometer of a specific model when evaluating pedometers is supported 
by Schneider et al. (2004).  
 
Participants were given the following instructions: 
 to wear the pedometer for seven consecutive days from getting up in the morning until going to 
bed at night. It was requested that the SW200 should be worn on the left and the CW600 on 
the right side of the body. This particular body placement, if the SW200 is to be used as the 
criterion, is supported by Schneider et al. (2004). Pedometer placement was standardised by 
placing it on the belt or waistband, in the midline of the thigh, consistent with the 
manufacturer’s recommendations (Yamax, 2010).  
 
 to continue with their normal daily routine as this study focused on everyday physical activity.  
 
 to document their steps per day (SW200 and CW600) and physical activity time (CW600) on 
the physical activity log at night when removing the two pedometers.  
 
Statistical analysis 
Data collected were captured in Microsoft Excel 2007 spread sheets. Analyses were performed 
using Windows Microsoft 2007 Excel and SPSS version 18. An alpha of p ≤ 0.05 was used to 
denote statistical significance. Means and standard deviations were used to demonstrate average 
steps per day as well as physical activity time data of the study sample.  The student t-test was 
used to determine whether the pedometer-estimated steps were significantly different from the 
actual steps taken during the accuracy test as well as to assess the differences between steps 
counted with the two pedometers. The Pearson correlation coefficient was used to assess the 
association with regards to reliability between the two pedometers during physical activity 
assessment over the seven day assessment period as the data were normally distributed. The 
association between the counted steps and pedometer steps of the 12 individuals during the 
pedometer accuracy test were evaluated with the Spearman’s correlation coefficient as the data 
were not normally distributed. Accuracy of agreement between the two pedometers was evaluated 
using the Bland-Altman method and presented as a Bland-Altman plot.  
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Results 
The sample consisted of 10 women (83.30%) and two men (16.70%). One participant in the 
sample of twelve did not record data for consecutive days and this subject’s information was 
therefore not included during the data analysis of physical activity levels but included during 
pedometer accuracy analysis. Table 20.1 outlines the physical activity results of pilot study 1. 
  
Table 20.1: Physical activity level results of pilot study 1 (n = 11) 
Variable n SW 200 CW 600 
Mean (±SD) physical activity time 
 sample 
 men 
 women 
 
11 
2 
9 
 
This model does not 
reflect activity time. 
 
74 (±34) min 
86 (±34) min 
71 (±34) min 
Mean step count per day 
 sample 
 men 
 women 
 
11 
2 
9 
 
7 749 (±3 970) 
9 314 (±3 429) 
7 401 (±4 023) 
 
7 603 (±3 947) 
8 597 (±3 503) 
7 382 (±4 031) 
♦ m (meters), min (minutes) 
 
There was no statistically significant difference between the pedometer-estimated steps and actual 
counted steps for the accuracy tests (SW200: p=0.29; CW600: p=0.26). A higher correlation was 
observed between pedometer-estimated steps and actual counted steps during the accuracy test 
with the SW200 pedometer (r=0.96, p<0.00) compared to the CW600 pedometer (r=0.82, p<0.00). 
The results during the accuracy test of the SW200 were as follows (n=12): mean counted steps 
14.83 (±2.16) and mean pedometer steps 14.75 (±2.34). The results during the accuracy test of the 
CW600 were as follows (n=12): mean counted steps 15.08 (±1.93) and mean pedometer steps 
15.33 (±2.23). The difference between the mean counted steps and mean pedometer steps of the 
SW200 and CW600 respectively was as follows; SW200 tended to underestimate by 0.5% and the 
CW600 tended to overestimate by 1.02%.  
 
No statistically significant difference (p=0.13) was noted between the two pedometers with step 
count evaluation during everyday physical activities in this sample. The Pearson correlation 
coefficient between the SW200 and CW600 pedometers concerning step count was r=0.96 
(p=0.00) as depicted in Figure 20.1.  
 
It is important to note that one participant’s individualised data resulted in a correlation of r=0.52 
that slightly affected the scatter plot. The SW200 pedometer reading was significantly (p<0.00) 
lower than the CW600 reading in her case. 
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Figure 20.1: Scatter Plot of Pearson Correlation Coefficient Between SW200 and CW600 
Pedometer Models (r=0.96). 
 
Figure 20.2 displays the Bland-Altman plot depicting the difference in steps detected between the 
CW600 and SW200 (CW600 steps per day minus SW200 steps per day). The mean step count 
difference in steps detected between the two pedometers was 146 (±24) (SW200 > CW600).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20.2:  Bland-Altman Plot of Difference Between CW600 and SW200 is Drawn Against 
the Mean of CW600 and SW200.  
 
In 52 of the 77 days data sets analysed, the CW600 detected fewer steps per day than the “gold 
standard” SW200 pedometer.  The CW600 pedometer tended to underestimate step count during 
everyday physical activity assessment in study participants. 
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Discussion 
The primary purpose of this pilot study was to determine the accuracy and reliability between the 
Yamax CW600 and Yamax SW200 pedometers during everyday physical activity assessment. 
Pilot study 1 found that there was no statistically significant difference in step count registered with 
the SW200 and CW600 Yamax pedometer models. The Pearson correlation coefficient suggested 
a very strong linear relationship between the two models and intra-model reliability was 
established. However, closer inspection of the data revealed a notable lack of agreement in steps 
detected between the two pedometers as evident by the Bland-Altman plot (Figure 20.2). When 
reviewing the Bland-Altman plot it was clear that an obvious pattern was present; the CW600 
pedometer regularly underestimated step count per day. Good agreement between instruments is 
revealed with a Bland-Altman plot when no discernible pattern can be observed (Myles, 2007; 
Bland and Altman 1999).  The mean difference in steps detected by the CW600 and the SW200 
was within an acceptable range. A cause for concern was that the CW600 underestimated steps 
counted in the majority of the 77 data set days. Cumulatively, these data suggested that one 
instrument’s step output might not be easily substituted for the other if an absolute number of steps 
taken was desired such as for research purposes. However the high correlation between the two 
pedometers does support the interchangeability of the two instruments with regards to steps taken 
if only relative values are required and not absolute.  
   
It is important to elaborate on one participant’s lower correlation finding and this can be done in the 
following way. This participant reported left sided lower back pain during the course of the study 
period at completion of data collection. It is however important to note that during the accuracy test 
of the pedometers during this particular participant’s evaluation, she did however not complain of 
any back symptoms and was walking at a similar pace as the other participants. The effects 
specific to one’s lifestyle activity on pedometer reading is not known e.g. carrying a child on one’s 
hip or back while wearing a pedometer. Lifestyle events might have affected the pedometer 
readings as the participant had a small child that she often carried on her hip. It might be 
suggested in future that participants with small children not carry them on their hips when physical 
activity assessment with a waist worn pedometer is being carried out as this might influence 
research findings.  
 
Challenges identified during pilot study 1 
1) Ladies might only wear dresses as clothing. The researcher should ensure that she has a belt 
available to secure at a participant’s waist to enable placement of the pedometer during the 
pedometer accuracy test in future studies related to the research project. Alternative 
suggestions should be given to ladies if they only wear dresses e.g. ensure you wear a dress 
with a secure fitting belt or wear pedometer on cycling shorts (tights) under dress during 
physical activity assessment in future studies. 
 
2)  Lifestyle events could possibly affect accuracy of pedometer findings when   participants wear 
waist worn pedometers and carry a small child on their hip or back during physical activity 
assessment. This is a very important factor to be aware of, as African women in South Africa 
often carry their small child on their back firmly secured with a blanket. This practice could 
result in the child dislodging the pedometer or bumping the pedometer leading to inaccurate 
step count findings. Women of other ethnic origin in South Africa also commonly carry their 
small child on their hip. This could also influence pedometer findings. It should therefore be 
suggested to women with small children to refrain from carrying their child in this manner 
during the seven day physical activity assessment in future studies. 
 
307 
 
3) Participants reported often looking for their physical activity log sheet. The researcher decided 
to add a bright colourful outer cover to the physical activity log to increase visibility of this 
document during future studies.  
 
4) During explanation of the pedometers at the start of the pilot study, the researcher had to 
repeat the workings of the CW600 pedometer a number of times before participants 
understood it as this particular pedometer had more functions. It was thus concluded that the 
SW200 was easier to understand compared to the CW600.  
 
 
Conclusion 
The intra-model and inter-model reliability of the Yamax SW200 and Yamax  CW600 pedometers 
indicate a close relationship when assessing step count and it can be suggested that these 
pedometers are suitable for everyday physical activity assessment. Due to the limited 
agreement/accuracy between the instruments one instrument’s steps data may not be easily 
substituted for the other. The population of the pilot study consisted of individuals with tertiary 
education and the researcher anticipated that participants in the future studies of the research 
project would not have such a high educational level. It was therefore concluded that the SW200 
should be used as it was easier understood by pilot study participants compared to the CW600. 
The Yamax SW200 therefore seemed to be more appropriate for research purposes if only steps 
per day were evaluated in a specific study. It was therefore decided to use the Yamax SW200 
pedometer during the rest of the PhD research project studies. 
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APPENDIX 21 
PILOT STUDY 2 
 
Procedure 
The procedure that was followed in pilot study 2, was the same as the procedure explained in 
chapter 4 section 4.4 of study 1. The only differences in the procedure of pilot study 2 were as 
follows: 
 
 A face-to-face interview for the participant with the researcher was scheduled at the 
physiotherapy room in the clinic following informed consent received. This was necessary as 
the “runner” (research assistant three) was not yet part of the research project.  
 
 Participants’ information pertaining to CD4 count, viral load and liver function tests were 
collected from their clinic files only as the researcher had not yet received permission to access 
the clinic’s National Health Laboratory database.  
 
 The verbal cues given to participants at the pedometer accuracy test was walk at a normal 
comfortable pace over the 10 meter distance starting with the right leg. 
 
 Two readings of each parameter being assessed were done to allow for reliability assessment.  
 
 During these sessions, if an individual had difficulty understanding information an interpreter 
(Themba Lethu clinic employee; counselor) was asked to translate for the researcher. The 
translator was instructed to translate word for word or as close as possible dependent on 
vernacular word availability. 
 
Statistical analysis 
Data collected during pilot study two was captured in Microsoft Excel 2007 spread sheets. 
Statistical analysis was performed using Microsoft Windows Excel 2007 and IMB SPSS version 20. 
Data was evaluated for normal distribution. The sample size was small (24 individuals) and 
variability existed between normal distributions of variables. It was therefore decided to use 
Spearman’s correlation coefficient to evaluate the intra-rater reliability of the pedometer during 
accuracy testing and researcher reliability during assessment procedures. Physical activity and 
body measurement findings are represented as medians (interquartile range) and physical activity 
categories as frequencies and percentages. The percentage difference between mean pedometer 
counted steps and actual counted steps are reported as part of pedometer accuracy evaluation. 
Reactivity (Clemes and Parker, 2008): a change in normal behaviour as a result of having to wear 
a pedometer between first and last day of pedometer wear was assessed with a student t-test. 
Level of significance was set with alpha at p≤0.05. The internal consistency of the PSS-10 was 
evaluated with a Cronbach alpha test.  
 
Results 
The pilot study consisted of 22 women (92%) and two men (0.08%) with a median age of 36.50 
(30.25–44.25) years. All participants attended both assessment sessions resulting in a 100% 
adherence rate of attendance. Most participants reported it was enjoyable seeing how their 
pedometer step counts differed from day to day and no specific problems related to wearing the 
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pedometer were reported. Table 21.1 is a representation of the body measurements (vital signs 
and anthropometric measurements) observed in participants.  
 
Table 21.1:  Results of the Body Measurements of Participants (n = 24). 
Variable n Median Interquartile range 
Resting heart rate (bpm) 24 79.75 74.13 – 87.69 
Systolic blood pressure (mmHg) 24 112.88 106.00 – 120.44 
Diastolic blood pressure (mmHg) 24 74.25 68.94 – 80.38 
Weight (kg) 24 66.25 58.00 – 70.58 
Height (cm) 24 160.50 158.25 – 163.75 
Body mass index (kg/m2) 24 23.26 21.29 – 27.92 
Waist circumference (cm) 
 Men 
 Women 
24 
2 
22 
80.50 
83.25 
80.50 
73.13 – 89.50 
77.00 – 83.25 
72.88 – 89.50 
Hip circumference (cm) 24 102.25 96.13 – 109.50 
Waist: hip ratio 
 Men 
 Women 
24 
2 
22 
0.80 
0.85 
0.80 
0.72 – 0.86 
0.80 – 0.85 
0.71 – 0.85 
♦ bpm (beats per minute), mmHg (millimeters mercury), kg (kilograms), cm (centimetres), kg/m2 (kilograms 
per meters squared). 
 
All median values were within normal levels when reviewing the body measurements of the 
sample. The median pedometer step count finding of the sample was 9 367.14 (5 299.32–14 
876.21) steps per day with men (18 442.57 [16 032.14–20 853]) being more active than women (8 
360.43 [5 166.96–12 488.29]). The median physical activity category of the sample as a whole was 
the “somewhat active” category.  
 
The participant frequencies according to the pedometer categories were as follows: “sedentary”, 4 
(16.7%); “light active”, 6 (25%); “somewhat active”, 4 (16.7%); “active”, 3 (12.5%) and “very active”, 
7 (29.2%). Thus 14 individuals fell into the less than active categories (less than 10 000 steps per 
day).  
 
The intra-rater reliability of the pedometer during the accuracy test was r=0.59 (p=0.03). The mean 
actual counted steps during the accuracy test was 15.63 (±1.76) and the mean pedometer 
measured steps during the accuracy test was 15 (±1.93). The percentage difference between 
these two measurements was 0.04%. The researcher did notice that the instruction “walk at a 
normal comfortable pace” resulted in a slower walking pace when compared to pilot study 1 
participants’ response.  
 
No significant reactivity was noted between the first and last day of pedometer data collection 
(p=0.40). This indicated that participants did not change their physical activity behaviour due to 
wearing a pedometer and documenting their findings of the physical activity log sheet. Table 21.2 
is a representation of the intra-rater reliability of the researcher when conducting body 
measurement (vital signs and anthropometric) assessment in pilot study 2 participants with study 
instrumentation.  
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Table 21.2:  Results of the Intra-Rater Reliability of the Researcher (n = 24). 
Variable n r – value p – value 
Heart rate one (bpm) 24 0.92 <0.00 
Heart rate two (bpm) 24 0.93 <0.00 
Systolic blood pressure one (mmHg) 24 0.90 <0.00 
Systolic blood pressure two (mmHg) 24 0.88 <0.00 
Diastolic blood pressure one (mmHg) 24 0.82 <0.00 
Diastolic blood pressure two (mmHg) 24 0.90 <0.00 
Height (cm) 24 0.99 <0.00 
Weight (kg) 24 1.00 <0.00 
Waist circumference (cm) 24 0.99 <0.00 
Hip circumference (cm) 24 0.99 <0.00 
♦ bpm (beats per minute), mmHg (millimeters mercury), kg (kilograms), cm (centimetres). 
 
The intra-rater reliability of the researcher when conducting body measurement assessment of 
study participants in pilot study 2 with the specific instruments were all significant and fell into the 
“good to excellent” association category of Portney and Watkins (2009). This indicated that the 
method and procedure that was followed during assessments were reliable.   
 
No specific challenges were identified when participants completed the demographic questionnaire 
one and the PSS-10 except that a counselor assisted with translation when one pilot study 2 
individuals were interviewed. The only modification that was made to the demographic 
questionnaire was to question 14.3 that stated “How often do you eat fish in a week? The answers 
that participants could choose from initially were “I do not eat fish” or “Once a week” and lastly 
“More than two times per week”. An additional option of “I do not eat fish every week” was added to 
the demographic questionnaire one following the pilot study two. During the pilot study it became 
apparent that participants could enjoy eating fish but due to personal reasons e.g. finances might 
not be able to afford to buy fish every week to eat it. 
 
The median perceived stress level of the sample was 20 (14.00–25.75) with women reporting 
higher stress levels (20 [12.50–26.50]) than men (19 [14-19]). The reliability statistics as per 
Cronbach’s Alpha analysis of the PSS-10 when assessing perceived stress levels in pilot study 2 
participants was 0.82. The item-total statistics of the PSS-10 is presented in Table 21.3. 
 
  
311 
 
Table 21.3:  Item-Total Statistics of PSS-10 in Pilot Study 2 
PSS-10 
Questions 
Scale mean if 
item deleted 
Scale variance 
if item deleted 
Corrected item-
total correlation 
Squared multiple 
correlation 
Cronbach’s 
Alpha if item 
deleted 
Question 1 16.96 67.43 0.32 0.49 0.83 
Question 2 17.23 68.20 0.26 0.22 0.83 
Question 3 17.42 59.65 0.76 0.68 0.78 
Question 4 18.13 64.20 0.51 0.37 0.81 
Question 5 17.63 61.55 0.56 0.61 0.80 
Question 6 17.08 69.21 0.24 0.38 0.83 
Question 7 17.67 62.93 0.58 0.53 0.80 
Question 8 17.54 58.52 0.65 0.52 0.79 
Question 9 17.25 64.02 0.58 0.61 0.80 
Question 10 17.21 58.17 0.69 0.75 0.79 
 
The item-total statistics of the PSS-10 maintain a Cronbach’s Alpha value 0.70 to 0.90. It can 
therefore be concluded that the scale has strong internal consistency as supported by Portney and 
Watkins (2009). 
 
Challenges identified during pilot study 2 
A number of challenges were identified during the course of pilot study 2. These challenges were 
mostly related to logistical matters in the clinic and scheduling appointments for participants. The 
following is a brief outline of the challenges encountered: 
 
1) When participants were attending the clinic due to reasons not pertaining to the study, it was 
not possible to test participants on the same day. Participants often supplied the following 
reasons: they would be tired following queuing, often finishing late for primary reason attending 
the clinic on the specific day and/or did not plan to attend the physiotherapy session as well. 
The need for a specific separate appointment for physiotherapy then became apparent but 
resulted in additional challenges. 
 
2) Participants were subsequently phoned to schedule an appointment with the researcher. A 
number of cell phone telephone numbers were no longer in use. The clinic reported that they 
had the same problem and said that patients often bought new SIM-cards instead of doing top-
up on existing numbers due to cost. It was less expensive to buy a new SIM-card with added 
phone time compared to keeping the existing number and buying airtime. If participants did not 
attend three scheduled first visits appointments, their consent form was filed in the lost to 
follow-up (post recruitment file). 
 
3) Financial constraints amongst study participants were evident as the unemployment rate was 
high. This posed some challenges concerning scheduling appointments and adherence to 
appointments. The researcher did reimburse the participants their travel expenses but 
participants had to firstly have enough finances to pay for public transport to get to the clinic.  
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4) Acquiring the participant’s file for review was often difficult, due to being in use somewhere in 
the clinic. The researcher therefore had to rely on subjective feedback from participants when 
reviewing the inclusion and exclusion criteria related to the study. Information found regarding 
participants’ blood results in clinic files were often absent or very old (older than a year). 
Following a discussion with the medical manager and nursing manager of Themba Lethu clinic 
they reported that results are not always printed from the National Health Laboratory database 
system but viewed electronically.  
 
5) The cue used during the accuracy test: “walk at a normal comfortable pace” resulted in a 
slower walking pace compared to pilot study one participants. This finding was of benefit as it 
highlighting the importance of tailoring the cue to the specific study population. The cue during 
the accuracy test was changed to: “walk at a normal fast pace as if you are trying to catch a 
taxi” for the remainder of study one. 
 
6) Three of the female participants of pilot study two only wore dresses. This created some 
challenges concerning doing an accuracy test and placement of the pedometer during physical 
activity assessment. It was partly overcome by using a belt during accuracy testing in the clinic. 
Fortunately, these three women always wore lycra cycling shorts underneath their dresses. It 
was subsequently requested that the pedometer should be worn on these shorts during 
evaluation periods underneath their dresses. 
 
7) One participant in the pilot study requested that a translator should assist during explanation of 
her study findings to improve her understanding. A nurse working in Themba Lethu clinic 
helped with this activity. 
 
8) To overcome some of the challenges mentioned above a third research assistant was 
employed to function as “runner/place keeper” in the queue. This facilitated testing of 
participants on the day that informed consent was obtained. After informed consent was 
received, the researcher took the participant out of the queue, the runner stepped into the clinic 
queue and kept the participant’s place. This strategy assisted in lessening drop-out rates 
following gaining informed consent from eligible participants. This research assistant also 
assisted with translation when the need arose creating more stability. 
 
Conclusions 
Pilot study 2 indicated that the researcher conducted reliable assessments when evaluating vital 
signs and anthropometric measurements in study participants with the chosen instruments. The 
internal consistency of the PSS-10 was demonstrated when evaluating perceived stress levels in 
individuals living with HIV. Accuracy testing of the Yamax SW200 pedometer in the study 
population revealed that cues needed to be changed to be more socially context specific during the 
accuracy test. The method of collecting pedometer step count findings (participants wearing the 
pedometer and documenting their own findings in the evening) were reliable as participants did not 
alter their walking behaviour when the first and last day of assessment were compared. This 
method of collecting step count findings were therefore continued in the rest of the research 
project. The pilot study found that the sample as a whole were “somewhat” active. However, more 
than half of the sample took less than 10 000 steps and had scope for improvement. All 
participants enjoyed wearing the Yamax SW200 pedometer and gave positive feedback regarding 
this activity.  
  
313 
 
APPENDIX 22 
SEMI-STRUCTURED INTERVIEW QUESTIONNAIRE (ENGLISH) 
 
Phase one: Semi-structured interview    Participant’s Code: 
 
1. What do you understand by  “living a healthy lifestyle”? 
 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
2. What complications or diseases can develop when one is not “living a healthy lifestyle”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
3. Can you look at the cards spread out in front of you and choose cards you would associate with 
a person who is “living a healthy lifestyle”?  
 
Please place these cards in front of you on the table. 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Now, would you please organize those cards you chose in order that you think is of priory and 
tell me what is most important and least important?   
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Why are the cards you have chosen important to you? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
4. Are you “living a healthy lifestyle”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
If yes what are you already doing right in your life and if no why? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
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Can you tell me what is preventing you from saying that you are “living a healthy lifestyle” that 
you still need to improve on?   
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Which elements can you improve on? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
5. What do you know about ischemic heart disease or heart disease? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
6. What does a person with ischemic heart disease complain of? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
7. Is there anyone in your family who has heart disease and what is your relation to that person? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
8. What do you think causes ischemic heart disease? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
9. Do you think ischemic heart disease and “living a healthy lifestyle” are related? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
If yes, why? And if no, why not? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
10. Do you think that a person can prevent heart disease from occurring in his life? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
  
315 
 
If yes, why? And if no, why not? 
___________________________________________________________________________
___________________________________________________________________________
__________________________________________________________________________ 
 
 
11. Do you consider yourself at risk of ischemic heart disease?  
 
If yes, why? And if no, why not? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Thank you very much for participating in this interview! 
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APPENDIX 23 
CARD SORT FLASH CARDS 
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APPENDIX 24 
SEMI-STRUCTURED INTERVIEW QUESTIONNAIRE (ISIZULU) 
 
Isiwombe sokuqala: Ingxoxiswano enohlakana  Ikhodi Lombambi-qhaza: 
 
1. Wena ucabanga ukuthi kuyini “ukuphila ngendlela enempilo”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
2. Nkinga zini noma izifo ezingadaleka uma umuntu engakwenzi “ukuphila ngendlela enempilo”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
3. Ingabe ungabheka amakhadi achaywe phambi kwakho bese ukhetha amakhadi 
ongawahlobanisa nomuntu owenza “ukuphila ngendlela enempilo”? 
 
Ucelwa ukuba ubeke la makhadi phambi kwakho phezu kwetafula. 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Manje-ke, ingabe ungawahlela lawo makhadi owakhethayo uwalandelanise ngendlela 
ocabanga ukuthi abaluleke ngayo futhi ungitshele ukuthi yikuphi okubaluleke kakhulu 
nokubaluleke kancane kunako konke? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Kungani la makhadi owakhethile ebalulekile kuwe? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
4. Ingabe wena uyakwenza “ukuphila ngendlela enempilo”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Uma kunjalo, yini kakade oyenza kahle ekuphileni kwakho futhi uma kungenjalo kungani? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
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Ungangitshela ukuthi yini ekuvimba ungakwazi ukuthi uyakwenza “ukuphila ngendlela 
enempilo”? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Yiziphi izici ongathuthukisa kuzo? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
5. Wazini ngesifo senhliziyo se-ischemia noma isifo senhliziyo? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
6.  Umuntu onesifo senhliziyo se-ischemia uyaye akhale ngani? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
7.  Is there anyone in your family who has heart disease and what is your relation to that person? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
8. Wena ucabanga ukuthi yini ebanga isifo senhliziyo se-ischemia? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
9. Ingabe wena ucabanga ukuthi isifo senhliziyo se-ischemia kanye “nokuphila ukuphila 
okunempilo” kuhlobene? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Uma kunjalo, kungani kunjalo? Uma kungenjalo, kungani kungenjalo? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
10 Ingabe wena ucabanga ukuthi umuntu unako ukuvimba isifo senhliziyo singenzeki ekuphileni 
kwakhe? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
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Uma kunjalo, kungani kunjalo? Uma kungenjalo, kungani kungenjalo? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
11. Ingabe uzibona usethubeni lengozi yokubanjwa yisifo senhliziyo se-ischemia?  
  
 Uma kunjalo, kungani kunjalo? Uma kungenjalo, kungani kungenjalo? 
___________________________________________________________________________
___________________________________________________________________________
_________________________________________________________________________ 
 
Sibonga kakhulu ngokubamba kwakho iqhaza kule ngxoxiswano! 
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APPENDIX 25 
CONSENT FORM 2 (ISIZULU) 
 
Isihloko Salolu Cubungulo: Amaphuzu amathuba engozi (risk factors) kanye nomthelela 
wokushintshwa komnyakazo womzimba mayelana nesifo senhliziyo se-ischemia (ukushoda 
kwezinhlayiya zegazi ezibomvu endaweni ethile emzimbeni) kubantu abaphila ne-HIV. 
 
Ifomu Lemvume Emva Kokuchazelwa: Ingxoxiswano Enohlakana 
 
 Ngaloku ngiyaqinisekisa ukuthi ngazisiwe wumcubunguli, uRonel Roos noma umsizi wakhe 
wocwaningo ukuthi le ngxoxiswano ethe ukuba nohlaka yesiwombe sokuqala salolu cubungulo 
izoqoshwa ngebhande ukuze kwenzeke ukubhaleka okushiwo ngezwi emva kwale 
ngxoxiswano. 
 
 Ngaloku ngiyaqinisekisa ukuthi ngazisiwe wumcubunguli, uRonel Roos noma umsizi wakhe 
wocwaningo ukuthi lemiqopho yebhande izogcinwa endaweni ephephile futhi ikhiyelwe 
iminyaka emihlanu emva kokuphothulwa kwalolu cubungulo. Emva kweminyaka emihlanu la 
mabhande azobhujiswa. 
 
UMBAMBI-QHAZA: 
 
 
Igama Eliprintiwe  Isiginesha / Uphawu noma Isithupha  Usuku Nesikhathi 
 
Mina, Ronel Roos noma umsizi wocwaningo, ngaloku ngiqinisekisa ukuthi lo mbambi-qhaza 
ongenhla uye waziswa ngokugcwele ngobunjalo bale ngxoxiswano enohlakana. 
 
UMCWANINGI / UMSIZI WOCWANINGO: 
 
 
Igama Eliprintiwe   Isiginesha   Usuku Nesikhathi 
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APPENDIX 26 
PILOT STUDY 3 
 
Procedure 
The interviews of the two lay persons were conducted separately in a private room at their home 
and with the qualitative researcher in a quiet tutorial room in the researcher’s department. The 
aims and objectives of the pilot study were again explained to study participants. The interview was 
conducted using the semi-structured interview questionnaire and card sort technique. All interviews 
were tape recorded.  
 
Following the interviews the participants were asked if the questions posed to them were easy to 
understand and the qualitative researcher was also asked to make suggestions on how the 
researcher should adapt her interview skills. Interviews were first conducted with the lay persons to 
assist with practise of the flow of the interview, using the tape recorder and practising interview 
skills. The third interview was then held with the qualitative researcher for review and academic 
feedback. The skills learned through the interviews above were then evaluated during the first 
qualitative interview with an individual living with HIV at Themba Lethu clinic. No additional 
adjustment needed to be made to interview sessions.  
 
Results 
The interviews were conducted with pilot study 3 participants using the selected instruments and 
procedures. No problems were experienced with the tape recorder during the separate interviews 
and recordings made were audible and clear. The questions on the semi-structured questionnaire 
and phrases on the flash cards were understood by all study participants.  
 
The sequence of the interview followed the semi-structured interview questionnaire lay-out. The 
procedure concerning the card sort technique in the pilot study were as follows: cards were spread 
in front of participants on a table; they could then select cards that they deemed appropriate; the 
remaining non-selected cards were then removed from participants’ view; participants then 
grouped the cards from most important to least important on a continuous line and they were able 
to overlap or stack cards if they thought the significance of cards were similar.  
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APPENDIX 27 
CARD SORT TECHNIQUE (ADDITIONAL ANALYSIS) 
 
Figure 27.1 is a representation of the cards that participants stacked into pile two on the 
continuous line during their interview therefore indicating that they deemed those cards as the 
second most important components of living a healthy lifestyle.  
 
 
Figure 27.1: Second Most Important Behaviours or Components Related to Living a 
Healthy Lifestyle (n = 30) 
 
Figure 27.2 is a representation of the cards that participants stacked into pile three on the 
continuous line during their interview therefore indicating that they deemed those cards as third 
most important components of living a healthy lifestyle. Twenty seven individuals made three piles 
during the interviews. 
 
10
9
9
8
7
7
7
7
5
5
4
3
3
2
1
1
1
0 2 4 6 8 10 12
Knowing your HIV status
Eating vegetables and fruit daily
Eating fish regularly during the week
Drinking 5 ‐8 glasses of water daily
Washing fruit and vegetables before use
Brisk walking daily
Participating in protected sexual activity
Doing own yard or garden work regularly
Using your prescribed medication
Washing hands regularly
Eating pap and meat 3 ‐ 5 times a week
Doing own housework regularly
Sleeping 4 ‐ 6 hours per night
Blowing a vuvuzela daily
Drinking red wine daily
Eating sweets and cookies daily
Watching TV for more than two hours at one time
Frequency of participants
Be
ha
vi
ou
rs
 or
 co
m
po
ne
nt
s to
 liv
in
g a
 he
al
th
y 
liv
es
ty
le
326 
 
 
Figure 27.2: Third Most Important Behaviours or Components Related to Living a Healthy 
Lifestyle (n = 27) 
 
Figure 27.3 is a representation of the cards that participants stacked into the fourth pile  on the 
continuous line during their interview therefore indicating that they deemed those cards as fourth 
most important components of living a healthy lifestyle. Twenty two individuals made four piles 
during their interviews. 
 
 
Figure 27.3: Fourth Most important behaviours or components related to living a Healthy 
Lifestyle (n = 22) 
 
6
6
6
6
6
5
5
5
4
4
4
2
2
2
2
2
1
1
1
0 1 2 3 4 5 6 7
Eating vegetables and fruit daily
Drinking 5 ‐8 glasses of water daily
Washing fruit and vegetables before use
Eating fish regularly during the week
Doing own yard or garden work regularly
Brisk walking daily
Sleeping 4 ‐ 6 hours per night
Washing hands regularly
Eating pap and meat 3 ‐ 5 times a week
Doing own housework regularly
Participating in protected sexual activity
Talking on a cellphone regularly during the day
Knowing your HIV status
Watching TV for more than two hours at one time
Eating sweets and cookies daily
Cooking with oil and fat regularly
Drinking red wine daily
Using your prescribed medication
Sitting a lot during the day
Frequency of participants
Be
ha
vi
ou
rs
 or
 co
m
po
ne
nt
s to
 liv
in
g a
 he
al
th
y li
fe
st
yl
e
5
4
4
3
3
3
2
2
2
2
1
1
1
1
1
0 1 2 3 4 5 6
Doing own housework regularly
Eating fish regularly during the week
Washing hands regularly
Brisk walking daily
Doing own yard or garden work regularly
Washing fruit and vegetables before use
Sleeping 4 ‐ 6 hours per night
Drinking 5 ‐8 glasses of water daily
Sitting a lot during the day
Eating vegetables and fruit daily
Eating sweets and cookies daily
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Eating pap and meat 3 ‐ 5 times a week
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Drinking red wine daily
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Figure 27.4 is a representation of the cards that participants stacked into the fifth pile on the 
continuous line during their interview therefore indicating that they deemed those cards as fifth 
most important components of living a healthy lifestyle. Seventeen individuals made five piles 
during their interviews. 
 
 
Figure 27.4:  Fifth Most Important Behaviours or Components Related to Living a Healthy 
Lifestyle (n = 17) 
 
Figure 27.5 is a representation of the cards that participants stacked into the sixth pile on the 
continuous line during their interview therefore indicating that they deemed those cards as sixth 
most important components of living a healthy lifestyle. Nine individuals made sixth piles during 
their interviews. 
 
 
Figure 27.5:  Sixth Most Important Behaviours or Components Related to Living a Healthy 
Lifestyle (n = 9) 
 
Figure 27.6 is a representation of the cards that participants stacked into the seventh pile on the 
continuous line during their interview therefore indicating that they deemed those cards as second 
least important components of living a healthy lifestyle. Three individuals made seven piles during 
their interviews. 
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Figure 27.6:  Second Least Important Behaviours or Components Related to Living a 
Healthy Lifestyle (n = 3) 
 
Figure 27.7 is a representation of the cards that participants stacked into the eight pile on the 
continuous line during their interview therefore indicating that they deemed those cards as least 
important components of living a healthy lifestyle. Two individuals made eight piles during their 
interviews. 
 
 
Figure 27.7:  Least Important Behaviours or Components Related to Living a Healthy 
Lifestyle (n = 2) 
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APPENDIX 28 
“COMMITMENT TO MYSELF” DOCUMENT 
 
Figure 28.1 is a copy of the behavioural contract included in the education physical activity diary. 
 
 
 
 
Figure 28.1: Commitment to Myself Document Included in the Education Physical Activity 
Diary 
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APPENDIX 29 
EDUCATION PHYSICAL ACTIVITY DIARY: PHYSIOTHERAPY PEER-REVIEW PANEL 
FEEDBACK 
 
The following suggestions were made by the academic peer-review panel that assisted with 
establishing the content validity of the education physical activity diary used in study 3: 
 
 Grammatical errors were highlighted for correction. 
 
 A number of suggestions were made regarding simplifying words throughout the document to 
improve understanding. Below is a table consisting of a few examples of such words or 
phrases. 
 
Table 29.1:  Suggestions for Simplifying Words 
Initial wording Suggested changes to be implemented 
Modifiable risk factors Change to “controllable risk factors” as it implies that an individual has some form of control over the risk factor. 
Muscles are strengthened  Muscles become stronger 
Muscle endurance Muscles will not tire as quickly 
Joint flexible Joint move easier 
Stay positive Change to “stay motivated” as positive may reflect on HIV status. 
Glucose Sugar level 
Cholesterol Fatty deposits 
Calories Energy 
Brisk pace Brisk/ fast walk 
Lifestyle Way of living 
  
 Suggestions were made regarding the order of the sections in the booklet and to add a heading 
to break some of the education material e.g. “What is physical activity?” 
 
 The panel suggested adding the researcher’s telephone contact details to the education 
physical activity diary in case a participant needed to inform the researcher about a change in 
their contact details and/or inability to attend appointments. 
 
 The behavioural contract was initially worded as “Contract with myself” and the peer-review 
panel suggested changing it to “Commitment to myself” as the word contract implied a legal 
document and agreement. 
 It was suggested that photographs be added to demonstrate the gentle exercises and to use 
different shapes and sized models as well as pictures to explain some of the education 
material. Local and contextual photographs were suggested e.g. adding a picture of the clinic 
or sign of the clinic. 
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 It was suggested to define certain terms that were used e.g. brisk walk. It was subsequently 
explained with regards to walking pattern: “A brisk/ fast walk is when you walk with big steps 
and is also swinging your arms to give you a bit more speed as if you are trying to catch a taxi”. 
When explaining brisk walking as an example of a moderate intensity activity level it was 
related more to a feeling of breathing faster and heart beating faster when doing a focussed 
walk. 
 
 Adding additional words to text were suggested to improve understanding of certain concepts 
e.g. when describing moderate intensity adding the word medium and also adding “not too fast 
and not too slow”. 
 
 The initial format had “toi-toi” as an example on how to improve one’s physical activity level. 
The panel suggested removing this as “toi-toi” dancing is only performed at political rallies 
and/or strikes in South Africa. It was suggested to rather use dancing, dancing lifting knees up 
high or running on the spot to explain the same activity without the political implications.  
 
 Then suggestions were made to improve safety when participants were walking in their 
communities e.g. “If you can, walk with friends in a group” and/or “If you are worried about 
traffic when walking, remember you can walk around a soccer or sports field in your 
neighbourhood” and/or “Be safe when walking outdoors”. 
 
The suggestions made by the academic peer-review panel were reviewed and implemented as 
appropriately prior to review by the physiotherapy clinician and a Themba Lethu patient group. 
Adding photographs and pictures were done during the design phase of the diary. 
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APPENDIX 30 
EDUCATION PHYSICAL ACTIVITY DIARY: THEMBA LETHU CLINIC PATIENT GROUP 
FEEDBACK 
 
Procedure of patient review of education physical activity diary 
 
Individuals attending Themba Lethu clinic as patients were approached while they were sitting 
queuing at the pharmacy in the clinic to ask if they were willing to participate in the review of the 
education material to be added in the diary. Information pertaining to the research project as set 
out in the information document was verbally explained to participants to give them an 
understanding regarding the planned use of the diary. Willing participants were asked which format 
they would prefer to review: the English or the isiZulu format. A copy of the selected format was 
then given to each participant. They were requested to read the document and write any questions 
or comments on the document. A short discussion regarding the comments and questions written 
were held with each participant respectively following their review. Participants were asked a few 
demographic detail questions and their demographic feedback was recorded on their individual 
copies of the education physical activity diary that they reviewed. The researcher compiled the 
participants’ feedback in a Microsoft Word document for review and use during the finalisation of 
the education physical activity diary. Participants’ demographic details were analysed with IBM 
SPSS 21 following Microsoft Excel 2010 data capture.  
 
Demographic details of patient group 
 
Five female individuals attending Themba Lethu clinic as patients agreed to participate in the 
review of the education physical activity diary and provide feedback regarding its content. The 
home languages of participants were as follows: participant one (isiZulu and Sotho), participant two 
(isiZulu), participant three (isiZulu), participant four (isiZulu) and participant five (isiZulu). All 
participants reported that they were also able to speak English. Three (60%) participants requested 
an English format and two (40%) an isiZulu format for review. The demographic details of 
individuals are provided in the Table 31.1below. 
  
Table 30.1:  Demographic Details of Themba Lethu Patient Group 
Variable n Median (Interquartile range) or n (%) 
Age (years) 5 29 (22 – 34) 
Education level 
 Primary school education 
 Secondary school education 
 Post-secondary school education 
5  
1 (20%) 
2 (40%) 
2 (40%) 
Time attending Themba Lethu clinic (years) 5 3 (1.5 – 5) 
Time since diagnosed as HIV+ (years) 5 6 (3.5 – 9) 
Time on HAART (years) 5 5 (1.7 – 5) 
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General suggestions made by participants 
 
Participants made the following general suggestions: 
 
 Participants suggested the use of pictures in the diary especially at the gentle exercise section 
and at the paragraph explaining how to palpate their pulse rate to improve understanding. 
 Participants suggested printing a small booklet that one could easily carry around in one’s 
handbag. 
 A space in the book to be able to record information was suggested. This space was 
suggested at the end of the book for note taking. 
 A suggestion was made to have a section in the book where participants could make notes on 
how they felt and how they were exercising e.g. how many times they exercised per week. 
 
Specific suggestions from participants 
 
Participants made the following suggestions regarding queries they had when reviewing the diary: 
 
 They did not know what a pedometer was and suggested explaining the device. A notation 
from one participant was as follows: “not well explained; what it is? Is it a gadget? Or 
schedule?” 
 A participant suggested renaming the gentle exercise section. Her suggestion was as follows: 
“maybe you should say stretch or warm-up exercises”. 
 One participant highlighted the following words as difficult to understand: cholesterol level, 
narrowing, arteriosclerosis, alternating, quadriceps muscle,  
 buttocks.  
 
Participants also made notations regarding things they would like to be explained to them. A few 
examples are provided below for review. 
 
“Uncontrollable risk factors; gender and age” – During the discussion with the researcher the 
participant explained she is not sure how gender and age can be a risk factor for IHD and wanted it 
explained. The relationship between age and gender were subsequently explained to this 
participant.  
 
 “If taking medication, and cholesterol affected, how can you control cholesterol to be stable and 
with your diet” – The participant reported that her cholesterol was high and she was on medication 
to lower her cholesterol level. She wanted to know what food will have a beneficial effect on 
lowering her cholesterol level. A low-fat diet with high fruit and vegetable intake was explained to 
her but it was also suggested that she speak with the dietician in Themba Lethu clinic regarding 
more specifics.  
 
“Signs of chronic inflammation and how to prevent it” – She asked if one can see when one has 
chronic inflammation. It was explained to her that it can be evaluated by a blood test e.g. hs-CRP.  
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Conclusion 
All participants wanted to take the information home with them but the researcher had to explain 
that the information was not yet finalised and being used in the research project at that time. 
Participants reported that reading the different copies were not difficult and they found the reading 
informative. One participant noted the following at the end of the booklet: “Informative – well written 
and interesting”. The suggestions made by participants were implemented during the finalisation of 
the diary prior to graphic designing the education physical activity diary. These changes included: 
 
 Making the diary an A5 size to easily fit into a handbag. 
 Adding illustrations, graphics and photographs. 
 Adding the self-monitoring tools e.g. weekly pedometer physical activity tracking sheets. 
 The “gentle exercise” section was renamed to “warm-up and cool-down” activities. 
 A picture of a pedometer and words such as step counter were added. 
 Initially the quadriceps stretch exercise was worded “anterior thigh stretch (quadriceps muscle 
stretch)” this was subsequently changed to only state “thigh stretch one”. 
 Specific words were changed e.g. buttocks to bum and terms were more defined for improved 
understanding.   
335 
 
APPENDIX 31 
EXAMPLE PAGES FROM THE EDUCATION PHYSICAL ACTIVITY DIARY 
 
A.  Education material regarding IHD 
How can I make my lifestyle healthier? (Page 10) 
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B.  Education material regarding the physical activity programme 
How do I know I am exercising at a moderate intensity level? (Page 17) 
 
 
 
How do I know I am exercising at a moderate intensity level? (Page 18) 
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C.  Warm-up and cool-down activities 
Shoulder and trunk exercise, ankle exercise, calf stretch (Page 22) 
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APPENDIX 32 
DEMOGRAPHIC QUESTIONNAIRE (2) 
 
Participant Code: ……………………….…………… Date: …………………………………… 
 
Section A 
1. Employment status: 
□ Employed 
□ Self employed 
□ Unemployed 
□ Retired 
□ Other: Specify…………………………………………………………………………………...……… 
 
2. Do you receive a governmental grant? □ Yes   □ No  
 
3. If you do receive a grant, what grant do you received?  
……………………………………………………………………………………………………………… 
 
4. Gross monthly income 
□ R0 – R500 
□ R501 – R1000 
□ R1001 - R2000 
□ R2001 - R5000 
□ R5001 – R10 000 
□ More than R10 000 
 
5. Source of income: ………………………………………………………………………………………... 
 
6. Marital status: 
□ Single 
□ Married 
□ Divorced 
□ Separated 
□ Cohabitating 
□ Widower/widow 
□ Other: Specify…………………………………………………………………………………...……… 
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Section B 
1. Housing environment (Do you live in the following dwelling?) 
□ “Share a space” 
□ Informal settlement: Shack 
□ RDP house 
□ Hostel 
□ Flat 
□ Town house 
□ Residential house 
□ Other: Specify…………………………………………………………………………………...……… 
 
2. What means of transport do you use on a daily basis? 
□ Walking 
□ Bus 
□ Taxi 
□ Train 
□ Bicycle 
□ Motor vehicle 
□ Other: Specify…………………………………………………………………………………...……… 
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APPENDIX 33 
6MWT EVALUATION FORM 
 
Participant Code: ……………………….…………… Date: …………………………………… 
 
Gender: Male  □ Female  □     Age:………………… 
 
Height:………………. Weight:……………… Blood pressure:………… 
 
Parameters Baseline Ax End of test Ax 
Time   
Heart rate                        bpm                                      bpm               
Respiratory rate                        bpm                        bpm 
Oxygen saturation (SpO2)                        %                        % 
Level of dyspnea                        (Borg scale)                        (Borg scale) 
Level of fatigue                        (Borg scale)                        (Borg scale) 
Pedometer step count                         steps                         steps 
 
1) Stopped or paused before 6 minutes? No  □  Yes  □ reason:…………….………… 
 
2) Other symptoms at end of test: No  □  Yes  □: dizziness  □  pain  □ 
 
Lap counter: One lap = 30m x 2 
                  
                  
                  
                  
 
3) Number of laps:………(x 60m) + final partial lap:………meters. = ……... 
 
4) Total distance walked in 6 minutes:…………meters 
 
5) Predicted distance:………….meters  Percentage predicted:……..% 
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APPENDIX 34 
STANDARDISED INSTRUCTION DURING 6MWT 
 
Instructions during the six minute walk test 
 
1. “The object of this test is to walk as far as possible for 6 minutes. “ 
 
2. “Six minutes is a long time to walk so you will probably get breathless and tired. You are 
permitted to slow down, stop and rest as needed but start walking again as soon as able.” 
 
3. “You will walk back and forth in this hallway around the cones.”  
 
4. “Remember the aim is to walk as far as possible for 6 minutes, but don’t run or jog.” 
 
5. “Start now, or whenever you are ready.” 
 
6. Instructions during the test: 
 
- After 1 minute: “You are doing well. You have 5 minutes to go” 
 
- After 2 minutes: “Keep up the good work, you have 4 minutes to go” 
 
- After 3 minutes: “You are doing well. You are halfway done” 
 
- After 4 minutes: “Keep up the good work. You have only 2 minute left” 
 
- After 5 minutes: “You are doing well. You have only 1 minute to go” 
 
- “In a moment I’m going to tell you to stop. When I do, just stop right where you are and I will 
come to you” 
 
- “Stop!” 
 
7. After assessing parameters ask the patient “What if anything kept you from walking 
farther?” 
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APPENDIX 35 
BORG SCALE 
 
Number Description  
0 Nothing at all 
0.5 Very, very slight (just noticeable) 
1 Very slight (very light) 
2 Slight (light) 
3 Moderate 
4 Somewhat severe (somewhat heavy) 
5 Severe (heavy) 
6  
7 Very severe (very heavy) 
8  
9  
10 Very, very severe (very, very heavy) [maximal]  
 
Ask these two questions before the six-minute walk test to the study participant: 
1) “Please grade your shortness of breath using this scale” 
 
2) “Please grade your level of fatigue/tiredness using this scale” 
 
At completion of the exercise test, remind the participant of the breathing number that they chose 
before the exercise. Ask the “Please grade your shortness of breath using this scale” again.  
 
Secondly, remind the participant of their fatigue/tiredness number that they chose before the 
exercise test. Then ask them “Please grade your level of fatigue/tiredness using this scale” again. 
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APPENDIX 36 
PHASE 2 EVALUATION FORM 
 
Participant Code: ……………………….…………… Date: …………………………………… 
MEASUREMENTS  
Vital Signs: 
Heart rate: 
HR 1:                       HR 1: 
Average HR: 
 
Blood pressure: 
Right SBP: 
Right DBP: 
 
Left SBP: 
Left DBP: 
 
Average SBP: 
Average DBP: 
 
Respiratory rate: 
Anthropometric measure: 
Height: 
 
Weight: 
 
Waist circumference: 
 
Hip circumference: 
 
 
Placement during hip circumference 
Waist: Hip ratio Body Mass Index: 
(kg/m²) 
Pedometer results 
Steps per day: 
Steps per seven days: 
 
 
 
LABORATORY RESULTS  
Hs-CRP 
 Date: 
 Results: 
Glucose level 
 Date: 
 Results: 
Lipid Profile 
 Date: 
 Results: 
Total cholesterol: 
 
HDL: 
Lipid Profile (cont) 
 LDL: 
 
 Triglycerides: 
Existing data from participants file  
Liver Function Data 
(Participants clinical captured data) 
 Date of latest full LFD data 
 
 Date of latest AST/ALT data 
 
 
 
_____________________________________ 
 
_____________________________________ 
 
Latest full LFD results 
AST: 
ALT: 
GGT: 
Latest AST/ALT results 
AST: 
 
ALT: 
Viral load 
 Date of latest results. 
___________________________________
 Results: 
___________________________________
 
CD4 count 
 Date of latest results. 
___________________________________
 Results: 
___________________________________
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APPENDIX 37 
FRAMINGHAM IHD RISK PREDICTION EQUATION TABLES 
 
 
(Source: Blom, 2011) 
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APPENDIX 38 
FACE-TO-FACE SESSION WITH PHYSIOTHERAPIST CONTACT SESSION SHEET 
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APPENDIX 39 
WEEKLY PHYSICAL ACTIVITY TRACKING SHEET 
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APPENDIX 40 
POST INTERVENTION QUESTIONNAIRE 
 
Participant’s Code: …………. ………………………….. Date: ……………………………………... 
 
(Answer each question below and tick the appropriate box when applicable). 
 
1)  Did you receive a pedometer and physical activity diary at the start of the exercise 
programme ? 
 
○ Yes 
○ No 
 
2)  Did you experience any problems with the pedometer during the course of the exercise 
programme? 
 
○ Yes 
○ No 
 
3)  If you did experience problems with the pedometer, what were the problems? 
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
……………………………………………………………………………………………………….. 
 
4)  Did you use/ wear the pedometer during the period of the exercise programme when you 
had follow-up sessions with the researcher (baseline to six months)?  
 
○ Yes 
○ No 
 
5)  Did you use/ wear the pedometer during the period of the exercise programme when you 
did not have follow-up sessions with the researcher (six to twelve month period)? 
 
○ Yes 
○ No 
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6)  If you used the pedometer during the time when you did not have follow-up sessions with 
the researcher (six to twelve month period), how often did you wear the pedometer? 
 
○ 1-3 times per week 
○ 4 times per week 
○  5 times per week 
○ I wore the pedometer every day 
○ I did not use the pedometer frequently during this period 
○ I could not use the pedometer during this period due to equipment problems e.g. 
pedometer broken 
○ I did not use the pedometer during this period 
 
7)  Do you feel wearing the pedometer motivated you to increase your physical activity level? 
 
○ Yes 
○ No 
 
8) Would you advise other people to use a pedometer to help them if they wanted to increase 
their physical activity level? 
 
○ Yes 
○ No 
 
9) Did you find it beneficial to have the monthly contact sessions with the researcher 
(physiotherapist) during the baseline to six month period during the exercise programme? 
 
○ Yes 
○ No 
 
10)  Did you find it easy to continue with your exercise programme during the six to twelve 
month period when you did not have monthly contact sessions with the researcher 
(physiotherapist)? 
 
○ Yes 
○ No 
 
11) Did you find the information in the physical activity diary educational?  
 
○ Yes 
○ No 
 
12) Did you learn information during the monthly contact sessions with the researcher 
(physiotherapist) that would motivate you to exercise? 
 
○ Yes 
○ No 
 
  
350 
 
13)  What information did you learn during the monthly education sessions that you found most 
helpful? 
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
……………………………………………………………………………………………………….. 
 
14) If you used the pedometer during the time when you did not have follow-up sessions with 
the researcher (six to twelve month period), did you document your pedometer step count 
findings in your physical activity diary? 
 
○ Yes 
○ No 
 
15)  If you did not document your pedometer step count findings in your physical activity diary 
during the six to twelve month period, what are possible reasons for not documenting your 
findings? 
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
……………………………………………………………………………………………………….. 
 
16) Did you sign the “Commitment to Myself” form in the front of your physical activity diary? 
 
○ Yes 
○ No 
 
17) If you did not sign the “Commitment to Myself” form, what are possible reasons why you did 
not? 
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
……………………………………………………………………………………………………….. 
 
18)  Did you find it easy to palpate/feel for your pulse and count your heart rate/pulse rate? 
 
○ Yes 
○ No 
 
19) Did you monitor your heart rate/pulse rate when you exercised? 
 
○ Yes 
○ No 
 
20)  Did you monitor your effort during exercise by evaluating your breathing and/or ability to 
speak to others when you were exercising? 
 
○ Yes 
○ No 
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21) Did you regularly to do the warm-up and cool-down exercises as was taught during the 
exercise programme? 
 
○ Yes 
○ No 
 
22)  How often did you do the warm-up and cool-down exercises? 
 
○ Daily 
○ Weekly 
○ Monthly 
○ I did not do the warm-up and cool-down exercises? 
 
23) Did you enjoy participating in the education and exercise programme that the researcher 
(physiotherapist) did with you? 
 
○ Yes 
○ No 
 
24) What did you enjoy the most during the education and exercise programme that the 
researcher (physiotherapist) did with you? 
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
……………………………………………………………………………………………………….. 
 
25)  Would you recommend the education and exercise programme to other individuals? 
 
○ Yes 
○ No 
 
 
 
 
 
Thank you for participating in the programme and completing this questionnaire! 
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APPENDIX 41 
RANDOMISATION LIST OF STUDY 4 
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APPENDIX 42 
PILOT STUDY 4 
 
Procedure 
An appointment was scheduled for each participant with the research assistant at the 
physiotherapy room in Themba Lethu clinic. The research assistant followed the same assessment 
procedure that was followed during the first session of pilot study 2 with the small adjustments 
concerning cues given during the accuracy test as explained at study 1 in chapter 4.  The second 
adjustment included performing the 6MWT following the pedometer accuracy test as described 
below.  
 
Procedure for 6MWT  
 
A 30 meter distance was demarcated with two orange cones in a hospital corridor close to the 
clinic on the ground floor. Participants walked +/- 200 meters to this corridor following the 
pedometer accuracy test. The participant sat on a stool for a minimum of five minutes at one end of 
the corridor at the start of the 6MWT to rest. The research assistant explained the parameters that 
would be assessed prior and after the 6MWT to participants at this time.  
 
a)  Evaluation of pulse rate, oxygen saturation and respiratory rate: 6MWT 
 
Pulse rate and oxygen saturation were measured with the finger probe pulse oximeter that 
was placed on the participant’s right index finger while resting his/her hand on his/her thigh. 
After these two measurements the research assistant counted the participant’s respiratory 
rate for thirty seconds while the pulse oximeter was still positioned on the participant’s 
finger to ensure participants were unaware of this procedure being done.  
 
b) Evaluation of perceived breathlessness and fatigue: 6MWT 
 
The participant was then asked his or her level of breathlessness and fatigue according to 
the Borg scale as suggested by the American Thoracic Society Guideline (ATS) (2002). All 
evaluation findings were documented on the 6MWT evaluation sheet.  
 
c) Instructions given to study participants: 6MWT 
 
The participant was instructed to walk as far as possible for six minutes between two 
cones. They were informed that they could stop at any time if they felt unwell during the six 
minutes and experienced any symptoms such as severe shortness of breath, fatigue or 
pain. A second stool was placed at the other end of the corridor near the second cone for in 
case the research assistant needed to provide a stool for a patient to sit on if he/she felt 
unwell. The researcher was close by to assist the research assistant in case of an 
emergency. The participant stood at the first cone where their pedometer was recalibrated 
to zero at the start of the 6MWT. The test was done according to standardised prompts as 
per the ATS guidelines. At completion of the test, if participants did not complete a full lap 
the particular distance that needed to be added was measured with the measuring wheel 
by the researcher while the research assistant re-evaluated the patient. The research 
assistant read the pedometer counted steps off the pedometer and documented this finding 
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on the 6MWT evaluation sheet.  The participants rested for a minimum period of thirty 
minutes and the 6MWT procedure was repeated.      
 
Statistical analysis 
Data was captured on Microsoft Excel 2010 spread sheets and imported into IBM SPSS 20 for 
data analysis by the researcher. Due to the small sample size of pilot study 4, the intra-rater 
reliability evaluation of the research assistant when performing body measurements, pedometer 
accuracy test and the 6MWT were assessed using Spearman’s rho correlation coefficient. Baseline 
findings of pilot study 4 participants’ body measurements, pedometer accuracy test and 6MWT are 
reflected as median (Interquartile range). A student’s t-test was performed to determine if a 
significant difference was noted in distanced walked in 6MWT trail one and two. A test was 
statistical significant if p ≤ 0.05. 
 
Results 
Pilot study 4 consisted of seven women (87.5%) and one male (12.5%) participant with a median 
age of 32 (29–37.25) years. The median daily pedometer step count of the sample was 5 256.86 (3 
434.04–6 833.43) steps per day indicating a “light active” pedometer physical activity category. The 
pedometer median step count recorded during the pedometer accuracy test was 15.5 (13.25–16) 
steps and actual counted steps noted to be 13.5 (12.25–15) steps. The Spearman’s rho correlation 
between actual counted steps and pedometer counted steps during the pedometer accuracy test 
was r=0.66 (p=0.07). The correlation fell within the “moderate to good relationship” category of 
Portney and Watkins (2009) but the finding was not significant. Table 42.1 reflects the body 
measurement of pilot study 4 participants. 
 
Table 42.1:  Results of the Body Measurements of Pilot Study 4 Participants (n = 8) 
Variable n Median Interquartile range Normal range 
Resting heart rate (bpm) 8 82.75 75.5 - 95.50 Less than 80 (Palatini, 2007) 
Systolic blood pressure (mmHg) 8 115.13 110.31 - 119.56 
Less than 120 
(Collins and Dias, 
2009) 
Diastolic blood pressure (mmHg) 8 79.63 72.31 - 82.50 
Less than 80 
(Collins and Dias, 
2009) 
Weight (kg) 8 71.25 59.78 – 79.90  
Height (cm) 8 166.25 160.69 – 168.06  
BMI (kg/m2) 8 24.75 22.05 – 28.90 18.5 – 24.9 (WHO, 2004) 
Waist circumference (cm) 
 Men 
 Women 
8 
1 
7 
79.88 
81.50 
79.00 
73.44 – 84.13 
81.50 – 81.50 
73.25 – 85 
 
Less than 102 
Less than 88 
(ACSM, 2010) 
Hip circumference (cm) 8 108.50 96.56 – 110.38  
Waist: hip ratio 
 Men 
 Women 
8 
1 
7 
0.77 
0.85 
0.76 
0.73 – 0.82 
0.85 – 0.85 
0.72 – 0.77 
 
Less than 0.95 
Less than 0.86 
(ACSM, 2010) 
♦ bpm (beats per minute), mmHg (millimetres mercury), kg (kilograms), cm (centimetres), kg/m2 (kilograms 
per meters squared). 
 
Resting heart rate was slightly above the suggested normal of less than 80 bpm.  Table 42.2 
depicts the 6MWT findings of pilot study 4 participants. 
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Table 42.2: Results of 6MWT of Pilot Study 4 participants (n = 8) 
Variable n 
Trial one:  
Median  
(Interquartile range) 
Trial two:  
Median  
(Interquartile range) 
6MWT distance (m) 8 539.30 (490.03 – 572.80) 527.20 (489.48 – 588.40) 
6MWT Pedometer step count 8 756.00 (703.75 – 797.50) 749.50 (706.25 – 788.75) 
6MWT predicted distance (m) 8 704.40 (688.73 – 707.40) 704.40 (688.73 – 707.40) 
6MWT % of predicted distance  8 77.00 (70.75 – 81.75) 75.26 (71.09 – 82.75) 
6MWD work (kg.m) 8 38 972.60  (31 734.49 – 43 102.30) 
39 216.15  
(31 134.88 – 43 759.48) 
6MWT HR before (bpm) 8 88.00 (78.00 – 91.25) 86.50 (79.25 – 108.00) 
6MWT HR after (bpm) 8 111.00 (94.75 – 121.00) 119.50 (97.75 – 132.00) 
Age predicted maximum HR (bpm) 8 184.60 (180.93 – 186.70) 184.60 (180.93 – 186.70) 
% of age predicted maximum HR achieved 8 59.69 (52.23 – 65.88) 64.13 (53.64 – 72.19) 
6MWT RR before (bpm) 8 16.00 (14.50 – 17.50)  16.00 (14.00 – 18.00) 
6MWT RR after (bpm) 8 20.00 (18.50 – 27.00) 27.00 (20.50 – 28.00) 
6MWT SpO2 before (%) 8 98.00 (97.00 – 99.00) 96.00 (95.00 – 98.00) 
6MWT SpO2 after (%) 8 97.00 (95.25 – 97.75) 97.00 (96.25 – 98.50) 
6MWT SOB before 8 0.00 (0.00 – 0.38) 0.00 (0.00 – 0.00) 
6MWT SOB after 8 0.25 (0.00 – 1.75) 0.50 (0.00 – 1.63) 
6MWT Fatigue before 8 0.00 (0.00 – 0.00) 0.00 (0.00 – 0.38) 
6MWT Fatigue after 8 0.50 (0.00 – 1.75) 0.50 (0.00 – 1.00) 
♦ 6MWT (six minute walk test), m (meters). % (percentage), HR (heart rate); bpm (beats per minute), RR 
(respiratory rate); bpm (breaths per minute), SpO2 (percutaneous oxygen saturation), SOB (shortness of 
breath), kg.m (kilograms time distance walked in meters).  
 
No participants had difficulty performing the 6MWT or experienced symptoms such as dizziness or 
pain during the test. In both 6MWT trials, participants walked less than 82% of their predicted 
6MWT distance indicating that their distance walked was abnormal (Troosters, Gosselink and 
Decramer, 1999). Participants walked a shorter distance in their second trial and therefore the less 
predicted percentage walked and lower pedometer step count recorded. Even though the distance 
walked in the second trail was less than the first the difference was not statistically significant 
(p=0.88). During the second trial participants exerted more cardiovascular effort as demonstrated 
by the higher percentage of predicted maximum heart rate achieved and 6MWD work.  
Participants’ perceived fatigue only changed from a “nothing at all” to a “very, very slight (just 
noticeable)” level from beginning to end of both walking trials. Minimal fluctuation was noted in 
oxygen saturation. Table 42.3 is a representation of the intra-rater reliability findings of the 
research assistant when performing body measurements during pilot study 4. 
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Table 42.3: Results of the Intra-Rater Reliability of Research Assistant Four when 
Performing Body Measurement During Pilot Study 4 (n = 8) 
Variable n r - value p - value 
Heart rate one   8 0.79 0.02 
Heart rate one  8 1.00 <0.00 
Systolic blood pressure one  8 0.70 0.05 
Systolic blood pressure two  8 0.90 <0.00 
Diastolic blood pressure one  8 0.61 0.11 
Diastolic blood pressure two  8 0.93 <0.00 
Height  8 0.93 <0.00 
Weight  8 1.00 <0.00 
Waist circumference  8 0.97 <0.00 
Hip circumference  8 0.97 <0.00 
 
A “good to excellent relationship” (Portney and Watkins, 2009) with significant p - values were 
noted in all variables except systolic blood pressure and diastolic blood pressure one.  The 
relationship in these two variables was “moderate to good” (Portney and Watkins, 2009) but not 
significant. Table 42.4 is a representation of the intra-rater reliability of the research assistant when 
performing the 6MWT with participants.  
 
 
Table 42.4:  Results of the intra-rater reliability of research assistant four when performing 
the 6MWT (n = 8) 
Variable n r - value p - value 
6MWT distance 8 0.95 <0.00 
♦ 6MWT (six minute walk test) 
 
Even though the distance walked during the second trial of the 6MWT was less than the first, a 
“good to excellent relationship” (Portney and Watkins, 2009) existed and was also significant 
(p<0.00).  
 
Conclusion 
The primary aim of pilot study 4 was to evaluate the research assistant’s intra-rater reliability when 
performing assessments of pilot study 4 participants. The intra-rater reliability of the research 
assistant when performing the pedometer accuracy tests was “moderate to good”. This finding was 
similar to the researcher’s results in pilot study 2 when conducting the pedometer accuracy test in 
individuals living with HIV.  Due to the p – value in pilot study 4 not being significant the finding 
could have been due to chance. With a larger sample size, the p–value might be significant as 
demonstrated in pilot study 2. Even so, an adequate relationship was found between actual 
counted steps and pedometer steps. This finding indicated that the pedometers used were reliable 
and explanations given by the research assistant good. 
 
The intra-rater reliability of the research assistant when evaluating participants’ body 
measurements were “good to excellent”. This finding was again similar to the researcher’s intra-
rater reliability assessment when evaluating body measurements in individuals living with HIV 
during pilot study 2. It therefore indicated that she followed the assessment procedure effectively 
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and the equipment used was giving reproducible results. An additional objective of pilot study 4 
was to evaluate participants’ functional exercise capacity with the 6MWT and tolerance of the test. 
 
The 6MWT was tolerated by all participants and no adverse side effects occurred. It became 
apparent to the research assistant and the researcher that participants viewed the 6MWT as a bout 
of exercise as interpreted from their informal feedback given following performing the test. Even 
though participants achieved a lower than normal median value of their predicted 6MWT distance, 
they all walked at a comfortable fast pace and seemed focused and determined to walk far. The 
lower distance walked however did indicate that their functional exercise tolerance was reduced. 
Their median pedometer physical activity level also indicated that the sample’s activity level was 
“light active” which could explain the reduced exercise tolerance.   
 
More noticeable during the 6MWT was the cardiorespiratory changes that occurred compared to 
perceived fatigue and SOB experienced by participants. This finding was of clinical significance for 
the larger study 4. It was deemed more important to teach participants’ how to monitor their pulse 
rate and breathing when performing a walking programme if included in the intervention. As these 
parameters might fluctuate more during a focussed walk compared to their subjective parameters. 
The pilot study also highlighted that participants’ physical effort during the 6MWT fluctuated 
59.69% to 64.13% of age predicted maximum heart rate. The American College of Sports Medicine 
state that 64-76% of age predicted maximal heart rate is equal to a moderate intensity level (2010). 
Participants therefore achieved a borderline moderate intensity level during the 6MWT. The aim of 
the intervention was to encourage a moderate intensity walking programme in intervention 
participants. Due to them achieving a moderate intensity walking level during the 6MWT, the 
researcher used the 6MWT as an example to explain to intervention participants the brisk walking 
speed at which they should perform a focused walk. An additional beneficial finding of pilot study 4 
was that no significant difference in distance walked occurred between the first and second trail.  
 
The median 6MWT distance walked during the second trial was less than the first. Having the 
participants do a second 6MWT did therefore not result in a training effect causing them to walk 
further in the second trial during pilot study four. This finding was significant considering a 
challenge that was encountered earlier on in the research project. During study 1 it was identified 
that participants had difficulty attending research and general clinic appointments due to their work 
obligations. This challenge was also encountered when doing the 6MWT during pilot study 4 as 
two individuals declined participation in a second 6MWT due to not willing to wait 30 minutes 
before repeating the test because of work obligations. Few (n=5) of the remaining participants that 
did consent to wait 30 minutes to repeat the test were keen to finish their assessments so they 
could go to work.  The remaining three were unemployed and did not have this concern. Due to the 
6MWT finding of pilot study 4 and challenge regarding participants’ ability to attend appointments 
as noted in study 1, only one 6MWT trial were done during the remaining assessments of study 4.  
 
One additional challenge that was identified during pilot study 4 was the specific corridor in which 
the 6MWT was done. The corridor was chosen because it was long enough, close to Themba 
Lethu clinic, on the ground floor and seemed quiet. During the pilot study it was however noted that 
the corridor was very cold as the central heating in the corridor did not work and a cold draft 
permeated through the passage. This was of significance as pilot study 4 was done during the 
winter season. In addition it also became apparent that the corridor was not as quiet as initially 
assessed. Hospital traffic frequently passed through this particular corridor that needed to be 
redirected by the researcher to not disturb the research assistant and study participants. The 
hospital traffic also tended to stop, wanted to know why the participants were “exercising” and 
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wished to participate and also “exercise”. Due to these reasons, the remainder of the 6MWT trials 
of baseline study 4 evaluations were done in a different corridor on the first floor next to a second 
entrance of Themba Lethu clinic.  This corridor was much quieter, a bit closer to the clinic and the 
central heading in the passage worked in sporadic spots so it was warmer.  
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APPENDIX 43 
ASSESSMENT PROCEDURE OF STUDY 4 
 
The research assistant requested that the participant remove any bulky clothing and position this 
and any bags on stool in the room. The participant sat in a chair next to the assessment table and 
the research assistant positioned a pillow behind their back to ensure an upright posture before 
sitting down on the chair. At the baseline assessment the demographic questionnaire two was 
firstly completed and then the PSS-10. This process took +/- 15 minutes. At the six and 12 month 
assessments only the PSS-10 was done at the start of the assessments. 
  
Respiratory rate assessment 
 
The research assistant then asked the participants to expose their arms and/or remove any tight 
fitting clothing at their arms that could influence their blood circulation. They were instructed to rest 
their arms on the desk in front of them while the research assistant firstly positioned the 
sphygmomanometer cuff on their left upper arm +/- 2-3 cm above the elbow joint line. The 
participant sat quietly on a chair for five minutes while the research assistant started by evaluating 
their respiratory rate. The participants were not informed that the research assistant was assessing 
their respiratory rate in an attempt to prevent them from altering their respiratory rate. The research 
assistant observed the participants’ “chest rise” as indicative of respiratory rate for 30 seconds. 
The value was multiplied by two to equal a value of respiratory rate per minute. Two observations 
were documented on the phase 2 evaluation form and during statistical analysis the mean of these 
two observations were analysed. 
 
Heart rate and blood pressure assessment 
 
Resting heart rate and blood pressure were then evaluated with the Microlife BP A100 automated 
blood pressure sphygmomanometer. Two measurements were taken in the left arm and then 
subsequently in the right arm. Between each measurement the participant’s reading was displayed 
on the monitor of the device for one minute. After a minute the reading disappeared and the 
research assistant could do a next measurement. These four measurements were documented on 
the phase 2 evaluation form. During statistical analysis the mean of the four measurements were 
analysed.  
 
Weight assessment 
 
The participants were then instructed to remove their shoes and any articles out of their clothing 
pockets e.g. wallet or cellphones. The participants were weighed on the portable scale twice. Prior 
to each measurement the device was calibrated as per the manufacturer’s instructions. Weight 
was measured to the nearest 0.1kg. Both these measurements were documented on the phase 2 
evaluation form. During statistical analysis the mean of the two measurements were analysed. 
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Height assessment 
 
The participants were then instructed to stand upright on the Micro Health stadiometer device 
facing the research assistant with their head in a neutral position to enable the research assistant 
to measure their height with the stadiometer attached. The research assistant took two height 
measurements that she documented on the phase 2 evaluation form.  Height was measured to the 
nearest 0.1cm. During statistical analysis the mean of the two measurements were analysed.  
 
Waist and hip circumference 
 
The participants then stepped down of the Micro Health scale to enable the research assistant to 
evaluate their waist and hip circumference. Waist circumference was measured with a non-stretch 
tape measure at the narrowest circumference halfway between the lowest ribs and iliac crests (a 
horizontal measure was taken at the narrowest part of the torso: above the umbilicus but below the 
xiphoid process) (ACSM, 2010). The participants were encouraged to exhale gently at time of 
measurement. Participants were standing with their arms at their side’s feet together and their 
abdomen relaxed (ACSM, 2010). Two measurements were taken and documented on the phase 2 
evaluation form. During statistical analysis the mean of the two measurements were analysed. 
Participants’ hip circumference was subsequently measured with the non-stretch tape measure at 
the broadest circumference of the participants’ buttocks (ACSM, 2010). Participants stood upright 
with their feet together during this measurement. Two measurements were taken and documented 
on the phase 2 evaluation form. During statistical analysis the mean of the two measurements 
were analysed.    
 
Pedometer and physical activity log sheet 
 
At the baseline assessment the research assistant gave each participant a pedometer to position 
at the right side of their body at their hip to enable the researcher to measure their physical activity 
level. The pedometer and physical activity log sheet were again explained to study 4 participants. 
Factors related to the pedometer that was covered during this discussion were: how to open and 
close the pedometer, how to reset the pedometer, when and where to wear the waist worn 
pedometer. Participants were requested to continue with their daily life as normal during the seven 
days when they wore the pedometer. They were asked to wear the pedometer from the time they 
got up in the morning until they went to bed at night for seven consecutive days. They were 
instructed not to wear the pedometer when bathing, showering, swimming or sleeping. Prior to 
positioning the pedometer each morning, they had to reset the pedometer to zero. They were 
asked to document the step count recorded by the pedometer on the pedometer log sheet in the 
evening when the removed the device.  The research assistant and participant then stepped 
outside the room to test the pedometer with the accuracy test and then do the SMWT after.   
 
Pedometer accuracy test 
 
Accuracy was determined by demarcating a 10 meter distance in a corridor outside the 
physiotherapy room. Pedometer placement in each participant was standardised by positioning the 
pedometer anterior to the right hip in approximately mid-thigh position. This position was 
suggested by the manufacturers (Yamax, 2011). The participants were instructed to walk at a 
normal fast pace as if they were trying to catch a taxi over the 10 meter distance, starting with the 
right leg. The researcher assistant counted the actual steps taken by the participant and was 
positioned at a distance behind the participant to not influence the walking speed. This procedure 
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was done twice. The counted steps were evaluated against the pedometer reading and 
documented on a pedometer accuracy sheet.  
 
Procedure for 6MWT  
 
A 30 meter distance was demarcated with two orange cones in the same corridor. The participant 
sat on a stool for a minimum of five minutes after the pedometer accuracy test at the starting point 
of the 6MWT to rest. Research assistant four explained the parameters that would be assessed 
prior and after the 6MWT to participants at this time. Pulse rate and oxygen saturation were 
measured with the finger probe pulse oximeter that was placed on the participant’s right index 
finger while resting his/her hand on his/her thigh. After these two measurements the research 
assistant counted the participant’s respiratory rate for thirty seconds while the pulse oximeter was 
still positioned on the participant’s finger to ensure participants were unaware of this procedure 
being done. The participant was asked his or her level of breathlessness and fatigue according to 
the Borg scale. All evaluation findings were documented on the 6MWT evaluation sheet. The 
participant was instructed to walk as far as possible for six minutes between the two cones. They 
were informed that they could stop at any time if they felt unwell during the six minutes and 
experienced any symptoms such as severe shortness of breath, fatigue or pain. A second stool 
was placed at the other end of the corridor near the second cone for in case the research assistant 
needed to provide a stool for a patient to sit on if he/she felt unwell. The researcher was close by to 
assist the research assistant in case of an emergency. The participant stood at the first cone where 
their pedometer was recalibrated to zero at the start of the 6MWT. The test was done according to 
standardised prompts as per the ATS guidelines. At completion of the test, if participants did not 
complete a full lap the particular distance that needed to be added was measured with the 
measuring wheel by the researcher while the research assistant re-evaluated the patient. The 
research assistant read the pedometer counted steps off the pedometer and documented this 
finding on the 6MWT evaluation sheet.   
 
Assessment calculations 
 
 Individuals’ predictive 6MWT distance was calculated with Gibbons (2001) prediction equation: 
868.8 – (age years x 2.99) – (sex men = 0; women = 1 x 74.7).  
 Percentage walked of predicted 6MWT distance was calculated as follows: Distance walked/ 
predicted distance x 100 
 The participants’ BMI was calculated with the following equation: BMI= weight (kg)/ height (m) ² 
(ACSM, 2010) 
 The participants’ waist and hip circumference were converted from centimeters to meters and 
waist: hip ratio was calculated with the following equation: waist: hip ratio = waist/hip 
circumference. 
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APPENDIX 44 
LABORATORY TESTS INFORMATION SHEET FOR PHASE TWO 
 
Dear Participant, 
 
As part of phase two of this physiotherapy research study, the laboratory nursing sister will need to 
collect blood samples from you. These blood samples will be collected from your arm. It might be a 
little bit uncomfortable but it is similar to the blood tests done at the clinic.  
 
The blood test will enable me to evaluate your glucose, cholesterol and inflammatory hs-CRP 
levels in your blood. This procedure will be done at the beginning of phase two of the research 
study but also in six months’ time and at the end of 12 months when the study is completed. We 
will therefore be able to see how your blood chemistry changed over this period.  
 
To ensure that the procedure is successful I would appreciate it if you could do the following before 
your appointment at Helen Joseph Hospital for the blood test: 
 
 Ensure that you had a good night’s rest the night before. Try to sleep six to nine hours. 
 
 Don’t do any exercise or take any alcohol beverages in the 24 hours (one day) before your 
appointment. 
 
 The blood sample to be taken should be a “fasting” blood sample. This means that you should 
not eat anything following your dinner the previous night. No breakfast is therefore allowed on 
the morning of the blood test. After the blood test you can eat again. You can drink water in the 
“fasting” period but no milk, tea, coffee, juice or cold drinks should be taken in this period. 
 
It is very important that you continue with your antiretroviral medication as prescribed by your 
medical doctor at Themba Lethu clinic. 
 
Thank you for adhering to these “do’s and don’ts” of the blood test. 
 
The Researcher, 
Ronel Roos 
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APPENDIX 45 
CONTRACT LABORATORY SERVICES REQUISITION FORM 
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APPENDIX 46 
PHLEBOTOMY SET-UP STATION 
 
 
               
 
 
 
 
 
 
 
                                                                    
   
 
 
 
 
 
 
 
 
 
 
Figure 46.1:  Blood Sampling Testing Kit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46.2:  Phlebotomy Set-Up Station  
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APPENDIX 47 
INTERVENTION PROGRAMME OF STUDY 4 
 
Introduction 
The intervention programme was initiated with study 4 participants allocated to the intervention 
group at their second baseline assessment session. At this time the aim of the specific home-
based education and walking programme was explained. The aim of the intervention was to assist 
study participants in increasing their physical activity level (total pedometer step count per day) as 
a means of addressing their risk factors for IHD. To improve individuals understanding on why they 
should be more active certain educational topics were covered during the contact sessions. These 
topics were informed by results found in study 1 and 2. A strong emphasis was placed on self-
monitoring during this programme as a means of making participants aware of how their body 
reacted when they were active at a moderate intensity level. An important aim was ultimately to 
encourage self-management through empowerment by education and monthly guidance. To 
achieve this aim the programme consisted of the following facets: 
 
 Each participant received a Yamax SW200 pedometer to allow for self-monitoring of daily step 
count at home. 
 Each participant received an education physical activity diary to be used during the course of 
the programme as an educational and self-monitoring tool.  
 Participants were encouraged to attend the five monthly face-to-face contact sessions with the 
researcher at Themba Lethu clinic during the baseline to six month period. The role of these 
sessions was to create a supportive environment where participants’ adherence to the 
programme could be monitored and barriers and facilitators could be highlighted. Pedometer 
walking goals would be set and strategies suggested improving adherence to walking. 
 Participants were sent five cellphone SMS texts messages (one per month) as a reminder to 
encourage increased walking behavior during the baseline to six month period.  
 
The home-based education and walking programme focused on two main areas: education of 
individuals and encouraging increased physical activity in the form of a home-based walking 
programme.  
 
Education Component 
The Five A’s organisational construct for clinical counseling was followed during the contact 
sessions to assist with providing a motivational atmosphere to enhance physical activity levels of 
participants (Jamison, 2010; Whitlock et al., 2002). The Five A’s consist of the following: Assess 
(e.g. screen risk factors), advise (e.g. advice on how these risk factors can be modified), agree 
(e.g. participant and physiotherapist liaise on what needs to be altered), assist (e.g. implementation 
of strategies) and arrange (e.g. monitor progress and arrange follow-up sessions). The educational 
topics that were discussed during the contact sessions are presented below. During these 
sessions their education physical activity diary was used as reference guide for explanations. 
 
Second baseline assessment session 
 
Participants were given their Yamax SW200 pedometer that they used during their physical activity 
level assessment at baseline for use during the programme. They were informed that the 
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pedometer would be the tool that they could use to self-monitor their daily step count to ensure that 
they reached the specific daily pedometer step count goal.  
 
Each participant received an education physical activity diary and was orientated regarding the 
specific sections in the diary that would be covered during the course of the programme. Their 
baseline assessment findings were documented in their dairy and explained. The risk factors that 
could be improved during the course of the programme were highlighted at this stage. Each 
participant’s daily step count goal for the next month was then calculated using their baseline value 
as reference point and subsequently documented on the “weekly physical activity tracking sheets”. 
Kindly refer to the pedometer step count goal table at the end of the appendix for how step counts 
were calculated throughout the programme.  
 
Their step count goal was explained using the pedometer step count achieved during the 6MWT to 
give the participants an idea of how long they should walk e.g. a participant might have clocked 
700 pedometer steps in six minutes. During the first month they were encouraged to monitor their 
intensity of walking according to their perceived level of breathlessness and how fast they were 
breathing. It was emphasized that they should walk at a brisk pace to ensure a moderate intensity 
level (Murtagh, Boreham and Murphy, 2002). A brisk pace was defined as a faster than normal 
pace that would leave the participants’ slightly breathless but still able to talk (Tully et al., 2005). 
The researcher referred back to the Borg scale that was used during the 6MWT to explain the 
levels of breathlessness. The following example was used: if they were walking with a friend and 
were able to talk in short phrases because of feeling moderately breathless they would be 
exercising at a moderate intensity level. If they were walking and able to have a long conversation 
without feeling breathless they were walking at too low an intensity level. Lastly, if they were 
walking and unable to talk at all due to feeling severely breathless they were exercising at too high 
a level.  
 
At this session the warm-up and cool down ankle exercise presented in their education physical 
activity diary was demonstrated and taught to participants. Their first monthly appointment were 
scheduled and documented in their education physical activity diary. 
 
Face-to-face contact session one 
 
A discussion regarding how participants managed with the walking programme in the preceding 
month was held and specific questions related to their health raised. If they achieved their daily 
pedometer step count goals they were asked to explain what enabled them to do this. If they could 
not achieve their aims they were requested to elaborate on the possible barriers that they had 
encountered. These barriers were discussed and possible solutions for these challenges 
suggested to be implemented in the next month. 
 
 Body measurements of participants were done e.g. blood pressure, weight, waist circumference 
and documented on the “face-to-face interview with physiotherapist” sheet of the researcher and 
participant’s education physical activity diary. These evaluations were done to monitor participants’ 
physical status. Their notations on the “weekly physical activity tracking sheets” in their education 
physical activity diary were reviewed and discussed.  
 
An educational discussion was held concerning the benefits of being physically active and methods 
to increase once daily pedometer step count. Secondly, the intensity (moderate intensity level) was 
again explained according to breathlessness level as well as heart rate ranges. A moderate 
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intensity physical activity level is classified as a range of three to six metabolic equivalent units. 
This metabolic equivalent range is equal to 40-59 oxygen uptake reserve percentage which is said 
to be equal to 64-76 maximal heart rate percentage (ACSM, 2010). An exercise intensity level of 
40-60% of oxygen uptake researve is suggested as a save exercise intensity level in individuals 
living with HIV to avoid possible immune suppression from occurring with more intense exercise 
(ACSM, 2010). The participants were asked if they knew how to palpate their pulse rate. None of 
them knew how to perform this assessment technique. The researcher then taught them how to 
measure their radial pulse rate.  
 
Their age predicted maximum heart rate was calculated with the following equation: 207 – (0.7 x 
age) (ACSM, 2010; Gellish et al., 2007). Their individualised 60 to 75% of age predicted maximum 
heart rate range was calculated and documented on their “weekly physical activity tracking sheets” 
for the next month. The slightly lower start range (60%) was chosen due to the participants in this 
study presented with already low CD4 values when compared to an international home-based 
exercise study population group (Dolan et al., 2006). The aim was also to start at a lower level and 
slowly progress in an attempt to ensure adherence to exercise prescription.  
 
Individuals were asked to assess their pulse rate prior to a focused walk and again at completion to 
see if they were able to increase their heart rate to the specific intensity level. Additional warm-up 
and cool-down exercises were taught as the walking programme had now progressed and would 
require walking for a longer period of time to achieve the required step count goal. The additional 
exercises were a calve stretch, anterior thigh stretch and posterior thigh stretch as explained in 
their educational physical activity diary. Their daily pedometer step count goals were progressed to 
the next level if they achieved their previous month’s goals. If they did not achieve their specific 
goals the daily step count goals were not adjusted. The daily pedometer step count goals were 
documented on the “weekly physical activity tracking sheets” for the next month. Their next 
month’s appointment was scheduled. 
 
Face-to-face contact session two 
 
The above format for the second physiotherapy appointment was again followed. At this session 
the participants were specifically asked if participants were coping with evaluating their pulse rate. 
The majority of them reported that they palpated their pulse to review if a change in speed 
occurred but did not necessarily count the number of beats. This was due to difficulty palpating the 
pulse point and often having difficulty counting. The educational session consisted of a discussion 
regarding what is IHD and how can being physically active influence IHD. Their daily step count 
goal was progressed if they achieved their goals and maintained the same if not. The warm-up and 
cool down activities that were added at this session were a range of motion neck exercise and 
range of motion trunk exercise. Their next month’s appointment was scheduled.  
 
Face-to-face contact session three 
 
The above format for the third physiotherapy appointment was again followed. The educational 
session consisted of a discussion regarding the risk factors of IHD and how being physically active 
could potentially influence these risk factors of IHD. They were informed about the normal value 
ranges of the risk factors measured and how their findings related to the normal. Their daily step 
count was progressed if they achieved their goals and maintained the same if not. Participants 
were encouraged to when they do a focussed walk to walk with “attitude”. This entailed a good 
upright posture with a more focussed hip propelling action to increase contraction of muscles 
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around the trunk and pelvis area. This walking pattern also encouraged a longer stride length. The 
walking pattern was explained, demonstrated and participant’s attempt reviewed. The warm-up 
and cool down exercises incorporated at this session included two range of motion exercises of the 
shoulder joints. Their next month’s appointment was scheduled.  
 
Face-to-face contact session four 
 
The above format for the fourth physiotherapy appointment was again followed. At this stage of the 
programme it was summer in South Africa. A number of participants reported it was more difficult 
to follow the programme due to difficulty walking outside in the heat. Strategies to overcome this 
was suggested e.g. walking early in the morning or late in the afternoon when it was not as warm, 
ensuring good hydration before/during and after a focused walk, walking in an air conditioned 
shopping center or increasing physical activity indoors while doing housework. Their daily step 
count was progressed if they achieved their goals and maintained the same if not. The warm-up 
and cool down exercises were reviewed. Their next month’s appointment was scheduled and 
documented in their educational physical activity diary. 
 
Face-to-face contact session five 
 
The above format for the fifth physiotherapy appointment was again followed. The majority of 
participants were now doing the activity programme five times a week. They were motivated to 
keep up the good work for the remainder of the programme. At this stage the six month 
assessment procedure was again reviewed with them and an appointment scheduled. 
 
 
Exercise Component 
The ACSM and American Heart Association (AHA) recommend the following guidelines for 
physical activity: ≥ 30 minutes of moderate intensity five times per week or ≥ 20 minutes of 
vigorous activity on three days per week (Haskell et al., 2007). Marshall et al. (2009) translated 
these recommendations into pedometer based step goals. The researchers reported that 3 000 
pedometer steps walking at a moderate intensity level would equal to 30 minutes of walking time.  
 
The current study’s walking programme was created to incrementally progress to ultimately reach 
the ACSM and American Heart Association recommendations while monitoring how participants 
reacted to the changed activity level. The walking programme is presented below in the table. If 
participants achieved their pedometer step count goals their step count was progressed bi-weekly 
as set out in the table. If they did not achieve their specific step count goals, they were motivated to 
try and implement the suggested strategies to reach their goal and their goal was not altered until 
this was achieved. 
 
If participants developed an illness e.g. flu or cold during the course of the programme they were 
instructed to stop exercising and to only resume their programme when their physical ailment had 
passed. When restarting their walking programme they were initiated at a lower level than prior to 
their illness. The timeframes to achieve a goal could therefore not be standardised between 
individuals.  
 
The exercise programme also included the specific warm-up and cool-down exercises that were 
systematically included as they progressed through the programme.  
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The following general advice was given to participants regarding the walking programme: 
 
 Wear comfortable shoes and clothing when walking. 
 They should try and incorporate the warm-up and cool-down exercises before and after the 
walking programme. 
 When they walked in the summer they should wear light weight clothing. 
 When they walked outside in the winter they had to remember to dress warmly. 
 If it was very hot or cold outside, they could have rather walked in a shopping center where the 
temperature was controlled. 
 If they were worried about traffic when walking, they could walk around a soccer or sports field 
or park in their neighbourhood. 
 When they walked they should try to take big steps and swing their arms. 
 Drinking water regularly was important during and after their walking programme. 
 If they could walk with friends in a group it was better for safety as well as companionship. 
 They had to be safe when walking outdoors. 
 
Table 47.1: Six-Month Pedometer Based Home-Based Walking Programme 
Timeframe Pedometer step count goal 
Week 1 To walk an extra 1000 steps (from baseline value) on at least 3 days of week. 
Week 2 To walk an extra 1000 steps (from baseline value) on at least 3 days of week. 
Week 3 To walk an extra 1500 steps (from baseline value) on at least 3 days of week. 
Week 4 To walk an extra 1500 steps (from baseline value) on at least 3 days of week. 
Week 5 To walk an extra 2000 steps (from baseline value) on at least 3 days of week. 
Week 6 To walk an extra 2000 steps (from baseline value) on at least 3 days of week. 
Week 7 To walk an extra 2500 steps (from baseline value) on at least 3 days of week. 
Week 8 To walk an extra 2500 steps (from baseline value) on at least 3 days of week. 
Week 9 To walk an extra 3000 steps (from baseline value) on at least 3 days of week. 
Week 10 To walk an extra 3000 steps (from baseline value) on at least 3 days of week. 
Week 11-14 To walk an extra 3000 steps (from baseline value) on at least 4 days of the week. 
Week 15-24 To walk an extra 3000 steps (from baseline value) on at least 5 days of week. 
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APPENDIX 48 
SMS PROMPTS OF THE INTERVENTION PROGRAMME OF STUDY 4 
 
1. Good morning, I hope you are enjoying the lovely weather! Remember your walking and step 
count goals, Ronel. 
 
2. Good afternoon, hope you are all well! Enjoy your walking, Ronel. 
 
3. Good afternoon, you are all doing really well with your walking. Remember to drink enough 
fluids now that it is warmer, when you are walking, Ronel. 
 
4. Good afternoon, remember to do your walking, Ronel. 
 
5. Good afternoon, remember exercise (walking) is “medicine” and should be done regularly so 
maintain your step count goals! Have a lovely festive season and blessed 2013, Ronel. 
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APPENDIX 49 
GOODNESS TO FIT TESTING 
 
Figure 49.1 presents information pertaining to pedometer physical activity level data without 
restrictions applied during the goodness to fit testing in the GEE model prior to multiple variate 
logistic regression analysis.  
 
 
Figure 49.1:  Pedometer Physical Activity Level Prior to Restrictions Applied in GEE Model 
 
Applying the restriction more than -3 reduced the outlier effect of the residuals as noted by the y 
axis (Zgee) and the restriction less than 11 lessened the outlier effect of the leverage as noted on 
the x axis (log_paaave). 
 
Figure 49.2 provides information pertaining to the goodness to fit testing in the MEM model when 
restrictions were not yet applied and Figure 51.3 presents the scatter plot with restrictions (> -2 and 
< +2) applied.   
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Figure 49.2:  Pedometer Physical Activity Level Prior to Restrictions Applied in MEM Model 
  
 
Figure 49.3: Pedometer Physical Activity with Restrictions (> -2 and < +2) in MEM Model 
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APPENDIX 50 
INTERVENTION PARTICIPANTS’ FEEDBACK POST PHYSICAL ACTIVITY MODIFICATION 
 
Table 50.1:  Participants’ Feedback Regarding Helpful Monthly Session Information 
ID Helpful Information Obtained at Monthly Sessions 
1 Be active and try and do exercise. 
5 The information about exercise and the contact sessions to motivate patient. Participant started 
walking then running and cycling. 
6 How exercise can help lose weight and how exercise can improve heart health. 
8 Exercises helped to feel healthier. 
9 Exercise helps to improve the pumping of the heart and can improve heart health. 
14 How to monitor that you are exercising enough. How to check your pulse. 
16 The warm up and cool down exercises as it was not difficult to do. 
27 The importance of doing exercise to lessen stress and maintain joint mobility. 
29 Information on intensity of exercise motivated her to walk fast and increase her exercise level. 
30 Motivation received in contact session and exercises done in session. 
32 The importance of exercising regularly for your health.  
35 How to use the pedometer to increase your walking. To do the warm-up and cool- down exercises 
before doing the programme to lessen stiffness.  
36 Exercise is important in her life and should not only depend on medication. 
39 Exercise is important and can use walking to increase exercise level. 
42 Exercise can lessen cholesterol level and increase fitness. Exercise helps control lifestyle diseases. 
50 How exercise is important for your heart.  
52 Using the pedometer to exercise. 
55 How exercise is helpful for health. 
57 Healthy eating, not to stress too much, exercise to help your heart. 
58 Exercise makes you stronger. It helps to make your legs stronger and help with the blood flow. If you 
live well, not smoking and drinking it helps to protect your heart. 
61 Warm-up and cool-down exercises. Exercise is important for health. 
62 Warm-up and cool-down exercises very helpful to prepare to exercise. Learning how exercise can 
helps to reduce heart problems. The risk factors of heart disease. 
63 Exercises are important to improve your health and it made her feel good.  
64 Exercise can influence viral load and exercise is important for health. 
72 Exercise is very healthy and can protect you from other types of diseases e.g. heart problems. How 
exercise can affect cholesterol and how exercise can protect against stroke and heart problems by 
lessening cholesterol. 
73 It is good and healthy to do exercise. 
80 Exercise helps for circulation, smoking and how it relates to circulatory problems. 
83 Exercise is important to improve one's health. How to do cool- down and warm-up exercises.  
84 The function of the heart and influences of doing exercise. Effects of smoking. 
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Table 50.2: Participants’ Feedback Regarding what they Enjoyed most about the 
Education and Home-Based Walking Programme 
 
ID Participants’ Feedback 
1 Exercises; warm-up and cool-down. Having a pedometer and a booklet to record findings. Monthly 
sessions with education. 
5 Having to do exercise increased her friends. She met people when she exercised and known friends 
exercised with patient. This gave patient support. 
6 The exercises and walking programme. Being able to walk with family. 
8 Everything: walking and face to face sessions 
9 The walking encouraged her to exercise and get out of the house. Before she was just at home the 
whole time. 
14 Exercises made her feel well physically. 
16 The exercises especially the warm up and cool down exercises. 
27 Receiving a SMS to remind regarding exercise as this indicated that someone cared about you. 
Having a pedometer and the walking programme. 
29 Exercises and walking with the pedometer. 
30 Enjoyed everything 
32 The exercising especially learning the warm-up and cool-down exercises. Now able to walk far. 
35 Having a pedometer and being able to monitor the steps that you take per day and to try and walk 
more to increase steps. 
36 Stretches improved mobility in legs 
39 Walking programme and warm-up and cool-down exercise. The programme reminded her that 
exercise is important. 
42 The walking programme. 
50 Walking programme as she lost weight. 
52 The exercises. 
55 Exercise and monthly sessions were helpful and enjoyable. 
57 Contact session for motivation, receiving SMS for motivation, physiotherapist was friendly. 
58 It helped to keep her focused on the importance of exercising even though she had a lot of problems 
in her family and being unemployed. It helped her to decrease her stress level by walking and using 
the pedometer.  
61 Knowledge that he gained during the programme. Knowledge about exercise, weight, warm-up and 
cool-down exercise. 
62 Having the pedometer to self-monitor activity level and see if she was improving or not doing so well. 
Also motivated her to keep up with her volleyball.  
63 Her tiredness is less since doing exercise and she did not get flu during this period. Her body is feeling 
better. She enjoyed the warm-up and cool-down exercises and walking with the pedometer. With the 
pedometer she was able to see her steps and adjust her walking. 
64 Having a pedometer and activity booklet. 
72 Exercise is important to live a healthy lifestyle. Enjoyed the exercises and found it helpful to lessen her 
stress levels. 
73 Walking programme 
80 Motivation received to exercise, and information on effect of exercise on blood pressure. 
83 The exercises; warm-up and cool-down and walking with pedometer. 
84 Exercises and motivation received. 
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APPENDIX 51 
ABSTRACTS OF JOURNAL ARTICLES SUBMITTED FOR PUBLICATION 
 
Authors: Roos R, Myezwa H, Van Aswegen H, Musenge E 
 
Title: Physical activity and risk factor screening for ischaemic heart disease in South African 
individuals living with HIV. 
 
Abstract: 
Individuals living with HIV are at risk of developing chronic lifestyle diseases such as ischaemic 
heart disease (IHD). Physical inactivity is a well known modifiable risk factor for IHD. Currently, the 
level of ambulation physical activity in individuals living with HIV in a South African context is not 
known. The aim of this study was to assess the physical activity levels and other risk factors for 
IHD in individuals living with HIV on antiretroviral therapy. An observational study was conducted 
from October 2010 to June 2012 at a large outpatient clinic in Johannesburg, South Africa. Two 
hundred and five individuals who were on antiretroviral therapy for 6-12 months were screened. 
Physical activity was measured with the Yamax SW200 pedometer over a seven day period.  
Physical activity of the sample was reduced at 7 673.2 (±4 017.7) steps per day with women 
walking less than men [6 993.3 (±3 462.6) and 10 076.3 (±4885.6) respectively]. Body mass index 
was increased to 25.6 (±1.4) kg/m2 with women noted to be overweight [26.6 (±5.5) kg/m2]. 
Independent predictors of being overweight were systolic blood pressure, waist and hip 
circumference, CD4 count and daily fruit and vegetable intake. Smoking was less common in the 
study population with 16.1% of the sample being current smokers and former smokers at 25.9%. 
Individuals’ mean perceived stress levels were 19.2 (±7.8) on the Cohen’s Perceived Stress Scale.  
The physical activity level of individuals living with HIV requires modification to assist with reducing 
risk factors of IHD.  
 
Keywords: physical activity level, HIV, ischemic heart disease  
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Authors: Roos R, Myezwa H, Van Aswegen H 
 
Title: Physical activity levels and activity preferences of a cohort of South African individuals living 
with HIV. 
 
Abstract: 
Physical inactivity is a risk factor for many lifestyle diseases. It is still poorly understood in 
individuals living with HIV. The aims of this study were to evaluate the physical activity levels of 
individuals living with HIV on antiretroviral therapy (ARV) and to assess their physical activity 
preferences. An observation study was done from October 2010 to June 2012 at a large urban HIV 
clinic in Johannesburg where 205 individuals were consecutively sampled. Physical activity was 
assessed with the Yamax SW200 pedometer over a seven day period. The mean age of the 
sample was 38 (±9.5) years, CD4 count 285.1 (±157.9) and time on ARV 8.7 (±2.3) months.  
Physical activity of the sample was reduced at 7 673.2 (± 4 017.7) steps per day with women 
walking less than men [6 993.3 (±3 462.6) and 10 076.3 (±4 885.6) respectively]. Eight individuals 
(3.9%) did formal sporting activities and a hundred and twenty three individuals (60%) did some 
form of exercise. Walking (45.5%, n=56) and running (26.8%, n=33) were most frequently reported. 
Physical inactivity was present in the majority of the sample and interventions including activity 
preferences of individuals could be strategies to address this health concern. 
 
Keywords: Physical activity, pedometer, activity preferences, HIV  
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Authors: Roos R, Myezwa H, Van Aswegen H, Musenge E 
 
Title: Effects of an education and home-based pedometer walking programme on ischemic heart 
disease risk factors in people infected with the human immunodefiency virus: a randomised trial. 
 
Abstract: 
People infected with the human immunodeficiency virus (HIV) are at an increased risk of 
developing ischemic heart disease (IHD); however the effects of an education and home-based 
pedometer walking programme on risk factors of IHD are not known. We conducted a 12 month 
randomised study of an education and home-based pedometer walking programme in 84 HIV-
infected individuals with risk factors of IHD. Pedometer step count of the control and intervention 
group improved significantly (p=0.03 respectively) at six months but was not significant at 12 
months (p=0.33 and p=0.21). Significant between-group effects were observed in six-minute walk 
test distance (p=0.01), waist: hip ratio (p<0.00), glucose (p<0.00) and high density lipoprotein 
(p=0.01) over the 12 month period. The programme did not result in change in high sensitivity C-
reactive protein as it was associated with perceived stress (r=0.23; p=0.03), weight (r=0.28; 
p=0.01), body mass index (r=0.35; p<0.00), waist (r=0.28; p=0.01) and hip circumferences (r=0.28; 
p=0.01). Multivariate generalised estimation equation analysis demonstrated an inverse 
association between interaction and perceived stress (log B = -0.01; 95% CI: -0.02, -0.01; p <0.00) 
and body mass index (log B = -0.02: 95% CI: -0.03, -0.002; p = 0.02) at group level. An education 
and home-based pedometer walking programme improves physical activity levels and beneficial 
changes in other IHD risk factors were noted.   
 
Keywords: HIV, pedometer walking programme, heart disease  
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Authors: Roos R, Myezwa H, Van Aswegen H 
 
Title: “Not easy at all but I am trying”: Barriers and facilitators to physical activity in a South African 
cohort of PLWHA participating in a home-based pedometer walking programme. 
 
Abstract:  
The promotion of physical activity is encouraged in people living with HIV (PLWHA) as a means of 
promoting wellness and health. Adherence to programmes that promote exercise are often 
reduced and a home-based programme are suggested to improve adherence. This study 
investigated the personal and environmental factors that cause barriers and facilitators of physical 
activity in a home-based pedometer walking programme as a means of highlighting adherence 
challenges.  An observational study nested in a randomised controlled trial was conducted in a 
cohort of South African PLWHA on antiretroviral therapy over a six month period. Descriptive 
analysis and qualitative content analysis of 42 participants that underwent physical activity 
modification assisted with data review. The mean age of the sample was 38.7 (±8.9) years, 
consisted mostly of women (n=35; 83.3%) who were employed (n=19; 45.2%) but earning very 
little (less than R500 per month) and often single or widowed (n=23; 54.8%). Barriers to physical 
activity identified included physical complaints e.g. low energy levels and psychological complaints 
e.g. stress levels, family responsibility e.g. being primary care givers, the physical environment e.g. 
adverse weather conditions, social environment e.g. domestic abuse and crime and workplace e.g. 
being in a sedentary job. Facilitators of physical activity included support and encouragement from 
friends and family, religious practices during worship and community environment e.g. having 
access to parks and sport fields. The study is of benefit as it highlights personal and environmental 
factors that need to be considered when developing or implementing a home-based walking 
programme in PLWHA.  
Keywords: physical activity, adherence, HIV 
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Authors: Roos R, Myezwa H, Van Aswegen H 
 
Title: ‘If you have a problem with your heart, you have a problem with your life’: Self-perception 
and behaviour in relation to the risk of ischaemic heart disease in people living with HIV. 
 
Abstract: 
Ischaemic heart disease (IHD) is a global health problem and specifically relevant in the African 
context as the presence of risk factors for IHD is increasing due to the high prevalence of the 
human immunodeficiency virus (HIV). People living with HIV are at an increased risk for IHD due to 
increased longevity, treatment specific causes and viral effects. This study determined the self-
perception and behaviour in relation to the risk for IHD in a cohort of South African PLWHA. A 
qualitative study design using semi-structured interviews with a card sort technique was used to 
gather data from thirty individuals at an HIV clinic in Johannesburg, South Africa. Descriptive 
analysis and an inductive approach with conventional content analysis were done to generate the 
findings. The median age of the cohort was 36.5 (31.8 – 45.0) years and consisted mostly of 
women (n = 25; 83.3%) who were employed (n = 17; 56.7%) and supporting dependents (n = 26; 
86.7%). The majority of participants (n = 15; 50%) did not perceive themselves at risk of IHD due 
to reporting having adequate coping behaviour, living a healthy lifestyle and being healthy since 
initiating highly active antiretroviral therapy. Twelve (40%) participants did however because they 
experienced physical symptoms and had poor behaviour consisting of a poor diet, elevated stress 
levels and lack of exercise. Three (10%) participants were unsure of their risk for IHD. Knowledge 
and understanding related to IHD, insight into their own risk for IHD and health character in an HIV 
context were identified as three prominent themes, emerging from the data. This study highlights 
that participants did not perceive themselves to be at risk of IHD due to their HIV status or 
antiretroviral management. Education strategies are required in people living with HIV to inform 
their personal risk perception for IHD which may in turn influence behaviour changes and 
prevention of IHD.   
 
Keywords: ischaemic heart disease; HIV; risk perception. 
 
 
 
 
 
 
